Equitable Financial Life Insurance 10-K 28 Mar 19 2018 FY Annual report Financial data

DOCUMENT AND ENTITY INFORMATION

DOCUMENT AND ENTITY INFORMATION - USD ($)	12 Months Ended
	Dec. 31, 2018	Mar. 27, 2019	Jun. 30, 2018
Document and Entity Information [Abstract]
Document Type	10-K
Document Period End Date	Dec. 31, 2018
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2018
Amendment Flag	false
Entity Registrant Name	AXA EQUITABLE LIFE INSURANCE CO
Entity Central Index Key	0000727920
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Common Stock, Shares Outstanding		2,000,000
Entity Public Float			$ 0
Entity Shell Company	false

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Investments:
Fixed maturities available for sale, at fair value (amortized cost of $42,492 and $34,831)	$ 41,915	$ 36,358
Mortgage loans on real estate (net of valuation allowance of $7 and $8)	11,818	10,935
Real estate held for production of income	52	390
Policy loans	3,267	3,315
Other equity investments	1,144	1,264
Trading securities, at fair value	15,166	12,277
Other invested assets	1,554	1,830
Total investments	74,916	66,369
Cash and cash equivalents	2,622	2,400
Cash and securities segregated, at fair value	0	9
Deferred policy acquisition costs	5,011	4,492
Amounts due from reinsurers	3,124	5,079
Loans to affiliates	600	703
GMIB reinsurance contract asset, at fair value	1,991	10,488
Current and deferred income taxes	438	0
Other assets	2,763	4,018
Assets of disposed subsidiary	0	9,835
Separate Accounts assets	108,487	122,537
Total Assets	199,952	225,930
LIABILITIES
Policyholders' account balances	46,403	43,805
Future policy benefits and other policyholders' liabilities	29,808	29,070
Broker-dealer related payables	69	430
Securities sold under agreements to repurchase	573	1,887
Amounts due to reinsurers	113	134
Long-term debt	0	203
Current and deferred income taxes	0	1,550
Other liabilities	1,460	1,242
Liabilities of disposed subsidiary	0	4,954
Separate Accounts liabilities	108,487	122,537
Total Liabilities	187,485	205,812
Redeemable noncontrolling interest:
Continuing operations	39	24
Disposed subsidiary	0	602
Redeemable noncontrolling interest	39	626
Commitments and contingent liabilities
Equity attributable to AXA Equitable:
Common stock, $1.25 par value; 2,000,000 shares authorized, issued and outstanding	2	2
Capital in excess of par value	7,807	6,859
Retained earnings	5,098	8,938
Accumulated other comprehensive income (loss)	(491)	598
Total equity attributable to AXA Equitable	12,416	16,397
Noncontrolling interest	12	3,095
Total Equity	12,428	19,492
Total Liabilities, Redeemable Noncontrolling Interest and Equity	199,952	225,930
Loans from affiliates	$ 572	$ 0

CONSOLIDATED BALANCE SHEETS (PA

CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Fixed maturities available for sale, at fair value (amortized cost of $42,492 and $34,831)	$ 42,492	$ 34,988
Mortgage loans on real estate (net of valuation allowance of $7 and $8)	$ 7	$ 8
Common stock par value (in dollars per share)	$ 1.25	$ 1.25
Common stock authorized (in shares)	2,000,000	2,000,000
Common stock issued (in shares)	2,000,000	2,000,000
Common stock outstanding (in shares)	2,000,000	2,000,000
Fixed maturities
Fixed maturities available for sale, at fair value (amortized cost of $42,492 and $34,831)	$ 42,492	$ 34,831

CONSOLIDATED STATEMENTS OF INCO

CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
REVENUES
Policy charges and fee income	$ 3,523	$ 3,294	$ 3,311
Premiums	862	904	880
Net derivative gains (losses)	(1,010)	894	(1,321)
Net investment income (loss)	2,478	2,441	2,168
Investment gains (losses), net:
Total other-than-temporary impairment losses	(37)	(13)	(65)
Other investment gains (losses), net	41	(112)	83
Total investment gains (losses), net	4	(125)	18
Investment management and service fees	1,029	1,007	951
Other income	65	41	36
Total revenues	6,951	8,456	6,043
BENEFITS AND OTHER DEDUCTIONS
Policyholders’ benefits	3,005	3,473	2,771
Interest credited to policyholders’ account balances	1,002	921	905
Compensation and benefits	422	327	364
Commissions and distribution related payments	620	628	635
Interest expense	34	23	13
Amortization of deferred policy acquisition costs	(431)	(900)	(642)
Other operating costs and expenses	2,918	635	753
Total benefits and other deductions	8,432	6,907	6,083
Income (loss) from continuing operations, before income taxes	(1,481)	1,549	(40)
Income tax (expense) benefit from continuing operations	446	1,210	164
Net income (loss) from continuing operations	(1,035)	2,759	124
Net income (loss) from discontinued operations, net of taxes and noncontrolling interest	114	85	66
Net income (loss)	(921)	2,844	190
Less: net (income) loss attributable to the noncontrolling interest	3	(1)	0
Net income (loss) attributable to AXA Equitable	$ (918)	$ 2,843	$ 190

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended				12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Dec. 31, 2017	Sep. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
COMPREHENSIVE INCOME (LOSS)
Net income (loss)	$ 1,936	$ (509)	$ 1,515	$ 23	$ (921)	$ 2,844	$ 190
Other Comprehensive income (loss) net of income taxes:
Change in unrealized gains (losses), net of reclassification adjustment					(1,230)	625	(233)
Changes in defined benefit plan related items not yet recognized in periodic benefit cost, net of reclassification adjustment					(4)	(5)	(3)
Other comprehensive income (loss) from discontinued operations					0	(18)	17
Total other comprehensive income (loss), net of income taxes					(1,234)	602	(219)
Comprehensive income (loss) attributable to AXA Equitable					$ (2,155)	$ 3,446	$ (29)

CONSOLIDATED STATEMENTS OF EQUI

CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Millions	Total	Parent	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated other comprehensive income (loss) attributable to AXA Equitable	Noncontrolling Interest	Continuing OperationsNoncontrolling Interest	Discontinued OperationsNoncontrolling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of adoption | Accounting Standards Update 2014-09					$ 0
Beginning balance at Dec. 31, 2015			$ 2	$ 5,321	6,955	$ 215		$ 0	$ 3,059
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Capital contribution from parent company				0
Transfer for Deferred tax asset in GMxB Unwind				0
Settlement of intercompany payables in GMxB Unwind				0
Distribution of disposed subsidiary					0
Repurchase of AB Holding Units									(168)
Deconsolidation of real estate joint ventures								0	(384)
Net income (loss) attributable to AXA Equitable	$ 190				190			0	491
Net earnings (loss) attributable to redeemable noncontrolling interests								0
Dividend to parent company					(1,050)
Deconsolidation of real estate joint ventures								0	(384)
Consolidation of real estate joint ventures								0
Reclassification of net earnings (loss) attributable to redeemable noncontrolling interests								0
Cumulative effect of adoption of ASU 2018-02, Reclassification of Certain Tax Effects					0	0
Transfer AB Holding Units									0
Other comprehensive income (loss)	(219)					(219)			98
Other				18
Ending balance at Dec. 31, 2016	14,528	$ 11,432	2	5,339	6,095	(4)	$ 3,096	0	3,096
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of adoption | Accounting Standards Update 2014-09					0
Beginning balance at Dec. 31, 2016	14,528	11,432	2	5,339	6,095	(4)	3,096	0	3,096
Beginning balance at Dec. 31, 2016	14,528	11,432	2	5,339	6,095	(4)	3,096	0	3,096
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Capital contribution from parent company				1,500
Transfer for Deferred tax asset in GMxB Unwind				0
Settlement of intercompany payables in GMxB Unwind				0
Distribution of disposed subsidiary					0
Repurchase of AB Holding Units									(158)
Deconsolidation of real estate joint ventures								0	(457)
Net income (loss) attributable to AXA Equitable	2,844				2,843			0	485
Net earnings (loss) attributable to redeemable noncontrolling interests								(1)
Dividend to parent company					0
Deconsolidation of real estate joint ventures								0	(457)
Consolidation of real estate joint ventures								19
Reclassification of net earnings (loss) attributable to redeemable noncontrolling interests								1
Cumulative effect of adoption of ASU 2018-02, Reclassification of Certain Tax Effects					0	0
Transfer AB Holding Units									0
Other comprehensive income (loss)	602								110
Other				20
Ending balance at Dec. 31, 2017	19,492	16,397	2	6,859	8,938	598	3,095	19	3,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cumulative effect of adoption | Accounting Standards Update 2014-09					8
Ending balance at Mar. 31, 2018	18,492
Beginning balance at Dec. 31, 2017	19,492	16,397	2	6,859	8,938	598	3,095	19	3,076
Beginning balance at Dec. 31, 2017	19,492	16,397	$ 2	6,859	8,938	598	3,095	19	3,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Capital contribution from parent company				0
Transfer for Deferred tax asset in GMxB Unwind				1,209
Settlement of intercompany payables in GMxB Unwind				(297)
Distribution of disposed subsidiary					(1,175)
Repurchase of AB Holding Units									0
Deconsolidation of real estate joint ventures								(8)	0
Net income (loss) attributable to AXA Equitable	(921)				(918)			1	0
Net earnings (loss) attributable to redeemable noncontrolling interests								2
Dividend to parent company					(1,672)
Deconsolidation of real estate joint ventures								(8)	0
Consolidation of real estate joint ventures								0
Reclassification of net earnings (loss) attributable to redeemable noncontrolling interests								(2)
Cumulative effect of adoption of ASU 2018-02, Reclassification of Certain Tax Effects					(83)	83
Transfer AB Holding Units	(1,700)								(3,076)
Other comprehensive income (loss)	(1,234)					(1,234)			0
Other				36
Ending balance at Dec. 31, 2018	12,428	$ 12,416		$ 7,807	$ 5,098	$ (491)	$ 12	$ 12	$ 0
Beginning balance at Mar. 31, 2018	$ 18,492

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Net income (loss)	[1]	$ (358)	$ 3,377	$ 686
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances		1,002	921	905
Policy charges and fee income		(3,523)	(3,294)	(3,311)
Net derivative (gains) losses		1,010	(870)	1,337
Investment (gains) losses, net		(3)	125	(16)
Realized and unrealized (gains) losses on trading securities		221	(166)	41
Non-cash long term incentive compensation expense	[2]	218	185	152
Amortization of deferred cost of reinsurance asset		1,882	(84)	159
Other amortization and depreciation	[2]	340	825	614
Cash received on the recapture of captive reinsurance		1,273	0	0
Equity (income) loss from limited partnerships		(120)	(157)	(91)
Changes in:
Net broker-dealer and customer related receivables/payables		838	(278)	608
Reinsurance recoverable	[2]	(390)	(1,018)	(304)
Segregated cash and securities, net		(345)	130	(381)
Capitalization of deferred policy acquisition costs	[2]	(597)	(578)	(594)
Future policy benefits		(284)	1,189	431
Current and deferred income taxes		(556)	(1,174)	(753)
Other, net	[2]	810	486	56
Net cash provided by (used in) operating activities		1,418	(381)	(461)
Proceeds from the sale/maturity/prepayment of:
Fixed maturities, available-for-sale		8,935	9,738	7,154
Mortgage loans on real estate		768	934	676
Short-term investments	[2]	2,315	2,204	2,984
Trading account securities		9,298	9,125	6,271
Real estate joint ventures		139	0	0
Other		190	228	32
Payment for the purchase/origination of:
Fixed maturities, available-for-sale		(11,110)	(12,465)	(7,873)
Mortgage loans on real estate		(1,642)	(2,108)	(3,261)
Trading account securities		(11,404)	(12,667)	(8,691)
Short-term investments	[2]	(1,852)	(2,456)	(3,187)
Other		(170)	(280)	(250)
Cash settlements related to derivative instruments		805	(1,259)	102
Repayments of loans to affiliates		900	0	384
Investment in capitalized software, leasehold improvements and EDP equipment		(115)	(100)	(85)
Purchase of business, net of cash acquired		0	(130)	(21)
Issuance of loans to affiliates		(1,100)	0	0
Cash disposed due to distribution of disposed subsidiary		(672)	0	0
Other, net	[2]	(91)	322	407
Net cash provided by (used in) investing activities		(4,806)	(8,914)	(5,358)
Cash flows from financing activities:
Deposits		9,365	9,334	9,746
Withdrawals		(4,496)	(3,926)	(2,874)
Transfer (to) from Separate Accounts		1,809	1,566	1,202
Change in short-term financings		(26)	53	(69)
Change in collateralized pledged assets		1	710	(677)
Change in collateralized pledged liabilities		(291)	1,108	125
(Decrease) increase in overdrafts payable		3	63	(85)
Additional loans from affiliates		572	0	0
Shareholder dividends paid		(1,672)	0	(1,050)
Repurchase of AB Holding Units		(267)	(220)	(236)
Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds		(472)	120	(137)
Distribution to noncontrolling interest of consolidated subsidiaries		(610)	(457)	(385)
Increase (decrease) in securities sold under agreement to repurchase		(1,314)	(109)	104
(Increase) decrease in securities purchased under agreement to resell		0	0	79
Capital contribution from parent company		0	1,500	0
Other, net		11	(10)	8
Net cash provided by (used in) financing activities		2,613	9,732	5,751
Effect of exchange rate changes on cash and cash equivalents		(12)	22	(10)
Change in cash and cash equivalents		(787)	459	(78)
Cash and cash equivalents, beginning of year		3,409	2,950	3,028
Cash and cash equivalents, end of year		2,622	3,409	2,950
Beginning of year		1,009	1,006	561
End of year			1,009	1,006
Beginning of year		2,400	1,944	2,467
End of year		2,622	2,400	1,944
Cash flows of disposed subsidiary:
Net cash provided by (used in) operating activities		1,137	715	1,041
Net cash provided by (used in) investing activities		(102)	(297)	323
Net cash provided by (used in) financing activities		(1,360)	(437)	(909)
Effect of exchange rate changes on cash and cash equivalents		(12)	22	(10)
Cash and cash equivalents of disposed subsidiary, end of year		0
Supplemental cash flow information:
Interest paid		0	(8)	(11)
Income taxes (refunded) paid		(8)	(33)	613
Non-cash transactions:
(Settlement) issuance of long-term debt		(202)	202	0
Transfer of assets to reinsurer		(604)	0	0
Repayments of loans from affiliates		300	0	0
Assets disposed		9,156	0	0
Liabilities disposed		4,914	0	0
Net assets disposed		4,242	0	0
Cash disposed		672	0	0
Net non-cash disposed		3,570	0	0
Discontinued Operations
Non-cash transactions:
Fair value of assets acquired		0	0	34
Fair value of liabilities assumed		0	0	1
Payables recorded under contingent payment arrangements		$ 0	$ 0	$ 12
[1]	Net income (loss) includes $564 million, $533 million and $496 million in 2018, 2017 and 2016, respectively, of the discontinued operations that are not included in net income (loss) in the Consolidated Statements of Income (Loss).
[2]	Prior period amounts have been reclassified to conform to current period presentation. See Note 20 for further information.

CONSOLIDATED STATEMENTS OF CA_2

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Net (income) loss attributable to the noncontrolling interest					$ 3	$ (1)	$ 0
Alliance Bernstein | Discontinued Operations
Net (income) loss attributable to the noncontrolling interest	$ (154)	$ (118)	$ (310)	$ (231)	$ (564)	$ (533)	$ (496)

ORGANIZATION

ORGANIZATION	12 Months Ended
	Dec. 31, 2018
Organization [Abstract]
Organization	ORGANIZATION Consolidation AXA Equitable Life Insurance Company’s (“AXA Equitable” and, collectively with its consolidated subsidiaries, the “Company”) primary business is providing life insurance and employee benefit products to both individuals and businesses. The Company is an indirect, wholly-owned subsidiary of AXA Equitable Holdings, Inc. (“Holdings”). Prior to the closing of the initial public offering of shares of Holdings’ common stock on May 14, 2018 (the “IPO”), Holdings was a wholly-owned subsidiary of AXA S.A. (“AXA”), a French holding company for the AXA Group, a worldwide leader in life, property and casualty, and health insurance and asset management. As of December 31, 2018 , AXA owns approximately 59% of the outstanding common stock of Holdings. In March 2018, AXA contributed its 0.5% minority interest in AXA Financial, Inc. (“AXA Financial”) to Holdings, increasing Holdings’ ownership of AXA Financial to 100% . On October 1, 2018, AXA Financial merged with and into its direct parent, Holdings, with Holdings continuing as the surviving entity (the “AXA Financial Merger”). As a result of the AXA Financial Merger, Holdings assumed all of AXA Financial’s liabilities, including two assumption agreements under which it legally assumed primary liability for certain employee benefit plans of AXA Equitable Life and various guarantees for its subsidiaries. The accompanying consolidated financial statements represent the consolidated results and financial position of AXA Equitable and not the consolidated results and financial position of Holdings. Discontinued Operations In the fourth quarter of 2018, the Company transferred its economic interest in the business of AllianceBernstein Holding L.P. (“AB Holding”), AllianceBernstein L.P. (“ABLP”) and their subsidiaries (collectively, “AB”) to a newly created wholly-owned subsidiary of Holdings (the “AB Business Transfer”). The results of AB are reflected in the Company’s consolidated financial statements as a discontinued operation and, therefore, are presented as Assets of disposed subsidiary, Liabilities of disposed subsidiary on the consolidated balance sheets and Net income (loss) from discontinued operations, net of taxes, on the consolidated statements of income (loss). Intercompany transactions between the Company and AB prior to the AB Business Transfer have been eliminated. Ongoing service transactions will be reported as related party transactions going forward. See Note 19 for information on discontinued operations and transactions with AB. As a result of the AB Business Transfer , we have reassessed the Company's segment structure and concluded that the Company operates as a single reportable segment as information on a more segmented basis is not evaluated by the Chief Operating Decision Maker and as such there is only a single reporting segment.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Significant Accounting Policies	SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions (including normal, recurring accruals) that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. The accompanying consolidated financial statements present the consolidated results of operations, financial condition and cash flows of the Company and its subsidiaries and those investment companies, partnerships and joint ventures in which the Company has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation. Financial results in the historical consolidated financial statements may not be indicative of the results of operations, comprehensive income (loss), financial position, equity or cash flows that would have been achieved had we operated as a separate, standalone entity during the reporting periods presented. We believe that the consolidated financial statements include all adjustments necessary for a fair presentation of the results of operations of the Company. All significant intercompany transactions and balances have been eliminated in consolidation. The years “ 2018 ”, “ 2017 ” and “ 2016 ” refer to the years ended December 31, 2018 , 2017 and 2016 , respectively. Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2014-09: Revenue from Contracts with Customers (Topic 606) This ASU contains new guidance that clarifies the principles for recognizing revenue arising from contracts with customers and develops a common revenue standard for U.S. GAAP. On January 1, 2018, the Company adopted the new revenue recognition guidance on a modified retrospective basis. The impact of the adoption of the new revenue recognition guidance related to the disposed subsidiary resulted in an opening retained earnings adjustment to the Company of $8 million. Adoption did not change the amounts or timing of the Company’s revenue recognition for investment management and advisory fees related to continuing operations. ASU 2016-01: Financial Instruments - Overall (Subtopic 825-10) This ASU provides new guidance related to the recognition and measurement of financial assets and financial liabilities. The new guidance primarily affects the accounting for equity investments, financial liabilities under the fair value option, and presentation and disclosure requirements for financial instruments. The FASB also clarified guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on AFS debt securities. The new guidance requires equity investments in unconsolidated entities, except those accounted for under the equity method, to be measured at fair value through earnings, thereby eliminating the AFS classification for equity securities with readily determinable fair values for which changes in fair value currently were reported in AOCI. On January 1, 2018, the Company adopted the new recognition requirements on a modified retrospective basis for changes in the fair value of AFS equity securities, resulting in no material reclassification adjustment from AOCI to opening retained earnings for the net unrealized gains, net of tax, related to approximately $13 million of common stock securities and eliminated their designation as AFS equity securities. The Company does not currently report any of its financial liabilities under the fair value option. ASU 2016-15: Statement of Cash Flows (Topic 230) This ASU provides new guidance to simplify elements of cash flow classification. The new guidance is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The new guidance requires application of a retrospective transition method. Adoption of this guidance on January 1, 2018, did not have a material impact on the Company’s consolidated financial statements. ASU 2017-07: Compensation - Retirement Benefits (Topic 715) This ASU provides new guidance on the presentation of net periodic pension and post-retirement benefit costs that requires retrospective disaggregation of the service cost component from the other components of net benefit costs on the income statement. On January 1, 2018, the Company adopted the change in the income statement presentation utilizing the practical expedient for determining the historical components of net benefit costs, resulting in no material impact to the consolidated financial statements. In addition, no changes to the Company’s capitalization policies with respect to benefit costs resulted from the adoption of the new guidance. ASU 2017-09: Compensation - Stock Compensation (Topic 718) This ASU provides clarity and reduces both 1) diversity in practice and 2) cost and complexity when applying guidance in Topic 718, Compensation - Stock Compensation, to a change to the terms or conditions of a share-based payment award. Adoption of this amendment on January 1, 2018 did not have a material impact on the Company’s consolidated financial statements. ASU 2018-02: Income Statement - Reporting Comprehensive Income This ASU contains new guidance that permits entities to reclassify to retained earnings tax effects “stranded” in AOCI resulting from the change in federal tax rate enacted by the Tax Cuts and Jobs Act (the “Tax Reform Act”) on December 22, 2017. If elected, the stranded tax effects for all items must be reclassified in AOCI, including, but not limited to, AFS securities and employee benefits. The company early adopted the ASU effective October 1, 2018 and recognized the impact in the period of adoption. As a result, the company reclassified stranded effects resulting from the Tax Act of 2017 by decreasing AOCI and increasing retained earnings by $83 million. ASU 2018-14: Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20) Description Effect on the Financial Statement or Other Significant Matters This ASU improves the effectiveness of disclosures related to defined benefit plans in the notes to the financial statements. The amendments in this ASU remove disclosures that are no longer considered cost beneficial, clarify the specific requirements of disclosures, and add new, relevant disclosure requirements. Effective for the year ended December 31, 2018 the Company early adopted new guidance that amends the disclosure guidance for employee benefit plans, applied on a retrospective basis to all periods presented. See Note 13 for additional information regarding the Company’s employee benefit plans. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-17: Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. Effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. All entities are required to apply the amendments in this update retrospectively with a cumulative-effect adjustment to retained earnings at the beginning of the earliest period presented. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. ASU 2018-13: Fair Value Measurement (Topic 820) This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU impact the disclosure requirements in Topic 820, including the removal, modification and addition to existing disclosure requirements. Effective for fiscal years beginning after December 15, 2019. Early adoption is permitted, with the option to early adopt amendments to remove or modify disclosures, with full adoption of additional disclosure requirements delayed until the stated effective date. Amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively. Management currently is evaluating the impact of the guidance on the Company’s financial statement disclosures but has concluded that this guidance will not impact the Company’s consolidated financial position or results of operations. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12: Financial Services - Insurance (Topic 944) This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary update, cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred acquisition costs. The ASU simplifies the amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. Expanded footnote disclosures. The ASU requires additional disclosures including disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, MRBs, separate account liabilities and deferred acquisition costs. Companies will also be required to disclose information about significant inputs, judgements, assumptions and methods used in measurement. Effective date for public business entities for fiscal years and interim periods with those fiscal years, beginning after December 31, 2020. Early adoption is permitted. For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for deferred acquisition costs. For MRBs, the ASU should be applied retrospectively as of the earliest period presented by a retrospective application to all prior periods. For deferred acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. The Company has formed a project implementation team to work on compiling all significant information needed to assess the impact of the new guidance, including changes to system requirements and internal controls. The Company expects adoption of the ASU will have a significant impact on its consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-07 : Compensation - Stock Compensation (Topic 718) This ASU contains new guidance that largely aligns the accounting for share-based payment awards issued to employees and non-employees. Effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods, with early adoption permitted. The Company has granted share-based payment awards only to employees as defined by accounting guidance and does not expect this guidance will have a material impact on its consolidated financial statements. ASU 2017-12: Derivatives and Hedging (Topic 815) The amendments in this ASU better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results. Effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years, with early adoption permitted. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption. Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements. ASU 2017-08 : Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20) This ASU requires certain premiums on callable debt securities to be amortized to the earliest call date and is intended to better align interest income recognition with the manner in which market participants price these instruments. Effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted and is to be applied on a modified retrospective basis. Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements. ASU 2016-13 : Financial Instruments - Credit Losses (Topic 326) This ASU contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. These amendments should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements. Although early adoption is permitted, the Company expects to adopt ASU 2016-13 when it becomes effective for the Company on January 1, 2020. ASU 2016-02: Leases (Topic 842) This ASU contains revised guidance to lease accounting that will require lessees to recognize on the balance sheet a “right-of-use” asset and a lease liability for virtually all lease arrangements, including those embedded in other contracts. Lessor accounting will remain substantially unchanged from the current model but has been updated to align with certain changes made to the lessee model. Effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, for public business entities. Early application is permitted. Lessees and lessors are required to apply a modified retrospective transition approach, which includes optional practical expedients that entities may elect to apply. In July 2018, the FASB issued ASU 2018-11 which allows for an additional transition method. The Company will adopt the standard utilizing the additional transition method, which allows entities to initially apply the new leases standard at the adoption date. The Company adopted ASU 2016-02, as well as other related clarifications and interpretive guidance issued by the FASB effective January 1, 2019. The Company has identified its significant existing leases, which primarily include real estate leases for office space, that will be impacted by the new guidance. The Company’s adoption of this guidance is expected to result in a material impact on the consolidated balance sheets, however it will not have a material impact on the Consolidated Statement of Income (Loss). The Company’s adoption of this guidance will result in the recognition, as of January 1, 2019, of additional right of use (RoU) operating lease assets ranging from $300 million to $400 million and operating lease liabilities ranging from $400 million to $500 million, respectively. The adoption of this standard will not have a significant impact on opening retained earnings. Investments The carrying values of fixed maturities classified as available-for-sale (“AFS”) are reported at fair value. Changes in fair value are reported in other comprehensive income (“OCI”), net of policy related amounts and deferred income taxes. The amortized cost of fixed maturities is adjusted for impairments in value deemed to be other than temporary which are recognized in Investment gains (losses), net. The redeemable preferred stock investments that are reported in fixed maturities include real estate investment trusts (“REIT”), perpetual preferred stock and redeemable preferred stock. These securities may not have a stated maturity, may not be cumulative and do not provide for mandatory redemption by the issuer. The Company determines the fair values of fixed maturities and equity securities based upon quoted prices in active markets, when available, or through the use of alternative approaches when market quotes are not readily accessible or available. These alternative approaches include matrix or model pricing and use of independent pricing services, each supported by reference to principal market trades or other observable market assumptions for similar securities. More specifically, the matrix pricing approach to fair value is a discounted cash flow methodology that incorporates market interest rates commensurate with the credit quality and duration of the investment. The Company’s management, with the assistance of its investment advisors, monitors the investment performance of its portfolio and reviews AFS securities with unrealized losses for other-than-temporary impairments (“OTTI”). Integral to this review is an assessment made each quarter, on a security-by-security basis, by the Company’s Investments Under Surveillance (“IUS”) Committee, of various indicators of credit deterioration to determine whether the investment security is expected to recover. This assessment includes, but is not limited to, consideration of the duration and severity of the unrealized loss, failure, if any, of the issuer of the security to make scheduled payments, actions taken by rating agencies, adverse conditions specifically related to the security or sector, the financial strength, liquidity and continued viability of the issuer. If there is no intent to sell or likely requirement to dispose of the fixed maturity security before its recovery, only the credit loss component of any resulting OTTI is recognized in income (loss) and the remainder of the fair value loss is recognized in OCI. The amount of credit loss is the shortfall of the present value of the cash flows expected to be collected as compared to the amortized cost basis of the security. The present value is calculated by discounting management’s best estimate of projected future cash flows at the effective interest rate implicit in the debt security at the date of acquisition. Projections of future cash flows are based on assumptions regarding probability of default and estimates regarding the amount and timing of recoveries. These assumptions and estimates require use of management judgment and consider internal credit analyses as well as market observable data relevant to the collectability of the security. For mortgage and asset-backed securities, projected future cash flows also include assumptions regarding prepayments and underlying collateral value. Real estate held for the production of income is stated at depreciated cost less valuation allowances. Depreciation of real estate held for production of income is computed using the straight-line method over the estimated useful lives of the properties, which generally range from 40 to 50 years. Policy loans represent funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in net investment income at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Partnerships, investment companies and joint venture interests that the Company has control of and has an economic interest in or those that meet the requirements for consolidation under accounting guidance for consolidation of VIEs are consolidated. Those that the Company does not have control of and does not have a majority economic interest in and those that do not meet the VIE requirements for consolidation are reported on the equity method of accounting and are reported in other equity investments. The Company records its interests in certain of these partnerships on a month or one quarter lag. Trading securities, which include equity securities and fixed maturities, are carried at fair value based on quoted market prices, with realized and unrealized gains (losses) reported in net investment income (loss) in the statements of Net income (loss). Corporate owned life insurance (“COLI”) has been purchased by the Company and certain subsidiaries on the lives of certain key employees and the Company and these subsidiaries are named as beneficiaries under these policies. COLI is carried at the cash surrender value of the policies. At December 31, 2018 , 2017 and 2016 the carrying value of COLI was $873 million, $911 million and $892 million, respectively, and is reported in Other invested assets in the consolidated balance sheets. Cash and cash equivalents includes cash on hand, demand deposits, money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the recorded value is deemed to approximate fair value. All securities owned, including U.S. government and agency securities, mortgage-backed securities, futures and forwards transactions, are reported in the consolidated financial statements on a trade date basis. Derivatives Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, values of securities or commodities, credit spreads, market volatility, expected returns and liquidity. Values can also be affected by changes in estimates and assumptions, including those related to counterparty behavior and non-performance risk used in valuation models. Derivative financial instruments generally used by the Company include equity, currency, and interest rate futures, total return and/or other equity swaps, interest rate swaps and floors, swaptions, variance swaps and equity options, all of which may be exchange-traded or contracted in the over-the-counter market. All derivative positions are carried in the consolidated balance sheets at fair value, generally by obtaining quoted market prices or through the use of valuation models. Freestanding derivative contracts are reported in the consolidated balance sheets either as assets within “Other invested assets” or as liabilities within “Other liabilities”. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related Credit Support Annex (“CSA”) have been executed. The Company uses derivatives to manage asset/liability risk and has designated some of those economic relationships under the criteria to qualify for hedge accounting treatment. All changes in the fair value of the Company’s freestanding derivative positions not designated to hedge accounting relationships, including net receipts and payments, are included in “Net derivative gains (losses)” without considering changes in the fair value of the economically associated assets or liabilities. The Company is a party to financial instruments and other contracts that contain “embedded” derivative instruments. At inception, the Company assesses whether the economic characteristics of the embedded instrument are “clearly and closely related” to the economic characteristics of the remaining component of the “host contract” and whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. When those criteria are satisfied, the resulting embedded derivative is bifurcated from the host contract, carried in the consolidated balance sheets at fair value, and changes in its fair value are recognized immediately and captioned in the consolidated statements of income (loss) according to the nature of the related host contract. For certain financial instruments that contain an embedded derivative that otherwise would need to be bifurcated and reported at fair value, the Company instead may elect to carry the entire instrument at fair value. Securities Repurchase and Reverse Repurchase Agreements Securities repurchase and reverse repurchase transactions involve the temporary exchange of securities for cash or other collateral of equivalent value, with agreement to redeliver a like quantity of the same or similar securities at a future date prior to maturity at a fixed and determinable price. Transfers of securities under these agreements to repurchase or resell are evaluated by the Company to determine whether they satisfy the criteria for accounting treatment as secured borrowing or lending arrangements. Agreements not meeting the criteria would require recognition of the transferred securities as sales or purchases with related forward repurchase or resale commitments. All of the Company’s securities repurchase transactions are accounted for as collateralized borrowings with the related obligations distinctly captioned in the consolidated balance sheets. Earnings from investing activities related to the cash received under the Company’s securities repurchase arrangements are reported in the consolidated statements of income (loss) as “Net investment income” and the associated borrowing cost is reported as “Interest expense.” The Company has not actively engaged in securities reverse repurchase transactions. Commercial and Agricultural Mortgage Loans on Real Estate Mortgage loans are stated at unpaid principal balances, net of unamortized discounts and valuation allowances. Valuation allowances are based on the present value of expected future cash flows discounted at the loan’s original effective interest rate or on its collateral value if the loan is collateral dependent. However, if foreclosure is or becomes probable, the collateral value measurement method is used. For commercial and agricultural mortgage loans, an allowance for credit loss is typically recommended when management believes it is probable that principal and interest will not be collected according to the contractual terms. Factors that influence management’s judgment in determining allowance for credit losses include the following: • Loan-to-value ratio – Derived from current loan balance divided by the fair market value of the property. An allowance for credit loss is typically recommended when the loan-to-value ratio is in excess of 100% . In the case where the loan-to-value is in excess of 100% , the allowance for credit loss is derived by taking the difference between the fair market value (less cost of sale) and the current loan balance. • Debt service coverage ratio – Derived from actual operating earnings divided by annual debt service. If the ratio is below 1.0 x, then the income from the property does not support the debt. • Occupancy – Criteria varies by property type but low or below market occupancy is an indicator of sub-par property performance. • Lease expirations – The percentage of leases expiring in the upcoming 12 to 36 months are monitored as a decline in rent and/or occupancy may negatively impact the debt service coverage ratio. In the case of single-tenant properties or properties with large tenant exposure, the lease expiration is a material risk factor. • Maturity – Mortgage loans that are not fully amortizing and have upcoming maturities within the next 12 to 24 months are monitored in conjunction with the capital markets to determine the borrower’s ability to refinance the debt and/or pay off the balloon balance. • Borrower/tenant related issues – Financial concerns, potential bankruptcy or words or actions that indicate imminent default or abandonment of property. • Payment status (current vs. delinquent) – A history of delinquent payments may be a cause for concern. • Property condition – Significant deferred maintenance observed during the lenders annual site inspections. • Other – Any other factors such as current economic conditions may call into question the performance of the loan. Mortgage loans also are individually evaluated quarterly by the Company’s IUS Committee for impairment, including an assessment of related collateral value. Commercial mortgages 60 days or more past due and agricultural mortgages 90 days or more past due, as well as all mortgages in the process of foreclosure, are identified as problem mortgages. Based on its monthly monitoring of mortgages, a class of potential problem mortgages are also identified, consisting of mortgage loans not currently classified as problem mortgages but for which management has doubts as to the ability of the borrower to comply with the present loan payment terms and which may result in the loan becoming a problem or being restructured. The decision whether to classify a performing mortgage loan as a potential problem involves significant subjective judgments by management as to likely future industry conditions and developments with respect to the borrower or the individual mortgaged property. For problem mortgage loans, a valuation allowance is established to provide for the risk of credit losses inherent in the lending process. The allowance includes loan specific reserves for mortgage loans determined to be non-performing as a result of the loan review process. A non-performing loan is defined as a loan for which it is probable that amounts due according to the contractual terms of the loan agreement will not be collected. The loan-specific portion of the loss allowance is based on the Company’s assessment as to ultimate collectability of loan principal and interest. Valuation allowances for a non-performing loan are recorded based on the present value of expected futur

INVESTMENTS

INVESTMENTS	12 Months Ended
	Dec. 31, 2018
Investments, Debt and Equity Securities [Abstract]
Investments	INVESTMENTS Fixed Maturities The following tables provide information relating to fixed maturities classified as AFS. As a result of the adoption of “Financial Instruments - Recognition and Measurement of Financial Assets and Financial Liabilities” (ASU 2016-01) on January 1, 2018 (see Note 2 ), equity securities are no longer classified and accounted for as available-for-sale securities. Available-for-Sale Securities by Classification Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value OTTI in AOCI (4) (in millions) December 31, 2018: Fixed Maturities: Corporate (1) $ 26,690 $ 385 $ 699 $ 26,376 $ — U.S. Treasury, government and agency 13,646 143 454 13,335 — States and political subdivisions 408 47 1 454 — Foreign governments 515 17 13 519 — Residential mortgage-backed (2) 193 9 — 202 — Asset-backed (3) 600 1 11 590 2 Redeemable preferred stock 440 16 17 439 — Total at December 31, 2018 $ 42,492 $ 618 $ 1,195 $ 41,915 $ 2 December 31, 2017: Fixed Maturities: Corporate (1) $ 20,596 $ 942 $ 56 $ 21,482 $ — U.S. Treasury, government and agency 12,644 676 185 13,135 — States and political subdivisions 414 67 — 481 — Foreign governments 387 27 5 409 — Residential mortgage-backed (2) 236 15 — 251 — Asset-backed (3) 93 3 — 96 2 Redeemable preferred stock 461 44 1 504 — Total Fixed Maturities 34,831 1,774 247 36,358 2 Equity securities 157 — — 157 — Total at December 31, 2017 $ 34,988 $ 1,774 $ 247 $ 36,515 $ 2 ____________ (1) Corporate fixed maturities include both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Amounts represent OTTI losses in AOCI, which were not included in income (loss) in accordance with current accounting guidance. The contractual maturities of AFS fixed maturities at December 31, 2018 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Contractual Maturities of Available-for-Sale Fixed Maturities Amortized Cost Fair Value (in millions) December 31, 2018: Due in one year or less $ 2,085 $ 2,090 Due in years two through five 8,087 8,141 Due in years six through ten 14,337 14,214 Due after ten years 16,750 16,239 Subtotal 41,259 40,684 Residential mortgage-backed securities 193 202 Asset-backed securities 600 590 Redeemable preferred stock 440 439 Total at December 31, 2018 $ 42,492 $ 41,915 The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities for the years ended December 31, 2018 , 2017 and 2016 : For the Years Ended December 31, 2018 2017 2016 (in millions) Proceeds from sales $ 7,136 $ 7,232 $ 4,324 Gross gains on sales $ 145 $ 98 $ 111 Gross losses on sales $ (103 ) $ (211 ) $ (58 ) Total OTTI $ (37 ) $ (13 ) $ (65 ) Non-credit losses recognized in OCI — — — Credit losses recognized in net income (loss) $ (37 ) $ (13 ) $ (65 ) The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts: Fixed Maturities - Credit Loss Impairments 2018 2017 (in millions) Balances at January 1, $ (10 ) $ (190 ) Previously recognized impairments on securities that matured, paid, prepaid or sold 1 193 Recognized impairments on securities impaired to fair value this period (1) — — Impairments recognized this period on securities not previously impaired (37 ) (13 ) Additional impairments this period on securities previously impaired — — Increases due to passage of time on previously recorded credit losses — — Accretion of previously recognized impairments due to increases in expected cash flows — — Balances at December 31, $ (46 ) $ (10 ) ____________ (1) Represents circumstances where the Company determined in the current period that it intends to sell the security or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost. Net unrealized investment gains (losses) on fixed maturities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated: As of December 31, 2018 2017 (in millions) AFS Securities: Fixed maturities: With OTTI loss $ — $ 1 All other (577 ) 1,526 Net Unrealized Gains (Losses) $ (577 ) $ 1,527 Changes in net unrealized investment gains (losses) recognized in AOCI include reclassification adjustments to reflect amounts realized in Net income (loss) for the current period that had been part of OCI in earlier periods. The tables that follow below present a roll-forward of net unrealized investment gains (losses) recognized in AOCI, split between amounts related to fixed maturities on which an OTTI loss has been recognized and all other: Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2018 $ 1 $ 1 $ (1 ) $ (5 ) $ (4 ) Net investment gains (losses) arising during the period (1 ) — — — (1 ) Reclassification adjustment: Included in Net income (loss) — — — — — Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — (1 ) — — (1 ) Deferred income taxes — — — 5 5 Policyholders’ liabilities — — 1 — 1 Balance, December 31, 2018 $ — $ — $ — $ — $ — Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2017 $ 19 $ (1 ) $ (10 ) $ (3 ) $ 5 Net investment gains (losses) arising during the period (18 ) — — — (18 ) Reclassification adjustment: Included in Net income (loss) — — — — — Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — 2 — — 2 Deferred income taxes — — — (2 ) (2 ) Policyholders’ liabilities — — 9 — 9 Balance, December 31, 2017 $ 1 $ 1 $ (1 ) $ (5 ) $ (4 ) ____________ (1) Represents “transfers in” related to the portion of OTTI losses recognized during the period that were not recognized in income (loss) for securities with no prior OTTI loss. All Other Net Unrealized Investment Gains (Losses) in AOCI Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2018 $ 1,526 $ (315 ) $ (232 ) $ (300 ) $ 679 Net investment gains (losses) arising during the period (2,098 ) — — — (2,098 ) Reclassification adjustment: Included in Net income (loss) (5 ) — — — (5 ) Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — 354 — — 354 Deferred income taxes (2) — — — 425 425 Policyholders’ liabilities — — 177 — 177 Balance, December 31, 2018 $ (577 ) $ 39 $ (55 ) $ 125 $ (468 ) Balance, January 1, 2017 $ 428 $ (104 ) $ (188 ) $ (47 ) $ 89 Net investment gains (losses) arising during the period 1,085 — — — 1,085 Reclassification adjustment: Included in Net income (loss) 13 — — — 13 Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — (211 ) — — (211 ) Deferred income taxes — — — (253 ) (253 ) Policyholders’ liabilities — — (44 ) — (44 ) Balance, December 31, 2017 $ 1,526 $ (315 ) $ (232 ) $ (300 ) $ 679 ____________ (1) Represents “transfers out” related to the portion of OTTI losses during the period that were not recognized in income (loss) for securities with no prior OTTI loss. (2) Includes a $86 million income tax benefit from the impact of adoption of ASU 2018-02. The following tables disclose the fair values and gross unrealized losses of the 1,471 issues at December 31, 2018 and the 620 issues at December 31, 2017 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated: Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) December 31, 2018: Fixed Maturities: Corporate $ 8,369 $ 306 $ 6,161 $ 393 $ 14,530 $ 699 U.S. Treasury, government and agency 2,636 68 3,154 386 5,790 454 States and political subdivisions — — 19 1 19 1 Foreign governments 109 3 76 10 185 13 Residential mortgage-backed — — 13 — 13 — Asset-backed 558 11 6 — 564 11 Redeemable preferred stock 160 12 31 5 191 17 Total $ 11,832 $ 400 $ 9,460 $ 795 $ 21,292 $ 1,195 December 31, 2017: Fixed Maturities: Corporate $ 2,102 $ 17 $ 1,163 $ 39 $ 3,265 $ 56 U.S. Treasury, government and agency 2,150 6 3,005 179 5,155 185 States and political subdivisions 20 — — — 20 — Foreign governments 11 — 73 5 84 5 Residential mortgage-backed 18 — — — 18 — Asset-backed 7 — 2 — 9 — Redeemable preferred stock 7 — 12 1 19 1 Total $ 4,315 $ 23 $ 4,255 $ 224 $ 8,570 $ 247 The Company’s investments in fixed maturities do not include concentrations of credit risk of any single issuer greater than 10% of the consolidated equity of the Company, other than securities of the U.S. government, U.S. government agencies, and certain securities guaranteed by the U.S. government. The Company maintains a diversified portfolio of corporate securities across industries and issuers and does not have exposure to any single issuer in excess of 0.8% of total investments. The largest exposures to a single issuer of corporate securities held at December 31, 2018 and 2017 were $210 million and $182 million , respectively. Corporate high yield securities, consisting primarily of public high yield bonds, are classified as other than investment grade by the various rating agencies, i.e., a rating below Baa3/BBB- or the National Association of Insurance Commissioners (“NAIC”) designation of 3 (medium investment grade), 4 or 5 (below investment grade) or 6 (in or near default). At December 31, 2018 and 2017 , respectively, approximately $1,228 million and $1,309 million , or 2.9% and 3.8% , of the $42,492 million and $34,831 million aggregate amortized cost of fixed maturities held by the Company were considered to be other than investment grade. These securities had net unrealized (losses) and gains of $(30) million and $5 million at December 31, 2018 and 2017 , respectively. At December 31, 2018 and 2017 , respectively, the $795 million and $224 million of gross unrealized losses of twelve months or more were concentrated in corporate and U.S. Treasury, government and agency securities. In accordance with the policy described in Note 2 , the Company concluded that an adjustment to income for OTTI for these securities was not warranted at either December 31, 2018 or 2017 . At December 31, 2018 , the Company did not intend to sell the securities nor will it likely be required to dispose of the securities before the anticipated recovery of their remaining amortized cost basis. The Company does not originate, purchase or warehouse residential mortgages and is not in the mortgage servicing business. At December 31, 2018 , the carrying value of fixed maturities that were non-income producing for the twelve months preceding that date was $1 million . At December 31, 2018 and 2017 , respectively, the fair value of the Company’s trading account securities was $15,166 million and $12,277 million . Also at December 31, 2018 and 2017 , respectively, trading account securities included the General Account’s investment in Separate Accounts, which had carrying values of $48 million and $49 million . Mortgage Loans The payment terms of mortgage loans may from time to time be restructured or modified. At December 31, 2018 and 2017 , the carrying values of problem commercial mortgage loans on real estate that had been classified as non-accrual loans were $19 million and $19 million , respectively. Valuation Allowances for Mortgage Loans: The change in the valuation allowance for credit losses for commercial mortgage loans during the years ended December 31, 2018 , 2017 and 2016 was as follows: Commercial Mortgage Loans 2018 2017 2016 (in millions) Allowance for credit losses: Beginning Balance, January 1, $ 8 $ 8 $ 6 Charge-offs — — — Recoveries (1 ) — (2 ) Provision — — 4 Ending Balance, December 31, $ 7 $ 8 $ 8 Ending Balance, December 31, Individually Evaluated for Impairment $ 7 $ 8 $ 8 There were no allowances for credit losses for agricultural mortgage loans in 2018 , 2017 and 2016 . The following tables provide information relating to the loan-to-value and debt service coverage ratios for commercial and agricultural mortgage loans at December 31, 2018 and 2017 . The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios Debt Service Coverage Ratio (1) Loan-to-Value Ratio: (2) Greater than 2.0x 1.8x to 2.0x 1.5x to 1.8x 1.2x to 1.5x 1.0x to 1.2x Less than 1.0x Total Mortgage Loans (in millions) December 31, 2018: Commercial Mortgage Loans (1) 0% - 50% $ 780 $ 21 $ 247 $ 24 $ — $ — $ 1,072 50% - 70% 4,908 656 1,146 325 151 — 7,186 70% - 90% 260 — 117 370 98 — 845 90% plus — — — 27 — — 27 Total Commercial Mortgage Loans $ 5,948 $ 677 $ 1,510 $ 746 $ 249 $ — $ 9,130 Agricultural Mortgage Loans (1) 0% - 50% $ 282 $ 147 $ 267 $ 543 $ 321 $ 51 $ 1,611 50% - 70% 112 46 246 379 224 31 1,038 70% - 90% — — — 19 27 — 46 90% plus — — — — — — — Total Agricultural Mortgage Loans $ 394 $ 193 $ 513 $ 941 $ 572 $ 82 $ 2,695 Total Mortgage Loans (1) 0% - 50% $ 1,062 $ 168 $ 514 $ 567 $ 321 $ 51 $ 2,683 50% - 70% 5,020 702 1,392 704 375 31 8,224 70% - 90% 260 — 117 389 125 — 891 90% plus — — — 27 — — 27 Total Mortgage Loans $ 6,342 $ 870 $ 2,023 $ 1,687 $ 821 $ 82 $ 11,825 December 31, 2017: Commercial Mortgage Loans (1) 0% - 50% $ 742 $ — $ 320 $ 74 $ — $ — $ 1,136 50% - 70% 4,088 682 1,066 428 145 — 6,409 70% - 90% 169 110 196 272 50 — 797 90% plus — — 27 — — — 27 Total Commercial Mortgage Loans $ 4,999 $ 792 $ 1,609 $ 774 $ 195 $ — $ 8,369 Agricultural Mortgage Loans (1) 0% - 50% $ 272 $ 149 $ 275 $ 515 $ 316 $ 30 $ 1,557 50% - 70% 111 46 227 359 221 49 1,013 70% - 90% — — — 4 — — 4 90% plus — — — — — — — Total Agricultural Mortgage Loans $ 383 $ 195 $ 502 $ 878 $ 537 $ 79 $ 2,574 Total Mortgage Loans (1) 0% - 50% $ 1,014 $ 149 $ 595 $ 589 $ 316 $ 30 $ 2,693 50% - 70% 4,199 728 1,293 787 366 49 7,422 70% - 90% 169 110 196 276 50 — 801 90% plus — — 27 — — — 27 Total Mortgage Loans $ 5,382 $ 987 $ 2,111 $ 1,652 $ 732 $ 79 $ 10,943 __________ (1) The debt service coverage ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. (2) The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually. The following table provides information relating to the aging analysis of past due mortgage loans at December 31, 2018 and 2017 , respectively: Age Analysis of Past Due Mortgage Loans 30-59 Days 60-89 Days 90 Days or More Total Current Total Financing Receivables Recorded Investment 90 Days or More and Accruing (in millions) December 31, 2018: Commercial $ — $ — $ 27 $ 27 $ 9,103 $ 9,130 $ — Agricultural 18 8 42 68 2,627 2,695 40 Total Mortgage Loans $ 18 $ 8 $ 69 $ 95 $ 11,730 $ 11,825 $ 40 December 31, 2017: Commercial $ 27 $ — $ — $ 27 $ 8,342 $ 8,369 $ — Agricultural 49 3 22 74 2,500 2,574 22 Total Mortgage Loans $ 76 $ 3 $ 22 $ 101 $ 10,842 $ 10,943 $ 22 The following table provides information relating to impaired mortgage loans at December 31, 2018 and 2017 , respectively: Impaired Mortgage Loans Recorded Investment Unpaid Principal Balance Related Allowance Average Recorded Investment (1) Interest Income Recognized (in millions) December 31, 2018: With no related allowance recorded: Commercial mortgage loans - other $ — $ — $ — $ — $ — Agricultural mortgage loans 2 2 — — — Total $ 2 $ 2 $ — $ — $ — With related allowance recorded: Commercial mortgage loans - other $ 27 $ 31 $ (7 ) $ 27 $ — Agricultural mortgage loans — — — — — Total $ 27 $ 31 $ (7 ) $ 27 $ — December 31, 2017: With no related allowance recorded: Commercial mortgage loans - other $ — $ — $ — $ — $ — Agricultural mortgage loans — — — — — Total $ — $ — $ — $ — $ — With related allowance recorded: Commercial mortgage loans - other $ 27 $ 31 $ (8 ) $ 27 $ 2 Agricultural mortgage loans — — — — — Total $ 27 $ 31 $ (8 ) $ 27 $ 2 ____________ (1) Represents a five-quarter average of recorded amortized cost. Derivatives and Offsetting Assets and Liabilities The Company uses derivatives as part of its overall asset/liability risk management primarily to reduce exposures to equity market and interest rate risks. Derivative hedging strategies are designed to reduce these risks from an economic perspective and are all executed within the framework of a “Derivative Use Plan” approved by applicable states’ insurance law. Derivatives are generally not accounted for using hedge accounting, with the exception of Treasury Inflation-Protected Securities (“TIPS”), which is discussed further below. Operation of these hedging programs is based on models involving numerous estimates and assumptions, including, among others, mortality, lapse, surrender and withdrawal rates, election rates, fund performance, market volatility and interest rates. A wide range of derivative contracts are used in these hedging programs, including exchange traded equity, currency and interest rate futures contracts, total return and/or other equity swaps, interest rate swap and floor contracts, bond and bond-index total return swaps, swaptions, variance swaps and equity options, credit and foreign exchange derivatives, as well as bond and repo transactions to support the hedging. The derivative contracts are collectively managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in capital markets. In addition, as part of its hedging strategy, the Company targets an asset level for all variable annuity products at or above a CTE98 level under most economic scenarios (CTE is a statistical measure of tail risk which quantifies the total asset requirement to sustain a loss if an event outside a given probability level has occurred. CTE98 denotes the financial resources a company would need to cover the average of the worst 2% of scenarios.) Derivatives utilized to hedge exposure to Variable Annuities with Guarantee Features The Company has issued and continues to offer variable annuity products with GMxB features. The risk associated with the GMDB feature is that under-performance of the financial markets could result in GMDB benefits, in the event of death, being higher than what accumulated policyholders’ account balances would support. The risk associated with the GMIB feature is that under-performance of the financial markets could result in the present value of GMIB, in the event of annuitization, being higher than what accumulated policyholders’ account balances would support, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. The risk associated with products that have a GMxB derivative features liability is that under-performance of the financial markets could result in the GMxB derivative features’ benefits being higher than what accumulated policyholders’ account balances would support. For GMxB features, the Company retains certain risks including basis, credit spread and some volatility risk and risk associated with actual versus expected actuarial assumptions for mortality, lapse and surrender, withdrawal and policyholder election rates, among other things. The derivative contracts are managed to correlate with changes in the value of the GMxB features that result from financial markets movements. A portion of exposure to realized equity volatility is hedged using equity options and variance swaps and a portion of exposure to credit risk is hedged using total return swaps on fixed income indices. Additionally, the Company is party to total return swaps for which the reference U.S. Treasury securities are contemporaneously purchased from the market and sold to the swap counterparty. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. The Company has also purchased reinsurance contracts to mitigate the risks associated with GMDB features and the impact of potential market fluctuations on future policyholder elections of GMIB features contained in certain annuity contracts issued by the Company. Derivatives utilized to hedge crediting rate exposure on SCS, SIO, MSO and IUL products/investment options The Company hedges crediting rates in the Structured Capital Strategies (“SCS”) variable annuity, Structured Investment Option in the EQUI-VEST variable annuity series (“SIO”), Market Stabilizer Option (“MSO”) in the variable life insurance products and Indexed Universal Life (“IUL”) insurance products. These products permit the contract owner to participate in the performance of an index, ETF or commodity price movement up to a cap for a set period of time. They also contain a protection feature, in which the Company will absorb, up to a certain percentage, the loss of value in an index, ETF or commodity price, which varies by product segment. In order to support the returns associated with these features, the Company enters into derivative contracts whose payouts, in combination with fixed income investments, emulate those of the index, ETF or commodity price, subject to caps and buffers without any basis risk due to market exposures, thereby substantially reducing any exposure to market-related earnings volatility. Derivatives used for General Account Investment Portfolio The Company maintains a strategy in its General Account investment portfolio to replicate the credit exposure of fixed maturity securities otherwise permissible for investment under its investment guidelines through the sale of credit default swaps (“CDSs”). Under the terms of these swaps, the Company receives quarterly fixed premiums that, together with any initial amount paid or received at trade inception, replicate the credit spread otherwise currently obtainable by purchasing the referenced entity’s bonds of similar maturity. These credit derivatives generally have remaining terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net investment income (loss). The Company manages its credit exposure taking into consideration both cash and derivatives based positions and selects the reference entities in its replicated credit exposures in a manner consistent with its selection of fixed maturities. In addition, the Company generally transacts the sale of CDSs in single name reference entities of investment grade credit quality and with counterparties subject to collateral posting requirements. If there is an event of default by the reference entity or other such credit event as defined under the terms of the swap contract, the Company is obligated to perform under the credit derivative and, at the counterparty’s option, either pay the referenced amount of the contract less an auction-determined recovery amount or pay the referenced amount of the contract and receive in return the defaulted or similar security of the reference entity for recovery by sale at the contract settlement auction. To date, there have been no events of default or circumstances indicative of a deterioration in the credit quality of the named referenced entities to require or suggest that the Company will have to perform under these CDSs. The maximum potential amount of future payments the Company could be required to make under these credit derivatives is limited to the par value of the referenced securities which is the dollar or euro-equivalent of the derivative notional amount. The Standard North American CDS Contract (“SNAC”) or Standard European Corporate Contract (“STEC”) under which the Company executes these CDS sales transactions does not contain recourse provisions for recovery of amounts paid under the credit derivative. The Company purchased 30-year TIPS and other sovereign bonds, both inflation linked and non-inflation linked, as General Account investments and enters into asset or cross-currency basis swaps, to result in payment of the given bond’s coupons and principal at maturity in the bond’s specified currency to the swap counterparty in return for fixed dollar amounts. These swaps, when considered in combination with the bonds, together result in a net position that is intended to replicate a dollar-denominated fixed-coupon cash bond with a yield higher than a term-equivalent U.S. Treasury bond. The Company implemented a strategy to hedge a portion of the credit exposure in its General Account investment portfolio by buying protection through a swap. These are swaps on the “super senior tranche” of the investment grade CDX index. Under the terms of these swaps, the Company pays quarterly fixed premiums that, together with any initial amount paid or received at trade inception, serve as premiums paid to hedge the risk arising from multiple defaults of bonds referenced in the CDX index. These credit derivatives have terms of five years or less and are recorded at fair value with changes in fair value, including the yield component that emerges from initial amounts paid or received, reported in Net derivative gains (losses). In 2016 , the Company implemented a program to mitigate its duration gap using total return swaps for which the reference U.S. Treasury securities are sold to the swap counterparty under arrangements economically similar to repurchase agreements. As these transactions result in a transfer of control of the U.S. Treasury securities to the swap counterparty, the Company derecognizes these securities with consequent gain or loss from the sale. Under this program, the Company derecognized approximately $3,905 million of U.S. Treasury securities for which the Company received proceeds of approximately $3,905 million at inception of the total return swap contract. Under the terms of these swaps, the Company retains ongoing exposure to the total returns of the underlying U.S. Treasury securities in exchange for a financing cost. At December 31, 2018 , the aggregate fair value of U.S. Treasury securities derecognized under this program was approximately $3,690 million . Reported in Other invested assets in the Company’s balance sheet at December 31, 2018 is approximately $24 million , representing the fair value of the total return swap contracts. Derivatives used to hedge currency fluctuations on affiliated loans The Company uses foreign exchange derivatives to reduce exposure to currency fluctuations that may arise from non-U.S.-dollar denominated financial instruments. The Company had a currency swap contract with AXA to hedge foreign exchange exposure from affiliated loans, which matured in March 2018. The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments: Derivative Instruments by Category At December 31, 2018 Fair Value Gains (Losses) Notional Asset Liability (in millions) Freestanding Derivatives (1) (4): Equity contracts: Futures $ 10,411 $ — $ — $ 550 Swaps 7,697 140 168 675 Options 21,698 2,119 1,163 (899 ) Interest rate contracts: Swaps 27,003 632 194 (456 ) Futures 11,448 — — 118 Credit contracts: Credit default swaps 1,282 17 — (3 ) Other freestanding contracts: Foreign currency contracts 2,097 27 14 6 Margin — 7 5 — Collateral — 3 1,564 — Embedded Derivatives: GMIB reinsurance contracts (4) — 1,991 — (1,068 ) GMxB derivative features liability (2) (4) — — 5,431 (786 ) SCS, SIO, MSO and IUL indexed features (3) (4) — — 687 853 Balances, December 31, 2018 $ 81,636 $ 4,936 $ 9,226 $ (1,010 ) ____________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (3) SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. (4) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). Derivative Instruments by Category At December 31, 2017 Fair Value Gains (Losses) Notional Amount Asset Derivatives Liability Derivatives (in millions) Freestanding Derivatives (1) (4): Equity contracts: Futures $ 2,950 $ — $ — $ (655 ) Swaps 4,587 3 125 (842 ) Options 20,630 3,334 1,426 1,203 Interest rate contracts: Swaps 18,988 319 190 655 Futures 11,032 — — 125 Credit contracts: Credit default swaps 2,057 34 2 21 Other freestanding contracts: Foreign currency contracts 1,297 11 2 (38 ) Margin — 18 — — Collateral — 3 1,855 — Embedded Derivatives: GMIB reinsurance contracts (4) — 10,488 — 69 GMxB derivative features liability (2) (4) — — 4,256 1,592 SCS, SIO, MSO and IUL indexed features (3) (4) — — 1,698 (1,236 ) Balances, December 31, 2017 $ 61,541 $ 14,210 $ 9,554 $ 894 ____________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (3) SCS, SIO, MSO and UIL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. (4) Reported in Net derivative gains (losses) in the consolidated statements of income (loss). Equity-Based and Treasury Futures Contracts Margin All outstanding equity-based and treasury futures contracts at December 31, 2018 are exchange-traded and net settled daily in cash. At December 31, 2018 , the Company had open exchange-traded futures positions on: (i) the S&P 500, Russell 2000 and Emerging Market indices, having initial margin requirements of $245 million , (ii) the 2-year, 5-year and 10-year U.S. Treasury Notes on U.S. Treasury bonds and ultra-long bonds, having initial margin requirements of $70 million and (iii) the Euro Stoxx, FTSE 100, Topix, ASX 200 and European, Australasia, and Far East (“EAFE”) indices as well as corresponding currency futures on the Euro/U.S. dollar, Pound/U.S. dollar, Australian dollar/U.S. dollar, and Yen/U.S. dollar, having initial margin requirements of $25 million . Collateral Arrangements The Company generally has executed a Credit Support Annex (“CSA”) under the International Swaps and Derivatives Association Master Agreement (“ISDA Master Agreement”) it maintains with each of its over-the-counter (“OTC”) derivative counterparties that requires both posting and accepting collateral either in the form of cash or high-quality securities, such as U.S. Treasury securities, U.S. government and government agency securities and investment grade corporate bonds. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related CSA have been executed. At December 31, 2018 and 2017 , respectively, the Company held $1,564 million and $1,855 million in cash and securities collateral delivered by trade counterparties, representing the fair value of the related derivative agreements. The unrestricted cash collateral is reported in Other invested assets. The Company posted collateral of $3 million and $3 million at December 31, 2018 and 2017 , respectively, in the normal operation of its collateral arrangements. Securities Repurchase and Reverse Repurchase Transactions Securities repurchase and reverse repurchase trans

INTANGIBLE ASSETS

INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	INTANGIBLE ASSETS Capitalized Software Capitalized software, net of accumulated amortization, amounted to $115 million and $96 million at December 31, 2018 and 2017 , respectively, and is recorded in Other assets. Amortization of capitalized software in 2018 , 2017 and 2016 was $35 million , $37 million and $42 million , respectively, recorded in other Operating costs and expenses in the consolidated statements of income (loss). Amortization expense for capitalized software is expected to be approximately $43 million in 2019, $47 million in 2020, $47 million in 2021, $47 million in 2022 and $47 million 2023.

CLOSED BLOCK

CLOSED BLOCK	12 Months Ended
	Dec. 31, 2018
Closed Block Disclosure [Abstract]
Closed Block	CLOSED BLOCK As a result of demutualization, the Company’s Closed Block was established in 1992 for the benefit of certain individual participating policies that were in force on that date. Assets, liabilities and earnings of the Closed Block are specifically identified to support its participating policyholders. Assets allocated to the Closed Block inure solely to the benefit of the Closed Block policyholders and will not revert to the benefit of the Company. No reallocation, transfer, borrowing or lending of assets can be made between the Closed Block and other portions of the Company’s General Account, any of its Separate Accounts or any affiliate of the Company without the approval of the New York State Department of Financial Services (the “NYDFS”). Closed Block assets and liabilities are carried on the same basis as similar assets and liabilities held in the General Account. The excess of Closed Block liabilities over Closed Block assets (adjusted to exclude the impact of related amounts in AOCI) represents the expected maximum future post-tax earnings from the Closed Block that would be recognized in income from continuing operations over the period the policies and contracts in the Closed Block remain in force. As of January 1, 2001, the Company has developed an actuarial calculation of the expected timing of the Closed Block’s earnings. If the actual cumulative earnings from the Closed Block are greater than the expected cumulative earnings, only the expected earnings will be recognized in net income. Actual cumulative earnings in excess of expected cumulative earnings at any point in time are recorded as a policyholder dividend obligation because they will ultimately be paid to Closed Block policyholders as an additional policyholder dividend unless offset by future performance that is less favorable than originally expected. If a policyholder dividend obligation has been previously established and the actual Closed Block earnings in a subsequent period are less than the expected earnings for that period, the policyholder dividend obligation would be reduced (but not below zero). If, over the period the policies and contracts in the Closed Block remain in force, the actual cumulative earnings of the Closed Block are less than the expected cumulative earnings, only actual earnings would be recognized in income from continuing operations. If the Closed Block has insufficient funds to make guaranteed policy benefit payments, such payments will be made from assets outside the Closed Block. Many expenses related to Closed Block operations, including amortization of DAC, are charged to operations outside of the Closed Block; accordingly, net revenues of the Closed Block do not represent the actual profitability of the Closed Block operations. Operating costs and expenses outside of the Closed Block are, therefore, disproportionate to the business outside of the Closed Block. Summarized financial information for the Company’s Closed Block is as follows: As of December 31, 2018 2017 (in millions) Closed Block Liabilities: Future policy benefits, policyholders’ account balances and other $ 6,709 $ 6,958 Policyholder’ dividend obligation — 19 Other liabilities 47 271 Total Closed Block liabilities 6,756 7,248 Assets Designated To The Closed Block: Fixed maturities, available for sale, at fair value (amortized cost of $ 3,680 and $3,923) 3,672 4,070 Mortgage loans on real estate, net of valuation allowance of $- and $- 1,824 1,720 Policy loans 736 781 Cash and other invested assets 76 351 Other assets 179 182 Total assets designated to the Closed Block 6,487 7,104 Excess of Closed Block liabilities over assets designated to the Closed Block 269 144 Amounts included in Accumulated other comprehensive income (loss): Net unrealized investment gains (losses), net of policyholders’ dividend obligation of $- and $19 8 138 Maximum future income to be recognized from closed block assets and liabilities $ 277 $ 282 The Company’s Closed Block revenues and expenses follow: Years ended December 31, 2018 2017 2016 (in millions) Revenues: Premiums and other income $ 194 $ 224 $ 212 Net investment income (loss) 291 314 349 Investment gains (losses), net (3 ) (20 ) (1 ) Total revenues 482 518 560 Benefits and Other Deductions: Policyholders’ benefits and dividends 471 537 522 Other operating costs and expenses 3 2 4 Total benefits and other deductions 474 539 526 Net income, before income taxes 8 (21 ) 34 Income tax (expense) benefit (3 ) (36 ) (12 ) Net income (losses) $ 5 $ (57 ) $ 22 A reconciliation of the Company’s policyholders ’ dividend obligation follows: December 31, 2018 2017 (in millions) Balance, beginning of year $ 19 $ 52 Unrealized investment gains (losses) (19 ) (33 ) Balance, end of year $ — $ 19

DAC AND POLICYHOLDER BONUS INTE

DAC AND POLICYHOLDER BONUS INTEREST CREDITS	12 Months Ended
	Dec. 31, 2018
Contractholder Bonus Interest Credits [Abstract]
DAC and Policyholder Bonus Interest Credits	DAC AND POLICYHOLDER BONUS INTEREST CREDITS Changes in the deferred policy acquisition cost asset for the years ended December 31, 2018 , 2017 and 2016 were as follows: Years Ended December 31, 2018 2017 2016 (in millions) Balance, beginning of year $ 4,492 $ 5,025 $ 5,079 Capitalization of commissions, sales and issue expenses 597 578 594 Amortization: Impact of assumptions updates and model changes 165 (247 ) (193 ) All other (596 ) (653 ) (449 ) Total amortization (431 ) (900 ) (642 ) Change in unrealized investment gains and losses 353 (211 ) (6 ) Balance, end of year $ 5,011 $ 4,492 $ 5,025 Changes in the deferred asset for policyholder bonus interest credits for the years ended December 31, 2018 , 2017 and 2016 were as follows: Years Ended December 31, 2018 2017 2016 (in millions) Balance, beginning of year $ 473 $ 504 $ 534 Policyholder bonus interest credits deferred 4 6 13 Amortization charged to income (51 ) (37 ) (43 ) Balance, end of year $ 426 $ 473 $ 504

FAIR VALUE DISCLOSURES

FAIR VALUE DISCLOSURES	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Fair Value Disclosures	FAIR VALUE DISCLOSURES The accounting guidance establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value, and identifies three levels of inputs that may be used to measure fair value: Level 1 Unadjusted quoted prices for identical instruments in active markets. Level 1 fair values generally are supported by market transactions that occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2 Observable inputs other than Level 1 prices, such as quoted prices for similar instruments, quoted prices in markets that are not active, and inputs to model-derived valuations that are directly observable or can be corroborated by observable market data. Level 3 Unobservable inputs supported by little or no market activity and often requiring significant management judgment or estimation, such as an entity’s own assumptions about the cash flows or other significant components of value that market participants would use in pricing the asset or liability. The Company uses unadjusted quoted market prices to measure fair value for those instruments that are actively traded in financial markets. In cases where quoted market prices are not available, fair values are measured using present value or other valuation techniques. The fair value determinations are made at a specific point in time, based on available market information and judgments about the financial instrument, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such adjustments do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value cannot be substantiated by direct comparison to independent markets, nor can the disclosed value be realized in immediate settlement of the instrument. Management is responsible for the determination of the value of investments carried at fair value and the supporting methodologies and assumptions. Under the terms of various service agreements, the Company often utilizes independent valuation service providers to gather, analyze, and interpret market information and derive fair values based upon relevant methodologies and assumptions for individual securities. These independent valuation service providers typically obtain data about market transactions and other key valuation model inputs from multiple sources and, through the use of widely accepted valuation models, provide a single fair value measurement for individual securities for which a fair value has been requested. As further described below with respect to specific asset classes, these inputs include, but are not limited to, market prices for recent trades and transactions in comparable securities, benchmark yields, interest rate yield curves, credit spreads, quoted prices for similar securities, and other market-observable information, as applicable. Specific attributes of the security being valued also are considered, including its term, interest rate, credit rating, industry sector, and when applicable, collateral quality and other security- or issuer-specific information. When insufficient market observable information is available upon which to measure fair value, the Company either will request brokers knowledgeable about these securities to provide a non-binding quote or will employ internal valuation models. Fair values received from independent valuation service providers and brokers and those internally modeled or otherwise estimated are assessed for reasonableness. Assets and liabilities measured at fair value on a recurring basis are summarized below. At December 31, 2018 and December 31, 2017 , no assets were required to be measured at fair value on a non-recurring basis. Fair value measurements are required on a non-recurring basis for certain assets, including goodwill and mortgage loans on real estate, only when an OTTI or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. The Company recognizes transfers between valuation levels at the beginning of the reporting period. Fair Value Measurements at December 31, 2018 Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, available-for-sale: Corporate (1) $ — $ 25,202 $ 1,174 $ 26,376 U.S. Treasury, government and agency — 13,335 — 13,335 States and political subdivisions — 416 38 454 Foreign governments — 519 — 519 Residential mortgage-backed (2) — 202 — 202 Asset-backed (3) — 71 519 590 Redeemable preferred stock 163 276 — 439 Total fixed maturities, available-for-sale 163 40,021 1,731 41,915 Other equity investments 12 — — 12 Trading securities 218 14,919 29 15,166 Other invested assets: Short-term investments — 412 — 412 Assets of consolidated VIEs/VOEs — — 19 19 Swaps — 423 — 423 Credit default swaps — 17 — 17 Options — 956 — 956 Total other invested assets — 1,808 19 1,827 Cash equivalents 2,160 — — 2,160 GMIB reinsurance contracts asset — — 1,991 1,991 Separate Accounts assets 105,159 2,733 374 108,266 Total Assets $ 107,712 $ 59,481 $ 4,144 $ 171,337 Liabilities GMxB derivative features’ liability $ — $ — $ 5,431 $ 5,431 SCS, SIO, MSO and IUL indexed features’ liability — 687 — 687 Total Liabilities $ — $ 687 $ 5,431 $ 6,118 ____________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. Fair Value Measurements at December 31, 2017 Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, available-for-sale: Corporate (1) $ — $ 20,343 $ 1,139 $ 21,482 U.S. Treasury, government and agency — 13,135 — 13,135 States and political subdivisions — 441 40 481 Foreign governments — 409 — 409 Residential mortgage-backed (2) — 251 — 251 Asset-backed (3) — 88 8 96 Redeemable preferred stock 180 324 — 504 Total fixed maturities, available-for-sale 180 34,991 1,187 36,358 Other equity investments 13 — — 13 Trading securities 180 12,097 — 12,277 Other invested assets Short-term investments — 763 — 763 Assets of consolidated VIEs/VOEs — — 25 25 Swaps — 15 — 15 Credit default swaps — 33 — 33 Options — 1,907 — 1,907 Total other invested assets — 2,718 25 2,743 Cash equivalents 1,908 — — 1,908 Segregated securities — 9 — 9 GMIB reinsurance contracts asset — — 10,488 10,488 Separate Accounts assets 118,983 2,983 349 122,315 Total Assets $ 121,264 $ 52,798 $ 12,049 $ 186,111 Liabilities GMxB derivative features’ liability $ — $ — $ 4,256 $ 4,256 SCS, SIO, MSO and IUL indexed features’ liability — 1,698 — 1,698 Total Liabilities $ — $ 1,698 $ 4,256 $ 5,954 _______________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. The fair values of the Company’s public fixed maturities are generally based on prices obtained from independent valuation service providers and for which the Company maintains a vendor hierarchy by asset type based on historical pricing experience and vendor expertise. Although each security generally is priced by multiple independent valuation service providers, the Company ultimately uses the price received from the independent valuation service provider highest in the vendor hierarchy based on the respective asset type, with limited exception. To validate reasonableness, prices also are internally reviewed by those with relevant expertise through comparison with directly observed recent market trades. Consistent with the fair value hierarchy, public fixed maturities validated in this manner generally are reflected within Level 2, as they are primarily based on observable pricing for similar assets and/or other market observable inputs. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If as a result it is determined that the independent valuation service provider is able to reprice the security in a manner agreed as more consistent with current market observations, the security remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company’s own assumptions about market-participant inputs would be used in pricing the security. The fair values of the Company’s private fixed maturities are determined from prices obtained from independent valuation service providers. Prices not obtained from an independent valuation service provider are determined by using a discounted cash flow model or a market comparable company valuation technique. In certain cases, these models use observable inputs with a discount rate based upon the average of spread surveys collected from private market intermediaries who are active in both primary and secondary transactions, taking into account, among other factors, the credit quality and industry sector of the issuer and the reduced liquidity associated with private placements. Generally, these securities have been reflected within Level 2. For certain private fixed maturities, the discounted cash flow model or a market comparable company valuation technique may also incorporate unobservable inputs, which reflect the Company’s own assumptions about the inputs market participants would use in pricing the asset. To the extent management determines that such unobservable inputs are significant to the fair value measurement of a security, a Level 3 classification generally is made. The net fair value of the Company’s freestanding derivative positions as disclosed in Note 3 are generally based on prices obtained either from independent valuation service providers or derived by applying market inputs from recognized vendors into industry standard pricing models. The majority of these derivative contracts are traded in the OTC derivative market and are classified in Level 2. The fair values of derivative assets and liabilities traded in the OTC market are determined using quantitative models that require use of the contractual terms of the derivative instruments and multiple market inputs, including interest rates, prices, and indices to generate continuous yield or pricing curves, including overnight index swap (“OIS”) curves, and volatility factors, which then are applied to value the positions. The predominance of market inputs is actively quoted and can be validated through external sources or reliably interpolated if less observable. If the pricing information received from independent valuation service providers is not reflective of market activity or other inputs observable in the market, the Company may challenge the price through a formal process in accordance with the terms of the respective independent valuation service provider agreement. If as a result it is determined that the independent valuation service provider is able to reprice the derivative instrument in a manner agreed as more consistent with current market observations, the position remains within Level 2. Alternatively, a Level 3 classification may result if the pricing information then is sourced from another vendor, non-binding broker quotes, or internally-developed valuations for which the Company’s own assumptions about market-participant inputs would be used in pricing the security. Investments classified as Level 1 primarily include redeemable preferred stock, trading securities, cash equivalents and Separate Account assets. Fair value measurements classified as Level 1 include exchange-traded prices of fixed maturities, equity securities and derivative contracts, and net asset values for transacting subscriptions and redemptions of mutual fund shares held by Separate Accounts. Cash equivalents classified as Level 1 include money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less and are carried at cost as a proxy for fair value measurement due to their short-term nature. Investments classified as Level 2 are measured at fair value on a recurring basis and primarily include U.S. government and agency securities and certain corporate debt securities, such as public and private fixed maturities. As market quotes generally are not readily available or accessible for these securities, their fair value measures are determined utilizing relevant information generated by market transactions involving comparable securities and often are based on model pricing techniques that effectively discount prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Segregated securities classified as Level 2 are U.S. Treasury bills segregated in a special reserve bank custody account for the exclusive benefit of brokerage customers, as required by Rule 15c3-3 of the Exchange Act and for which fair values are based on quoted yields in secondary markets. Observable inputs generally used to measure the fair value of securities classified as Level 2 include benchmark yields, reported secondary trades, issuer spreads, benchmark securities and other reference data. Additional observable inputs are used when available, and as may be appropriate, for certain security types, such as prepayment, default, and collateral information for the purpose of measuring the fair value of mortgage- and asset-backed securities. The Company’s AAA-rated mortgage- and asset-backed securities are classified as Level 2 for which the observability of market inputs to their pricing models is supported by sufficient, albeit more recently contracted, market activity in these sectors. Certain Company products such as the SCS and EQUI-VEST variable annuity products, and in the MSO fund available in some life contracts offer investment options which permit the contract owner to participate in the performance of an index, ETF or commodity price. These investment options, which depending on the product and on the index selected can currently have 1, 3, 5, or 6-year terms, provide for participation in the performance of specified indices, ETF or commodity price movement up to a segment-specific declared maximum rate. Under certain conditions that vary by product, e.g. holding these segments for the full term, these segments also shield policyholders from some or all negative investment performance associated with these indices, ETF or commodity prices. These investment options have defined formulaic liability amounts, and the current values of the option component of these segment reserves are accounted for as Level 2 embedded derivatives. The fair values of these embedded derivatives are based on data obtained from independent valuation service providers. The Company’s investments classified as Level 3 primarily include corporate debt securities, such as private fixed maturities. Determinations to classify fair value measures within Level 3 of the valuation hierarchy generally are based upon the significance of the unobservable factors to the overall fair value measurement. Included in the Level 3 classification are fixed maturities with indicative pricing obtained from brokers that otherwise could not be corroborated to market observable data. The Company applies various due diligence procedures, as considered appropriate, to validate these non-binding broker quotes for reasonableness, based on its understanding of the markets, including use of internally-developed assumptions about inputs a market participant would use to price the security. In addition, asset-backed securities are classified as Level 3. The Company also issues certain benefits on its variable annuity products that are accounted for as derivatives and are also considered Level 3. The GMIBNLG feature allows the policyholder to receive guaranteed minimum lifetime annuity payments based on predetermined annuity purchase rates applied to the contract’s benefit base if and when the contract account value is depleted and the NLG feature is activated. The GMWB feature allows the policyholder to withdraw at minimum, over the life of the contract, an amount based on the contract’s benefit base. The GWBL feature allows the policyholder to withdraw, each year for the life of the contract, a specified annual percentage of an amount based on the contract’s benefit base. The GMAB feature increases the contract account value at the end of a specified period to a GMAB base. The GIB feature provides a lifetime annuity based on predetermined annuity purchase rates if and when the contract account value is depleted. This lifetime annuity is based on predetermined annuity purchase rates applied to a GIB base. Level 3 also includes the GMIB reinsurance contract assets which are accounted for as derivative contracts. The GMIB reinsurance contract asset and liabilities’ fair value reflects the present value of reinsurance premiums and recoveries and risk margins over a range of market consistent economic scenarios while GMxB derivative features liability reflects the present value of expected future payments (benefits) less fees, adjusted for risk margins and nonperformance risk, attributable to GMxB derivative features’ liability over a range of market-consistent economic scenarios. The valuations of the GMIB reinsurance contract asset and GMxB derivative features liability incorporate significant non-observable assumptions related to policyholder behavior, risk margins and projections of equity separate account funds. The credit risks of the counterparty and of the Company are considered in determining the fair values of its GMIB reinsurance contract asset and GMxB derivative features liability positions, respectively, after taking into account the effects of collateral arrangements. Incremental adjustment to the swap curve for non-performance risk is made to the fair values of the GMIB reinsurance contract asset and liabilities and GMIBNLG feature to reflect the claims-paying ratings of counterparties and the Company. Equity and fixed income volatilities were modeled to reflect current market volatilities. Due to the unique, long duration of the GMIBNLG feature, adjustments were made to the equity volatilities to remove the illiquidity bias associated with the longer tenors and risk margins were applied to the non-capital markets inputs to the GMIBNLG valuations. After giving consideration to collateral arrangements, the Company reduced the fair value of its GMIB reinsurance contract asset by $184 million and $69 million at December 31, 2018 and 2017 , respectively, to recognize incremental counterparty non-performance risk. Lapse rates are adjusted at the contract level based on a comparison of the actuarially calculated guaranteed values and the current policyholder account value, which include other factors such as considering surrender charges. Generally, lapse rates are assumed to be lower in periods when a surrender charge applies. A dynamic lapse function reduces the base lapse rate when the guaranteed amount is greater than the account value as in the money contracts are less likely to lapse. For valuing the embedded derivative, lapse rates vary throughout the period over which cash flows are projected. The Company’s consolidated VIEs/VOEs hold investments that are classified as Level 3 and primarily consist of corporate bonds that are vendor priced with no ratings available, bank loans, non-agency collateralized mortgage obligations and asset-backed securities. In 2018 , AFS fixed maturities with fair values of $28 million w ere transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $83 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.9% of total equity at December 31, 2018 . In 2017 , AFS fixed maturities with fair values of $6 million were transferred out of Level 3 and into Level 2 principally due to the availability of trading activity and/or market observable inputs to measure and validate their fair values. In addition, AFS fixed maturities with fair value of $7 million were transferred from Level 2 into the Level 3 classification. These transfers in the aggregate represent approximately 0.1% of total equity at December 31, 2017 . The table below presents a reconciliation for all Level 3 assets and liabilities at December 31, 2018 , 2017 and 2016 respectively: Level 3 Instruments Fair Value Measurements Corporate State and Political Subdivisions Foreign Governments Commercial Mortgage- backed Asset-backed (in millions) Balance, January 1, 2018 $ 1,139 $ 40 $ — $ — $ 8 Total gains (losses), realized and unrealized, included in: Income (loss) as: Net investment income (loss) 7 — — — (2 ) Investment gains (losses), net (8 ) — — — — Subtotal (1 ) — — — (2 ) Other comprehensive income (loss) (20 ) (1 ) — — (7 ) Purchases 322 — — — 550 Sales (321 ) (1 ) — — (30 ) Transfers into Level 3 (1) 83 — — — — Transfers out of Level 3 (1) (28 ) — — — — Balance, December 31, 2018 $ 1,174 $ 38 $ — $ — $ 519 Corporate State and Political Subdivisions Foreign Governments Commercial Mortgage- backed Asset-backed (in millions) Balance, January 1, 2017 $ 845 $ 42 $ — $ 349 $ 24 Total gains (losses), realized and unrealized, included in: Income (loss) as: Net investment income (loss) 5 — — (2 ) — Investment gains (losses), net 2 — — (63 ) 15 Subtotal 7 — — (65 ) 15 Other comprehensive income (loss) 4 (1 ) — 45 (9 ) Purchases 612 — — — — Sales (331 ) (1 ) — (329 ) (21 ) Transfers into Level 3 (1) 7 — — — — Transfers out of Level 3 (1) (5 ) — — — (1 ) Balance, December 31, 2017 $ 1,139 $ 40 $ — $ — $ 8 Balance, January 1, 2016 $ 420 $ 45 $ 1 $ 503 $ 40 Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net 1 — — (67 ) — Subtotal 1 — — (67 ) — Other comprehensive income (loss) 7 (2 ) — 14 1 Purchases 572 — — — — Sales (142 ) (1 ) — (87 ) (8 ) Transfers into Level 3 (1) 25 — — — — Transfers out of Level 3 (1) (38 ) — (1 ) (14 ) (9 ) Balance, December 31, 2016 $ 845 $ 42 $ — $ 349 $ 24 Redeemable Preferred Stock Other Equity Investments (2) GMIB Reinsurance Asset Separate Account Assets GMxB Derivative Features Liability (in millions) Balance, January 1, 2018 $ — $ 25 $ 10,488 $ 349 $ (4,256 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — — 26 — Net derivative gains (losses), excluding non-performance risk — — (972 ) — (296 ) Non-performance risk (4) — — (96 ) — (490 ) Subtotal — — (1,068 ) 26 (786 ) Purchases (2) — 29 96 5 (403 ) Sales (3) — — (62 ) (1 ) 14 Settlements — — (7,463 ) (5 ) — Activity related to consolidated VIEs/VOEs — (6 ) — — — Transfers into Level 3 (1) — 5 — — — Transfers out of Level 3 (1) — (5 ) — — — Balance, December 31, 2018 $ — $ 48 $ 1,991 $ 374 $ (5,431 ) Redeemable Preferred Stock Other Equity Investments (2) GMIB Reinsurance Asset Separate Account Assets GMxB Derivative Features Liability (in millions) Balance, January 1, 2017 $ 1 $ 40 $ 10,313 $ 313 $ (5,473 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — — 29 — Net derivative gains (losses), excluding non-performance risk — — (6 ) — 1,443 Non-performance risk (4) — — 75 — 149 Subtotal — — 69 29 1,592 Other comprehensive income(loss) (1 ) — — — — Purchases (2) — — 221 13 (381 ) Sales (3) — — (115 ) (2 ) 6 Settlements — — — (4 ) — Activity related to consolidated VIEs/VOEs — (15 ) — — — Transfers into level 3 (1) — — — — — Transfers out of level 3 (1) — — — — — Balance, December 31, 2017 $ — $ 25 $ 10,488 $ 349 $ (4,256 ) Balance, January 1, 2016 $ — $ 1 $ 10,582 $ 313 $ (5,266 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — — 19 — Net derivative gains (losses), excluding non-performance risk — — (242 ) — (126 ) Non-performance risk (4) — — (20 ) — 263 Subtotal — — (262 ) 19 137 Other comprehensive income (loss) — (1 ) — — — Purchases (2) 1 — 223 10 (348 ) Sales (3) — — (230 ) — 4 Settlements — — — (7 ) — Activities related to consolidated VIEs/VOEs — 40 — — — Transfers into level 3 (1) — — — 1 — Transfers out of level 3 (1) — — (23 ) — Balance, December 31, 2016 $ 1 $ 40 $ 10,313 $ 313 $ (5,473 ) ______________ (1) Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values. (2) For the GMIB reinsurance contract asset, and GMxB derivative features liability, represents attributed fee. (3) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid. (4) The Company’s non-performance risk is recorded through Net derivative gains (losses). The table below details changes in unrealized gains (losses) for 2018 , 2017 and 2016 by category for Level 3 assets and liabilities still held at December 31, 2018 , 2017 and 2016 respectively. Earnings (Loss) Investment Gains (Losses), Net Net Derivative Gains (Losses) OCI (in millions) Held as of December 31, 2018: Change in unrealized gains (losses): Fixed maturities, available-for-sale Corporate $ — $ — $ (18 ) State and political subdivisions — — (1 ) Asset-backed — — (7 ) Subtotal — — (26 ) GMIB reinsurance contracts — (1,068 ) — Separate Accounts assets (1) 26 — — GMxB derivative features liability — (786 ) — Total $ 26 $ (1,854 ) $ (26 ) Held as of December 31, 2017: Change in unrealized gains (losses): Fixed maturities, available-for-sale Corporate $ — $ — $ 4 Commercial mortgage-backed — — 45 Asset-backed — — (9 ) Subtotal — — 40 GMIB reinsurance contracts — 69 — Separate Accounts assets (1) 29 — — GMxB derivative features liability — 1,592 — Total $ 29 $ 1,661 $ 40 Held as of December 31, 2016: Change in unrealized gains (losses): Fixed maturities, available-for-sale Corporate $ — $ — $ 11 State and political subdivisions — — (1 ) Commercial mortgage-backed — — 9 Asset-backed — — 1 Subtotal — — 20 GMIB reinsurance contracts — (262 ) — Separate Accounts assets (1) 20 — — GMxB derivative features liability — 137 — Total $ 20 $ (125 ) $ 20 ____________ (1) There is an investment expense that offsets this investment gain (loss). The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities as of December 31, 2018 and 2017 , respectively. Quantitative Information about Level 3 Fair Value Measurements at December 31, 2018 Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (in millions) Assets: Investments: Fixed maturities, available-for-sale: Corporate $ 93 Matrix pricing Spread over Benchmark 15 - 580 bps 104 bps 881 Market EBITDA multiples 4.1x - 37.8x 12.1x Separate Accounts assets 352 Third party appraisal Capitalization rate 4.4% 1 Discounted cash flow Spread over U.S. Treasury curve 248 bps GMIB reinsurance contract asset 1,991 Discounted cash flow Lapse rates 1.0% - 6.27% Liabilities: GMIBNLG 5,341 Discounted cash flow Non-performance risk 189 bps GWBL/GMWB 130 Discounted cash flow Lapse rates 0.5% - 5.7% GIB (48 ) Discounted cash flow Lapse rates 0.5% - 5.7% GMAB 7 Discounted cash flow Lapse rates 1.0% - 5.7% ____________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. Quantitative Information about Level 3 Fair Value Measurements at December 31, 2017 Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (in millions) Assets: Investments: Fixed maturities, available-for-sale: Corporate $ 53 Matrix pricing model Spread over the industry-specific benchmark yield curve 0 - 565 bps 125 bps 789 Market comparable companies EBITDA multiples 5.3x - 27.9x 12.9x 11.1% 13.1x Separate Accounts assets 326 Third party appraisal Capitalization rate 4.6% 1 Discounted Spread over U.S. Treasury curve 243 bps GMIB reinsurance contract asset 10,488 Discounted cash flow Lapse rates 1.0% - 6.3% Liabilities: GMIBNLG 4,149 Discounted cash flow Non-performance risk 1.0% GWBL/GMWB 130 Discounted cash flow Lapse rates 0.9% - 5.7% GIB (27 ) Discounted cash flow Lapse rates 0.5% - 11.0% GMAB 5 Discounted cash flow Lapse rates 0.5% - 11.0% ____________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. Excluded from the tables above at December 31, 2018 and 2017 , respectively, are approximately $826 million and $392 million of Level 3 fair value measurements of investments for which the underlying quantitative inputs are not developed by the Company and are not readily available. These investments primarily consist of certain privately placed debt securities with limited trading activity, including residential mortgage- and asset-backed instruments, and their fair values generally reflect unadjusted prices obtained from independent valuation service providers and indicative, non-binding quotes obtained from third-party broker-dealers recognized as market participants. Significant increases or decreases in the fair value amounts received from these pricing sources may result in the Company’s reporting significantly higher or lower fair value measurements for these Level 3 investments. The fair value of private placement securities is determined by application of a matrix pricing model or a market comparable company value technique. The significant unobservable input to the matrix pricing model valuation technique is the spread over the industry-specific benchmark yield curve. Generally, an increase or decrease in spreads would lead to directionally inverse movement in the fair value measurements of these securities. The significant unobservable input to the market comparable company valuation technique is the discount rate. Generally, a significant increase (decrease) in the discount rate would result in significantly lower (higher) fair value measurements of these securities. Residential mortgage-backed securities classified as Level 3 primarily consist of non-agency paper with low trading activity. Included in the tables above at December 31, 2018 and 2017 , there were no Level 3 securities that were determined by application of a matrix-pricing model and for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Generally, a change in spreads would lead to directionally inverse movement in the fair value measurements of these securities. Asset-backed securities classified as Level 3 primarily consist of non-agency mortgage loan trust certificates, including subprime and Alt-A paper, credit tenant loans, and equipment financings. Included in the tables above at December 31, 2018 and 2017 , there were no securities that were determined by the application of matrix-pricing for which the spread over the U.S. Treasury curve is the most significant unobservable input to the pricing result. Significant increases (decreases) in spreads would result in significantly lower (higher) fair value measurements. Included in other eq

INSURANCE LIABILITIES

INSURANCE LIABILITIES	12 Months Ended
	Dec. 31, 2018
Insurance [Abstract]
Insurance Liabilities	INSURANCE LIABILITIES Variable Annuity Contracts – GMDB, GMIB, GIB and GWBL and Other Features The Company has certain variable annuity contracts with GMDB, GMIB, GIB and GWBL and other features in-force that guarantee one of the following: • Return of Premium: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals); • Ratchet: the benefit is the greatest of current account value, premiums paid (adjusted for withdrawals), or the highest account value on any anniversary up to contractually specified ages (adjusted for withdrawals); • Roll-Up: the benefit is the greater of current account value or premiums paid (adjusted for withdrawals) accumulated at contractually specified interest rates up to specified ages; • Combo: the benefit is the greater of the ratchet benefit or the roll-up benefit, which may include either a five year or an annual reset; or • Withdrawal: the withdrawal is guaranteed up to a maximum amount per year for life. Liabilities for Variable Annuity Contracts with GMDB and GMIB Features and no NLG Feature The change in the liabilities for variable annuity contracts with GMDB and GMIB features and no NLG feature are summarized in the tables below. The amounts for the direct contracts (before reinsurance ceded) and assumed contracts are reflected in the consolidated balance sheets in Future policy benefits and other policyholders’ liabilities. The amounts for the ceded contracts are reflected in the consolidated balance sheets in Amounts due from reinsurers. Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No NLG Feature For the Years Ended December 31, 2018, 2017 and 2016 GMDB GMIB Direct Ceded Direct Ceded (in millions) Balance at January 1, 2016 $ 2,991 $ (1,430 ) $ 3,886 $ (10,575 ) Paid guarantee benefits (357 ) 174 (281 ) 230 Other changes in reserve 525 (302 ) 203 31 Balance at December 31, 2016 3,159 (1,558 ) 3,808 (10,314 ) Paid guarantee benefits (354 ) 171 (151 ) 115 Other changes in reserve 1,249 (643 ) 1,097 (289 ) Balance at December 31, 2017 4,054 (2,030 ) 4,754 (10,488 ) Paid guarantee benefits (394 ) 70 (153 ) 61 Other changes in reserve 994 1,853 (860 ) 8,435 Balance at December 31, 2018 $ 4,654 $ (107 ) $ 3,741 $ (1,992 ) Liabilities for Embedded and Freestanding Insurance Related Derivatives The liability for the GMxB derivative features liability, the liability for SCS, SIO, MSO and IUL indexed features and the asset and liability for the GMIB reinsurance contracts are considered embedded or freestanding insurance derivatives and are reported at fair value. For the fair value of the assets and liabilities associated with these embedded or freestanding insurance derivatives , see Note 7 . Account Values and Net Amount at Risk Account Values and Net Amount at Risk (“NAR”) for direct variable annuity contracts in force with GMDB and GMIB features as of December 31, 2018 are presented in the following tables by guarantee type. For contracts with the GMDB feature, the NAR in the event of death is the amount by which the GMDB feature exceeds the related Account Values. For contracts with the GMIB feature, the NAR in the event of annuitization is the amount by which the present value of the GMIB benefits exceed the related Account Values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB features may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive. Direct Variable Annuity Contracts with GMDB and GMIB Features As of December 31, 2018 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions; except age and interest rate) Variable annuity contracts with GMDB features Account Values invested in: General Account $ 14,035 $ 102 $ 61 $ 184 $ 14,382 Separate Accounts 41,463 8,382 2,903 30,406 83,154 Total Account Values $ 55,498 $ 8,484 $ 2,964 $ 30,590 $ 97,536 Net Amount at Risk, gross $ 418 $ 791 $ 2,291 $ 20,587 $ 24,087 Net Amount at Risk, net of amounts reinsured $ 418 $ 772 $ 1,615 $ 20,587 $ 23,392 Average attained age of policyholders (in years) 51.4 67.0 73.6 69.0 55.3 Percentage of policyholders over age 70 10.0 % 43.0 % 65.5 % 49.9 % 18.8 % Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Variable annuity contracts with GMIB features Account Values invested in: General Account $ — $ — $ 19 $ 251 $ 270 Separate Accounts — — 19,407 33,428 52,835 Total Account Values $ — $ — $ 19,426 $ 33,679 $ 53,105 Net Amount at Risk, gross $ — $ — $ 994 $ 9,156 $ 10,150 Net Amount at Risk, net of amounts reinsured $ — $ — $ 309 $ 8,268 $ 8,577 Average attained age of policyholders (in years) N/A N/A 68.9 68.8 68.8 Weighted average years remaining until annuitization N/A N/A 1.7 0.5 0.6 Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% For more information about the reinsurance programs of the Company’s GMDB and GMIB exposure, see “Reinsurance Agreements” in Note 10 . Separate Account Investments by Investment Category Underlying Variable Annuity Contracts with GMDB and GMIB Features The total Account Values of variable annuity contracts with GMDB and GMIB features include amounts allocated to the guaranteed interest option, which is part of the General Account and variable investment options that invest through Separate Accounts in variable insurance trusts. The following table presents the aggregate fair value of assets, by major investment category, held by Separate Accounts that support variable annuity contracts with GMDB and GMIB features. The investment performance of the assets impacts the related Account Values and, consequently, the NAR associated with the GMDB and GMIB benefits and guarantees. Because the Company’s variable annuity contracts offer both GMDB and GMIB features, GMDB and GMIB amounts are not mutually exclusive. Investment in Variable Insurance Trust Mutual Funds As of December 31, 2018 2017 GMDB GMIB GMDB GMIB (in millions) Investment type: Equity $ 35,541 $ 15,759 $ 41,658 $ 19,676 Fixed income 5,173 2,812 5,469 3,110 Balanced 41,588 33,974 46,577 38,398 Other 852 290 968 314 Total $ 83,154 $ 52,835 $ 94,672 $ 61,498 Hedging Programs for GMDB, GMIB, GIB and Other Features Beginning in 2003, the Company established a program intended to hedge certain risks associated first with the GMDB feature and, beginning in 2004, with the GMIB feature of the Accumulator series of variable annuity products. The program has also been extended to cover other guaranteed benefits as they have been made available. This program utilizes derivative contracts, such as exchange-traded equity, currency and interest rate futures contracts, total return and/or equity swaps, interest rate swap and floor contracts, swaptions, variance swaps as well as equity options, that collectively are managed in an effort to reduce the economic impact of unfavorable changes in guaranteed benefits’ exposures attributable to movements in the capital markets. At the present time, this program hedges certain economic risks on products sold from 2001 forward, to the extent such risks are not externally reinsured. These programs do not qualify for hedge accounting treatment. Therefore, gains (losses) on the derivatives contracts used in these programs, including current period changes in fair value, are recognized in Net investment income (loss) in the period in which they occur, and may contribute to income (loss) volatility. Variable and Interest-Sensitive Life Insurance Policies - NLG The NLG feature contained in variable and interest-sensitive life insurance policies keeps them in force in situations where the policy value is not sufficient to cover monthly charges then due. The NLG remains in effect so long as the policy meets a contractually specified premium funding test and certain other requirements. The change in the liabilities for NLG liabilities, reflected in the General Account in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets is summarized in the table below: Direct Liability Reinsurance Ceded Net (in millions) Balance at January 1, 2016 $ 1,144 $ (510 ) $ 634 Other changes in reserves 38 (96 ) (58 ) Balance at December 31, 2016 1,182 (606 ) 576 Paid guarantee benefits (24 ) — (24 ) Other changes in reserves (466 ) (58 ) (524 ) Balance at December 31, 2017 692 (664 ) 28 Direct Liability Reinsurance Ceded Net (in millions) Paid guarantee benefits (23 ) — (23 ) Other changes in reserves 118 (69 ) 49 Balance at December 31, 2018 $ 787 $ (733 ) $ 54

REVENUE RECOGNITION

REVENUE RECOGNITION	12 Months Ended
	Dec. 31, 2018
Revenue from Contract with Customer [Abstract]
Revenue Recognition	REVENUE RECOGNITION See “Revenue Recognition” in Note 2 for a description of the revenues presented in the table below. The adoption of ASC 606 had no material impact on revenue recognition in 2018. The table below presents the revenues recognized for the years ended December 31, 2018 , 2017 and 2016 , disaggregated by category: Years Ended December 31, 2018 2017 2016 (in millions) Investment management, advisory and service fees: Base fees $ 728 $ 720 $ 674 Distribution services 301 287 277 Total investment management and service fees $ 1,029 $ 1,007 $ 951 Other income $ 33 $ 35 $ 23 For revenue related to AB, see Note 19 .

REINSURANCE AGREEMENTS

REINSURANCE AGREEMENTS	12 Months Ended
	Dec. 31, 2018
Reinsurance Disclosures [Abstract]
Reinsurance Agreements	REINSURANCE AGREEMENTS The Company assumes and cedes reinsurance with other insurance companies. The Company evaluates the financial condition of its reinsurers to minimize its exposure to significant losses from reinsurer insolvencies. Ceded reinsurance does not relieve the originating insurer of liability. The following table summarizes the effect of reinsurance: Years Ended December 31, 2018 2017 2016 (in millions) Direct premiums $ 836 $ 880 $ 850 Reinsurance assumed 186 195 206 Reinsurance ceded (160 ) (171 ) (176 ) Net premiums $ 862 $ 904 $ 880 Policy charges and fee income ceded $ 467 $ 718 $ 640 Policyholders’ benefits ceded $ 592 $ 694 $ 942 Ceded Reinsurance The Company reinsures most of its new variable life, UL and term life policies on an excess of retention basis. The Company generally retains on a per life basis up to $25 million for single lives and $30 million for joint lives with the excess 100% reinsured. The Company also reinsures risk on certain substandard underwriting risks and in certain other cases. Effective February 1, 2018, AXA Equitable Life entered into a coinsurance reinsurance agreement (the “Coinsurance Agreement”) to cede 90% of its single premium deferred annuities (“SPDA”) products issued between 1978-2001 and its Guaranteed Growth Annuity (“GGA”) single premium deferred annuity products issued between 2001-2014. As a result of this agreement, AXA Equitable Life transferred securi ties with a market value of $604 million and cash of $31 million to equal the statutory reserves of approximately $635 million . As the risks transferred by AXA Equitable Life to the reinsurer under the Coinsurance Agreement are not considered insurance risks and therefore do not qualify for reinsurance accounting, AXA Equitable Life applied deposit accounting. Accordingly, AXA Equitable Life recorded the transferred assets of $635 million as a deposit asset recorded in O ther assets, net of the ceding commissions paid to the reinsurer. At December 31, 2018 and 2017 , the Company had reinsured with non-affiliates in the aggregate approximately 2.9 % and 3.5% , respectively, of its current exposure to the GMDB obligation on annuity contracts in-force and, subject to certain maximum amounts or caps in any one period, approximately 15.5 % and 16.8% of its current liability exposure, respectively, resulting from the GMIB feature. For additional information, see Note 8 . Based on management’s estimates of future contract cash flows and experience, the estimated net fair values of the ceded GMIB reinsurance contracts, considered derivatives were $1,991 million and $10,488 million at December 31, 2018 and 2017 , respectively. The estimated fair values decreased $8,497 million and $268 million during 2018 and 2016 , respectively, and increased $174 million during 2017 . At December 31, 2018 and 2017 , third-party reinsurance recoverables related to insurance contracts amounted to $2,243 million and $2,420 million , respectively. Additionally, $1,689 million and $1,882 million of the amounts due from reinsurers related to two specific reinsurers, Zurich Insurance Company Ltd. (AA - rating by S&P ), and Paul Revere Life Insurance Company (A- rating by S&P ). Reinsurance payables related to insurance contracts were $113 million and $134 million , at December 31, 2018 and 2017 , respectively. The Company cedes substantially all of its group health business to a third-party insurer. Insurance liabilities ceded totaled $62 million and $71 million at December 31, 2018 and 2017 , respectively. The Company also cedes a portion of its extended term insurance and paid-up life insurance and substantially all of its individual disability income business through various coinsurance agreements. Assumed Reinsurance In addition to the sale of insurance products, the Company currently acts as a professional retrocessionaire by assuming risk from professional reinsurers. The Company assumes accident, life, health, aviation, special risk and space risks by participating in or reinsuring various reinsurance pools and arrangements. Reinsurance assumed reserves were $712 million and $716 million at December 31, 2018 and 2017 , respectively. For reinsurance agreements with affiliates, see “Related Party Transactions” in Note 12 .

LONG-TERM DEBT

LONG-TERM DEBT	12 Months Ended
	Dec. 31, 2018
Debt Disclosure [Abstract]
Short-Term Debt	LONG-TERM DEBT Disposition of Real Estate Joint Ventures In March 2018, the Company sold its interest in two consolidated real estate joint ventures to AXA France for a total purchase price of approximately $143 million , which resulted in a pre-tax loss of $0.2 million and the reduction of $202 million of long-term debt on the Company’s balance sheet for the year ended December 31, 2018 .

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2018
Related Party Transactions [Abstract]
Related Party Transactions	RELATED PARTY TRANSACTIONS Parties are considered to be related if one party has the ability to control or exercise significant influence over the other party in making financial or operating decisions. The Company has entered into a number of related party transactions with AXA and its subsidiaries that are not part of the Company (collectively, “AXA Affiliates”) and other related parties that are described herein. Since transactions with related parties may raise potential or actual conflicts of interest between the related party and the Company, the Company is subject to Holdings’ related party transaction policy which requires certain related party transactions to be reviewed and approved by independent Audit Committee members. Cost Sharing and General Service Agreements In the second quarter of 2018, AXA Equitable entered into a general services agreement with Holdings whereby AXA Equitable will benefit from the services received by Holdings from AXA Affiliates for a limited period following the Holdings IPO under a transition services agreement. The general services agreement with Holdings replaces existing cost-sharing and general service agreements with various AXA Affiliates. AXA Equitable continues to provide services to Holdings and various AXA Affiliates under a separate existing general services agreement with Holdings. Costs allocated to the Company from Holdings totaled $138 million for the year ended December 31, 2018 and are allocated based on cost center tracking of expenses. The cost centers are approved once a year and are updated based on business area needs throughout the year. Loans to Affiliates: Affiliate Loans On April 20, 2018, AXA Equitable made a loan of $800 million to Holdings with an interest rate of 3.69% and maturing on April 20, 2021. Holdings repaid $200 million of the note on December 21, 2018. The unpaid principal balance of the note as of December 31, 2018 is $600 million . In September 2007, AXA issued a $700 million 5.7% Senior Unsecured Note to the Company. In January 2018, AXA pre-paid $50 million of the note. In April 2018, AXA pre-paid the remaining unpaid principal balance of this note. Senior Surplus Notes On December 28, 2018 , AXA Equitable, issued a $572 million senior surplus note due December 28, 2019 to Holdings, which bears interest at a fixed rate of 3.75% , payable semi-annually. The surplus note is intended to have priority in right of payments and in all other respects to any and all other surplus notes issued by AXA Equitable at any time. AXA Equitable repaid this note on March 5, 2019 . Affiliate fees, revenue and expenses Investment management and service fees and expenses AXA Equitable FMG, a subsidiary of AXA Equitable, provides investment management and administrative services to EQAT, VIP Trust, 1290 Funds and Other AXA Trusts, all of which are considered related parties. Investment management and service fees earned are calculated as a percentage of assets under management and are recorded as revenue as the related services are performed. AXA Investment Managers Inc. (“AXA IM”) and AXA Rosenberg Investment Management LLC (“AXA Rosenberg”) provide sub-advisory services with respect to certain portfolios of EQAT, VIP Trust and the Other AXA Trusts. Also, AXA IM and AXA Real Estate Investment Managers (“AXA REIM”) manage certain General Account investments. Fees paid to these affiliates are based on investment advisory service agreements with each affiliate. Effective December 31, 2018, AXA Equitable transferred its interest in ABLP, AB Holdings and the General Partner to a newly formed subsidiary and distributed the shares of the subsidiary to its direct parent which subsequently distributed the shares to Holdings (the “AB Business Transfer”). Accordingly, AB’s related party transactions with AXA Affiliates and mutual funds sponsored by AB are now reflected as a discontinued operation in the Company’s consolidated financial statements for all periods presented. Investment management and other services provided by AB to mutual funds sponsored by AB prior to th e AB Business Transfer will continue based upon the Company’s business needs. See Note 19 for further details of the AB Business Transfer and the discontinued operation. Affiliated distribution revenue and expenses AXA Distributors receives commissions and fee revenue from MONY America for sales of its insurance products. The commissions and fees earned from MONY America are based on the various selling agreements. AXA Equitable pays commissions and fees to AXA Distribution Holding Corporation and its subsidiaries (“AXA Distribution”) for sales of insurance products. The commissions and fees paid to AXA Distribution are based on various selling agreements. Insurance related transactions Prior to April 2018, AXA Equitable ceded to AXA RE Arizona, an indirect, wholly owned subsidiary of Holdings, a (i) 100% quota share of all liabilities for variable annuities with GMxB riders issued on or after January 1, 2006 and in-force on September 30, 2008 (the “GMxB Business”), (ii) 100% quota share of all liabilities for variable annuities with GMIB riders issued on or after May 1, 1999 through August 31, 2005 in excess of the liability assumed by two unaffiliated reinsurers, which are subject to certain maximum amounts or limitations on aggregate claims, and (iii) 90% quota share of level premium term insurance issued by AXA Equitable on or after March 1, 2003 through December 31, 2008 and lapse protection riders under certain series of universal life insurance policies issued by AXA Equitable on or after June 1, 2003 through June 30, 2007. On April 12, 2018, AXA Equitable completed the unwind of the reinsurance previously provided to AXA Equitable by AXA RE Arizona. Accordingly, all of the business previously ceded to AXA RE Arizona, with the exception of the GMxB Business, was novated to EQ AZ Life Re Company (“EQ AZ Life Re”), a newly formed captive insurance company organized under the laws of Arizona, which is an indirect wholly owned subsidiary of Holdings. Following the novation of business to EQ AZ Life Re, AXA RE Arizona was merged with and into AXA Equitable. Following AXA RE Arizona’s merger with and into AXA Equitable, the GMxB Business is not subject to any new internal or third-party reinsurance arrangements, though in the future AXA Equitable may reinsure the GMxB Business with third parties. AXA RE Arizona novated the Life Business from AXA RE Arizona to EQ AZ Life Re as part of the GMxB Unwind. As a result, EQ AZ Life Re reinsures a 90% quota share of level premium term insurance issued by AXA Equitable on or after March 1, 2003 through December 31, 2008 and lapse protection riders under UL insurance policies issued by AXA Equitable on or after June 1, 2003 through June 30, 2007 and the Excess Risks. The GMxB Unwind was considered a pre-existing relationship required to be effectively settled at fair value. The loss relating to this relationship resulted from the settlement of the reinsurance contracts at fair value and the write-off of previously recorded assets and liabilities related to this relationship recorded in the Company’s historical accounts. The pre-tax loss recognized in the second quarter of 2018 was $2.6 billion ( $2.1 billion net of tax). The Company wrote-off a $1.8 billion deferred cost of reinsurance asset which was previously reported in Other assets. Additionally, the remaining portion of the loss was determining by calculating the difference between the fair value of the assets received compared to the fair value of the assets and liabilities already recorded within the Company’s consolidated financial statements. The Company’s primary assets previously recorded were reinsurance recoverables, including the reinsurance recoverable associated with GMDB business. There was an approximate $400 million difference between the fair value of the GMDB recoverable compared to its carrying value which is accounted for under ASC 944. The assets received and the assets removed were as follows: As of April 12, 2018 (in millions) Assets Received Assets Removed Assets at fair value: Fixed income securities $ 7,083 Short-term investments 205 Money market funds 2 Accrued interest 43 Derivatives 282 Cash and cash equivalents 1,273 Total $ 8,888 Deferred cost of reinsurance asset $ 1,839 GMDB ceded reserves 2,317 GMIB reinsurance contract asset 7,463 Payable to AXA RE Arizona 270 Total $ 11,889 Significant non-cash transactions involved in the unwind of the reinsurance previously provided to AXA Equitable Life by AXA RE Arizona included: (a) the increase in total investments includes non-cash activities of $7,615 million for assets received related to the recapture transaction, (b) cancellation of the $300 million surplus note between the Company and AXA RE Arizona, and (c) settlement of the intercompany receivables/payables to AXA RE Arizona of $270 million . In addition, upon merging the remaining assets of AXA Re Arizona into AXA Equitable, $1.2 billion of deferred tax assets were recorded on the balance sheet through an adjustment to Capital in excess of par value. The reinsurance arrangements with EQ AZ Life Re provide important capital management benefits to AXA Equitable. At December 31, 2018 , the Company’s GMIB reinsurance asset with EQ AZ Life Re had carrying values of $259 million and is reported in Guaranteed minimum income benefit reinsurance asset, at fair value in the consolidated balance sheets. Ceded premiums and policy fee income in 2018 totaled approximately $100 million . Ceded claims paid in 2018 were $78 million . Prior to April 2018, AXA Equitable reinsured to AXA RE Arizona, a 100% quota share of all liabilities for variable annuities with enhanced GMDB and GMIB riders issued on or after January 1, 2006 and in-force on September 30, 2008. AXA RE Arizona also reinsured a 90% quota share of level premium term insurance issued by AXA Equitable on or after March 1, 2003 through December 31, 2008 and lapse protection riders under UL insurance policies issued by AXA Equitable on or after June 1, 2003 through June 30, 2007. The reinsurance arrangements with AXA RE Arizona provided important capital management benefits to AXA Equitable. At December 31, 2017 , the Company’s GMIB reinsurance asset with AXA RE Arizona had a carrying value of $8,594 million and was reported in Guaranteed minimum income benefit reinsurance asset, at fair value in the consolidated balance sheets. Ceded premiums and policy fee income in 2017 and 2016 totaled approximately $454 million and $447 million , respectively. Ceded claims paid in 2017 and 2016 were $213 million and $65 million , respectively. The Company receives statutory reserve credits for reinsurance treaties with EQ AZ Life Re to the extent that EQ AZ Life Re holds assets in an irrevocable trust (the “Trust”). At December 31, 2018 , EQ AZ Life Re held assets of $1.6 billion in the Trust, and had letters of credit of $2.5 billion , which are guaranteed by Holdings. Under the reinsurance transactions, EQ AZ Life Re is permitted to transfer assets from the Trust under certain circumstances. The level of statutory reserves held by EQ AZ Life Re fluctuate based on market movements, mortality experience and policyholder behavior. Increasing reserve requirements may necessitate that additional assets be placed in trust and/or securing additional letters of credit, which could adversely impact EQ AZ Life Re’s liquidity. AXA Global Life retrocedes a quota share portion of certain life and health risks of various AXA Affiliates to AXA Equitable on a one-year term basis. Also, AXA Life Insurance Company Ltd. cedes a portion of its variable deferred annuity business to AXA Equitable. Premiums earned in 2018 , 2017 and 2016 were $20 million , $20 million and $20 million , respectively. Claims and expenses paid in 2018 , 2017 and 2016 were $8 million , $5 million , and $6 million , respectively. Reinsurance Ceded AXA Equitable cedes a portion of its life, health and catastrophe insurance business through reinsurance agreements to AXA Global Life, an affiliate. AXA Global Life, in turn, retrocedes a quota share portion of these risks prior to 2008 to AXA Equitable on a one-year term basis. AXA Equitable has entered into a Life Catastrophe Excess of Loss Reinsurance Agreement with a number of subscribing reinsurers, including AXA Global Life. AXA Global Life participates in 5% of the pool, pro-rata, across the upper and lower layers. Premiums and expenses paid for the above agreements in 2018 , 2017 and 2016 were $4 million , $4 million , and $4 million , respectively. Other Transactions On October 1, 2018, AXA Financial merged with and into its direct parent, Holdings, with Holdings continuing as the surviving entity. As a result, Holdings assumed AXA Financial’s obligations with respect to the Company, including obligations related to certain benefit plans. In March 2018, AXA Equitable sold its interest in two consolidated real estate joint ventures to AXA France for a total purchase price of approximately $143 million , which resulted in a pre-tax loss of $0.2 million and the reduction of $202 million of long-term debt on the Company’s balance sheet for the year ended December 31, 2018 . In 2016, AXA Equitable and Saum Sing LLC (“Saum Sing”), an affiliate, formed Broad Vista Partners LLC (“Broad Vista”), of which AXA Equitable owns 70% and Saum Sing owns 30% . On June 30, 2016, Broad Vista entered into a real estate joint venture with a third party and AXA Equitable invested approximately $25 million . Insurance Coverage Provided by XL Catlin On September 12, 2018, AXA Group acquired XL Catlin. Prior to the acquisition, AXA Equitable had ceded part of our disability income business to XL Catlin and as of December 31, 2018 , the reserves ceded were $93 million . Expenses and Revenues for 2018, 2017 and 2016 The table below summarizes the expenses reimbursed to/from the Company and the fees received/paid by the Company in connection with certain services described above for the years ended December 31, 2018 , 2017 and 2016 . Years ended December 31, 2018 2017 2016 (in millions) Expenses paid or accrued for: Paid or accrued commission and fee expenses for sale of insurance products by AXA Distribution $ 613 $ 608 $ 587 General services provided by AXA Affiliates 109 186 188 Investment management services provided by AXA IM, AXA REIM and AXA Rosenberg 2 5 2 Total $ 724 $ 799 $ 777 Revenue received or accrued for: Investment management and administrative services provided to EQAT, VIP Trust, 1290 Funds and Other AXA Trusts $ 727 $ 720 $ 674 General services provided to AXA Affiliates 463 439 497 Amounts received or accrued for commissions and fees earned for sale of MONY America’s insurance products 44 45 43 Total $ 1,234 $ 1,204 $ 1,214

EMPLOYEE BENEFIT PLANS

EMPLOYEE BENEFIT PLANS	12 Months Ended
	Dec. 31, 2018
Retirement Benefits [Abstract]
Employee Benefit Plans	EMPLOYEE BENEFIT PLANS 401(k) AXA Equitable sponsors the AXA Equitable 401(k) Plan, a qualified defined contribution plan for eligible employees and financial professionals. The plan provides for both a company contribution and a discretionary profit-sharing contribution. Expenses associated with this 401(k) Plan were $19 million , $15 million and $16 million for the years ended December 31, 2018 , 2017 and 2016 , respectively. In December 2018 the Company announced a 3% Company match for the AXA Equitable 401(k) Plan beginning January 1, 2019. This match will supplement the existing Company contribution on eligible compensation. Pension plan AXA Equitable also sponsors the AXA Equitable Retirement Plan (the “AXA Equitable QP”), a frozen qualified defined benefit pension plan covering its eligible employees and financial professionals. This pension plan is non-contributory and its benefits are generally based on a cash balance formula and/or, for certain participants, years of service and average income over a specified period in the plan. Effective December 31, 2015, primary liability for the obligations of AXA Equitable Life under the AXA Equitable Life QP was transferred from AXA Equitable Life to AXA Financial, and upon the merger of AXA Financial into Holdings, Holdings assumes primary liability under terms of an Assumption Agreement. AXA Equitable Life remains secondarily liable for its obligations under the AXA Equitable Life QP and would recognize such liability in the event Holdings does not perform under the terms of the Assumption Agreement. The AXA Equitable QP is not governed by a collective-bargaining agreement and is not under a financial improvement plan or a rehabilitation plan. For the years ended December 31, 2018 , 2017 and 2016 , expenses related to the plan were $60 million , $27 million and $31 million , respectively. The following table presents the funded status of the plan. As of December 31, 2018 2017 (in millions) Legal Name of Plan: AXQ Equitable Retirement Plan EIN# 13-5570651 Total Plan Assets $ 1,993 $ 2,325 Accumulated Benefit Obligation $ 2,039 $ 2,389 Funded Status 97.8 % 97.3 % In addition to the AXA Equitable QP, AXA Equitable Life sponsors a non-qualified retirement plan, a medical and life retiree plan, and a post employment plan. The expenses related to these plans were $70 million , $37 million and $44 million for the years ended December 31, 2018 , 2017 and 2016 , respectively.

SHARE-BASED AND OTHER COMPENSAT

SHARE-BASED AND OTHER COMPENSATION PROGRAMS	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-Based and Other Compensation Programs	SHARE-BASED COMPENSATION PROGRAMS Compensation costs for 2018 , 2017 and 2016 for share-based payment arrangements as further described herein are as follows: Years Ended December 31, 2018 2017 2016 (in millions) Performance Shares (1) $ 12 $ 18 $ 17 Stock Options 2 1 1 AXA Shareplan — 9 14 Restricted Stock Unit Awards (2) 16 2 — Other Compensation Plans (3) — — 1 Total Compensation Expenses $ 30 $ 30 $ 33 ____________ (1) Reflects change to performance share retirement rules. Specifically, individuals who retire at any time after the grant date will continue to vest in their 2017 performance shares while individuals who retire prior to March 1, 2019 will forfeit all 2018 performance shares. (2) Reflects a $10 million adjustment for awards in 2018 with graded vesting, service-only conditions from the graded to the straight-line attribution method. (3) Includes stock appreciation rights and employee stock purchase plans. In 2017 and prior years, equity awards for employees and directors were available under the umbrella of AXA’s global equity program. Accordingly, equity awards granted in 2017 and prior years were linked to AXA’s stock. Following the IPO, Holdings has granted equity awards under the AXA Equitable Holdings, Inc. 2018 Omnibus Incentive Plan (the “Omnibus Plan”) which was adopted by Holdings on April 25, 2018. Awards under the Omnibus Plan are linked to Holdings’ common stock. As of December 31, 2018 , the common stock reserved and available for issuance under the Omnibus Plan was 5.5 million shares. 2018 Equity Awards All 2018 equity awards for Company employees and directors were granted under the Omnibus Plan. Accordingly, all grants discussed in this section will be settled in shares of Holdings’ common stock. As described below, Holdings made various grants of equity awards linked to the value of Holdings’ common stock in 2018 . For awards with graded vesting schedules and service-only vesting conditions, including restricted stock units (“RSUs”) and other forms of share-based payment awards, the Company applies a straight-line expense attribution policy for the recognition of compensation cost. Actual forfeitures with respect to the 2018 grants were considered immaterial in the recognition of compensation cost. Transaction Incentive Awards On May 9, 2018 , coincident with the IPO, Holdings granted one-time “Transaction Incentive Awards” to executive officers and certain other Company employees in the form of 0.6 million Holdings RSUs. Fifty percent of the Holdings RSUs will vest based on service over a two -year period from the IPO date (the “Service Units”), and fifty percent will vest based on service and a market condition (the “Performance Units”). The market condition is based on share price growth of at least 130% or 150% within a two or five -year period, respectively. If the market condition is not achieved, 50% of the Performance Units may still vest based on five years of continued service and the remaining Performance Units will be forfeited. The $6 million aggregate grant-date fair value of the 0.3 million Service Units was measured at the $20 IPO price of a Holdings share and will be charged to compensation expense over the stated requisite service periods. The grant-date fair value of half of the Performance Units, or 0.2 million Holdings RSUs, was also measured at the $20 IPO price for a Holdings share as employees are still able to vest in these awards even if the share price growth targets are not achieved. The resulting $3 million for these awards will be charged to compensation expense over the five -year requisite service period. The grant-date fair value of $16.47 was used to value the remaining half of the Performance Units that are subject to risk of forfeiture for non-achievement of the Holdings share price conditions. The grant date fair value was measured using a Monte Carlo simulation from which a five -year requisite service period was derived, representing the median of the distribution of stock price paths on which the market condition is satisfied, over which the total $3 million compensation expense will be recognized. In 2018 , the Company recognized compensation expense associated with the Transaction Incentive Awards of approximately $6 million . Special IPO Grant Also, on May 9, 2018, Holdings made a grant of 0.2 million Holdings RSUs to Company employees , or 50 restricted stock units to each eligible individual, that cliff vested on November 9, 2018. The grant-date fair value of the award was measured using the $20 IPO price for a Holdings share and the resulting $5 million has been recognized as compensation expense over the six-month service period ending November 9, 2018. Annual Awards Under 2018 Equity Program Annual awards under Holdings’ 2018 equity program consisted of a mix of equity vehicles including Holdings RSUs, Holdings stock options and Holdings performance shares. If Holdings pays any ordinary dividend in cash, all outstanding Holdings RSUs and performance shares will accrue dividend equivalents in the form of additional Holdings RSUs or performance shares to be settled or forfeited consistent with the terms of the related award. Holdings RSUs On May 17, 2018, Holdings granted 0.8 million Holdings RSUs to Company employees that vest ratably in equal annual installments over a three -year period on each of the first three anniversaries of March 1, 2018. The fair value of the award was measured using the closing price of the Holdings share on the grant date, and the resulting $18 million will be recognized as compensation expense over the shorter of the vesting term or the period up to the date at which the participant becomes retirement eligible but not prior to March 1, 2019. Holdings Stock Options On June 11, 2018, Holdings granted 0.9 million Holdings stock options to Company employees. These options expire on March 1, 2028 and have a three -year graded vesting schedule, with one-third vesting on each of the three anniversaries of March 1, 2018. The exercise price for the options is $21.34 , which was the closing price of a Holdings share on the grant date. The weighted average grant date fair value per option was estimated at $4.61 using a Black-Scholes options pricing model. Key assumptions used in the valuation included expected volatility of 25.4% based on historical selected peer data, a weighted average expected term of 5.7 years as determined by the simplified method, an expected dividend yield of 2.44% based on Holdings’ expected annualized dividend, and a risk-free interest rate of 2.83% . The total fair value of these options of approximately $4 million will be charged to expense over the shorter of the vesting period or the period up to the date at which the participant becomes retirement eligible but not prior to March 1, 2019. In 2018 , the Company recognized expense associated with the June 11, 2018 option grant of approximately $2 million . Holdings Performance Shares On May 17, 2018, Holdings granted 0.4 million unearned Holdings performance shares to Company employees, subject to performance conditions and a cliff-vesting term ending March 1, 2021. The performance shares consist of two distinct tranches; one based on the Company’s return-on-equity targets (the “ROE Performance Shares”) and the other based on the Holdings’ relative total shareholder return targets (the “TSR Performance Shares”), each comprising approximately one-half of the award. Participants may receive from 0% to 200% of the unearned performance shares granted. The grant-date fair value of the ROE Performance Shares will be established once the 2019 and 2020 Non-GAAP ROE target are determined and approved. The grant-date fair value of the TSR Performance Shares was measured at $23.17 using a Monte Carlo approach. Under the Monte Carlo approach, stock returns were simulated for Holdings and the selected peer companies to estimate the payout percentages established by the conditions of the award. The resulting $4 million aggregate grant-date fair value of the unearned TSR Performance Shares will be recognized as compensation expense over the shorter of the cliff-vesting period or the period up to the date at which the participant becomes retirement eligible but not prior to March 1, 2019. In 2018 , the Company recognized expense associated with the TSR Performance Share awards of approximately $2 million . Prior Equity Award Grants and Settlements Prior to adoption of the Omnibus Plan, Company employees were granted AXA ordinary share options under the AXA Stock Option Plan for AXA Financial Employees and Associates (the “Stock Option Plan”). There is no limitation in the Stock Option Plan on the number of shares that may be issued pursuant to option or other grants. Employees were also granted AXA performance shares under the AXA International Performance Shares Plan established for each year (the “Performance Share Plan”). The fair values of these prior awards are measured at the grant date by reference to the closing price of the AXA ordinary share, and the result, as adjusted for achievement of performance targets and pre-vesting forfeitures, generally is attributed over the shorter of the requisite service period, the performance period, if any, or to the date at which retirement eligibility is achieved and subsequent service no longer is required for continued vesting of the award. 2017 Performance Shares Grant On June 21, 2017, under the terms of the Performance Share Plan, AXA awarded approximately 1.7 million unearned performance shares to Company employees. The extent to which 2017-2019 cumulative performance targets measuring the performance of AXA and the Company are achieved will determine the number of performance shares earned, which may vary between 0 % and 130 % of the number of performance shares at stake. The performance shares earned during this performance period will vest and be settled on the fourth anniversary of the award date. The plan will settle in AXA ordinary shares to all participants. In 2018 and 2017 , the expense associated with the June 21, 2017 grant of performance shares was approximately $4 million and $9 million , respectively. 2016 Performance Shares Grant On June 6, 2016, under the terms of the Performance Share Plan, AXA awarded approximately 1.9 million unearned performance shares to Company employees of AXA Equitable. The extent to which 2017-2019 cumulative performance targets measuring the performance of AXA and the Company are achieved will determine the number of performance shares earned, which may vary between 0% and 130% of the number of performance shares at stake. The performance shares earned during this performance period will vest and be settled on the fourth anniversary of the award date. The plan will settle in AXA ordinary shares to all participants. In 2018 , 2017 and 2016 , the expense associated with the June 6, 2016 grant of performance shares was approximately $4 million , $4 million and $10 million , respectively. Settlement of 2014 Grant in 2017 On March 24, 2017, share distributions totaling of approximately $21 million were made to active and former AXA Equitable employees in settlement of 2.3 million performance shares earned under the terms of the AXA Performance Share Plan 2014. Other Grants Prior to the IPO, non-officer directors were granted restricted AXA ordinary shares (prior to 2011, AXA ADRs) and unrestricted AXA ordinary shares (prior to March 15, 2010, AXA ADRs) annually under The Equity Plan for Directors. AXA restricted stock units (“AXA RSUs”) were also granted to certain Company executives. The AXA RSUs are phantom AXA ordinary shares that, once vested, entitle the recipient to a cash payment based on the average closing price of the AXA ordinary share over the twenty trading days immediately preceding the vesting date. Summary of Stock Option Activity A summary of activity in the AXA and Holdings option plans during 2018 follows: Options Outstanding EQH Shares AXA Ordinary Shares AXA ADRs (2) Number Outstanding (In 000’s) Weighted Average Exercise Price Number Outstanding (In 000’s) Weighted Average Exercise Price Number Outstanding (In 000’s) Weighted Average Exercise Price Options Outstanding at January 1, 2018 — $ — 3,653 € 17.36 20 $ 20.98 Options granted 869 $ 21.34 — € — — $ — Options exercised — $ — (337 ) € 11.80 — $ — Options forfeited, net (35 ) $ 21.34 — € — — $ — Options expired — $ — (707 ) € 17.45 (5 ) $ 35.25 Options Outstanding at December 31, 2018 834 $ 21.34 2,609 € 18.20 15 $ 15.37 Aggregate Intrinsic Value (1) $ — € 2,383 $ 151 Weighted Average Remaining Contractual Term (in years) 9.16 4.50 0.58 Options Exercisable at December 31, 2018 — $ — 1,369 € 15.27 15 $ 15.37 Aggregate Intrinsic Value (1) $ — € 7,698 $ 151 Weighted Average Remaining Contractual Term (in years) — 2.45 0.58 ____________ (1) Aggregate intrinsic value, presented in thousands, is calculated as the excess of the closing market price on December 31, 2018 of the respective underlying shares over the strike prices of the option awards. For awards with strike prices higher then market prices, intrinsic value is shown as zero. (2) AXA ordinary shares will be delivered to participants in lieu of AXA ADRs at exercise or maturity. For the purpose of estimating the fair value of stock option awards, the Company applies the Black-Scholes model and attributes the result over the requisite service period using the graded-vesting method. A Monte-Carlo simulation approach was used to model the fair value of the conditional vesting feature of the awards of options to purchase Holdings and AXA ordinary shares. Shown below are the relevant input assumptions used to derive the fair values of options awarded in 2018 , 2017 and 2016 , respectively. EQH Shares AXA Ordinary Shares (1) 2018 2018 2017 2016 Dividend yield 2.44 % NA 6.53 % 6.49 % Expected volatility 25.40 % NA 25.05 % 26.6 % Risk-free interest rates 2.83 % NA 0.59 % 0.33 % Expected life in years 9.7 NA 8.8 8.1 Weighted average fair value per option at grant date $ 4.61 NA $ 2.01 $ 2.06 ____________ (1) There were no options to buy AXA Ordinary Shares awarded durin g 2018 . As such, the input assumptions for 2018 are not applicable. As of December 31, 2018 , approximately $1 million of unrecognized compensation cost related to unvested stock option awards, net of estimated pre-vesting forfeitures, is expected to be recognized by the Company over a weighted average period of 2.2 years. As of December 31, 2018 , approximately $3 million of unrecognized compensation cost related to Holdings unvested stock option awards, net of estimated pre-vesting forfeitures, is expected to be recognized by the Company over a weighted average period of 0.8 years. Options The fair value of AXA stock options is calculated using the Black-Scholes option pricing model. The expected AXA dividend yield is based on market consensus. AXA share price volatility is estimated on the basis of implied volatility, which is checked against an analysis of historical volatility to ensure consistency. The risk-free interest rate is based on the Euro Swap Rate curve for the appropriate term. The effect of expected early exercise is taken into account through the use of an expected life assumption based on historical data. Restricted Awards The market price of a Holdings share is used as the basis for the fair value measure of a Holdings RSU. For purposes of determining compensation cost for stock-settled Holdings RSUs, fair value is fixed at the grant date until settlement, absent modification to the terms of the award. For 2018 , 2017 and 2016 , respectively, the Company recognized compensation costs of $16 million , $2 million and $0 million for outstanding restricted stock and AXA RSUs. The fair values of awards made under these programs are measured at the grant date by reference to the closing price of the unrestricted shares, and the result generally is attributed over the shorter of the requisite service period, the performance period, if any, or to the date at which retirement eligibility is achieved and subsequent service no longer is required for continued vesting of the award. Remeasurements of fair value for subsequent price changes until settlement are made only for AXA RSUs. At December 31, 2018 , approximately 2.3 million restricted Holdings and AXA ordinary share awards remain unvested. Unrecognized compensation cost related to these awards totaled approximately $19 million , net of estimated pre-vesting forfeitures, and is expected to be recognized over a weighted average period of 1.2 years. The following table summarizes restricted Holdings share and AXA ordinary share activity for 2018 . Shares of Holdings Restricted Stock (in thousands) Weighted Average Grant Date Fair Value Shares of AXA Restricted Stock (in thousands) Weighted Average Grant Date Fair Value Unvested as of January 1, 2018 — $ — 84 $ 21.07 Granted 1,696 $ 20.83 — $ — Cancelled 56 $ 21.21 — $ 26.64 Vested 381 $ 21.09 $ — 36 $ 21.99 Unvested as of December 31, 2018 1,259 $ 21.00 $ — 48 $ 20.38 Employee Stock Purchase Plans AXA Shareplan 2017 In 2017 , eligible employees of AXA Equitable were offered the opportunity to purchase newly issued AXA ordinary shares, subject to plan limits, under the terms of AXA Shareplan, AXA’s annual global stock purchase plan. Eligible employees could have reserved a share purchase during the reservation period from August 28, 2017 through September 8, 2017 and could have canceled their reservation or elected to make a purchase for the first time during the retraction/subscription period from October 13, 2017 through October 17, 2017. The U.S. dollar purchase price was determined by applying the U.S. dollar/Euro forward exchange rate on October 11, 2017 to the discounted formula subscription price in Euros. Investment Option A permitted participants to purchase AXA ordinary shares at a 20% formula discounted price of €20.19 per share. Investment Option B permitted participants to purchase AXA ordinary shares at an 8.98% formula discounted price of €22.96 per share on a leveraged basis with a guaranteed return of initial investment plus a portion of any appreciation in the undiscounted value of the total shares purchased. For purposes of determining the amount of any appreciation, the AXA ordinary share price will be measured over a fifty-two week period preceding the scheduled end date of AXA Shareplan 2018, which is July 1, 2022. All subscriptions became binding and irrevocable on October 17, 2017. The Company recognized compensation expense of $9 million and $14 million in the years ended December 31, 2017 and 2016 respectively, in connection with each respective year’s offering of AXA stock under the AXA Shareplan, representing the aggregate discount provided to AXA Equitable participants for their purchase of AXA stock under each of those plans, as adjusted for the post-vesting, five -year holding period. AXA Equitable participants in AXA Shareplan 2017 and 2016 primarily invested under Investment Option B for the purchase of approximately of 4 million and 6 million AXA ordinary shares, respectively. Holdings Stock Purchase Plan During 2018 , Holdings introduced the AXA Equitable Holdings, Inc. Stock Purchase Program (“SPP”). Participants are able to contribute up to 100% of their eligible compensation and receive a matching contribution in cash equal to 15% of their payroll contribution, which will be used to purchase Holdings shares. Purchases will be made on the last trading day of each month at the prevailing market rate.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES A summary of the income tax (expense) benefit in the consolidated statements of income (loss) follows: Years Ended December 31, 2018 2017 2016 (in millions) Income tax (expense) benefit: Current (expense) benefit $ 234 $ (6 ) $ (274 ) Deferred (expense) benefit 212 1,216 438 Total $ 446 $ 1,210 $ 164 The Federal income taxes attributable to consolidated operations are different from the amounts determined by multiplying the earnings before income taxes and noncontrolling interest by the expected Federal income tax rate of 21% , 35% and 35% for 2018 , 2017 and 2016 , respectively. The sources of the difference and their tax effects are as follows: Years Ended December 31, 2018 2017 2016 (in millions) Expected income tax (expense) benefit $ 311 $ (542 ) $ 14 Noncontrolling interest (1 ) — — Non-taxable investment income (loss) 104 241 173 Tax audit interest (11 ) (6 ) (14 ) State income taxes (1 ) (3 ) (6 ) Tax settlements/uncertain tax position release — 221 — Change in tax law 46 1,308 — Other (2 ) (9 ) (3 ) Income tax (expense) benefit $ 446 $ 1,210 $ 164 The Tax Cuts and Jobs Act (the “Tax Reform Act”) was enacted on December 22, 2017. The SEC issued Staff Accounting Bulletin No. 118 (“SAB 118”) to address the application of U.S. GAAP in situations where a company does not have the necessary information available to complete its accounting for certain income tax effects of the Tax Reform Act. In accordance with SAB 118, the Company determined reasonable estimates for certain effects of the Tax Reform Act and recorded those estimates as provisional amounts in the 2017 financial statements. The accounting for the income tax effects of the Tax Reform Act has been completed. The components of change in tax law are as follows: • An income tax expense of $4 million from the revaluation of deferred tax assets and liabilities that existed at the time of enactment. The calculation of cumulative temporary differences has been refined. • An income tax expense of $13 million related to the decrease in federal tax benefit allowable for audit interest as a result of lower corporate tax rates. • An income tax benefit of $20 million to reverse the sequestration fee applied to a portion of accumulated minimum tax credits in the 2017 financial statements. The Internal Revenue Service has since clarified that refundable minimum tax credits are not subject to sequestration. • During the fourth quarter of 2018, the Company adopted the Internal Revenue Service’s directive related to the calculation of tax reserves for variable annuity contracts. As a result of adoption of the directive, the Company released audit interest accrued for uncertainties in the calculation of variable annuity tax reserves. The impact on the Company’s financial statements was a benefit of $43 million . During the second quarter of 2017, the Company agreed to the Internal Revenue Service’s Revenue Agent’s Report for its consolidated 2008 and 2009 Federal corporate income tax returns. The impact on the Company’s financial statements and unrecognized tax benefits was a tax benefit of $221 million . The components of the net deferred income taxes are as follows: As of December 31, 2018 2017 Assets Liabilities Assets Liabilities (in millions) Compensation and related benefits $ 47 $ — $ 47 $ — Net operating loss 239 — — — Reserves and reinsurance — 32 — 83 DAC — 864 — 821 Unrealized investment gains (losses) 123 — — 298 Investments 670 — — 997 Tax credits 314 — 387 — Other 14 — 67 — Total $ 1,407 $ 896 $ 501 $ 2,199 The Company had $314 million and $387 million of AMT credits for the years ended December 31, 2018 and 2017 , respectively, which are expected to be refunded or utilized against future taxable income. A reconciliation of unrecognized tax benefits (excluding interest and penalties) follows: Years Ended December 31, 2018 2017 2016 (in millions) Balance at January 1, $ 205 $ 444 $ 406 Additions for tax positions of prior years 98 28 38 Reductions for tax positions of prior years (30 ) (234 ) — Settlements with tax authorities — (33 ) — Balance at December 31, $ 273 $ 205 $ 444 Unrecognized tax benefits that, if recognized, would impact the effective rate $ 202 $ 172 $ 329 The Company recognizes accrued interest and penalties related to unrecognized tax benefits in tax expense. Interest and penalties included in the amounts of unrecognized tax benefits at December 31, 2018 and 2017 were $41 million and $23 million , respectively. For 2018 , 2017 and 2016 , respectively, there w ere $18 million , $(44) million and $15 million in interest expense (benefit) related to unrecognized tax benefits. It is reasonably possible that the total amount of unrecognized tax benefits will change within the next 12 months due to the conclusion of IRS proceedings and the addition of new issues for open tax years. The possible change in the amount of unrecognized tax benefits cannot be estimated at this time. As of December 31, 2018 , tax years 2010 and subsequent remain subject to examination by the IRS.

ACCUMULATED OTHER COMPREHENSIVE

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) AOCI represents cumulative gains (losses) on items that are not reflected in income (loss). The balances for the past three years follow: December 31, 2018 2017 2016 (in millions) Unrealized gains (losses) on investments (1) $ (484 ) $ 581 $ (44 ) Defined benefit pension plans (2) (7 ) (51 ) (46 ) Total accumulated other comprehensive income (loss) from continuing operations (491 ) 530 (90 ) Less: Accumulated other comprehensive (income) loss attributable to non-controlling interest — 68 86 Accumulated other comprehensive income (loss) attributable to AXA Equitable $ (491 ) $ 598 $ (4 ) ____________ (1) 2018 includes a $86 million decrease to Accumulated other comprehensive loss from the impact of adoption of ASU 2018-02. (2) 2018 includes a $3 million increas e to Accumulated other comprehensive loss from the impact of adoption of ASU 2018-02. The components of OCI for the years ended December 31, 2018, 2017 and 2016, net of tax, follow: Years Ended December 31, 2018 2017 2016 (in millions) Change in net unrealized gains (losses) on investments: Net unrealized gains (losses) arising during the year $ (1,663 ) $ 782 $ (178 ) (Gains) losses reclassified into net income (loss) during the year (1) (4 ) 8 2 Net unrealized gains (losses) on investments (1,667 ) 790 (176 ) Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other 437 (165 ) (57 ) Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $(310), $244, and $(97)) (1,230 ) 625 (233 ) Change in defined benefit plans: Less: Reclassification adjustments to Net income (loss) for: (2) Amortization of net (gains) losses included in net periodic cost (4 ) (5 ) (3 ) Change in defined benefit plans (net of deferred income tax expense (benefit) of $0, $(2) and $(2)) (4 ) (5 ) (3 ) Total other comprehensive income (loss), net of income taxes from continuing operations (1,234 ) 620 (236 ) Other comprehensive income (loss) from discontinued operations, net of income taxes — (18 ) 17 Other comprehensive income (loss) attributable to AXA Equitable $ (1,234 ) $ 602 $ (219 ) ____________ (1) See “Reclassification adjustments” in Note 3 . Reclassification amounts presented net of income tax expense (benefit) of $(1) million , $(5) million and $(1) million for the years ended December 31, 2018 , 2017 and 2016 , respectively. (2) These AOCI components are included in the computation of net periodic costs (see “Employee Benefit Plans” in Note 13 ). Reclassification amounts presented net of income tax expense (benefit) of $ 0 million, $2 million and $2 million for the years ended December 31, 2018 , 2017 and 2016 , respectively. Investment gains and losses reclassified from AOCI to net income (loss) primarily consist of realized gains (losses) on sales and OTTI of AFS securities and are included in Total investment gains (losses), net on the consolidated statements of income (loss). Amounts reclassified from AOCI to Net income (loss) as related to defined benefit plans primarily consist of amortizations of net (gains) losses and net prior service cost (credit) recognized as a component of net periodic cost and reported in Compensation and benefit expenses in the consolidated statements of income (loss). Amounts presented in the table above are net of tax.

COMMITMENTS AND CONTINGENT LIAB

COMMITMENTS AND CONTINGENT LIABILITIES	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingent Liabilities	COMMITMENTS AND CONTINGENT LIABILITIES Litigation Litigation, regulatory and other loss contingencies arise in the ordinary course of the Company’s activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters arising from the conduct of its business. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages and other relief. Claimants are not always required to specify the monetary damages they seek or they may be required only to state an amount sufficient to meet a court’s jurisdictional requirements. Moreover, some jurisdictions allow claimants to allege monetary damages that far exceed any reasonably possible verdict. The variability in pleading requirements and past experience demonstrates that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. Litigation against the Company includes a variety of claims including, among other things, insurers’ sales practices, alleged agent misconduct, alleged failure to properly supervise agents, contract administration, product design, features and accompanying disclosure, cost of insurance increases, the use of captive reinsurers, payments of death benefits and the reporting and escheatment of unclaimed property, alleged breach of fiduciary duties, alleged mismanagement of client funds and other matters. As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters. The outcome of a litigation or regulatory matter is difficult to predict and the amount or range of potential losses associated with these or other loss contingencies requires significant management judgment. It is not possible to predict the ultimate outcome or to provide reasonably possible losses or ranges of losses for all pending regulatory matters, litigation and other loss contingencies. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company’s financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters, nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company’s litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company’s results of operations or cash flows in a particular quarterly or annual period. For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company, however, believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of December 31, 2018 , the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date to be up to approximately $95 million . For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company’s accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews. In August 2015, a lawsuit was filed in Connecticut Superior Court, Judicial Division of New Haven entitled Richard T. O’Donnell, on behalf of himself and all others similarly situated v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action on behalf of all persons who purchased variable annuities from AXA Equitable, which were subsequently subjected to the volatility management strategy and who suffered injury as a result thereof. Plaintiff asserts a claim for breach of contract alleging that AXA Equitable Life implemented the volatility management strategy in violation of applicable law. In November 2015, the Connecticut Federal District Court transferred this action to the United States District Court for the Southern District of New York. In March 2017, the Southern District of New York granted AXA Equitable Life’s motion to dismiss the complaint. In April 2017, the plaintiff filed a notice of appeal. In April 2018, the United States Court of Appeals for the Second Circuit reversed the trial court’s decision with instructions to remand the case to Connecticut state court. In September 2018, the Second Circuit issued its mandate, following AXA Equitable Life’s notification to the court that it would not file a petition for writ of certiorari. The case was transferred in December 2018 and is pending in Connecticut Superior Court, Judicial District of Stamford. We are vigorously defending this matter. In February 2016, a lawsuit was filed in the United States District Court for the Southern District of New York entitled Brach Family Foundation, Inc. v. AXA Equitable Life Insurance Company. This lawsuit is a putative class action brought on behalf of all owners of universal life (“UL”) policies subject to AXA Equitable Life’s COI rate increase. In early 2016, AXA Equitable Life raised COI rates for certain UL policies issued between 2004 and 2007, which had both issue ages 70 and above and a current face value amount of $1 million and above. A second putative class action was filed in Arizona in 2017 and consolidated with the Brach matter. The current consolidated amended class action complaint alleges the following claims: breach of contract; misrepresentations by AXA Equitable Life in violation of Section 4226 of the New York Insurance Law; violations of New York General Business Law Section 349; and violations of the California Unfair Competition Law, and the California Elder Abuse Statute. Plaintiffs seek; (a) compensatory damages, costs, and, pre- and post-judgment interest; (b) with respect to their claim concerning Section 4226, a penalty in the amount of premiums paid by the plaintiffs and the putative class; and (c) injunctive relief and attorneys’ fees in connection with their statutory claims. Five other federal actions challenging the COI rate increase are also pending against AXA Equitable and have been coordinated with the Brach action for the purposes of pre-trial activities. They contain allegations similar to those in the Brach action as well as additional allegations for violations of various states’ consumer protection statutes and common law fraud. Two actions are also pending against AXA Equitable in New York state court. AXA Equitable is vigorously defending each of these matters. Leases The Company has entered into operating leases for office space and certain other assets, principally information technology equipment and office furniture and equipment. Future minimum payments under non-cancelable operating leases for 2019 and the four successive years are $81 million , $74 million , $69 million , $67 million , $63 million and $66 million thereafter. Minimum future sublease rental income on these non-cancelable operating leases for 2019 and the four successive years is $12 million , $12 million , $12 million , $12 million , $12 million and $0 million thereafter. Rent expense, which is amortized on a straight-line basis over the life of the lease, was $82 million , $78 million , $72 million , respect ive ly, for the years ended December 31, 2018 , 2017 and 2016 , net of su blease income of $12 million , $16 million , $13 million , respectively, for the years ended December 31, 2018 , 2017 and 2016 . Obligations under Funding Agreements Entering into FHLBNY membership, borrowings and funding agreements requires the ownership of FHLBNY stock and the pledge of assets as collateral. AXA Equitable has purchased FHLBNY stock of $190 million and pledged collateral with a carrying value of $6.1 billion , as of December 31, 2018 . AXA Equitable issues short-term funding agreements to the FHLBNY and uses the funds for asset liability and cash management purposes. AXA Equitable issues long-term funding agreements to the FHLBNY and uses the funds for spread lending purposes. Funding agreements are reported in Policyholders’ account balances in the consolidated balance sheets. For other instruments used for asset/liability and cash management purposes, see “Derivative and offsetting assets and liabilities” included in Note 3 . The table below summarizes the Company’s activity of funding agreements with the FHLBNY. Outstanding balance at end of period Maturity of outstanding balance Issued during the period Repaid during the period (in millions) December 31, 2018: Short-term FHLBNY funding agreements $ 1,490 Less than one month $ 7,980 $ 6,990 Long-term FHLBNY funding agreements 1,621 Less than four years — — 98 Less than five years — — 781 Greater than five years — — Total long-term funding agreements 2,500 — — Total FHLBNY funding agreements at December 31, 2018 (1) $ 3,990 $ 7,980 $ 6,990 December 31, 2017: Short-term FHLBNY funding agreements $ 500 Less than one month $ 6,000 $ 6,000 Long-term FHLBNY funding agreements 1,244 Less than four years 324 377 Less than five years 303 879 Greater than five years 135 Total long-term funding agreements 2,500 762 $ — Total FHLBNY funding agreements at December 31, 2017 (1) $ 3,000 $ 6,762 $ 6,000 ____________ (1) The $11 million and $14 million difference between the funding agreements carrying value shown in fair value table for 2018 and 2017 , respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements borrowing rates. Guarantees and Other Commitments The Company provides certain guarantees or commitments to affiliates and others. At December 31, 2018 , these arrangements include commitments by the Company to provide equity financing of $927 million (including $280 million with affiliates and $12 million on consolidated VIEs) to certain limited partnerships and real estate joint ventures under certain conditions. Management believes the Company will not incur material losses as a result of these commitments. AXA Equitable is the obligor under certain structured settlement agreements it had entered into with unaffiliated insurance companies and beneficiaries. To satisfy its obligations under these agreements, AXA Equitable owns single premium annuities issued by previously wholly owned life insurance subsidiaries. AXA Equitable has directed payment under these annuities to be made directly to the beneficiaries under the structured settlement agreements. A contingent liability exists with respect to these agreements should the previously wholly owned subsidiaries be unable to meet their obligations. Management believes the need for AXA Equitable to satisfy those obligations is remote. The Company had $18 million of undrawn letters of credit related to reinsurance at December 31, 2018 . The Company had $606 million of commitments under existing mortgage loan agreements at December 31, 2018 . Pursuant to certain assumption agreements (the “Assumption Agreements”), AXA Financial legally assumed primary liability from AXA Equitable for all current and future liabilities of AXA Equitable under certain employee benefit plans that provide participants with medical, life insurance and deferred compensation benefits as well as under the AXA Equitable Retirement plan, a frozen qualified pension plan. AXA Equitable remains secondarily liable for its obligations under these plans and would recognize such liabilities in the event AXA Financial does not perform under the terms of the Assumption Agreements. On October 1, 2018, AXA Financial merged with and into its direct parent, Holdings, with Holdings continuing as the surviving entity. See Note 1 for further information.

INSURANCE GROUP STATUTORY FINAN

INSURANCE GROUP STATUTORY FINANCIAL INFORMATION	12 Months Ended
	Dec. 31, 2018
Insurance Group Statutory Financial Information [Abstract]
Insurance Group Statutory Financial Information	INSURANCE GROUP STATUTORY FINANCIAL INFORMATION For 2018 , 2017 and 2016 , respectively, AXA Equitable’s statutory net income (loss) totaled $3,120 million , $748 million and $679 million . Statutory surplus, Capital stock and Asset Valuation Reserve (“AVR”) totaled $7.9 billion and $8.7 billion at December 31, 2018 and 2017 , respectively. At December 31, 2018 , AXA Equitable, in accordance with various government and state regulations, had $55 million of securities on deposit with such government or state agencies. In 2018, AXA Equitable Life paid to its direct parent which subsequently distributed such amount to Holdings an ordinary shareholder dividend of $1.1 billion . Also in 2018 , AXA Equitable Life transferred its interests in ABLP, AB Holding and the General Partner to Alpha Units Holdings, Inc., a newly formed subsidiary, and distributed the shares of that subsidiary to its direct parent which subsequently distributed such shares to Holdings (the “AB Ownership Transfer”). The AB Ownership transfer was considered an extraordinary dividend of $1.7 billion representing the equity value of Alpha Units Holdings, Inc. In connection with the AB Ownership Transfer, AXA Equitable Life paid an extraordinary cash dividend of $572 million and issued a surplus note to Holdings in the same amount. The surplus note was repaid on March 5, 2019 . In 2017 , AXA Equitable Life did not pay shareholder dividends and in 2016 , AXA Equitable paid $1.1 billion in shareholder dividends. Dividend Restrictions As a domestic insurance subsidiary regulated by the insurance laws of New York State, AXA Equitable Life, is subject to restrictions as to the amounts permitted to be paid as dividends and the amounts of any outstanding surplus notes permitted to be repaid to Holdings. New York State insurance law provides that a stock life insurer may not, without prior approval of the New York State Department of Financial Services (“NYDFS”), pay a dividend to its stockholders exceeding an amount calculated under one of two standards (the “Standards”). The first standard allows payment of an ordinary dividend out of the insurer’s earned surplus (as reported on the insurer’s most recent annual statement) up to a limit calculated pursuant to a statutory formula, provided that the NYDFS is given notice and opportunity to disapprove the dividend if certain qualitative tests are not met (the “Earned Surplus Standard”). The second standard allows payment of an ordinary dividend up to a limit calculated pursuant to a different statutory formula without regard to the insurer’s earned surplus. Dividends exceeding these prescribed limits require the insurer to file a notice of its intent to declare the dividends with the NYDFS and prior approval or non-disapproval from the NYDFS. In applying the Standards, AXA Equitable Life could pay ordinary dividends up to approximately $1.0 billion during 2019 or, if the amount under the Earned Surplus Standard was limited to the amount of AXA Equitable Life’s positive unassigned funds as reported on its 2019 annual statement, $2.1 billion . However, in connection with the AB Ownership Transfer, AXA Equitable Life agreed with the NYDFS that it would not seek a dividend of greater than $1.0 billion under the Earned Surplus Standard during 2019. Prescribed and Permitted Accounting Practices At December 31, 2018 and for the year then ended, there were no differences in net income (loss) and capital and surplus resulting from practices prescribed and permitted by NYDFS and those prescribed by NAIC Accounting Practices and Procedures effective at December 31, 2018 . The Company cedes a portion of their statutory reserves to EQ AZ Life Re , a captive reinsurer, as part of the Company’s capital management strategy. EQ AZ Life Re prepares financial statements in a special purpose framework for statutory reporting. Differences between Statutory Accounting Principles and U.S. GAAP Accounting practices used to prepare statutory financial statements for regulatory filings of stock life insurance companies differ in certain instances from U.S. GAAP. The differences between statutory surplus and capital stock determined in accordance with Statutory Accounting Principles (“SAP”) and total equity under GAAP are primarily: (a) the inclusion in SAP of an AVR intended to stabilize surplus from fluctuations in the value of the investment portfolio; (b) future policy benefits and policyholders’ account balances under SAP differ from U.S. GAAP due to differences between actuarial assumptions and reserving methodologies; (c) certain policy acquisition costs are expensed under SAP but deferred under U.S. GAAP and amortized over future periods to achieve a matching of revenues and expenses; (d) under SAP, Federal income taxes are provided on the basis of amounts currently payable with limited recognition of deferred tax assets while under U.S. GAAP, deferred taxes are recorded for temporary differences between the financial statements and tax basis of assets and liabilities where the probability of realization is reasonably assured; (e) the valuation of assets under SAP and U.S. GAAP differ due to different investment valuation and depreciation methodologies, as well as the deferral of interest-related realized capital gains and losses on fixed income investments; (f) the valuation of the investment in AB and AB Holding under SAP reflected a portion of the market value appreciation rather than the equity in the underlying net assets as required under U.S. GAAP; (g) reporting the surplus notes as a component of surplus in SAP but as a liability in U.S. GAAP; (h) computer software development costs are capitalized under U.S. GAAP but expensed under SAP; (i) certain assets, primarily prepaid assets, are not admissible under SAP but are admissible under U.S. GAAP, (j) the fair valuing of all acquired assets and liabilities including intangible assets are required for U.S. GAAP purchase accounting and (k) cost of reinsurance which is recognized as expense under SAP and amortized over the life of the underlying reinsured policies under U.S. GAAP.

DISCONTINUED OPERATIONS

DISCONTINUED OPERATIONS	12 Months Ended
	Dec. 31, 2018
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	DISCONTINUED OPERATIONS Distribution of AllianceBernstein to Holdings Effective December 31, 2018, the Company and its subsidiaries transferred all economic interests in the business of AB to a newly created entity, Alpha Unit Holdings, LLC (“Alpha”). The Company distributed all equity interests in Alpha to AXA Equitable Financial Services, LLC, a wholly-owned subsidiary of Holdings. The AB transfer and subsequent distribution of Alpha equity interests (“the AB Business Transfer”) removed the authority to control the business of AB and as such AB’s operations are now reflected as a discontinued operation in the Company’s consolidated financial statements in all periods presented. Prior to the fourth quarter of 2018, the Company reported the operations of AB as its Investment Management and Research segment. In connection with the transfer, the Company paid an extraordinary dividend in cash to Holdings in the amount of $572 million . The Company also issued a one-year senior surplus note to Holdings for $572 million that was repaid on March 5, 2019. See Note 12 for details of the senior surplus note. Transactions Prior to Distribution Intercompany transactions prior to the AB Business Transfer between the Company and AB were eliminated and excluded from the consolidated statements of income (loss) and consolidated balance sheets. The table below presents AB’s revenues recognized in 2018 , 2017 and 2016 , disaggregated by category: Years Ended December 31, 2018 2017 2016 (in millions) Investment management, advisory and service fees: Base fees $ 2,156 $ 2,025 $ 1,809 Performance-based fees 118 95 33 Research services 439 450 480 Distribution services 419 412 384 Other revenues: Shareholder services 76 75 78 Other 35 42 21 Total investment management and service fees $ 3,243 $ 3,099 $ 2,804 Transactions Ongoing after Distribution After the AB Business Transfer, services provided by AB will consist primarily of an investment management service agreement and will be included in investment expenses and identified as a related party transaction. Discontinued Operations The following table presents the amounts related to the Net income (loss) of AB that has been reflected in Discontinued operations: Years Ended December 31, 2018 2017 2016 (in millions) REVENUES Net derivative gains (losses) $ 12 $ (24 ) $ (16 ) Net investment income (loss) 24 142 150 Investment gains (losses), net: Other investment gains (losses), net — — (2 ) Total investment gains (losses), net — — (2 ) Investment management and service fees 3,243 3,099 2,804 Total revenues $ 3,279 $ 3,217 $ 2,936 BENEFITS AND OTHER DEDUCTIONS Compensation and benefits $ 1,370 $ 1,307 $ 1,231 Commissions and distribution related payments 427 415 372 Interest expense 8 6 3 Other operating costs and expenses 727 789 699 Total benefits and other deductions 2,532 2,517 2,305 Income (loss) from discontinued operations, before income taxes 747 700 631 Income tax (expense) benefit (69 ) (82 ) (69 ) Net income (loss) from discontinued operations, net of taxes 678 618 562 Less: Net (income) loss attributable to the noncontrolling interest (564 ) (533 ) (496 ) Net income (loss) from discontinued operations, net of taxes and noncontrolling interest $ 114 $ 85 $ 66 The following table presents the amounts related to the financial position of AB as of December 31, 2017. As the Company deconsolidated AB effective December 31, 2018, amounts related to AB’s financial position as of December 31, 2018 are not included in the Company’s consolidated balance sheet as of that date. The amounts as of December 31, 2017 have been reflected in either the Assets of disposed subsidiary or Liabilities of disposed subsidiary, as applicable, in the Company’s consolidated balance sheet: Assets and Liabilities of Disposed Subsidiary As of December 31, 2017 (in millions) ASSETS Investments: Other equity investments $ 87 Trading securities, at fair value 351 Other invested assets 1,291 Total investments 1,729 Cash and cash equivalents 1,009 Cash and securities segregated, at fair value 816 Broker-dealer related receivables 2,158 Intangible assets, net 3,709 Other assets 414 Total Assets of Disposed Subsidiary $ 9,835 As of December 31, 2017 (in millions) LIABILITIES Broker-dealer related payables $ 334 Customer related payables 2,229 Long-term debt 566 Current and deferred income taxes 404 Other liabilities 1,421 Total Liabilities of Disposed Subsidiary $ 4,954 Redeemable noncontrolling interest of disposed subsidiary 602

QUARTERLY FINANCIAL INFORMATION

QUARTERLY FINANCIAL INFORMATION (UNAUDITED)	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Data [Abstract]
Quarterly Financial Information (Unaudited)	QUARTERLY FINANCIAL INFORMATION (UNAUDITED) The unaudited quarterly financial information for the years ended December 31, 2018 and 2017 are summarized in the table below: Three Months Ended March 31 June 30 September 30 December 31 (in millions) 2018 Total revenues $ 1,139 $ 1,621 $ 27 $ 4,164 Total benefits and other deductions 1,512 4,278 763 1,879 Net income (loss) $ (264 ) $ (2,084 ) $ (509 ) $ 1,936 2017 Total revenues $ 1,554 $ 3,763 $ 1,621 $ 1,518 Total benefits and other deductions 1,921 1,858 1,708 1,420 Net income (loss) $ (201 ) $ 1,508 $ 23 $ 1,515 Net Income (Loss) Volatility With the exception of the GMxB Unwind during the second quarter of 2018 that is further described in Note 12, the fluctuation in the Company’s quarterly Net income (loss) during 2018 and 2017 is not due to any specific events or transactions, but instead is driven primarily by the impact of changes in market conditions on the Company’s liabilities associated with GMxB features embedded in its variable annuity products, partially offset by derivatives the Company has in place to mitigate the movement in those liabilities. As those derivatives do not qualify for hedge accounting treatment, volatility in Net income (loss) result from the changes in value of the derivatives being recognized in the period in which they occur, with offsetting changes in the liabilities being partially recognized in the current period. Reclassification of DAC Capitalization During the fourth quarter of 2018, the Company revised the presentation of the capitalization of deferred policy acquisition costs (“DAC”) in the consolidated statements of income for all prior periods presented herein by netting the capitalized amounts within the applicable expense line items, such as Compensation and benefits, Commissions and distribution plan payments and Other operating costs and expenses. Previously, the Company had netted the capitalized amounts within the Amortization of deferred acquisition costs. There was no impact on Net income (loss) or Comprehensive income of this reclassification. See Note 2 for further details of this reclassification. Revisions of Prior Period Interim Consolidated Financial Statements The Company’s third quarter 2018 financial statements were revised to reflect the correction of errors identified by the Company in its previously issued financial statements. The impact of these errors was not considered to be material. However, in order to improve the consistency and comparability of the financial statements, management revised the Company’s consolidated financial statements for the three and six months ended March 31, 2018 and June 30, 2018, respectively, as well as the three and six months ended March 31, 2017 and June 30, 2017. In addition, during the fourth quarter of 2018, the Company identified certain cash flows that were incorrectly classified in the Company’s historical consolidated statements of cash flows. The Company has determined that these mis-classifications were not material to the financial statements for any period. These misclassifications will be corrected in the comparative consolidated statements of cash flows for the three, six and nine months ended March 31, 2019, June 30, 2019 and September 30, 2019 that will appear in the Company’s first, second and third quarter 2019 Form 10-Q filings, respectively. Discontinued Operations In addition, as further described in Note 19, as a result of the AB Business Transfer effective as of December 31, 2018, AB’s operations are now reflected as Discontinued operations in the Company’s consolidated financial statements. The financial information for prior periods presented in the consolidated financial statements have been adjusted to reflect AB as Discontinued operations. Revision of Consolidated Financial Statements as of and for the Three Months Ended March 31, 2018 The following tables present line items of the consolidated financial statements as of and for the three months ended March 31, 2018 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s March 31, 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As of March 31, 2018 As Pre-viously Reported Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs 4,826 — 4,826 (119 ) 4,707 Total Assets $ 222,424 $ — $ 222,424 $ (119 ) $ 222,305 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities $ 28,374 $ — $ 28,374 $ (10 ) $ 28,364 Current and deferred taxes 1,728 (432 ) 1,296 (38 ) 1,258 Other liabilities 3,041 (1,941 ) 1,100 70 1,170 Total Liabilities $ 202,767 $ — $ 202,767 $ 22 $ 202,789 Equity: Retained Earnings $ 8,824 $ — $ 8,824 $ (141 ) $ 8,683 AXA Equitable Equity 15,545 — 15,545 (141 ) 15,404 Total Equity 18,633 — 18,633 (141 ) 18,492 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 222,424 $ — $ 222,424 $ (119 ) $ 222,305 Three Months Ended March 31, 2018 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 869 $ — $ — $ 869 $ (8 ) $ 861 Net derivative gains (losses) (777 ) — (2 ) (779 ) (38 ) (817 ) Total Revenues 2,031 — (846 ) 1,185 (46 ) 1,139 Benefits and other deductions: Policyholders’ benefits 489 — — 489 (9 ) 480 Interest credited to policyholders’ account balances 338 — — 338 (83 ) 255 Compensation and benefits 456 (33 ) (344 ) 79 70 149 Commissions and distribution related payments 371 (101 ) (110 ) 160 — 160 Amortization of deferred policy acquisition costs 10 135 — 145 64 209 Other operating costs and expenses 440 (1 ) (189 ) 250 — 250 Total benefits and other deductions 2,115 — (645 ) 1,470 42 1,512 Income (loss) from continuing operations, before income taxes (84 ) — (201 ) (285 ) (88 ) (373 ) Income tax (expense) benefit from continuing operations 44 — 17 61 19 80 Net income (loss) from continuing operations (40 ) — (184 ) (224 ) (69 ) (293 ) Net income (loss) (40 ) — (155 ) (195 ) (69 ) (264 ) Net income (loss) attributable to AXA Equitable $ (194 ) $ — $ — $ (194 ) $ (69 ) $ (263 ) Three Months Ended March 31, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Statements of Comprehensive Income (Loss): Net income (loss) $ (40 ) $ (155 ) $ (195 ) $ (69 ) $ (264 ) Comprehensive income (loss) $ (789 ) $ (162 ) $ (951 ) $ (69 ) $ (1,020 ) Comprehensive income (loss) attributable to AXA Equitable $ (950 ) $ — $ (950 ) $ (69 ) $ (1,019 ) Three Months Ended March 31, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 9,010 $ — $ 9,010 $ (72 ) $ 8,938 Net income (loss) (194 ) — (194 ) (69 ) (263 ) Retained earnings, end of period 8,824 — 8,824 (141 ) 8,683 Total AXA Equitable’s equity, end of period 15,545 15,545 (141 ) 15,404 Total Equity, End of Period $ 18,633 $ — $ 18,633 $ (141 ) $ 18,492 Three Months Ended March 31, 2018 As Reported Presentation Reclassifi- cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ (40 ) $ — $ (69 ) $ (109 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances $ 338 $ — $ (83 ) $ 255 Policy charges and fee income (869 ) — 8 (861 ) Net derivative (gains) losses 777 — 38 815 Amortization and depreciation — 137 64 201 Amortization of deferred sales commission 7 (7 ) — — Other depreciation and amortization (23 ) 23 — — Amortization of other Intangibles 8 (8 ) — — Equity (income) loss from limited partnerships — (39 ) — (39 ) Distributions from joint ventures and limited partnerships 25 (25 ) — — Changes in: Reinsurance recoverable 2 — (149 ) (147 ) Deferred policy acquisition costs 10 (10 ) — — Capitalization of deferred policy acquisition costs — (135 ) — (135 ) Future policy benefits (191 ) — (7 ) (198 ) Current and deferred income taxes (52 ) — 132 80 Other, net (122 ) 64 70 12 Net cash provided by (used in) operating activities $ (21 ) $ — $ 4 $ (17 ) Three Months Ended March 31, 2018 As Reported Presentation Reclassifi- cations Revisions As Revised (in millions) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Trading account securities $ 1,606 $ — $ 77 $ 1,683 Real estate held for the production of income — 140 — 140 Short-term investments — 688 — 688 Other 54 (140 ) — (86 ) Payment for the purchase/origination of: Short-term investments — (377 ) — (377 ) Cash settlements related to derivative instruments (14 ) — (489 ) (503 ) Change in short-term investments 396 (311 ) (85 ) — Other, net (560 ) — 153 (407 ) Net cash provided by (used in) investing activities $ (639 ) $ — $ (344 ) $ (983 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 2,366 $ — $ (468 ) $ 1,898 Withdrawals (1,322 ) — 241 (1,081 ) Transfer (to) from Separate Accounts (115 ) — 567 452 Net cash provided by (used in) financing activities $ 1,040 $ — $ 340 $ 1,380 ________________ (1) Net income (loss) includes $154 million in the three months ended March 31, 2018 of the discontinued operations that are not included in net income (loss) in the Consolidated Statements of Income (Loss). The following tables present line items of the consolidated financial statements as of June 30, 2018 and for the three and six months ended June 30, 2018 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s June 30, 2018 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, the adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As of June 30, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs $ 4,786 $ — $ 4,786 $ (76 ) $ 4,710 Amounts due from reinsurers 3,088 — 3,088 (9 ) 3,079 Current and deferred taxes 159 422 581 3 584 Total Assets $ 219,306 $ — $ 219,306 $ (82 ) $ 219,224 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities $ 28,122 $ — $ 28,122 $ (64 ) $ 28,058 Total Liabilities $ 202,196 $ — $ 202,196 $ (64 ) $ 202,132 Equity: Retained Earnings $ 6,617 $ — $ 6,617 $ (18 ) $ 6,599 AXA Equitable Equity 13,925 — 13,925 (18 ) 13,907 Total Equity 16,964 — 16,964 (18 ) 16,946 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 219,306 $ — $ 219,306 $ (82 ) $ 219,224 Three Months Ended June 30, 2018 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 904 $ — $ — $ 904 $ (21 ) $ 883 Net derivative gains (losses) (312 ) — — (312 ) 27 (285 ) Total revenues 2,439 — (824 ) 1,615 6 1,621 Benefits and other deductions: Policyholders’ benefits 1,339 — — 1,339 (38 ) 1,301 Compensation and benefits 466 (32 ) (360 ) 74 — 74 Commissions and distribution related payments 377 (112 ) (106 ) 159 — 159 Amortization of deferred policy acquisition costs 31 145 1 177 5 182 Other operating costs and expenses 2,486 (1 ) (172 ) 2,313 — 2,313 Total benefits and other deductions 4,950 — (639 ) 4,311 (33 ) 4,278 Income (loss) from continuing operations, before income taxes (2,511 ) — (185 ) (2,696 ) 39 (2,657 ) Income tax (expense) benefit from continuing operations 553 — 8 561 (9 ) 552 Net income (loss) from continuing operations (1,958 ) — (177 ) (2,135 ) 30 (2,105 ) Net income (loss) (1,958 ) — (156 ) (2,114 ) 30 (2,084 ) Net income (loss) attributable to AXA Equitable $ (2,114 ) $ — $ — $ (2,114 ) $ 30 $ (2,084 ) Three Months Ended June 30, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ (1,958 ) $ (156 ) $ (2,114 ) $ 30 $ (2,084 ) Comprehensive income (loss) (2,278 ) (142 ) (2,420 ) 30 (2,390 ) Comprehensive income (loss) attributable to AXA Equitable $ (2,420 ) $ — $ (2,420 ) $ 30 $ (2,390 ) Six Months Ended June 30, 2018 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 1,773 $ — $ — $ 1,773 $ (29 ) $ 1,744 Net derivative gains (losses) (1,172 ) — (2 ) (1,174 ) 72 (1,102 ) Total revenues 4,387 — (1,670 ) 2,717 43 2,760 Benefits and other deductions: Policyholders’ benefits 1,828 — — 1,828 (47 ) 1,781 Compensation and benefits 992 (65 ) (704 ) 223 — 223 Commissions and distribution related payments 748 (213 ) (216 ) 319 — 319 Amortization of deferred policy acquisition costs 89 280 1 370 21 391 Other operating costs and expenses 2,926 (2 ) (361 ) 2,563 — 2,563 Total benefits and other deductions 7,100 — (1,284 ) 5,816 (26 ) 5,790 Income (loss) from continuing operations, before income taxes (2,713 ) — (386 ) (3,099 ) 69 (3,030 ) Income tax (expense) benefit from continuing operations 622 — 25 647 (15 ) 632 Net income (loss) from continuing operations (2,091 ) — (361 ) (2,452 ) 54 (2,398 ) Net income (loss) (2,091 ) — (311 ) (2,402 ) 54 (2,348 ) Net income (loss) attributable to AXA Equitable $ (2,401 ) $ — $ — $ (2,401 ) $ 54 $ (2,347 ) Six Months Ended June 30, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ (2,091 ) $ (311 ) $ (2,402 ) $ 54 $ (2,348 ) Comprehensive income (loss) (3,160 ) (305 ) (3,465 ) 54 (3,411 ) Comprehensive income (loss) attributable to AXA Equitable $ (3,463 ) $ — $ (3,463 ) $ 54 $ (3,409 ) Six Months Ended June 30, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 9,010 $ — $ 9,010 $ (72 ) $ 8,938 Net income (loss) attributable to AXA Equitable (2,401 ) — (2,401 ) 54 (2,347 ) Retained earnings, end of period 6,617 — 6,617 (18 ) 6,599 Total AXA Equitable’s equity, end of period 13,925 — 13,925 (18 ) 13,907 Total Equity, End of Period $ 16,964 $ — $ 16,964 $ (18 ) $ 16,946 Six Months Ended June 30, 2018 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ (2,091 ) $ — $ 54 $ (2,037 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Policy charges and fee income (1,773 ) — 29 (1,744 ) Net derivative (gains) losses 1,172 — (72 ) 1,100 Amortization and depreciation — 335 21 356 Amortization of deferred sales commission 13 (13 ) — — Other depreciation and amortization (45 ) 45 — — Equity (income) loss from limited partnerships — (60 ) — (60 ) Distributions from joint ventures and limited partnerships 44 (44 ) — — Cash received on the recapture of captive reinsurance 1,099 — 174 1,273 Changes in: Reinsurance recoverable 15 — 166 181 Deferred policy acquisition costs 89 (89 ) — — Capitalization of deferred policy acquisition costs — (280 ) — (280 ) Future policy benefits 396 — (554 ) (158 ) Current and deferred income taxes (645 ) — 167 (478 ) Other, net 416 104 (304 ) 216 Net cash provided by (used in) operating activities $ 1,190 $ (2 ) $ (319 ) $ 869 Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Trading account securities 4,843 — 24 4,867 Real estate joint ventures $ — $ 140 $ — $ 140 Short-term investments — 1,331 (24 ) 1,307 Other 260 (140 ) — 120 Payment for the purchase/origination of: Short-term investments — (1,081 ) 205 (876 ) Cash settlements related to derivative instruments (267 ) — (489 ) (756 ) Change in short-term investments 248 (248 ) — — Other, net 379 — 11 390 Net cash provided by (used in) investing activities $ (1,605 ) $ 2 $ (273 ) $ (1,876 ) Six Months Ended June 30, 2018 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 5,227 $ — $ (1,107 ) $ 4,120 Withdrawals (2,611 ) — 480 (2,131 ) Transfer (to) from Separate Accounts (305 ) — 1,219 914 ________________ (1) Net income (loss) includes $310 million in the six months ended June 30, 2018 of the discontinued operations that are not included in net income (loss) in the Consolidated Statements of Income (Loss). The following tables present line items of the consolidated statement of cash flows for the nine months ended September 30, 2018 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s September 30, 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, the adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. Tables for the other consolidated financial statements as of or for the three and nine months ended September 30, 2018 are not presented as these revisions were already reflected in the Company’s September 30, 2018 Form 10-Q. Nine Months Ended September 30, 2018 As Reported Presentation Reclassifi- cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Amortization and depreciation $ — $ 258 $ — $ 258 Amortization of deferred sales commission 17 (17 ) — — Other depreciation and amortization (60 ) 60 — — Equity (income) loss from limited partnerships — (83 ) — (83 ) Distribution from joint ventures and limited partnerships 63 (63 ) — — Cash received on the recapture of captive reinsurance 1,099 — 174 1,273 Changes in: Reinsurance recoverable 20 — 86 106 Deferred policy acquisition costs (129 ) 129 — — Capitalization of deferred policy acquisition costs — (432 ) — (432 ) Future policy benefits (58 ) — (541 ) (599 ) Current and deferred income taxes (264 ) — (400 ) (664 ) Other, net 123 146 179 448 Net cash provided by (used in) operating activities $ 1,614 $ (2 ) $ (502 ) $ 1,110 Nine Months Ended September 30, 2018 As Reported Presentation Reclassifi- cations Revisions As Revised (in millions) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Trading account securities $ 6,913 $ — $ 77 $ 6,990 Real estate joint ventures — 140 — 140 Short-term investments — 1,806 — 1,806 Other 344 (140 ) — 204 Short-term investments — (1,530 ) 204 (1,326 ) Cash settlements related to derivative instruments (584 ) — (492 ) (1,076 ) Change in short-term investments 350 (274 ) (77 ) (1 ) Other, net 305 — (19 ) 286 Net cash provided by (used in) investing activities $ (2,990 ) $ 2 $ (307 ) $ (3,295 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 7,852 $ — $ (1,668 ) $ 6,184 Withdrawals (4,014 ) — 760 (3,254 ) Transfer (to) from Separate Accounts (338 ) — 1,717 1,379 Net cash provided by (used in) financing activities $ 1,293 $ — $ 809 $ 2,102 The following tables present line items of the consolidated financial statements as of and for the three months ended March 31, 20 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s March 31, 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, the adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As of March 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs 4,961 — 4,961 (64 ) 4,897 Total Assets $ 210,013 $ — $ 210,013 $ (64 ) $ 209,949 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities 28,691 — 28,691 66 28,757 Current and deferred taxes 2,726 (562 ) 2,164 (46 ) 2,118 Total Liabilities $ 195,091 $ — $ 195,091 $ 20 $ 195,111 Equity: Retained Earnings $ 5,978 $ — $ 5,978 $ (84 ) $ 5,894 AXA Equitable Equity 11,459 — 11,459 (84 ) 11,375 Noncontrolling interest 3,046 — 3,046 — 3,046 Total Equity 14,505 — 14,505 (84 ) 14,421 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 210,013 $ — $ 210,013 $ (64 ) $ 209,949 Three Months Ended March 31, 2017 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 852 $ — $ — $ 852 $ (22 ) $ 830 Net derivative gains (losses) (362 ) — 10 (352 ) 7 (345 ) Total revenues 2,314 — (745 ) 1,569 (15 ) 1,554 Benefits and other deductions: Policyholders’ benefits 975 — — 975 (3 ) 972 Interest credited to policyholders’ account balances 279 — — 279 (30 ) 249 Compensation and benefits 438 (33 ) (322 ) 83 — 83 Commissions and distribution related payments 382 (114 ) (96 ) 172 — 172 Amortization of deferred policy acquisition costs 29 148 — 177 63 240 Other operating costs and expenses 381 (1 ) (179 ) 201 — 201 Total benefits and other deductions 2,489 — (598 ) 1,891 30 1,921 Income (loss) from continuing operations, before income taxes (175 ) — (147 ) (322 ) (45 ) (367 ) Income tax (expense) benefit from continuing operations 121 — 11 132 16 148 Net income (loss) from continuing operations (54 ) — (136 ) (190 ) (29 ) (219 ) Net income (loss) (54 ) — (118 ) (172 ) (29 ) (201 ) Net income (loss) attributable to AXA Equitable $ (172 ) $ — $ — $ (172 ) $ (29 ) $ (201 ) Three Months Ended March 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ (54 ) $ (118 ) $ (172 ) $ (29 ) $ (201 ) Change in unrealized gains (losses), net of reclassification adjustment 92 — 92 21 113 Total other comprehensive income (loss), net of income taxes 127 (7 ) 120 21 141 Comprehensive income (loss) 73 (125 ) (52 ) (8 ) (60 ) Comprehensive income (loss) attributable to AXA Equitable $ (52 ) $ — $ (52 ) $ (8 ) $ (60 ) Three Months Ended March 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 6,150 $ — $ 6,150 $ (55 ) $ 6,095 Net income (loss) attributable to AXA Equitable (172 ) — (172 ) (29 ) (201 ) Retained earnings, end of period 5,978 — 5,978 (84 ) 5,894 Accumulated other comprehensive income, beginning of year 17 — 17 (21 ) (4 ) Other comprehensive income (loss) 120 — 120 21 141 Accumulated other comprehensive income, end of period 137 — 137 — 137 Total AXA Equitable’s equity, end of period 11,459 — 11,459 (84 ) 11,375 Total Equity, End of Period $ 14,505 $ — $ 14,505 $ (84 ) $ 14,421 Three Months Ended March 31, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ (54 ) $ — $ (29 ) $ (83 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances 279 — (30 ) 249 Policy charges and fee income (852 ) — 22 (830 ) Net derivative (gains) losses 362 — (7 ) 355 Amortization and depreciation — 229 63 292 Amortization of deferred sales commission 9 (9 ) — — Other depreciation and amortization 36 (36 ) — — Amortization of other intangibles 8 (8 ) — — Equity (income) loss from limited partnerships — (39 ) — (39 ) Distributions from joint ventures and limited partnerships 26 (26 ) — — Changes in: — Reinsurance recoverable (23 ) — (173 ) (196 ) Deferred policy acquisition costs 29 (29 ) — — Capitalization of deferred policy acquisition costs — (148 ) — (148 ) Future policy benefits 241 — 17 258 Current and deferred income taxes (188 ) — (6 ) (194 ) Other, net 151 65 — 216 Net cash provided by (used in) operating activities $ 18 $ (1 ) $ (143 ) $ (126 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Short-term investments — 631 — 631 Payment for the purchase/origination of: Short-term investments — (376 ) (289 ) (665 ) Change in short-term investments 254 (254 ) — — Other, net 43 — 100 143 Net cash provided by (used in) investing activities $ (2,447 ) $ 1 $ (189 ) $ (2,635 ) Three Months Ended March 31, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 2,240 $ — $ 269 $ 2,509 Withdrawals (785 ) — (157 ) (942 ) Transfer (to) from Separate Accounts 176 — 220 396 Net cash provided by (used in) financing activities $ 2,306 $ — $ 332 $ 2,638 ________________ (1) Net income (loss) includes $118 million in the three months ended March 31, 2017 of the discontinued operations that are not included in Net income (loss) in the Consolidated Statements of Income (Loss). The following tables present line items of the consolidated financial statements as of and for the three and six months ended June 30, 2017 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s June 30, 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, the adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As of June 30, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs 4,913 — 4,913 (63 ) 4,850 Total Assets $ 215,713 $ — $ 215,713 $ (63 ) $ 215,650 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities $ 29,679 $ — $ 29,679 $ 53 $ 29,732 Current and deferred taxes 3,267 (542 ) 2,725 (39 ) 2,686 Total Liabilities $ 199,095 $ — $ 199,095 $ 14 $ 199,109 Equity: Retained Earnings $ 7,479 $ — $ 7,479 $ (77 ) $ 7,402 AXA Equitable Equity 13,273 — 13,273 (77 ) 13,196 Total Equity 16,257 — 16,257 (77 ) 16,180 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 215,713 $ — $ 215,713 $ (63 ) $ 215,650 Three Months Ended June 30, 2017 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 846 $ — $ — $ 846 $ (12 ) $ 834 Net derivative gains (losses) 1,763 — 5 1,768 8 1,776 Total revenues 4,548 — (781 ) 3,767 (4 ) 3,763 Three Months Ended June 30, 2017 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Benefits and other deductions: Policyholders’ benefits 1,363 — — 1,363 (7 ) 1,356 Interest credited to policyholders’ account balances 208 — — 208 (9 ) 199 Compensation and benefits 450 (32 ) (328 ) 90 — 90 Commissions and distribution related payments 389 (116 ) (103 ) 170 — 170 Amortization of deferred policy acquisition costs (49 ) 150 — 101 (1 ) 100 Other operating costs and expenses 149 (2 ) (208 ) (61 ) — (61 ) Total benefits and other deductions 2,516 — (641 ) 1,875 (17 ) 1,858 Income (loss) from continuing operations, before income taxes 2,032 — (140 ) 1,892 13 1,905 Income tax (expense) benefit from continuing operations (419 ) — 11 (408 ) (5 ) (413 ) Net income (loss) from continuing operations 1,613 — (129 ) 1,484 8 1,492 Net income (loss) 1,613 — (113 ) 1,500 8 1,508 Net income (loss) attributable to AXA Equitable $ 1,500 $ — $ — $ 1,500 $ 8 $ 1,508 Three Months Ended June 30, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ 1,613 $ (113 ) $ 1,500 $ 8 $ 1,508 Comprehensive income (loss) 1,887 (93 ) 1,794 8 1,802 Comprehensive income (loss) attributable to AXA Equitable $ 1,794 $ — $ 1,794 $ 8 $ 1,802 Six Months Ended June 30, 2017 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 1,698 $ — $ — $ 1,698 $ (34 ) $ 1,664 Net derivative gains (losses) 1,362 — 15 1,377 54 1,431 Total revenues 6,823 — (1,526 ) 5,297 20 5,317 Six Months Ended June 30, 2017 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised Benefits and other deductions: Policyholders’ benefits 2,338 — — 2,338 (10 ) 2,328 Compensation and benefits 888 (65 ) (650 ) 173 — 173 Commissions and distribution related payments 771 (230 ) (199 ) 342 — 342 Amortization of deferred policy acquisition costs (20 ) 298 — 278 62 340 Other operating costs and expenses 530 (3 ) (387 ) 140 — 140 Total benefits and other deductions 4,966 — (1,239 ) 3,727 52 3,779 Income (loss) from continuing operations, before income taxes 1,857 — (287 ) 1,570 (32 ) 1,538 Income tax (expense) benefit from continuing operations (298 ) — 22 (276 ) 11 (265 ) Net income (loss) from continuing operations 1,559 — (265 ) 1,294 (21 ) 1,273 Net income (loss) 1,559 — (231 ) 1,328 (21 ) 1,307 Net income (loss) attributable to AXA Equitable $ 1,328 $ — $ — $ 1,328 $ (21 ) $ 1,307 Six Months Ended June 30, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ 1,559 $ (231 ) $ 1,328 $ (21 ) $ 1,307 Change in unrealized gains (losses), net of reclassification adjustment 386 — 386 21 407 Other comprehensive income 401 13 414 21 435 Comprehensive income (loss) attributable to AXA Equitable $ 1,742 $ — $ 1,742 $ — $ 1,742 Six Months Ended June 30, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Statements of Equity: Retained earnings, beginning of year $ 6,151 $ — $ 6,151 $ (56 ) $ 6,095 Net income (loss) attributable to AXA Equitable 1,328 — 1,328 (21 ) 1,307 Retained earnings, end of period 7,479 — 7,479 (77 ) 7,402 Accumulated other comprehensive income, beginning of year 17 — 17 (21 ) (4 ) Other comprehensive income (loss) 414 — 414 21 435 Accumulated other comprehensive income, end of period 431 — 431 — 431 Total AXA Equitable’s equity, end of period 13,273 — 13,273 (77 ) 13,196 Noncontrolling interest, end of period 2,984 — 2,984 — 2,984 Total Equity, End of Period $ 16,257 $ — $ 16,257 $ (77 ) $ 16,180 Six Months Ended June 30, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ 1,559 $ — $ (21 ) $ 1,538 Adjustments to reconcile net i

REVISION OF PRIOR PERIOD FINANC

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS	12 Months Ended
	Dec. 31, 2018
Accounting Changes and Error Corrections [Abstract]
Revision of Prior Period Financial Statements	REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS During the fourth quarter of 2018, the Company identified certain cash flows that were incorrectly classified in the Company’s consolidated statements of cash flows. The Company has determined that these misclassifications were not material to the financial statements of any period. These have been corrected in the comparative consolidated statements of cash flows for the year ended December 31, 2017 contained elsewhere in this filing. Reclassification of DAC Capitalization During the fourth quarter of 2018, the Company changed the presentation of the capitalization of deferred policy acquisition costs (“DAC”) in the consolidated statements of income for all prior periods presented herein by netting the capitalized amounts within the applicable expense line items, such as Compensation and benefits, Commissions and distribution plan payments and Other operating costs and expenses. Previously, the Company had netted the capitalized amounts within the Amortization of deferred acquisition costs. There was no impact on Net income (loss) or Comprehensive income of this reclassification. See Note 2 for further details of this reclassification. Discontinued Operations In addition, as further described in Note 19, as a result of the AB Business Transfer in the fourth quarter of 2018, AB’s operations are now reflected as a discontinued operation in the Company’s consolidated financial statements. The financial information for prior periods presented in the consolidated financial statements have been adjusted to reflect AB as a discontinued operation. Consolidated Financial Statements as of and for the Year Ended December 31, 2017 The following tables present line items in the consolidated financial statements as of and for the year ended December 31, 2017 that have been affected by the revisions. This information has been corrected from the information previously presented in the 2017 Form 10-K. For these items, the tables detail the amounts as previously reported, the impact upon those line items due to the revisions, and the amounts as currently revised. As of December 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs $ 4,547 $ — $ 4,547 $ (55 ) $ 4,492 Total Assets $ 225,985 $ — $ 225,985 $ (55 ) $ 225,930 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities 29,034 — 29,034 36 29,070 Current and deferred taxes 1,973 (404 ) 1,569 (19 ) 1,550 Total Liabilities 205,795 — 205,795 17 205,812 Equity: Retained Earnings 9,010 — 9,010 (72 ) 8,938 AXA Equitable Equity 16,469 — 16,469 (72 ) 16,397 Total Equity 19,564 — 19,564 (72 ) 19,492 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 225,985 $ — $ 225,985 $ (55 ) $ 225,930 Year Ended December 31, 2017 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 3,334 $ — $ — $ 3,334 $ (40 ) $ 3,294 Net derivative gains (losses) 890 — 24 914 (20 ) 894 Total revenues 11,733 — (3,217 ) 8,516 (60 ) 8,456 Benefits and other deductions: Policyholders’ benefits 3,462 — — 3,462 11 3,473 Interest credited to policyholder’s account balances 1,040 — — 1,040 (119 ) 921 Compensation and benefits 1,762 (128 ) (1,307 ) 327 — 327 Commissions and distribution related payments 1,486 (443 ) (415 ) 628 — 628 Amortization of deferred policy acquisition costs 268 578 — 846 54 900 Other operating costs and expenses 1,431 (7 ) (789 ) 635 — 635 Total benefits and other deductions 9,478 — (2,517 ) 6,961 (54 ) 6,907 Income (loss) from continuing operations, before income taxes 2,255 — (700 ) 1,555 (6 ) 1,549 Income tax (expense) benefit from continuing operations 1,139 — (111 ) 1,028 182 1,210 Net income (loss) from continuing operations 3,394 — (811 ) 2,583 176 2,759 Net income (loss) 3,394 — (533 ) 2,861 (17 ) 2,844 Net income (loss) attributable to AXA Equitable $ 2,860 $ — $ — $ 2,860 $ (17 ) $ 2,843 Year Ended December 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ 3,394 $ (533 ) $ 2,861 $ (17 ) $ 2,844 Change in unrealized gains (losses), net of reclassification adjustment 563 — 563 21 584 Other comprehensive income 599 (18 ) 581 21 602 Comprehensive income (loss) 3,993 (551 ) 3,442 4 3,446 Comprehensive income (loss) attributable to AXA Equitable $ 3,441 $ — $ 3,441 $ 4 $ 3,445 Year Ended December 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 6,150 $ — $ 6,150 $ (55 ) $ 6,095 Net income (loss) attributable to AXA Equitable 2,860 — 2,860 (17 ) 2,843 Retained earnings, end of period 9,010 — 9,010 (72 ) 8,938 Accumulated other comprehensive income, beginning of year 17 — 17 (21 ) (4 ) Other comprehensive income (loss) 581 — 581 21 602 Accumulated other comprehensive income, end of year 598 — 598 — 598 Total AXA Equitable’s equity, end of year 16,469 — 16,469 (72 ) 16,397 Total Equity, End of Year $ 19,564 $ — $ 19,564 $ (72 ) $ 19,492 Year Ended December 31, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ 3,394 $ — $ (17 ) $ 3,377 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances 1,040 — (119 ) 921 Policy charges and fee income (3,334 ) — 40 (3,294 ) Net derivative (gains) losses (890 ) — 20 (870 ) Amortization and depreciation (136 ) 907 54 825 Amortization of deferred sales commission 32 (32 ) — — Amortization of other intangibles 31 (31 ) — — Equity (income) loss from limited partnerships — (157 ) — (157 ) Distributions from joint ventures and limited partnerships 140 (140 ) — — Year Ended December 31, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Changes in: Reinsurance recoverable (416 ) — (602 ) (1,018 ) Deferred policy acquisition costs 268 (268 ) — — Capitalization of deferred policy acquisition costs — (578 ) — (578 ) Future policy benefits 1,511 — (322 ) 1,189 Current and deferred income taxes (664 ) — (510 ) (1,174 ) Other, net 189 297 — 486 Net cash provided by (used in) operating activities $ 1,077 $ (2 ) $ (1,456 ) $ (381 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Short-term investments $ — $ 2,204 $ — $ 2,204 Payment for the purchase/origination of: Short-term investments — (2,456 ) — (2,456 ) Change in short-term investments (264 ) 254 10 — Other, net 238 — 84 322 Net cash provided by (used in) investing activities $ (9,010 ) $ 2 $ 94 $ (8,914 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 9,882 $ — $ (548 ) $ 9,334 Withdrawals (5,926 ) — 2,000 (3,926 ) Transfer (to) from Separate Accounts 1,656 — (90 ) 1,566 Net cash provided by (used in) financing activities $ 8,370 $ — $ 1,362 $ 9,732 _______________ (1) Net income (loss) includes $533 million in 2017 of the discontinued operations that are not included in net income (loss) in the Consolidated Statements of Income (Loss). Consolidated Financial Statements for the Year Ended December 31, 2016 The following table presents line items for the consolidated financial statements for the year ended December 31, 2016 that have been affected by the aforementioned adjustments and revisions. This information has been corrected from the information previously presented and restated in the 2017 Form 10-K. For these items, the table details the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, adjustments for the discontinued operation, and revisions and the amounts as currently revised. Year Ended December 31, 2016 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 3,344 $ — $ — $ 3,344 $ (33 ) $ 3,311 Net derivative gains (losses) (1,211 ) — 16 (1,195 ) (126 ) (1,321 ) Total revenues 9,138 — (2,936 ) 6,202 (159 ) 6,043 Year Ended December 31, 2016 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Benefits and other deductions: Interest credited to Policyholder’s account balances 1,029 — — 1,029 (124 ) 905 Compensation and benefits 1,723 (128 ) (1,231 ) 364 — 364 Commissions and distribution related payments 1,467 (460 ) (372 ) 635 — 635 Amortization of deferred policy acquisition costs 52 594 — 646 (4 ) 642 Other operating costs and expenses 1,458 (6 ) (699 ) 753 — 753 Total benefits and other deductions 8,516 — (2,305 ) 6,211 (128 ) 6,083 Income (loss) from continuing operations, before income taxes 622 — (631 ) (9 ) (31 ) (40 ) Income tax (expense) benefit from continuing operations 84 — 69 153 11 164 Net income (loss) from continuing operations 706 — (562 ) 144 (20 ) 124 Net income (loss) 706 — (496 ) 210 (20 ) 190 Net income (loss) attributable to AXA Equitable $ 210 $ — $ — $ 210 $ (20 ) $ 190 Year Ended December 31, 2016 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ 706 $ (496 ) $ 210 $ (20 ) $ 190 Change in unrealized gains (losses), net of reclassification adjustment (194 ) — (194 ) (21 ) (215 ) Other comprehensive income (215 ) 17 (198 ) (21 ) (219 ) Comprehensive income (loss) 491 (479 ) 12 (41 ) (29 ) Comprehensive income (loss) attributable to AXA Equitable $ 12 $ — $ 12 $ (41 ) $ (29 ) Year Ended December 31, 2016 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 6,990 $ — $ 6,990 $ (35 ) $ 6,955 Net income (loss) attributable to AXA Equitable 210 — 210 (20 ) 190 Retained earnings, end of period 6,150 — 6,150 (55 ) 6,095 Other comprehensive income (loss) (198 ) — (198 ) (21 ) (219 ) Accumulated other comprehensive income, end of period 17 — 17 (21 ) (4 ) Total AXA Equitable’s equity, end of period $ 11,508 $ — $ 11,508 $ (76 ) $ 11,432 Year Ended December 31, 2016 As Reported Presentation Reclassifications Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ 706 $ — $ (20 ) $ 686 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances 1,029 — (124 ) 905 Policy charges and fee income (3,344 ) — 33 (3,311 ) Net derivative (gains) losses 1,211 — 126 1,337 Amortization and depreciation — 618 (4 ) 614 Amortization of deferred sales commission 41 (41 ) — — Other depreciation and amortization (98 ) 98 — — Amortization of other intangibles 29 (29 ) — — Equity (income) loss from limited partnerships — (91 ) — (91 ) Return of real estate joint venture and limited partnerships 126 (126 ) — — Changes in: Deferred policy acquisition costs 52 (52 ) — — Capitalization of deferred policy acquisition costs — (594 ) — (594 ) Current and deferred income taxes (742 ) — (11 ) (753 ) Other, net (161 ) 217 — 56 Net cash provided by (used in) operating activities $ (461 ) $ — $ — $ (461 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Short-term investments — 2,984 — 2,984 Payment for the purchase/origination of: Short-term investments — (3,187 ) — (3,187 ) Change in short-term investments (205 ) 205 — — Other, net 409 (2 ) — 407 Net cash provided by (used in) investing activities $ (5,358 ) $ — $ — $ (5,358 ) _______________ (1) Net income (loss) includes $496 million in 2016 of the discontinued operations that are not included in Net income (loss) in the Consolidated Statements of Income (Loss).

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2018
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTS AXA Equitable Holdings, Inc. 2019 Omnibus Incentive Plan (the “2019 Plan”) In November 2018, Holdings’ Board of Directors and AXA, as Holdings’ then controlling stockholder, adopted the 2019 Plan, which became effective January 1, 2019, with a total of 5.2 million shares of common stock reserved for issuance thereunder. On February 25, 2019, the Compensation Committee of Holdings’ Board of Directors approved an amendment to the 2019 Plan increasing the amount of shares of Holdings’ common stock available for issuance in connection with equity awards granted under the 2019 Plan by two million shares. The holder of a majority of the outstanding shares of Holdings’ common stock executed a written consent approving the increase on February 28, 2019. AXA Secondary Offering of Holdings Common Stock and Holdings Share Buy-back On March 25, 2019, AXA completed a follow-on secondary offering of 46 million shares of common stock of Holdings and the sale to Holdings of 30 million shares of common stock of Holdings. Following the completion of this secondary offering and the share buyback by Holdings, AXA owns 48.3% of the shares of common stock of Holdings. As a result, Holdings is no longer a majority owned subsidiary of AXA. Repayment of Senior Surplus Note On December 28, 2018 , the Company, issued a $572 million senior surplus note due December 28, 2019 to Holdings, which bears interest at a fixed rate of 3.75% , payable semi-annually. The Company repaid this note on March 5, 2019 .

SCHEDULE I - SUMMARY OF INVESTM

SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES	12 Months Ended
	Dec. 31, 2018
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]
Schedule I - Summary of Investments - Other than Investments in Related Parties	SCHEDULE I SUMMARY OF INVESTMENTS—OTHER THAN INVESTMENTS IN RELATED PARTIES AS OF DECEMBER 31, 2018 Cost (1) Fair Value Amount at Which Shown on Balance Sheet (in millions) Fixed Maturities: U.S. government, agencies and authorities $ 13,646 $ 13,335 $ 13,335 State, municipalities and political subdivisions 408 454 454 Foreign governments 515 519 519 Public utilities 4,614 4,569 4,569 All other corporate bonds 22,076 21,807 21,807 Residential mortgage-backed 193 202 202 Asset-backed 600 590 590 Redeemable preferred stocks 440 439 439 Total fixed maturities 42,492 41,915 41,915 Mortgage loans on real estate (2) 11,825 11,478 11,818 Real estate held for the production of income 52 52 52 Policy loans 3,267 3,944 3,267 Other equity investments 1,103 1,144 1,144 Trading securities 15,361 15,166 15,166 Other invested assets 1,554 1,554 1,554 Total Investments $ 75,654 $ 75,253 $ 74,916 _____________ (1) Cost for fixed maturities represents original cost, reduced by repayments and write-downs and adjusted for amortization of premiums or accretion of discount; cost for equity securities represents original cost reduced by write-downs; cost for other limited partnership interests represents original cost adjusted for equity in earnings and reduced by distributions. (2) Balance Sheet amount for mortgage loans on real estate represents original cost adjusted for amortization of premiums or accretion of discount and reduced by valuation allowance.

SCHEDULE IV - REINSURANCE

SCHEDULE IV - REINSURANCE	12 Months Ended
	Dec. 31, 2018
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]
Schedule IV - Reinsurance	SCHEDULE IV REINSURANCE (1) AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2018 , 2017 AND 2016 Gross Amount Ceded to Other Companies Assumed from Other Companies Net Amount Percentage of Amount Assumed to Net (in millions) As of December 31, 2018 Life insurance in-force $ 390,374 $ 69,768 $ 30,322 $ 350,928 8.6 % For the year ended December 31, 2018 Premiums: Life insurance and annuities $ 787 $ 128 $ 177 $ 836 21.2 % Accident and health 49 32 9 26 34.6 % Total Premiums $ 836 $ 160 $ 186 $ 862 21.6 % As of December 31, 2017 Life insurance in-force (2) $ 392,926 $ 73,843 $ 30,300 $ 349,383 8.7 % For the year ended December 31, 2017 Premiums: Life insurance and annuities $ 826 $ 135 $ 186 $ 877 21.2 % Accident and health 54 36 9 27 33.3 % Total Premiums $ 880 $ 171 $ 195 $ 904 21.6 % As of December 31, 2016 Life insurance in-force $ 399,230 $ 78,760 $ 31,722 $ 352,192 9.0 % For the year ended December 31, 2016 Premiums: Life insurance and annuities $ 790 $ 135 $ 197 $ 852 23.1 % Accident and health 60 41 9 28 32.1 % Total Premiums $ 850 $ 176 $ 206 $ 880 23.4 % _____________ (1) Includes amounts related to the discontinued group life and health business. (2) Previously reported amounts for “Life insurance in-force—Ceded to other companies” of $41,330 million and “Net amount” of $381,896 have been revised due to an error.

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The preparation of the accompanying consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and assumptions (including normal, recurring accruals) that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates. The accompanying consolidated financial statements present the consolidated results of operations, financial condition and cash flows of the Company and its subsidiaries and those investment companies, partnerships and joint ventures in which the Company has control and a majority economic interest as well as those variable interest entities (“VIEs”) that meet the requirements for consolidation. Financial results in the historical consolidated financial statements may not be indicative of the results of operations, comprehensive income (loss), financial position, equity or cash flows that would have been achieved had we operated as a separate, standalone entity during the reporting periods presented. We believe that the consolidated financial statements include all adjustments necessary for a fair presentation of the results of operations of the Company. All significant intercompany transactions and balances have been eliminated in consolidation. The years “ 2018 ”, “ 2017 ” and “ 2016 ” refer to the years ended December 31, 2018 , 2017 and 2016 , respectively.
Adoption of New and Future Accounting Pronouncements	Adoption of New Accounting Pronouncements Description Effect on the Financial Statement or Other Significant Matters ASU 2014-09: Revenue from Contracts with Customers (Topic 606) This ASU contains new guidance that clarifies the principles for recognizing revenue arising from contracts with customers and develops a common revenue standard for U.S. GAAP. On January 1, 2018, the Company adopted the new revenue recognition guidance on a modified retrospective basis. The impact of the adoption of the new revenue recognition guidance related to the disposed subsidiary resulted in an opening retained earnings adjustment to the Company of $8 million. Adoption did not change the amounts or timing of the Company’s revenue recognition for investment management and advisory fees related to continuing operations. ASU 2016-01: Financial Instruments - Overall (Subtopic 825-10) This ASU provides new guidance related to the recognition and measurement of financial assets and financial liabilities. The new guidance primarily affects the accounting for equity investments, financial liabilities under the fair value option, and presentation and disclosure requirements for financial instruments. The FASB also clarified guidance related to the valuation allowance assessment when recognizing deferred tax assets resulting from unrealized losses on AFS debt securities. The new guidance requires equity investments in unconsolidated entities, except those accounted for under the equity method, to be measured at fair value through earnings, thereby eliminating the AFS classification for equity securities with readily determinable fair values for which changes in fair value currently were reported in AOCI. On January 1, 2018, the Company adopted the new recognition requirements on a modified retrospective basis for changes in the fair value of AFS equity securities, resulting in no material reclassification adjustment from AOCI to opening retained earnings for the net unrealized gains, net of tax, related to approximately $13 million of common stock securities and eliminated their designation as AFS equity securities. The Company does not currently report any of its financial liabilities under the fair value option. ASU 2016-15: Statement of Cash Flows (Topic 230) This ASU provides new guidance to simplify elements of cash flow classification. The new guidance is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The new guidance requires application of a retrospective transition method. Adoption of this guidance on January 1, 2018, did not have a material impact on the Company’s consolidated financial statements. ASU 2017-07: Compensation - Retirement Benefits (Topic 715) This ASU provides new guidance on the presentation of net periodic pension and post-retirement benefit costs that requires retrospective disaggregation of the service cost component from the other components of net benefit costs on the income statement. On January 1, 2018, the Company adopted the change in the income statement presentation utilizing the practical expedient for determining the historical components of net benefit costs, resulting in no material impact to the consolidated financial statements. In addition, no changes to the Company’s capitalization policies with respect to benefit costs resulted from the adoption of the new guidance. ASU 2017-09: Compensation - Stock Compensation (Topic 718) This ASU provides clarity and reduces both 1) diversity in practice and 2) cost and complexity when applying guidance in Topic 718, Compensation - Stock Compensation, to a change to the terms or conditions of a share-based payment award. Adoption of this amendment on January 1, 2018 did not have a material impact on the Company’s consolidated financial statements. ASU 2018-02: Income Statement - Reporting Comprehensive Income This ASU contains new guidance that permits entities to reclassify to retained earnings tax effects “stranded” in AOCI resulting from the change in federal tax rate enacted by the Tax Cuts and Jobs Act (the “Tax Reform Act”) on December 22, 2017. If elected, the stranded tax effects for all items must be reclassified in AOCI, including, but not limited to, AFS securities and employee benefits. The company early adopted the ASU effective October 1, 2018 and recognized the impact in the period of adoption. As a result, the company reclassified stranded effects resulting from the Tax Act of 2017 by decreasing AOCI and increasing retained earnings by $83 million. ASU 2018-14: Compensation - Retirement Benefits - Defined Benefit Plans - General (Subtopic 715-20) Description Effect on the Financial Statement or Other Significant Matters This ASU improves the effectiveness of disclosures related to defined benefit plans in the notes to the financial statements. The amendments in this ASU remove disclosures that are no longer considered cost beneficial, clarify the specific requirements of disclosures, and add new, relevant disclosure requirements. Effective for the year ended December 31, 2018 the Company early adopted new guidance that amends the disclosure guidance for employee benefit plans, applied on a retrospective basis to all periods presented. See Note 13 for additional information regarding the Company’s employee benefit plans. Future Adoption of New Accounting Pronouncements Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-17: Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities This ASU provides guidance requiring that indirect interests held through related parties in common control arrangements be considered on a proportional basis for determining whether fees paid to decision makers and service providers are variable interests. Effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. All entities are required to apply the amendments in this update retrospectively with a cumulative-effect adjustment to retained earnings at the beginning of the earliest period presented. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. ASU 2018-13: Fair Value Measurement (Topic 820) This ASU improves the effectiveness of fair value disclosures in the notes to financial statements. Amendments in this ASU impact the disclosure requirements in Topic 820, including the removal, modification and addition to existing disclosure requirements. Effective for fiscal years beginning after December 15, 2019. Early adoption is permitted, with the option to early adopt amendments to remove or modify disclosures, with full adoption of additional disclosure requirements delayed until the stated effective date. Amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively. All other amendments should be applied retrospectively. Management currently is evaluating the impact of the guidance on the Company’s financial statement disclosures but has concluded that this guidance will not impact the Company’s consolidated financial position or results of operations. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-12: Financial Services - Insurance (Topic 944) This ASU provides targeted improvements to existing recognition, measurement, presentation, and disclosure requirements for long-duration contracts issued by an insurance entity. The ASU primarily impacts four key areas, including: Measurement of the liability for future policy benefits for traditional and limited payment contracts. The ASU requires companies to review, and if necessary update, cash flow assumptions at least annually for non-participating traditional and limited-payment insurance contracts. Interest rates used to discount the liability will need to be updated quarterly using an upper medium grade (low credit risk) fixed-income instrument yield. Measurement of market risk benefits (“MRBs”). MRBs, as defined under the ASU, will encompass certain GMxB features associated with variable annuity products and other general account annuities with other than nominal market risk. The ASU requires MRBs to be measured at fair value with changes in value attributable to changes in instrument-specific credit risk recognized in OCI. Amortization of deferred acquisition costs. The ASU simplifies the amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins, requiring such balances to be amortized on a constant level basis over the expected term of the contracts. Deferred costs will be required to be written off for unexpected contract terminations but will not be subject to impairment testing. Expanded footnote disclosures. The ASU requires additional disclosures including disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, MRBs, separate account liabilities and deferred acquisition costs. Companies will also be required to disclose information about significant inputs, judgements, assumptions and methods used in measurement. Effective date for public business entities for fiscal years and interim periods with those fiscal years, beginning after December 31, 2020. Early adoption is permitted. For the liability for future policyholder benefits for traditional and limited payment contracts, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for deferred acquisition costs. For MRBs, the ASU should be applied retrospectively as of the earliest period presented by a retrospective application to all prior periods. For deferred acquisition costs, companies can elect one of two adoption methods. Companies can either elect a modified retrospective transition method applied to contracts in force as of the beginning of the earliest period presented on the basis of their existing carrying amounts, adjusted for the removal of any related amounts in AOCI or a full retrospective transition method using actual historical experience information as of contract inception. The same adoption method must be used for the liability for future policyholder benefits for traditional and limited payment contracts. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements and related disclosures. The Company has formed a project implementation team to work on compiling all significant information needed to assess the impact of the new guidance, including changes to system requirements and internal controls. The Company expects adoption of the ASU will have a significant impact on its consolidated financial condition, results of operations, cash flows and required disclosures, as well as processes and controls. Description Effective Date and Method of Adoption Effect on the Financial Statement or Other Significant Matters ASU 2018-07 : Compensation - Stock Compensation (Topic 718) This ASU contains new guidance that largely aligns the accounting for share-based payment awards issued to employees and non-employees. Effective for public business entities for fiscal years beginning after December 15, 2018, including interim periods, with early adoption permitted. The Company has granted share-based payment awards only to employees as defined by accounting guidance and does not expect this guidance will have a material impact on its consolidated financial statements. ASU 2017-12: Derivatives and Hedging (Topic 815) The amendments in this ASU better align an entity’s risk management activities and financial reporting for hedging relationships through changes to both the designation and measurement guidance for qualifying hedging relationships and the presentation of hedge results. Effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years, with early adoption permitted. The effect of adoption should be reflected as of the beginning of the fiscal year of adoption. Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements. ASU 2017-08 : Receivables - Nonrefundable Fees and Other Costs (Subtopic 310-20) This ASU requires certain premiums on callable debt securities to be amortized to the earliest call date and is intended to better align interest income recognition with the manner in which market participants price these instruments. Effective for interim and annual periods beginning after December 15, 2018, with early adoption permitted and is to be applied on a modified retrospective basis. Management does not expect this guidance will have a material impact on the Company’s consolidated financial statements. ASU 2016-13 : Financial Instruments - Credit Losses (Topic 326) This ASU contains new guidance which introduces an approach based on expected losses to estimate credit losses on certain types of financial instruments. It also modifies the impairment model for available-for-sale debt securities and provides for a simplified accounting model for purchased financial assets with credit deterioration since their origination. Effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. These amendments should be applied through a cumulative-effect adjustment to retained earnings as of the beginning of the first reporting period in which the guidance is effective. Management currently is evaluating the impact that adoption of this guidance will have on the Company’s consolidated financial statements. Although early adoption is permitted, the Company expects to adopt ASU 2016-13 when it becomes effective for the Company on January 1, 2020. ASU 2016-02: Leases (Topic 842) This ASU contains revised guidance to lease accounting that will require lessees to recognize on the balance sheet a “right-of-use” asset and a lease liability for virtually all lease arrangements, including those embedded in other contracts. Lessor accounting will remain substantially unchanged from the current model but has been updated to align with certain changes made to the lessee model. Effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, for public business entities. Early application is permitted. Lessees and lessors are required to apply a modified retrospective transition approach, which includes optional practical expedients that entities may elect to apply. In July 2018, the FASB issued ASU 2018-11 which allows for an additional transition method. The Company will adopt the standard utilizing the additional transition method, which allows entities to initially apply the new leases standard at the adoption date. The Company adopted ASU 2016-02, as well as other related clarifications and interpretive guidance issued by the FASB effective January 1, 2019. The Company has identified its significant existing leases, which primarily include real estate leases for office space, that will be impacted by the new guidance. The Company’s adoption of this guidance is expected to result in a material impact on the consolidated balance sheets, however it will not have a material impact on the Consolidated Statement of Income (Loss). The Company’s adoption of this guidance will result in the recognition, as of January 1, 2019, of additional right of use (RoU) operating lease assets ranging from $300 million to $400 million and operating lease liabilities ranging from $400 million to $500 million, respectively. The adoption of this standard will not have a significant impact on opening retained earnings.
Investments	Investments The carrying values of fixed maturities classified as available-for-sale (“AFS”) are reported at fair value. Changes in fair value are reported in other comprehensive income (“OCI”), net of policy related amounts and deferred income taxes. The amortized cost of fixed maturities is adjusted for impairments in value deemed to be other than temporary which are recognized in Investment gains (losses), net. The redeemable preferred stock investments that are reported in fixed maturities include real estate investment trusts (“REIT”), perpetual preferred stock and redeemable preferred stock. These securities may not have a stated maturity, may not be cumulative and do not provide for mandatory redemption by the issuer. The Company determines the fair values of fixed maturities and equity securities based upon quoted prices in active markets, when available, or through the use of alternative approaches when market quotes are not readily accessible or available. These alternative approaches include matrix or model pricing and use of independent pricing services, each supported by reference to principal market trades or other observable market assumptions for similar securities. More specifically, the matrix pricing approach to fair value is a discounted cash flow methodology that incorporates market interest rates commensurate with the credit quality and duration of the investment. The Company’s management, with the assistance of its investment advisors, monitors the investment performance of its portfolio and reviews AFS securities with unrealized losses for other-than-temporary impairments (“OTTI”). Integral to this review is an assessment made each quarter, on a security-by-security basis, by the Company’s Investments Under Surveillance (“IUS”) Committee, of various indicators of credit deterioration to determine whether the investment security is expected to recover. This assessment includes, but is not limited to, consideration of the duration and severity of the unrealized loss, failure, if any, of the issuer of the security to make scheduled payments, actions taken by rating agencies, adverse conditions specifically related to the security or sector, the financial strength, liquidity and continued viability of the issuer. If there is no intent to sell or likely requirement to dispose of the fixed maturity security before its recovery, only the credit loss component of any resulting OTTI is recognized in income (loss) and the remainder of the fair value loss is recognized in OCI. The amount of credit loss is the shortfall of the present value of the cash flows expected to be collected as compared to the amortized cost basis of the security. The present value is calculated by discounting management’s best estimate of projected future cash flows at the effective interest rate implicit in the debt security at the date of acquisition. Projections of future cash flows are based on assumptions regarding probability of default and estimates regarding the amount and timing of recoveries. These assumptions and estimates require use of management judgment and consider internal credit analyses as well as market observable data relevant to the collectability of the security. For mortgage and asset-backed securities, projected future cash flows also include assumptions regarding prepayments and underlying collateral value. Real estate held for the production of income is stated at depreciated cost less valuation allowances. Depreciation of real estate held for production of income is computed using the straight-line method over the estimated useful lives of the properties, which generally range from 40 to 50 years. Policy loans represent funds loaned to policyholders up to the cash surrender value of the associated insurance policies and are carried at the unpaid principal balances due to the Company from the policyholders. Interest income on policy loans is recognized in net investment income at the contract interest rate when earned. Policy loans are fully collateralized by the cash surrender value of the associated insurance policies. Partnerships, investment companies and joint venture interests that the Company has control of and has an economic interest in or those that meet the requirements for consolidation under accounting guidance for consolidation of VIEs are consolidated. Those that the Company does not have control of and does not have a majority economic interest in and those that do not meet the VIE requirements for consolidation are reported on the equity method of accounting and are reported in other equity investments. The Company records its interests in certain of these partnerships on a month or one quarter lag. Trading securities, which include equity securities and fixed maturities, are carried at fair value based on quoted market prices, with realized and unrealized gains (losses) reported in net investment income (loss) in the statements of Net income (loss). Corporate owned life insurance (“COLI”) has been purchased by the Company and certain subsidiaries on the lives of certain key employees and the Company and these subsidiaries are named as beneficiaries under these policies. COLI is carried at the cash surrender value of the policies. At December 31, 2018 , 2017 and 2016 the carrying value of COLI was $873 million, $911 million and $892 million, respectively, and is reported in Other invested assets in the consolidated balance sheets. Cash and cash equivalents includes cash on hand, demand deposits, money market accounts, overnight commercial paper and highly liquid debt instruments purchased with an original maturity of three months or less. Due to the short-term nature of these investments, the recorded value is deemed to approximate fair value. All securities owned, including U.S. government and agency securities, mortgage-backed securities, futures and forwards transactions, are reported in the consolidated financial statements on a trade date basis.
Derivatives	Derivatives Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, values of securities or commodities, credit spreads, market volatility, expected returns and liquidity. Values can also be affected by changes in estimates and assumptions, including those related to counterparty behavior and non-performance risk used in valuation models. Derivative financial instruments generally used by the Company include equity, currency, and interest rate futures, total return and/or other equity swaps, interest rate swaps and floors, swaptions, variance swaps and equity options, all of which may be exchange-traded or contracted in the over-the-counter market. All derivative positions are carried in the consolidated balance sheets at fair value, generally by obtaining quoted market prices or through the use of valuation models. Freestanding derivative contracts are reported in the consolidated balance sheets either as assets within “Other invested assets” or as liabilities within “Other liabilities”. The Company nets the fair value of all derivative financial instruments with counterparties for which an ISDA Master Agreement and related Credit Support Annex (“CSA”) have been executed. The Company uses derivatives to manage asset/liability risk and has designated some of those economic relationships under the criteria to qualify for hedge accounting treatment. All changes in the fair value of the Company’s freestanding derivative positions not designated to hedge accounting relationships, including net receipts and payments, are included in “Net derivative gains (losses)” without considering changes in the fair value of the economically associated assets or liabilities. The Company is a party to financial instruments and other contracts that contain “embedded” derivative instruments. At inception, the Company assesses whether the economic characteristics of the embedded instrument are “clearly and closely related” to the economic characteristics of the remaining component of the “host contract” and whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. When those criteria are satisfied, the resulting embedded derivative is bifurcated from the host contract, carried in the consolidated balance sheets at fair value, and changes in its fair value are recognized immediately and captioned in the consolidated statements of income (loss) according to the nature of the related host contract. For certain financial instruments that contain an embedded derivative that otherwise would need to be bifurcated and reported at fair value, the Company instead may elect to carry the entire instrument at fair value.
Securities Repurchase and Reverse Repurchase Agreements	Securities Repurchase and Reverse Repurchase Agreements Securities repurchase and reverse repurchase transactions involve the temporary exchange of securities for cash or other collateral of equivalent value, with agreement to redeliver a like quantity of the same or similar securities at a future date prior to maturity at a fixed and determinable price. Transfers of securities under these agreements to repurchase or resell are evaluated by the Company to determine whether they satisfy the criteria for accounting treatment as secured borrowing or lending arrangements. Agreements not meeting the criteria would require recognition of the transferred securities as sales or purchases with related forward repurchase or resale commitments. All of the Company’s securities repurchase transactions are accounted for as collateralized borrowings with the related obligations distinctly captioned in the consolidated balance sheets. Earnings from investing activities related to the cash received under the Company’s securities repurchase arrangements are reported in the consolidated statements of income (loss) as “Net investment income” and the associated borrowing cost is reported as “Interest expense.” The Company has not actively engaged in securities reverse repurchase transactions.
Commercial and Agricultural Mortgage Loans on Real Estate	Commercial and Agricultural Mortgage Loans on Real Estate Mortgage loans are stated at unpaid principal balances, net of unamortized discounts and valuation allowances. Valuation allowances are based on the present value of expected future cash flows discounted at the loan’s original effective interest rate or on its collateral value if the loan is collateral dependent. However, if foreclosure is or becomes probable, the collateral value measurement method is used. For commercial and agricultural mortgage loans, an allowance for credit loss is typically recommended when management believes it is probable that principal and interest will not be collected according to the contractual terms. Factors that influence management’s judgment in determining allowance for credit losses include the following: • Loan-to-value ratio – Derived from current loan balance divided by the fair market value of the property. An allowance for credit loss is typically recommended when the loan-to-value ratio is in excess of 100% . In the case where the loan-to-value is in excess of 100% , the allowance for credit loss is derived by taking the difference between the fair market value (less cost of sale) and the current loan balance. • Debt service coverage ratio – Derived from actual operating earnings divided by annual debt service. If the ratio is below 1.0 x, then the income from the property does not support the debt. • Occupancy – Criteria varies by property type but low or below market occupancy is an indicator of sub-par property performance. • Lease expirations – The percentage of leases expiring in the upcoming 12 to 36 months are monitored as a decline in rent and/or occupancy may negatively impact the debt service coverage ratio. In the case of single-tenant properties or properties with large tenant exposure, the lease expiration is a material risk factor. • Maturity – Mortgage loans that are not fully amortizing and have upcoming maturities within the next 12 to 24 months are monitored in conjunction with the capital markets to determine the borrower’s ability to refinance the debt and/or pay off the balloon balance. • Borrower/tenant related issues – Financial concerns, potential bankruptcy or words or actions that indicate imminent default or abandonment of property. • Payment status (current vs. delinquent) – A history of delinquent payments may be a cause for concern. • Property condition – Significant deferred maintenance observed during the lenders annual site inspections. • Other – Any other factors such as current economic conditions may call into question the performance of the loan. Mortgage loans also are individually evaluated quarterly by the Company’s IUS Committee for impairment, including an assessment of related collateral value. Commercial mortgages 60 days or more past due and agricultural mortgages 90 days or more past due, as well as all mortgages in the process of foreclosure, are identified as problem mortgages. Based on its monthly monitoring of mortgages, a class of potential problem mortgages are also identified, consisting of mortgage loans not currently classified as problem mortgages but for which management has doubts as to the ability of the borrower to comply with the present loan payment terms and which may result in the loan becoming a problem or being restructured. The decision whether to classify a performing mortgage loan as a potential problem involves significant subjective judgments by management as to likely future industry conditions and developments with respect to the borrower or the individual mortgaged property. For problem mortgage loans, a valuation allowance is established to provide for the risk of credit losses inherent in the lending process. The allowance includes loan specific reserves for mortgage loans determined to be non-performing as a result of the loan review process. A non-performing loan is defined as a loan for which it is probable that amounts due according to the contractual terms of the loan agreement will not be collected. The loan-specific portion of the loss allowance is based on the Company’s assessment as to ultimate collectability of loan principal and interest. Valuation allowances for a non-performing loan are recorded based on the present value of expected future cash flows discounted at the loan’s effective interest rate or based on the fair value of the collateral if the loan is collateral dependent. The valuation allowance for mortgage loans can increase or decrease from period to period based on such factors. Impaired mortgage loans without provision for losses are mortgage loans where the fair value of the collateral or the net present value of the expected future cash flows related to the loan equals or exceeds the recorded investment. Interest income earned on mortgage loans where the collateral value is used to measure impairment is recorded on a cash basis. Interest income on mortgage loans where the present value method is used to measure impairment is accrued on the net carrying value amount of the loan at the interest rate used to discount the cash flows. Changes in the present value attributable to changes in the amount or timing of expected cash flows are reported as investment gains or losses. Mortgage loans are placed on nonaccrual status once management believes the collection of accrued interest is doubtful. Once mortgage loans are classified as nonaccrual mortgage loans, interest income is recognized under the cash basis of accounting and the resumption of the interest accrual would commence only after all past due interest has been collected or the mortgage loan has been restructured to where the collection of interest is considered likely.
Net Investment Income (Loss), Investment Gains (Losses), Net and Unrealized Investment Gains (Losses)	Net Investment Income (Loss), Investment Gains (Losses), Net and Unrealized Investment Gains (Losses) Realized investment gains (losses) are determined by identification with the specific asset and are presented as a component of revenue. Changes in the valuation allowances are included in Investment gains (losses), net. Realized and unrealized holding gains (losses) on trading and equity securities are reflected in Net investment income (loss). Unrealized investment gains (losses) on fixed maturities designated as AFS held by the Company are accounted for as a separate component of AOCI, net of related deferred income taxes, as are amounts attributable to certain pension operations, Closed Block’s policyholders’ dividend obligation, insurance liability loss recognition, DAC related to UL policies, investment-type products and participating traditional life policies. Changes in unrealized gains (losses) reflect changes in fair value of only those fixed maturities classified as AFS and do not reflect any change in fair value of policyholders’ account balances and future policy benefits.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. See Note 7 for additional information regarding determining the fair value of financial instruments.
Recognition of Insurance Income and Related Expenses	Recognition of Insurance Income and Related Expenses Deposits related to universal life (“UL”) and investment-type contracts are reported as deposits to policyholders’ account balances. Revenues from these contracts consist of fees assessed during the period against policyholders’ account balances for mortality charges, policy administration charges and surrender charges. Policy benefits and claims that are charged to expense include benefit claims incurred in the period in excess of related policyholders’ account balances. Premiums from participating and non-participating traditional life and annuity policies with life contingencies generally are recognized in income when due. Benefits and expenses are matched with such income so as to result in the recognition of profits over the life of the contracts. This match is accomplished by means of the provision for liabilities for future policy benefits and the deferral and subsequent amortization of DAC. For contracts with a single premium or a limited number of premium payments due over a significantly shorter period than the total period over which benefits are provided, premiums are recorded as revenue when due with any excess profit deferred and recognized in income in a constant relationship to insurance in-force or, for annuities, the amount of expected future benefit payments. Premiums from individual health contracts are recognized as income over the period to which the premiums relate in proportion to the amount of insurance protection provided.
DAC	DAC Acquisition costs that vary with and are primarily related to the acquisition of new and renewal insurance business, reflecting incremental direct costs of contract acquisition with independent third parties or employees that are essential to the contract transaction, as well as the portion of employee compensation, including payroll fringe benefits and other costs directly related to underwriting, policy issuance and processing, medical inspection, and contract selling for successfully negotiated contracts including commissions, underwriting, agency and policy issue expenses, are deferred. In each reporting period, DAC is amortized to Amortization of deferred policy acquisition costs of the accrual of imputed interest on DAC balances. DAC is subject to recoverability testing at the time of policy issue and loss recognition testing at the end of each accounting period. After the initial establishment of reserves, premium deficiency and loss recognition tests are performed each period end using best estimate assumptions as of the testing date without provisions for adverse deviation. When the liabilities for future policy benefits plus the present value of expected future gross premiums for the aggregate product group are insufficient to provide for expected future policy benefits and expenses for that line of business (i.e., reserves net of any DAC asset), DAC would first be written off and thereafter, if required, a premium deficiency reserve would be established by a charge to earnings. Amortization Policy In accordance with the guidance for the accounting and reporting by insurance enterprises for certain long-duration contracts and participating contracts and for realized gains and losses from the sale of investments, current and expected future profit margins for products covered by this guidance are examined regularly in determining the amortization of DAC. DAC associated with certain variable annuity products is amortized based on estimated assessments, with DAC on the remainder of variable annuities, UL and investment-type products amortized over the expected total life of the contract group as a constant percentage of estimated gross profits arising principally from investment results, Separate Accounts fees, mortality and expense margins and surrender charges based on historical and anticipated future experience, embedded derivatives and changes in the reserve of products that have indexed features such as SCS IUL and MSO, updated at the end of each accounting period. When estimated gross profits are expected to be negative for multiple years of a contract life, DAC is amortized using the present value of estimated assessments. The effect on the amortization of DAC of revisions to estimated gross profits or assessments is reflected in earnings (loss) in the period such estimated gross profits or assessments are revised. A decrease in expected gross profits or assessments would accelerate DAC amortization. Conversely, an increase in expected gross profits or assessments would slow DAC amortization. The effect on the DAC assets that would result from realization of unrealized gains (losses) is recognized with an offset to AOCI in consolidated equity as of the balance sheet date. A significant assumption in the amortization of DAC on variable annuities and, to a lesser extent, on variable and interest-sensitive life insurance relates to projected future separate account performance. Management sets estimated future gross profit or assessment assumptions related to separate account performance using a long-term view of expected average market returns by applying a Reversion to the Mean (“RTM”) approach, a commonly used industry practice. This future return approach influences the projection of fees earned, as well as other sources of estimated gross profits. Returns that are higher than expectations for a given period produce higher than expected account balances, increase the fees earned resulting in higher expected future gross profits and lower DAC amortization for the period. The opposite occurs when returns are lower than expected. In applying this approach to develop estimates of future returns, it is assumed that the market will return to an average gross long-term return estimate, developed with reference to historical long-term equity market performance. Management has set limitations as to maximum and minimum future rate of return assumptions, as well as a limitation on the duration of use of these maximum or minimum rates of return. At December 31, 2018 , the average gross short-term and long-term annual return estimate on variable and interest-sensitive life insurance and variable annuities was 7.0% ( 4.7% net of product weighted average Separate Accounts fees), and the gross maximum and minimum short-term annual rate of return limitations were 15.0% ( 12.7% net of product weighted average Separate Accounts fees) and 0.0% ( (2.3)% net of product weighted average Separate Accounts fees), respectively. The maximum duration over which these rate limitations may be applied is five years. This approach will continue to be applied in future periods. These assumptions of long-term growth are subject to assessment of the reasonableness of resulting estimates of future return assumptions. In addition, projections of future mortality assumptions related to variable and interest-sensitive life products are based on a long-term average of actual experience. This assumption is updated periodically to reflect recent experience as it emerges. Improvement of life mortality in future periods from that currently projected would result in future deceleration of DAC amortization. Conversely, deterioration of life mortality in future periods from that currently projected would result in future acceleration of DAC amortization. Other significant assumptions underlying gross profit estimates for UL and investment type products relate to contract persistency and General Account investment spread. For participating traditional life policies (substantially all of which are in the Closed Block), DAC is amortized over the expected total life of the contract group as a constant percentage based on the present value of the estimated gross margin amounts expected to be realized over the life of the contracts using the expected investment yield. At December 31, 2018 , the average rate of assumed investment yields, excluding policy loans, for the Company was 4.7% grading to 4.3% over six years. Estimated gross margins include anticipated premiums and investment results less claims and administrative expenses, changes in the net level premium reserve and expected annual policyholder dividends. The effect on the accumulated amortization of DAC of revisions to estimated gross margins is reflected in earnings in the period such estimated gross margins are revised. The effect on the DAC assets that would result from realization of unrealized gains (losses) is recognized with an offset to AOCI in consolidated equity as of the balance sheet date. Many of the factors that affect gross margins are included in the determination of the Company’s dividends to these policyholders. DAC adjustments related to participating traditional life policies do not create significant volatility in results of operations as the Closed Block recognizes a cumulative policyholder dividend obligation expense in “Policyholders’ dividends,” for the excess of actual cumulative earnings over expected cumulative earnings as determined at the time of demutualization. DAC associated with non-participating traditional life policies are amortized in proportion to anticipated premiums. Assumptions as to anticipated premiums are estimated at the date of policy issue and are consistently applied during the life of the contracts. Deviations from estimated experience are reflected in income (loss) in the period such deviations occur. For these contracts, the amortization periods generally are for the total life of the policy. DAC related to these policies are subject to recoverability testing as part of the Company’s premium deficiency testing. If a premium deficiency exists, DAC are reduced by the amount of the deficiency or to zero through a charge to current period earnings (loss). If the deficiency exceeds the DAC balance, the reserve for future policy benefits is increased by the excess, reflected in earnings (loss) in the period such deficiency occurs. For some products, policyholders can elect to modify product benefits, features, rights or coverages that occur by the exchange of a contract for a new contract, or by amendment, endorsement, or rider to a contract, or by election or coverage within a contract. These transactions are known as internal replacements. If such modification substantially changes the contract, the associated DAC is written off immediately through income and any new deferrable costs associated with the replacement contract are deferred. If the modification does not substantially change the contract, the DAC amortization on the original contract will continue and any acquisition costs associated with the related modification are expensed. Reinsurance For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Cessions under reinsurance agreements do not discharge the Company’s obligations as the primary insurer. The Company reviews all contractual features, including those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. For reinsurance of existing in-force blocks of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid (received), and the liabilities ceded (assumed) related to the underlying contracts is considered the net cost of reinsurance at the inception of the reinsurance agreement. The net cost of reinsurance is recorded as an adjustment to DAC and recognized as a component of other expenses on a basis consistent with the way the acquisition costs on the underlying reinsured contracts would be recognized. Subsequent amounts paid (received) on the reinsurance of in-force blocks, as well as amounts paid (received) related to new business, are recorded as Premiums ceded (assumed); and Amounts due from reinsurers (Amounts due to reinsurers) are established. Amounts currently recoverable under reinsurance agreements are included in Amounts due from reinsurers and amounts currently payable are included in Amounts due to reinsurers. Assets and liabilities relating to reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance. Premiums, Policy charges and fee income and Policyholders’ benefits include amounts assumed under reinsurance agreements and are net of reinsurance ceded. Amounts received from reinsurers for policy administration are reported in other revenues. With respect to GMIBs, a portion of the directly written GMIBs are accounted for as insurance liabilities, but the associated reinsurance agreements contain embedded derivatives. These embedded derivatives are included in GMIB reinsurance contract asset, at fair value with changes in estimated fair value reported in Net derivative gains (losses). If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. Deposits received are included in Other liabilities and deposits made are included within premiums, reinsurance and other receivables. As amounts are paid or received, consistent with the underlying contracts, the deposit assets or liabilities are adjusted. Interest on such deposits is recorded as other revenues or other expenses, as appropriate. Periodically, the Company evaluates the adequacy of the expected payments or recoveries and adjusts the deposit asset or liability through other revenues or other expenses, as appropriate. For reinsurance contracts other than those accounted for as derivatives, reinsurance recoverable balances are calculated using methodologies and assumptions that are consistent with those used to calculate the direct liabilities.
Policyholder Bonus Interest Credits	Policyholder Bonus Interest Credits Policyholder bonus interest credits are offered on certain deferred annuity products in the form of either immediate bonus interest credited or enhanced interest crediting rates for a period of time. The interest crediting expense associated with these policyholder bonus interest credits is deferred and amortized over the lives of the underlying contracts in a manner consistent with the amortization of DAC. Unamortized balances are included in Other assets in the consolidated balance sheets and amortization is included in Interest credited to policyholders’ account balances in the consolidated statements of income (loss).
Policyholders' Account Balances and Future Policy Benefits	Policyholders’ Account Balances and Future Policy Benefits Policyholders’ account balances relate to contracts or contract features where the Company has no significant insurance risk. This liability represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date. For participating traditional life insurance policies, future policy benefit liabilities are calculated using a net level premium method on the basis of actuarial insurance assumptions equal to guaranteed mortality and dividend fund interest rates. The liability for annual dividends represents the accrual of annual dividends earned. Terminal dividends are accrued in proportion to gross margins over the life of the contract. For non-participating traditional life insurance policies, future policy benefit liabilities are estimated using a net level premium method on the basis of actuarial assumptions as to mortality, persistency and interest established at policy issue. Assumptions established at policy issue as to mortality and persistency are based on the Company’s experience that, together with interest and expense assumptions, includes a margin for adverse deviation. Benefit liabilities for traditional annuities during the accumulation period are equal to accumulated policyholders’ fund balances and, after annuitization, are equal to the present value of expected future payments. Interest rates used in establishing such liabilities range from 4.5% to 6.3% (weighted average of 5.0% ) for approximately 99.2% of life insurance liabilities and from 1.6% to 5.5% (weighted average of 4.8% ) for annuity liabilities. Individual health benefit liabilities for active lives are estimated using the net level premium method and assumptions as to future morbidity, withdrawals and interest. Benefit liabilities for disabled lives are estimated using the present value of benefits method and experience assumptions as to claim terminations, expenses and interest. While management believes its disability income (“DI”) reserves have been calculated on a reasonable basis and are adequate, there can be no assurance reserves will be sufficient to provide for future liabilities. When the liabilities for future policy benefits plus the present value of expected future gross premiums for a product are insufficient to provide for expected future policy benefits and expenses for that product, DAC is written off and thereafter, if required, a premium deficiency reserve is established by a charge to earnings. Funding agreements are also reported in Policyholders’ account balances in the consolidated balance sheets. As a member of the Federal Home Loan Bank of New York (“FHLBNY”), the Company has access to collateralized borrowings. The Company may also issue funding agreements to the FHLBNY. Both the collateralized borrowings and funding agreements would require the Company to pledge qualified mortgage-backed assets and/or government securities as collateral. The Company has issued and continues to offer certain variable annuity products with guaranteed minimum death benefits (“GMDB”) and/or contain a guaranteed minimum living benefit (“GMLB,” and together with GMDB, the “GMxB features”) which, if elected by the policyholder after a stipulated waiting period from contract issuance, guarantees a minimum lifetime annuity based on predetermined annuity purchase rates that may be in excess of what the contract account value can purchase at then-current annuity purchase rates. This minimum lifetime annuity is based on predetermined annuity purchase rates applied to a guaranteed minimum income benefit (“GMIB”) base. The Company previously issued certain variable annuity products with and guaranteed income benefit (“GIB”) features, guaranteed withdrawal benefit for life (“GWBL”), guaranteed minimum withdrawal benefit (“GMWB”) and guaranteed minimum accumulation benefit (“GMAB”) features. The Company has also assumed reinsurance for products with GMxB features. Reserves for products that have GMIB features, but do not have no-lapse guarantee features, and products with GMDB features are determined by estimating the expected value of death or income benefits in excess of the projected contract accumulation value and recognizing the excess over the estimated life based on expected assessments (i.e., benefit ratio). The determination of this estimated liability is based on models that involve numerous estimates and subjective judgments, including those regarding expected market rates of return and volatility, contract surrender and withdrawal rates, mortality experience, and, for contracts with the GMIB feature, GMIB election rates. Assumptions regarding separate account performance used for purposes of this calculation are set using a long-term view of expected average market returns by applying a RTM approach, consistent with that used for DAC amortization. There can be no assurance that actual experience will be consistent with management’s estimates. Products that have a GMIB feature with a no-lapse guarantee rider (“GMIBNLG”), GIB, GWBL, GMWB and GMAB features and the assumed products with GMIB features (collectively “GMxB derivative features”) are considered either freestanding or embedded derivatives and discussed below under (“Embedded and Freestanding Insurance Derivatives”). After the initial establishment of reserves, premium deficiency and loss recognition tests are performed each period end using best estimate assumptions as of the testing date without provisions for adverse deviation. When the liabilities for future policy benefits plus the present value of expected future gross premiums for the aggregate product group are insufficient to provide for expected future policy benefits and expenses for that line of business (i.e., reserves net of any DAC asset), DAC would first be written off and thereafter, if required, a premium deficiency reserve would be established by a charge to earnings. Premium deficiency reserves have been recorded for the group single premium annuity business, certain interest-sensitive life contracts, structured settlements, individual disability income and major medical. Additionally, in certain instances the policyholder liability for a particular line of business may not be deficient in the aggregate to trigger loss recognition, but the pattern of earnings may be such that profits are expected to be recognized in earlier years followed by losses in later years. This pattern of profits followed by losses is exhibited in our VISL business and is generated by the cost structure of the product or secondary guarantees in the contract. The secondary guarantee ensures that, subject to specified conditions, the policy will not terminate and will continue to provide a death benefit even if there is insufficient policy value to cover the monthly deductions and charges. We accrue for these Profits Followed by Losses (“PFBL”) using a dynamic approach that changes over time as the projection of future losses change.
Embedded and Freestanding Insurance Derivatives	Embedded and Freestanding Insurance Derivatives Reserves for products considered either embedded or freestanding derivatives are measured at estimated fair value separately from the host variable annuity product, with changes in estimated fair value reported in Net derivative gains (losses). The estimated fair values of these derivatives are determined based on the present value of projected future benefits minus the present value of projected future fees attributable to the guarantee. The projections of future benefits and future fees require capital markets and actuarial assumptions, including expectations concerning policyholder behavior. A risk-neutral valuation methodology is used under which the cash flows from the guarantees are projected under multiple capital market scenarios using observable risk-free rates. Additionally, the Company cedes and assumes reinsurance of products with GMxB features, which are considered either an embedded or freestanding derivative and measured at fair value. The GMxB reinsurance contract asset and liabilities’ fair values reflect the present value of reinsurance premiums and recoveries and risk margins over a range of market-consistent economic scenarios. Changes in the fair value of embedded and freestanding derivatives are reported in Net derivative gains (losses). Embedded derivatives in direct and assumed reinsurance contracts are reported in Future policyholders’ benefits and other policyholders’ liabilities and embedded derivatives in ceded reinsurance contracts are reported in the GMIB reinsurance contract asset, at fair value in the consolidated balance sheets. Embedded and freestanding insurance derivatives fair values are determined based on the present value of projected future benefits minus the present value of projected future fees. At policy inception, a portion of the projected future guarantee fees to be collected from the policyholder equal to the present value of projected future guaranteed benefits is attributed to the embedded derivative. The percentage of fees included in the fair value measurement is locked-in at inception. Fees above those amounts represent “excess” fees and are reported in Policy charges and fee income.
Broker-Dealer Revenues and Payables	Broker-Dealer Revenues, Receivables and Payables AXA Advisors and certain of the Company’s other subsidiaries provide investment management, brokerage and distribution services for affiliates and third parties. Third-party revenues earned from these services are reported in Other income in the Company’s consolidated statement of income (loss). Receivables from and payables to clients include amounts due on cash and margin transactions. Securities owned by customers are held as collateral for receivables; such collateral is not reflected in the consolidated financial statements.
Separate Accounts	Separate Accounts Generally, Separate Accounts established under New York State and Arizona State Insurance Law are not chargeable with liabilities that arise from any other business of the Company. Separate Accounts assets are subject to General Account claims only to the extent Separate Accounts assets exceed separate accounts liabilities. Assets and liabilities of the Separate Account represent the net deposits and accumulated net investment earnings (loss) less fees, held primarily for the benefit of policyholders, and for which the Company does not bear the investment risk. Separate Accounts assets and liabilities are shown on separate lines in the consolidated balance sheets. Assets held in Separate Accounts are reported at quoted market values or, where quoted values are not readily available or accessible for these securities, their fair value measures most often are determined through the use of model pricing that effectively discounts prospective cash flows to present value using appropriate sector-adjusted credit spreads commensurate with the security’s duration, also taking into consideration issuer-specific credit quality and liquidity. Investment performance (including investment income, net investment gains (losses) and changes in unrealized gains (losses)) and the corresponding amounts credited to policyholders of such Separate Accounts are offset within the same line in the consolidated statements of income (loss). For 2018 , 2017 and 2016 , investment results of such Separate Accounts were losses of $7.2 billion, and gains of $16.7 billion and $8.2 billion, respectively. Deposits to Separate Accounts are reported as increases in Separate Accounts assets and liabilities and are not reported in revenues or expenses. Mortality, policy administration and surrender charges on all policies including those funded by Separate Accounts are included in revenues. The Company reports the General Account’s interests in Separate Accounts as Other trading in the consolidated balance sheets.
Internal-use Software	Internal-use Software Capitalized internal-use software, included in Other assets in the consolidated balance sheets, is amortized on a straight-line basis over the estimated useful life of the software that ranges between three and five years . Capitalized amounts are periodically tested for impairment in accordance with the guidance on impairment of long-lived assets. An immediate charge to earnings is recognized if capitalized software costs no longer are deemed to be recoverable. In addition, service potential is periodically reassessed to determine whether facts and circumstances have compressed the software’s useful life such that acceleration of amortization over a shorter period than initially determined would be required.
Income Taxes	Income Taxes The Company and certain of its consolidated subsidiaries and affiliates file a consolidated federal income tax return. The Company provides for federal and state income taxes currently payable, as well as those deferred due to temporary differences between the financial reporting and tax bases of assets and liabilities. Current federal income taxes are charged or credited to operations based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year. Deferred income tax assets and liabilities are recognized based on the difference between financial statement carrying amounts and income tax bases of assets and liabilities using enacted income tax rates and laws. Valuation allowances are established when management determines, based on available information, that it is more likely than not that deferred tax assets will not be realized. Under accounting for uncertainty in income taxes guidance, the Company determines whether it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities before any part of the benefit can be recorded in the consolidated financial statements. Tax positions are then measured at the largest amount of benefit that is greater than 50% likely of being realized upon settlement.
Policyholders' Dividend	Policyholders’ Dividends The amount of policyholders’ dividends to be paid (including dividends on policies included in the Closed Block) is determined annually by the board of directors of the issuing insurance company. The aggregate amount of policyholders’ dividends is related to actual interest, mortality, morbidity and expense experience for the year and judgment as to the appropriate level of statutory surplus to be retained by the Company.
Long-term Debt	Long-Term Debt Liabilities for long-term debt are primarily carried at an amount equal to unpaid principal balance, net of unamortized discount or premium and debt issue costs. Original-issue discount or premium and debt-issue costs are recognized as a component of interest expense over the period the debt is expected to be outstanding, using the interest method of amortization. Interest expense is generally presented within Interest expense in the consolidated statements of income (loss). See Note 11 for additional information regarding long-term debt.
Recognition of Investment Management and Service Fees and Related Expenses	Recognition of Investment Management and Service Fees and Related Expenses Investment management, advisory and service fees Reported as Investment management and service fees in the Company’s consolidated statements of income (loss) are investment management and administrative service fees earned by AXA Equitable Funds Management Group, LLC (“AXA Equitable FMG”) as well as certain asset-based fees associated with insurance contracts. AXA Equitable FMG provides investment management and administrative services, such as fund accounting and compliance services, to AXA Premier VIP Trust (“VIP Trust”), EQ Advisors Trust (“EQAT”) and 1290 Funds as well as two private investment trusts established in the Cayman Islands, AXA Allocation Funds Trust and AXA Offshore Multimanager Funds Trust (collectively, the “Other AXA Trusts”). The contracts supporting these revenue streams create a distinct, separately identifiable performance obligation for each day the assets are managed for the performance of a series of services that are substantially the same and have the same pattern of transfer to the customer. Accordingly, these investment management, advisory, and administrative service base fees are recorded over time as services are performed and entitle the Company to variable consideration. Base fees, generally calculated as a percentage of assets under management (“AUM”), are recognized as revenue at month-end when the transaction price no longer is variable and the value of the consideration is determined. These fees are not subject to claw back and there is minimal probability that a significant reversal of the revenue recorded will occur. Sub-advisory and sub-administrative expenses associated with these services are calculated and recorded as the related services are performed in Other operating costs and expense in the consolidated statements of income (loss) as the Company is acting in a principal capacity in these transactions and, as such, reflects these revenues and expenses on a gross basis. Distribution services Revenues from distribution services include fees received as partial reimbursement of expenses incurred in connection with the sale of certain mutual funds and the 1290 Funds and for the distribution primarily of EQAT and VIP Trust shares to separate accounts in connection with the sale of variable life and annuity contracts. The amount and timing of revenues recognized from performance of these distribution services often is dependent upon the contractual arrangements with the customer and the specific product sold as further described below. Most open-end management investment companies, such as U.S. funds and the EQAT and VIP Trusts and the 1290 Funds, have adopted a plan under Rule 12b-1 of the Investment Company Act that allows for certain share classes to pay out of assets, distribution and service fees for the distribution and sale of its shares (“12b-1 Fees”). These open-end management investment companies have such agreements with the Company, and the Company has selling and distribution agreements pursuant to which it pays sales commissions to the financial intermediaries that distribute the shares. These agreements may be terminated by either party upon notice (generally 30 days) and do not obligate the financial intermediary to sell any specific amount of shares. The Company records 12b-1 fees monthly based upon a percentage of the net asset value (“NAV”) of the funds. At month-end, the variable consideration of the transaction price is no longer constrained as the NAV can be calculated and the value of consideration is determined. These services are separate and distinct from other asset management services as the customer can benefit from these services independently of other services. The Company accrues the corresponding 12b-1 fees paid to sub-distributors monthly as the expenses are incurred. The Company is acting in a principal capacity in these transactions; as such, these revenues and expenses are recorded on a gross basis in the consolidated statements of income (loss). Other revenues Also reported as Investment management and service fees in the Company’s consolidated statements of income (loss) are other revenues from contracts with customers, primarily consisting of mutual fund reimbursements and other brokerage income. Other income Revenues from contracts with customers reported as Other Income in the Company’s consolidated statements of income (loss) primarily consist of advisory account fees and brokerage commissions from the Company’s subsidiary broker-dealer operations and sales commissions from the Company’s general agent for the distribution of non-affiliate insurers’ life insurance and annuity products. These revenues are recognized at month-end when constraining factors, such as AUM and product mix, are resolved and the transaction pricing no longer is variable such that the value of consideration can be determined.
Discontinued Operations	Discontinued Operations The results of operations of a component of the Company that has been disposed of are reported in discontinued operations if certain criteria are met; such as if the disposal represents a strategic shift that has or will have a major effect on the Company’s operations and financial results. The results of AB are reflected in the Company.’s consolidated financial statements as discontinued operations and, therefore, are presented as assets and liabilities of disposed subsidiary on the consolidated balance sheets and net income (loss) from discontinued operations, net of taxes and noncontrolling interest on the consolidated statements of income (loss). Intercompany transactions between the Company and AB prior to the disposal have been eliminated. See Note 19 for information on discontinued operations and transactions with AB.

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Abstract]
Schedule of New Accounting Pronouncements and Changes in Accounting Principles	The reclassification adjustments for the years ended December 31, 2017 and 2016 are presented in the table below. Capitalization of DAC reclassified to Compensation and benefits, Commissions and distribution plan payments, and Other operating costs and expenses reduced the amounts previously reported in those expense line items, while the capitalization of DAC reclassified from the Amortization of deferred policy acquisition costs line item increases that expense line item. Years Ended December 31, 2017 2016 (in millions) Reductions to expense line items: Compensation and benefits $ 128 $ 128 Commissions and distribution plan payments 443 460 Other operating costs and expenses 7 6 Total reductions $ 578 $ 594 Increase to expense line item: Amortization of deferred policy acquisition costs $ 578 $ 594

INVESTMENTS (Tables)

INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2018
Investments, Debt and Equity Securities [Abstract]
Available-for-sale Securities	The following tables provide information relating to fixed maturities classified as AFS. As a result of the adoption of “Financial Instruments - Recognition and Measurement of Financial Assets and Financial Liabilities” (ASU 2016-01) on January 1, 2018 (see Note 2 ), equity securities are no longer classified and accounted for as available-for-sale securities. Available-for-Sale Securities by Classification Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value OTTI in AOCI (4) (in millions) December 31, 2018: Fixed Maturities: Corporate (1) $ 26,690 $ 385 $ 699 $ 26,376 $ — U.S. Treasury, government and agency 13,646 143 454 13,335 — States and political subdivisions 408 47 1 454 — Foreign governments 515 17 13 519 — Residential mortgage-backed (2) 193 9 — 202 — Asset-backed (3) 600 1 11 590 2 Redeemable preferred stock 440 16 17 439 — Total at December 31, 2018 $ 42,492 $ 618 $ 1,195 $ 41,915 $ 2 December 31, 2017: Fixed Maturities: Corporate (1) $ 20,596 $ 942 $ 56 $ 21,482 $ — U.S. Treasury, government and agency 12,644 676 185 13,135 — States and political subdivisions 414 67 — 481 — Foreign governments 387 27 5 409 — Residential mortgage-backed (2) 236 15 — 251 — Asset-backed (3) 93 3 — 96 2 Redeemable preferred stock 461 44 1 504 — Total Fixed Maturities 34,831 1,774 247 36,358 2 Equity securities 157 — — 157 — Total at December 31, 2017 $ 34,988 $ 1,774 $ 247 $ 36,515 $ 2 ____________ (1) Corporate fixed maturities include both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. (4) Amounts represent OTTI losses in AOCI, which were not included in income (loss) in accordance with current accounting guidance.
Investments Classified by Contractual Maturity Date	The contractual maturities of AFS fixed maturities at December 31, 2018 are shown in the table below. Bonds not due at a single maturity date have been included in the table in the final year of maturity. Actual maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties. Contractual Maturities of Available-for-Sale Fixed Maturities Amortized Cost Fair Value (in millions) December 31, 2018: Due in one year or less $ 2,085 $ 2,090 Due in years two through five 8,087 8,141 Due in years six through ten 14,337 14,214 Due after ten years 16,750 16,239 Subtotal 41,259 40,684 Residential mortgage-backed securities 193 202 Asset-backed securities 600 590 Redeemable preferred stock 440 439 Total at December 31, 2018 $ 42,492 $ 41,915
Available For Sale Fixed Maturities Proceeds Gross Gains And Gross Losses From Sales And Other Than Temporary Impairments	The following table shows proceeds from sales, gross gains (losses) from sales and OTTI for AFS fixed maturities for the years ended December 31, 2018 , 2017 and 2016 : For the Years Ended December 31, 2018 2017 2016 (in millions) Proceeds from sales $ 7,136 $ 7,232 $ 4,324 Gross gains on sales $ 145 $ 98 $ 111 Gross losses on sales $ (103 ) $ (211 ) $ (58 ) Total OTTI $ (37 ) $ (13 ) $ (65 ) Non-credit losses recognized in OCI — — — Credit losses recognized in net income (loss) $ (37 ) $ (13 ) $ (65 )
Fixed Maturities Credit Loss Impairments	The following table sets forth the amount of credit loss impairments on AFS fixed maturities held by the Company at the dates indicated and the corresponding changes in such amounts: Fixed Maturities - Credit Loss Impairments 2018 2017 (in millions) Balances at January 1, $ (10 ) $ (190 ) Previously recognized impairments on securities that matured, paid, prepaid or sold 1 193 Recognized impairments on securities impaired to fair value this period (1) — — Impairments recognized this period on securities not previously impaired (37 ) (13 ) Additional impairments this period on securities previously impaired — — Increases due to passage of time on previously recorded credit losses — — Accretion of previously recognized impairments due to increases in expected cash flows — — Balances at December 31, $ (46 ) $ (10 ) ____________ (1) Represents circumstances where the Company determined in the current period that it intends to sell the security or it is more likely than not that it will be required to sell the security before recovery of the security’s amortized cost.
Unrealized Gain (Loss) on Investments	Net unrealized investment gains (losses) on fixed maturities classified as AFS are included in the consolidated balance sheets as a component of AOCI. The table below presents these amounts as of the dates indicated: As of December 31, 2018 2017 (in millions) AFS Securities: Fixed maturities: With OTTI loss $ — $ 1 All other (577 ) 1,526 Net Unrealized Gains (Losses) $ (577 ) $ 1,527
Unrealized Gain (Loss) On Investments With Other Than Temporary Impairment	Net Unrealized Gains (Losses) on Fixed Maturities with OTTI Losses Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2018 $ 1 $ 1 $ (1 ) $ (5 ) $ (4 ) Net investment gains (losses) arising during the period (1 ) — — — (1 ) Reclassification adjustment: Included in Net income (loss) — — — — — Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — (1 ) — — (1 ) Deferred income taxes — — — 5 5 Policyholders’ liabilities — — 1 — 1 Balance, December 31, 2018 $ — $ — $ — $ — $ — Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2017 $ 19 $ (1 ) $ (10 ) $ (3 ) $ 5 Net investment gains (losses) arising during the period (18 ) — — — (18 ) Reclassification adjustment: Included in Net income (loss) — — — — — Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — 2 — — 2 Deferred income taxes — — — (2 ) (2 ) Policyholders’ liabilities — — 9 — 9 Balance, December 31, 2017 $ 1 $ 1 $ (1 ) $ (5 ) $ (4 ) ____________ (1) Represents “transfers in” related to the portion of OTTI losses recognized during the period that were not recognized in income (loss) for securities with no prior OTTI loss.
Other Net Unrealized Investment Gains Losses In Accumulated Other Comprehensive Income	All Other Net Unrealized Investment Gains (Losses) in AOCI Net Unrealized Gains (Losses) on Investments DAC Policyholders’ Liabilities Deferred Income Tax Asset (Liability) AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) (in millions) Balance, January 1, 2018 $ 1,526 $ (315 ) $ (232 ) $ (300 ) $ 679 Net investment gains (losses) arising during the period (2,098 ) — — — (2,098 ) Reclassification adjustment: Included in Net income (loss) (5 ) — — — (5 ) Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — 354 — — 354 Deferred income taxes (2) — — — 425 425 Policyholders’ liabilities — — 177 — 177 Balance, December 31, 2018 $ (577 ) $ 39 $ (55 ) $ 125 $ (468 ) Balance, January 1, 2017 $ 428 $ (104 ) $ (188 ) $ (47 ) $ 89 Net investment gains (losses) arising during the period 1,085 — — — 1,085 Reclassification adjustment: Included in Net income (loss) 13 — — — 13 Excluded from Net income (loss) (1) — — — — — Impact of net unrealized investment gains (losses) on: DAC — (211 ) — — (211 ) Deferred income taxes — — — (253 ) (253 ) Policyholders’ liabilities — — (44 ) — (44 ) Balance, December 31, 2017 $ 1,526 $ (315 ) $ (232 ) $ (300 ) $ 679 ____________ (1) Represents “transfers out” related to the portion of OTTI losses during the period that were not recognized in income (loss) for securities with no prior OTTI loss. (2) Includes a $86 million income tax benefit from the impact of adoption of ASU 2018-02.
Schedule of Unrealized Loss on Investments	The following tables disclose the fair values and gross unrealized losses of the 1,471 issues at December 31, 2018 and the 620 issues at December 31, 2017 of fixed maturities that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position for the specified periods at the dates indicated: Less Than 12 Months 12 Months or Longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses (in millions) December 31, 2018: Fixed Maturities: Corporate $ 8,369 $ 306 $ 6,161 $ 393 $ 14,530 $ 699 U.S. Treasury, government and agency 2,636 68 3,154 386 5,790 454 States and political subdivisions — — 19 1 19 1 Foreign governments 109 3 76 10 185 13 Residential mortgage-backed — — 13 — 13 — Asset-backed 558 11 6 — 564 11 Redeemable preferred stock 160 12 31 5 191 17 Total $ 11,832 $ 400 $ 9,460 $ 795 $ 21,292 $ 1,195 December 31, 2017: Fixed Maturities: Corporate $ 2,102 $ 17 $ 1,163 $ 39 $ 3,265 $ 56 U.S. Treasury, government and agency 2,150 6 3,005 179 5,155 185 States and political subdivisions 20 — — — 20 — Foreign governments 11 — 73 5 84 5 Residential mortgage-backed 18 — — — 18 — Asset-backed 7 — 2 — 9 — Redeemable preferred stock 7 — 12 1 19 1 Total $ 4,315 $ 23 $ 4,255 $ 224 $ 8,570 $ 247
Allowance for Credit Losses on Financing Receivable	The change in the valuation allowance for credit losses for commercial mortgage loans during the years ended December 31, 2018 , 2017 and 2016 was as follows: Commercial Mortgage Loans 2018 2017 2016 (in millions) Allowance for credit losses: Beginning Balance, January 1, $ 8 $ 8 $ 6 Charge-offs — — — Recoveries (1 ) — (2 ) Provision — — 4 Ending Balance, December 31, $ 7 $ 8 $ 8 Ending Balance, December 31, Individually Evaluated for Impairment $ 7 $ 8 $ 8
Debt Service Coverage Ratio	The following tables provide information relating to the loan-to-value and debt service coverage ratios for commercial and agricultural mortgage loans at December 31, 2018 and 2017 . The values used in these ratio calculations were developed as part of the periodic review of the commercial and agricultural mortgage loan portfolio, which includes an evaluation of the underlying collateral value. Mortgage Loans by Loan-to-Value and Debt Service Coverage Ratios Debt Service Coverage Ratio (1) Loan-to-Value Ratio: (2) Greater than 2.0x 1.8x to 2.0x 1.5x to 1.8x 1.2x to 1.5x 1.0x to 1.2x Less than 1.0x Total Mortgage Loans (in millions) December 31, 2018: Commercial Mortgage Loans (1) 0% - 50% $ 780 $ 21 $ 247 $ 24 $ — $ — $ 1,072 50% - 70% 4,908 656 1,146 325 151 — 7,186 70% - 90% 260 — 117 370 98 — 845 90% plus — — — 27 — — 27 Total Commercial Mortgage Loans $ 5,948 $ 677 $ 1,510 $ 746 $ 249 $ — $ 9,130 Agricultural Mortgage Loans (1) 0% - 50% $ 282 $ 147 $ 267 $ 543 $ 321 $ 51 $ 1,611 50% - 70% 112 46 246 379 224 31 1,038 70% - 90% — — — 19 27 — 46 90% plus — — — — — — — Total Agricultural Mortgage Loans $ 394 $ 193 $ 513 $ 941 $ 572 $ 82 $ 2,695 Total Mortgage Loans (1) 0% - 50% $ 1,062 $ 168 $ 514 $ 567 $ 321 $ 51 $ 2,683 50% - 70% 5,020 702 1,392 704 375 31 8,224 70% - 90% 260 — 117 389 125 — 891 90% plus — — — 27 — — 27 Total Mortgage Loans $ 6,342 $ 870 $ 2,023 $ 1,687 $ 821 $ 82 $ 11,825 December 31, 2017: Commercial Mortgage Loans (1) 0% - 50% $ 742 $ — $ 320 $ 74 $ — $ — $ 1,136 50% - 70% 4,088 682 1,066 428 145 — 6,409 70% - 90% 169 110 196 272 50 — 797 90% plus — — 27 — — — 27 Total Commercial Mortgage Loans $ 4,999 $ 792 $ 1,609 $ 774 $ 195 $ — $ 8,369 Agricultural Mortgage Loans (1) 0% - 50% $ 272 $ 149 $ 275 $ 515 $ 316 $ 30 $ 1,557 50% - 70% 111 46 227 359 221 49 1,013 70% - 90% — — — 4 — — 4 90% plus — — — — — — — Total Agricultural Mortgage Loans $ 383 $ 195 $ 502 $ 878 $ 537 $ 79 $ 2,574 Total Mortgage Loans (1) 0% - 50% $ 1,014 $ 149 $ 595 $ 589 $ 316 $ 30 $ 2,693 50% - 70% 4,199 728 1,293 787 366 49 7,422 70% - 90% 169 110 196 276 50 — 801 90% plus — — 27 — — — 27 Total Mortgage Loans $ 5,382 $ 987 $ 2,111 $ 1,652 $ 732 $ 79 $ 10,943 __________ (1) The debt service coverage ratio is calculated using the most recently reported operating income results from property operations divided by annual debt service. (2) The loan-to-value ratio is derived from current loan balance divided by the fair market value of the property. The fair market value of the underlying commercial properties is updated annually.
Age Analysis Of Past Due Mortgage Loans	The following table provides information relating to the aging analysis of past due mortgage loans at December 31, 2018 and 2017 , respectively: Age Analysis of Past Due Mortgage Loans 30-59 Days 60-89 Days 90 Days or More Total Current Total Financing Receivables Recorded Investment 90 Days or More and Accruing (in millions) December 31, 2018: Commercial $ — $ — $ 27 $ 27 $ 9,103 $ 9,130 $ — Agricultural 18 8 42 68 2,627 2,695 40 Total Mortgage Loans $ 18 $ 8 $ 69 $ 95 $ 11,730 $ 11,825 $ 40 December 31, 2017: Commercial $ 27 $ — $ — $ 27 $ 8,342 $ 8,369 $ — Agricultural 49 3 22 74 2,500 2,574 22 Total Mortgage Loans $ 76 $ 3 $ 22 $ 101 $ 10,842 $ 10,943 $ 22
Impaired Mortgage Loans	The following table provides information relating to impaired mortgage loans at December 31, 2018 and 2017 , respectively: Impaired Mortgage Loans Recorded Investment Unpaid Principal Balance Related Allowance Average Recorded Investment (1) Interest Income Recognized (in millions) December 31, 2018: With no related allowance recorded: Commercial mortgage loans - other $ — $ — $ — $ — $ — Agricultural mortgage loans 2 2 — — — Total $ 2 $ 2 $ — $ — $ — With related allowance recorded: Commercial mortgage loans - other $ 27 $ 31 $ (7 ) $ 27 $ — Agricultural mortgage loans — — — — — Total $ 27 $ 31 $ (7 ) $ 27 $ — December 31, 2017: With no related allowance recorded: Commercial mortgage loans - other $ — $ — $ — $ — $ — Agricultural mortgage loans — — — — — Total $ — $ — $ — $ — $ — With related allowance recorded: Commercial mortgage loans - other $ 27 $ 31 $ (8 ) $ 27 $ 2 Agricultural mortgage loans — — — — — Total $ 27 $ 31 $ (8 ) $ 27 $ 2 ____________ (1) Represents a five-quarter average of recorded amortized cost.
Real Estate Investment Financial Statements, Disclosure	The tables below present quantitative disclosures about the Company’s derivative instruments, including those embedded in other contracts required to be accounted for as derivative instruments: Derivative Instruments by Category At December 31, 2018 Fair Value Gains (Losses) Notional Asset Liability (in millions) Freestanding Derivatives (1) (4): Equity contracts: Futures $ 10,411 $ — $ — $ 550 Swaps 7,697 140 168 675 Options 21,698 2,119 1,163 (899 ) Interest rate contracts: Swaps 27,003 632 194 (456 ) Futures 11,448 — — 118 Credit contracts: Credit default swaps 1,282 17 — (3 ) Other freestanding contracts: Foreign currency contracts 2,097 27 14 6 Margin — 7 5 — Collateral — 3 1,564 — Embedded Derivatives: GMIB reinsurance contracts (4) — 1,991 — (1,068 ) GMxB derivative features liability (2) (4) — — 5,431 (786 ) SCS, SIO, MSO and IUL indexed features (3) (4) — — 687 853 Balances, December 31, 2018 $ 81,636 $ 4,936 $ 9,226 $ (1,010 ) ____________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (3) SCS, SIO, MSO and IUL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. (4) Reported in Net derivative gains (losses) in the consolidated statements of income (loss).
Schedule of Derivative Instruments	Derivative Instruments by Category At December 31, 2017 Fair Value Gains (Losses) Notional Amount Asset Derivatives Liability Derivatives (in millions) Freestanding Derivatives (1) (4): Equity contracts: Futures $ 2,950 $ — $ — $ (655 ) Swaps 4,587 3 125 (842 ) Options 20,630 3,334 1,426 1,203 Interest rate contracts: Swaps 18,988 319 190 655 Futures 11,032 — — 125 Credit contracts: Credit default swaps 2,057 34 2 21 Other freestanding contracts: Foreign currency contracts 1,297 11 2 (38 ) Margin — 18 — — Collateral — 3 1,855 — Embedded Derivatives: GMIB reinsurance contracts (4) — 10,488 — 69 GMxB derivative features liability (2) (4) — — 4,256 1,592 SCS, SIO, MSO and IUL indexed features (3) (4) — — 1,698 (1,236 ) Balances, December 31, 2017 $ 61,541 $ 14,210 $ 9,554 $ 894 ____________ (1) Reported in Other invested assets in the consolidated balance sheets. (2) Reported in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets. (3) SCS, SIO, MSO and UIL indexed features are reported in Policyholders’ account balances in the consolidated balance sheets. (4) Reported in Net derivative gains (losses) in the consolidated statements of income (loss).
Offsetting Assets And Liabilities	The following table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at December 31, 2018 : Offsetting of Financial Assets and Liabilities and Derivative Instruments At December 31, 2018 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets (in millions) Assets Total Derivatives $ 2,946 $ 2,912 $ 34 Other financial instruments 1,520 — 1,520 Other invested assets $ 4,466 $ 2,912 $ 1,554 Liabilities Total Derivatives $ 3,109 $ 2,912 $ 197 Other financial liabilities 1,263 — 1,263 Other liabilities $ 4,372 $ 2,912 $ 1,460 Securities sold under agreement to repurchase (1) $ 571 $ — $ 571 ____________ (1) Excludes expense of $2 million in securities sold under agreement to repurchase. The foll ow ing table presents information about the Company’s offsetting of financial assets and liabilities and derivative instruments at December 31, 2017 . Offsetting of Financial Assets and Liabilities and Derivative Instruments At December 31, 2017 Gross Amount Recognized Gross Amount Offset in the Balance Sheets Net Amount Presented in the Balance Sheets (in millions) Assets Total Derivatives $ 3,740 $ 3,614 $ 126 Other financial instruments 1,704 — 1,704 Other invested assets $ 5,444 $ 3,614 $ 1,830 Liabilities Total Derivatives $ 3,614 $ 3,614 $ — Other financial liabilities 1,242 — 1,242 Other liabilities $ 4,856 $ 3,614 $ 1,242 Securities sold under agreement to repurchase (1) $ 1,882 $ — $ 1,882 ____________ (1) Excludes expense of $5 million included in Securities sold under agreements to repurchase on the consolidated balance sheets.
Collateral Arrangements By Counterparty Not Offset In Consolidated Balance Sheets	The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2017 : Collateral Amounts Not Offset in the Consolidated Balance Sheets At December 31, 2017 Net Amount Presented in the Balance Sheets Collateral (Received)/Held Financial Instruments Cash (3) Net Amount (in millions) Assets Total derivatives $ 1,954 $ — $ (1,828 ) $ 126 Other financial instruments 1,704 — — 1,704 Other invested assets $ 3,658 $ — $ (1,828 ) $ 1,830 Liabilities Other financial liabilities $ 1,242 $ — $ — $ 1,242 Other liabilities $ 1,242 $ — $ — $ 1,242 Securities sold under agreement to repurchase (1) (2) (3) $ 1,882 $ (1,988 ) $ (21 ) $ (127 ) ____________ (1) Excludes expense of $5 million in securities sold under agreement to repurchase. (2) U.S. Treasury and agency securities are in fixed maturities available-for-sale on the consolidated balance sheets. (3) Cash is included in Cash and cash equivalents on consolidated balance sheets. The following table presents information about the Company’s gross collateral amounts that are not offset in the consolidated balance sheets at December 31, 2018 . Collateral Amounts Not Offset in the Consolidated Balance Sheets At December 31, 2018 Net Amount Presented in the Balance Sheets Collateral (Received)/Held Financial Instruments Cash (3) Net Amount (in millions) Assets Total Derivatives $ 1,397 $ — $ (1,363 ) $ 34 Other financial instruments 1,520 — — 1,520 Other invested assets $ 2,917 $ — $ (1,363 ) $ 1,554 Liabilities Total Derivatives $ 197 $ — $ — $ 197 Other financial liabilities 1,263 — — 1,263 Other liabilities $ 1,460 $ — $ — $ 1,460 Securities sold under agreement to repurchase (1) (2) (3) $ 571 $ (588 ) $ — $ (17 ) ____________ (1) Excludes expense of $2 million in securities sold under agreement to repurchase. (2) US Treasury and agency securities are in fixed maturities available-for-sale on the consolidated balance sheets. (3) Cash is in Cash and cash equivalents on consolidated balance sheets.
Transfer Of Financial Assets Accounted For As Sales	The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2018 : Repurchase Agreement Accounted for as Secured Borrowings December 31, 2018 Remaining Contractual Maturity of the Agreements Overnight and Continuous Up to 30 days 30-90 days Greater Than 90 days Total (in millions) Securities sold under agreement to repurchase (1) U.S. Treasury and agency securities $ — $ 571 $ — $ — $ 571 Total $ — $ 571 $ — $ — $ 571 ____________ (1) Excludes expense of $2 million in securities sold under agreement to repurchase. The following table presents information about repurchase agreements accounted for as secured borrowings in the consolidated balance sheets at December 31, 2017 : Repurchase Agreement Accounted for as Secured Borrowings At December 31, 2017 Remaining Contractual Maturity of the Agreements Overnight and Continuous Up to 30 days 30-90 days Greater Than 90 days Total (in millions) Securities sold under agreement to repurchase (1) U.S. Treasury and agency securities $ — $ 1,882 $ — $ — $ 1,882 Total $ — $ 1,882 $ — $ — $ 1,882 ____________ (1) Excludes expense of $5 million in securities sold under agreements to repurchase on the consolidated balance sheets.
Investment Income	The following table breaks out Net investment income (loss) by asset category: Years Ended December 31 2018 2017 2016 (in millions) Fixed maturities $ 1,540 $ 1,365 $ 1,418 Mortgage loans on real estate 494 453 461 Real estate held for the production of income (6 ) 2 — Repurchase agreement — — 1 Other equity investments 123 169 55 Policy loans 201 205 210 Trading securities 128 258 64 Other investment income 69 54 16 Gross investment income (loss) 2,549 2,506 2,225 Investment expenses (1) (71 ) (65 ) (57 ) Net Investment Income (Loss) $ 2,478 $ 2,441 $ 2,168 ____________ (1) Investment expenses includes expenses related to the management of the two buildings sold in 2016. Net unrealized and realized gains (losses) on trading account equity securities are included in Net investment income (loss) in the consolidated statements of income (loss). The table below shows a breakdown of Net investment income from trading account securities during the years ended December 31, 2018 , 2017 and 2016 : Net Investment Income (Loss) from Trading Securities Years Ended December 31, 2018 2017 2016 (in millions) Net investment gains (losses) recognized during the period on securities held at the end of the period $ (174 ) $ 63 $ (45 ) Net investment gains (losses) recognized on securities sold during the period (24 ) (19 ) (11 ) Unrealized and realized gains (losses) on trading securities (198 ) 44 (56 ) Interest and dividend income from trading securities 326 214 120 Net investment income (loss) from trading securities $ 128 $ 258 $ 64
Investment Gains Losses Net Including Changes In Valuation Allowances	Investment gains (losses), net including changes in the valuation allowances and OTTI are as follows: Years Ended December 31, 2018 2017 2016 (in millions) Fixed maturities $ 6 $ (130 ) $ (3 ) Mortgage loans on real estate — 2 (2 ) Other equity investments — 3 — Other (2 ) — 23 Investment gains (losses), net $ 4 $ (125 ) $ 18

CLOSED BLOCK (Tables)

CLOSED BLOCK (Tables)	12 Months Ended
	Dec. 31, 2018
Closed Block Disclosure [Abstract]
Schedule of Closed Block Assets and Liabilities	Summarized financial information for the Company’s Closed Block is as follows: As of December 31, 2018 2017 (in millions) Closed Block Liabilities: Future policy benefits, policyholders’ account balances and other $ 6,709 $ 6,958 Policyholder’ dividend obligation — 19 Other liabilities 47 271 Total Closed Block liabilities 6,756 7,248 Assets Designated To The Closed Block: Fixed maturities, available for sale, at fair value (amortized cost of $ 3,680 and $3,923) 3,672 4,070 Mortgage loans on real estate, net of valuation allowance of $- and $- 1,824 1,720 Policy loans 736 781 Cash and other invested assets 76 351 Other assets 179 182 Total assets designated to the Closed Block 6,487 7,104 Excess of Closed Block liabilities over assets designated to the Closed Block 269 144 Amounts included in Accumulated other comprehensive income (loss): Net unrealized investment gains (losses), net of policyholders’ dividend obligation of $- and $19 8 138 Maximum future income to be recognized from closed block assets and liabilities $ 277 $ 282
Closed Block Operations, Net Results	The Company’s Closed Block revenues and expenses follow: Years ended December 31, 2018 2017 2016 (in millions) Revenues: Premiums and other income $ 194 $ 224 $ 212 Net investment income (loss) 291 314 349 Investment gains (losses), net (3 ) (20 ) (1 ) Total revenues 482 518 560 Benefits and Other Deductions: Policyholders’ benefits and dividends 471 537 522 Other operating costs and expenses 3 2 4 Total benefits and other deductions 474 539 526 Net income, before income taxes 8 (21 ) 34 Income tax (expense) benefit (3 ) (36 ) (12 ) Net income (losses) $ 5 $ (57 ) $ 22
Closed Block Dividend Obligation	A reconciliation of the Company’s policyholders ’ dividend obligation follows: December 31, 2018 2017 (in millions) Balance, beginning of year $ 19 $ 52 Unrealized investment gains (losses) (19 ) (33 ) Balance, end of year $ — $ 19

DAC AND POLICYHOLDER BONUS IN_2

DAC AND POLICYHOLDER BONUS INTEREST CREDITS (Tables)	12 Months Ended
	Dec. 31, 2018
Contractholder Bonus Interest Credits [Abstract]
Deferred Policy Acquisition Costs	Changes in the deferred policy acquisition cost asset for the years ended December 31, 2018 , 2017 and 2016 were as follows: Years Ended December 31, 2018 2017 2016 (in millions) Balance, beginning of year $ 4,492 $ 5,025 $ 5,079 Capitalization of commissions, sales and issue expenses 597 578 594 Amortization: Impact of assumptions updates and model changes 165 (247 ) (193 ) All other (596 ) (653 ) (449 ) Total amortization (431 ) (900 ) (642 ) Change in unrealized investment gains and losses 353 (211 ) (6 ) Balance, end of year $ 5,011 $ 4,492 $ 5,025
Schedule of Changes of Deferred Assets for Policyholder Bonus Credits and Deferred Acquisition Costs	Changes in the deferred asset for policyholder bonus interest credits for the years ended December 31, 2018 , 2017 and 2016 were as follows: Years Ended December 31, 2018 2017 2016 (in millions) Balance, beginning of year $ 473 $ 504 $ 534 Policyholder bonus interest credits deferred 4 6 13 Amortization charged to income (51 ) (37 ) (43 ) Balance, end of year $ 426 $ 473 $ 504

FAIR VALUE DISCLOSURES (Tables)

FAIR VALUE DISCLOSURES (Tables)	12 Months Ended
	Dec. 31, 2018
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	Assets and liabilities measured at fair value on a recurring basis are summarized below. At December 31, 2018 and December 31, 2017 , no assets were required to be measured at fair value on a non-recurring basis. Fair value measurements are required on a non-recurring basis for certain assets, including goodwill and mortgage loans on real estate, only when an OTTI or other event occurs. When such fair value measurements are recorded, they must be classified and disclosed within the fair value hierarchy. The Company recognizes transfers between valuation levels at the beginning of the reporting period. Fair Value Measurements at December 31, 2018 Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, available-for-sale: Corporate (1) $ — $ 25,202 $ 1,174 $ 26,376 U.S. Treasury, government and agency — 13,335 — 13,335 States and political subdivisions — 416 38 454 Foreign governments — 519 — 519 Residential mortgage-backed (2) — 202 — 202 Asset-backed (3) — 71 519 590 Redeemable preferred stock 163 276 — 439 Total fixed maturities, available-for-sale 163 40,021 1,731 41,915 Other equity investments 12 — — 12 Trading securities 218 14,919 29 15,166 Other invested assets: Short-term investments — 412 — 412 Assets of consolidated VIEs/VOEs — — 19 19 Swaps — 423 — 423 Credit default swaps — 17 — 17 Options — 956 — 956 Total other invested assets — 1,808 19 1,827 Cash equivalents 2,160 — — 2,160 GMIB reinsurance contracts asset — — 1,991 1,991 Separate Accounts assets 105,159 2,733 374 108,266 Total Assets $ 107,712 $ 59,481 $ 4,144 $ 171,337 Liabilities GMxB derivative features’ liability $ — $ — $ 5,431 $ 5,431 SCS, SIO, MSO and IUL indexed features’ liability — 687 — 687 Total Liabilities $ — $ 687 $ 5,431 $ 6,118 ____________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans. Fair Value Measurements at December 31, 2017 Level 1 Level 2 Level 3 Total (in millions) Assets Investments Fixed maturities, available-for-sale: Corporate (1) $ — $ 20,343 $ 1,139 $ 21,482 U.S. Treasury, government and agency — 13,135 — 13,135 States and political subdivisions — 441 40 481 Foreign governments — 409 — 409 Residential mortgage-backed (2) — 251 — 251 Asset-backed (3) — 88 8 96 Redeemable preferred stock 180 324 — 504 Total fixed maturities, available-for-sale 180 34,991 1,187 36,358 Other equity investments 13 — — 13 Trading securities 180 12,097 — 12,277 Other invested assets Short-term investments — 763 — 763 Assets of consolidated VIEs/VOEs — — 25 25 Swaps — 15 — 15 Credit default swaps — 33 — 33 Options — 1,907 — 1,907 Total other invested assets — 2,718 25 2,743 Cash equivalents 1,908 — — 1,908 Segregated securities — 9 — 9 GMIB reinsurance contracts asset — — 10,488 10,488 Separate Accounts assets 118,983 2,983 349 122,315 Total Assets $ 121,264 $ 52,798 $ 12,049 $ 186,111 Liabilities GMxB derivative features’ liability $ — $ — $ 4,256 $ 4,256 SCS, SIO, MSO and IUL indexed features’ liability — 1,698 — 1,698 Total Liabilities $ — $ 1,698 $ 4,256 $ 5,954 _______________ (1) Corporate fixed maturities includes both public and private issues. (2) Includes publicly traded agency pass-through securities and collateralized obligations. (3) Includes credit-tranched securities collateralized by sub-prime mortgages and other asset types and credit tenant loans.
Reconciliation of Assets and Liabilities at Level 3	The table below presents a reconciliation for all Level 3 assets and liabilities at December 31, 2018 , 2017 and 2016 respectively: Level 3 Instruments Fair Value Measurements Corporate State and Political Subdivisions Foreign Governments Commercial Mortgage- backed Asset-backed (in millions) Balance, January 1, 2018 $ 1,139 $ 40 $ — $ — $ 8 Total gains (losses), realized and unrealized, included in: Income (loss) as: Net investment income (loss) 7 — — — (2 ) Investment gains (losses), net (8 ) — — — — Subtotal (1 ) — — — (2 ) Other comprehensive income (loss) (20 ) (1 ) — — (7 ) Purchases 322 — — — 550 Sales (321 ) (1 ) — — (30 ) Transfers into Level 3 (1) 83 — — — — Transfers out of Level 3 (1) (28 ) — — — — Balance, December 31, 2018 $ 1,174 $ 38 $ — $ — $ 519 Corporate State and Political Subdivisions Foreign Governments Commercial Mortgage- backed Asset-backed (in millions) Balance, January 1, 2017 $ 845 $ 42 $ — $ 349 $ 24 Total gains (losses), realized and unrealized, included in: Income (loss) as: Net investment income (loss) 5 — — (2 ) — Investment gains (losses), net 2 — — (63 ) 15 Subtotal 7 — — (65 ) 15 Other comprehensive income (loss) 4 (1 ) — 45 (9 ) Purchases 612 — — — — Sales (331 ) (1 ) — (329 ) (21 ) Transfers into Level 3 (1) 7 — — — — Transfers out of Level 3 (1) (5 ) — — — (1 ) Balance, December 31, 2017 $ 1,139 $ 40 $ — $ — $ 8 Balance, January 1, 2016 $ 420 $ 45 $ 1 $ 503 $ 40 Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net 1 — — (67 ) — Subtotal 1 — — (67 ) — Other comprehensive income (loss) 7 (2 ) — 14 1 Purchases 572 — — — — Sales (142 ) (1 ) — (87 ) (8 ) Transfers into Level 3 (1) 25 — — — — Transfers out of Level 3 (1) (38 ) — (1 ) (14 ) (9 ) Balance, December 31, 2016 $ 845 $ 42 $ — $ 349 $ 24 Redeemable Preferred Stock Other Equity Investments (2) GMIB Reinsurance Asset Separate Account Assets GMxB Derivative Features Liability (in millions) Balance, January 1, 2018 $ — $ 25 $ 10,488 $ 349 $ (4,256 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — — 26 — Net derivative gains (losses), excluding non-performance risk — — (972 ) — (296 ) Non-performance risk (4) — — (96 ) — (490 ) Subtotal — — (1,068 ) 26 (786 ) Purchases (2) — 29 96 5 (403 ) Sales (3) — — (62 ) (1 ) 14 Settlements — — (7,463 ) (5 ) — Activity related to consolidated VIEs/VOEs — (6 ) — — — Transfers into Level 3 (1) — 5 — — — Transfers out of Level 3 (1) — (5 ) — — — Balance, December 31, 2018 $ — $ 48 $ 1,991 $ 374 $ (5,431 ) Redeemable Preferred Stock Other Equity Investments (2) GMIB Reinsurance Asset Separate Account Assets GMxB Derivative Features Liability (in millions) Balance, January 1, 2017 $ 1 $ 40 $ 10,313 $ 313 $ (5,473 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — — 29 — Net derivative gains (losses), excluding non-performance risk — — (6 ) — 1,443 Non-performance risk (4) — — 75 — 149 Subtotal — — 69 29 1,592 Other comprehensive income(loss) (1 ) — — — — Purchases (2) — — 221 13 (381 ) Sales (3) — — (115 ) (2 ) 6 Settlements — — — (4 ) — Activity related to consolidated VIEs/VOEs — (15 ) — — — Transfers into level 3 (1) — — — — — Transfers out of level 3 (1) — — — — — Balance, December 31, 2017 $ — $ 25 $ 10,488 $ 349 $ (4,256 ) Balance, January 1, 2016 $ — $ 1 $ 10,582 $ 313 $ (5,266 ) Total gains (losses), realized and unrealized, included in: Income (loss) as: Investment gains (losses), net — — — 19 — Net derivative gains (losses), excluding non-performance risk — — (242 ) — (126 ) Non-performance risk (4) — — (20 ) — 263 Subtotal — — (262 ) 19 137 Other comprehensive income (loss) — (1 ) — — — Purchases (2) 1 — 223 10 (348 ) Sales (3) — — (230 ) — 4 Settlements — — — (7 ) — Activities related to consolidated VIEs/VOEs — 40 — — — Transfers into level 3 (1) — — — 1 — Transfers out of level 3 (1) — — (23 ) — Balance, December 31, 2016 $ 1 $ 40 $ 10,313 $ 313 $ (5,473 ) ______________ (1) Transfers into/out of Level 3 classification are reflected at beginning-of-period fair values. (2) For the GMIB reinsurance contract asset, and GMxB derivative features liability, represents attributed fee. (3) For the GMIB reinsurance contract asset, represents recoveries from reinsurers and for GMxB derivative features liability represents benefits paid. (4) The Company’s non-performance risk is recorded through Net derivative gains (losses). The table below details changes in unrealized gains (losses) for 2018 , 2017 and 2016 by category for Level 3 assets and liabilities still held at December 31, 2018 , 2017 and 2016 respectively. Earnings (Loss) Investment Gains (Losses), Net Net Derivative Gains (Losses) OCI (in millions) Held as of December 31, 2018: Change in unrealized gains (losses): Fixed maturities, available-for-sale Corporate $ — $ — $ (18 ) State and political subdivisions — — (1 ) Asset-backed — — (7 ) Subtotal — — (26 ) GMIB reinsurance contracts — (1,068 ) — Separate Accounts assets (1) 26 — — GMxB derivative features liability — (786 ) — Total $ 26 $ (1,854 ) $ (26 ) Held as of December 31, 2017: Change in unrealized gains (losses): Fixed maturities, available-for-sale Corporate $ — $ — $ 4 Commercial mortgage-backed — — 45 Asset-backed — — (9 ) Subtotal — — 40 GMIB reinsurance contracts — 69 — Separate Accounts assets (1) 29 — — GMxB derivative features liability — 1,592 — Total $ 29 $ 1,661 $ 40 Held as of December 31, 2016: Change in unrealized gains (losses): Fixed maturities, available-for-sale Corporate $ — $ — $ 11 State and political subdivisions — — (1 ) Commercial mortgage-backed — — 9 Asset-backed — — 1 Subtotal — — 20 GMIB reinsurance contracts — (262 ) — Separate Accounts assets (1) 20 — — GMxB derivative features liability — 137 — Total $ 20 $ (125 ) $ 20 ____________ (1) There is an investment expense that offsets this investment gain (loss).
Quantitative Information About Level 3 Fair Value Measurement	The following tables disclose quantitative information about Level 3 fair value measurements by category for assets and liabilities as of December 31, 2018 and 2017 , respectively. Quantitative Information about Level 3 Fair Value Measurements at December 31, 2018 Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (in millions) Assets: Investments: Fixed maturities, available-for-sale: Corporate $ 93 Matrix pricing Spread over Benchmark 15 - 580 bps 104 bps 881 Market EBITDA multiples 4.1x - 37.8x 12.1x Separate Accounts assets 352 Third party appraisal Capitalization rate 4.4% 1 Discounted cash flow Spread over U.S. Treasury curve 248 bps GMIB reinsurance contract asset 1,991 Discounted cash flow Lapse rates 1.0% - 6.27% Liabilities: GMIBNLG 5,341 Discounted cash flow Non-performance risk 189 bps GWBL/GMWB 130 Discounted cash flow Lapse rates 0.5% - 5.7% GIB (48 ) Discounted cash flow Lapse rates 0.5% - 5.7% GMAB 7 Discounted cash flow Lapse rates 1.0% - 5.7% ____________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives. Quantitative Information about Level 3 Fair Value Measurements at December 31, 2017 Fair Value Valuation Technique Significant Unobservable Input Range Weighted Average (in millions) Assets: Investments: Fixed maturities, available-for-sale: Corporate $ 53 Matrix pricing model Spread over the industry-specific benchmark yield curve 0 - 565 bps 125 bps 789 Market comparable companies EBITDA multiples 5.3x - 27.9x 12.9x 11.1% 13.1x Separate Accounts assets 326 Third party appraisal Capitalization rate 4.6% 1 Discounted Spread over U.S. Treasury curve 243 bps GMIB reinsurance contract asset 10,488 Discounted cash flow Lapse rates 1.0% - 6.3% Liabilities: GMIBNLG 4,149 Discounted cash flow Non-performance risk 1.0% GWBL/GMWB 130 Discounted cash flow Lapse rates 0.9% - 5.7% GIB (27 ) Discounted cash flow Lapse rates 0.5% - 11.0% GMAB 5 Discounted cash flow Lapse rates 0.5% - 11.0% ____________ (1) Mortality rates vary by age and demographic characteristic such as gender. Mortality rate assumptions are based on a combination of company and industry experience. A mortality improvement assumption is also applied. For any given contract, mortality rates vary throughout the period over which cash flows are projected for purposes of valuating the embedded derivatives.
Fair Value Disclosure Financial Instruments Not Carried At Fair Value	The carrying values and fair values at December 31, 2018 and 2017 for financial instruments not otherwise disclosed in Note 3 are presented in the table below. Carrying Value Fair Value Level 1 Level 2 Level 3 Total (in millions) December 31, 2018: Mortgage loans on real estate $ 11,818 $ — $ — $ 11,478 $ 11,478 Loans to affiliates 600 — 603 — 603 Policyholders’ liabilities: Investment contracts 1,974 — — 2,015 2,015 FHLBNY funding agreements 4,002 — 3,956 — 3,956 Policy loans 3,267 — — 3,944 3,944 Short-term and long-term debt — — — — — Loans from affiliates 572 — 572 — 572 Separate Accounts liabilities 7,406 — — 7,406 7,406 December 31, 2017: Mortgage loans on real estate $ 10,935 $ — $ — $ 10,895 $ 10,895 Loans to affiliates 703 — 700 — 700 Policyholders’ liabilities: Investment contracts 2,068 — — 2,170 2,170 FHLBNY funding agreements 3,014 — 3,020 — 3,020 Policy loans 3,315 — — 4,210 4,210 Short-term and long-term debt 203 — 202 — 202 Separate Accounts liabilities 7,537 — — 7,537 7,537

INSURANCE LIABILITIES (Tables)

INSURANCE LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2018
Insurance [Abstract]
Variable Annuity Contracts- GMDB GMIB	Change in Liability for Variable Annuity Contracts with GMDB and GMIB Features and No NLG Feature For the Years Ended December 31, 2018, 2017 and 2016 GMDB GMIB Direct Ceded Direct Ceded (in millions) Balance at January 1, 2016 $ 2,991 $ (1,430 ) $ 3,886 $ (10,575 ) Paid guarantee benefits (357 ) 174 (281 ) 230 Other changes in reserve 525 (302 ) 203 31 Balance at December 31, 2016 3,159 (1,558 ) 3,808 (10,314 ) Paid guarantee benefits (354 ) 171 (151 ) 115 Other changes in reserve 1,249 (643 ) 1,097 (289 ) Balance at December 31, 2017 4,054 (2,030 ) 4,754 (10,488 ) Paid guarantee benefits (394 ) 70 (153 ) 61 Other changes in reserve 994 1,853 (860 ) 8,435 Balance at December 31, 2018 $ 4,654 $ (107 ) $ 3,741 $ (1,992 )
Schedule of Net Amount of Risk by Product and Guarantee	Account Values and Net Amount at Risk (“NAR”) for direct variable annuity contracts in force with GMDB and GMIB features as of December 31, 2018 are presented in the following tables by guarantee type. For contracts with the GMDB feature, the NAR in the event of death is the amount by which the GMDB feature exceeds the related Account Values. For contracts with the GMIB feature, the NAR in the event of annuitization is the amount by which the present value of the GMIB benefits exceed the related Account Values, taking into account the relationship between current annuity purchase rates and the GMIB guaranteed annuity purchase rates. Since variable annuity contracts with GMDB features may also offer GMIB guarantees in the same contract, the GMDB and GMIB amounts listed are not mutually exclusive. Direct Variable Annuity Contracts with GMDB and GMIB Features As of December 31, 2018 Guarantee Type Return of Premium Ratchet Roll-Up Combo Total (in millions; except age and interest rate) Variable annuity contracts with GMDB features Account Values invested in: General Account $ 14,035 $ 102 $ 61 $ 184 $ 14,382 Separate Accounts 41,463 8,382 2,903 30,406 83,154 Total Account Values $ 55,498 $ 8,484 $ 2,964 $ 30,590 $ 97,536 Net Amount at Risk, gross $ 418 $ 791 $ 2,291 $ 20,587 $ 24,087 Net Amount at Risk, net of amounts reinsured $ 418 $ 772 $ 1,615 $ 20,587 $ 23,392 Average attained age of policyholders (in years) 51.4 67.0 73.6 69.0 55.3 Percentage of policyholders over age 70 10.0 % 43.0 % 65.5 % 49.9 % 18.8 % Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5% Variable annuity contracts with GMIB features Account Values invested in: General Account $ — $ — $ 19 $ 251 $ 270 Separate Accounts — — 19,407 33,428 52,835 Total Account Values $ — $ — $ 19,426 $ 33,679 $ 53,105 Net Amount at Risk, gross $ — $ — $ 994 $ 9,156 $ 10,150 Net Amount at Risk, net of amounts reinsured $ — $ — $ 309 $ 8,268 $ 8,577 Average attained age of policyholders (in years) N/A N/A 68.9 68.8 68.8 Weighted average years remaining until annuitization N/A N/A 1.7 0.5 0.6 Range of contractually specified interest rates N/A N/A 3% - 6% 3% - 6.5% 3% - 6.5%
Schedule of Fair Value of Separate Accounts by Major Category of Investment	Investment in Variable Insurance Trust Mutual Funds As of December 31, 2018 2017 GMDB GMIB GMDB GMIB (in millions) Investment type: Equity $ 35,541 $ 15,759 $ 41,658 $ 19,676 Fixed income 5,173 2,812 5,469 3,110 Balanced 41,588 33,974 46,577 38,398 Other 852 290 968 314 Total $ 83,154 $ 52,835 $ 94,672 $ 61,498
No Lapse Guarantee Liabilities	The change in the liabilities for NLG liabilities, reflected in the General Account in Future policy benefits and other policyholders’ liabilities in the consolidated balance sheets is summarized in the table below: Direct Liability Reinsurance Ceded Net (in millions) Balance at January 1, 2016 $ 1,144 $ (510 ) $ 634 Other changes in reserves 38 (96 ) (58 ) Balance at December 31, 2016 1,182 (606 ) 576 Paid guarantee benefits (24 ) — (24 ) Other changes in reserves (466 ) (58 ) (524 ) Balance at December 31, 2017 692 (664 ) 28 Direct Liability Reinsurance Ceded Net (in millions) Paid guarantee benefits (23 ) — (23 ) Other changes in reserves 118 (69 ) 49 Balance at December 31, 2018 $ 787 $ (733 ) $ 54

REVENUE RECOGNITION (Tables)

REVENUE RECOGNITION (Tables)	12 Months Ended
	Dec. 31, 2018
Revenue from Contract with Customer [Abstract]
Revenues Disaggregated by Category	The table below presents the revenues recognized for the years ended December 31, 2018 , 2017 and 2016 , disaggregated by category: Years Ended December 31, 2018 2017 2016 (in millions) Investment management, advisory and service fees: Base fees $ 728 $ 720 $ 674 Distribution services 301 287 277 Total investment management and service fees $ 1,029 $ 1,007 $ 951 Other income $ 33 $ 35 $ 23 For revenue related to AB, see Note 19 .

REINSURANCE AGREEMENTS (Tables)

REINSURANCE AGREEMENTS (Tables)	12 Months Ended
	Dec. 31, 2018
Reinsurance Disclosures [Abstract]
Schedule Of Effect Of Reinsurance	The following table summarizes the effect of reinsurance: Years Ended December 31, 2018 2017 2016 (in millions) Direct premiums $ 836 $ 880 $ 850 Reinsurance assumed 186 195 206 Reinsurance ceded (160 ) (171 ) (176 ) Net premiums $ 862 $ 904 $ 880 Policy charges and fee income ceded $ 467 $ 718 $ 640 Policyholders’ benefits ceded $ 592 $ 694 $ 942

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	12 Months Ended
	Dec. 31, 2018
Related Party Transactions [Abstract]
Related Party Transactions	The table below summarizes the expenses reimbursed to/from the Company and the fees received/paid by the Company in connection with certain services described above for the years ended December 31, 2018 , 2017 and 2016 . Years ended December 31, 2018 2017 2016 (in millions) Expenses paid or accrued for: Paid or accrued commission and fee expenses for sale of insurance products by AXA Distribution $ 613 $ 608 $ 587 General services provided by AXA Affiliates 109 186 188 Investment management services provided by AXA IM, AXA REIM and AXA Rosenberg 2 5 2 Total $ 724 $ 799 $ 777 Revenue received or accrued for: Investment management and administrative services provided to EQAT, VIP Trust, 1290 Funds and Other AXA Trusts $ 727 $ 720 $ 674 General services provided to AXA Affiliates 463 439 497 Amounts received or accrued for commissions and fees earned for sale of MONY America’s insurance products 44 45 43 Total $ 1,234 $ 1,204 $ 1,214 The assets received and the assets removed were as follows: As of April 12, 2018 (in millions) Assets Received Assets Removed Assets at fair value: Fixed income securities $ 7,083 Short-term investments 205 Money market funds 2 Accrued interest 43 Derivatives 282 Cash and cash equivalents 1,273 Total $ 8,888 Deferred cost of reinsurance asset $ 1,839 GMDB ceded reserves 2,317 GMIB reinsurance contract asset 7,463 Payable to AXA RE Arizona 270 Total $ 11,889

EMPLOYEE BENEFIT PLANS (Tables)

EMPLOYEE BENEFIT PLANS (Tables)	12 Months Ended
	Dec. 31, 2018
Retirement Benefits [Abstract]
Schedule of Net Funded Status	The following table presents the funded status of the plan. As of December 31, 2018 2017 (in millions) Legal Name of Plan: AXQ Equitable Retirement Plan EIN# 13-5570651 Total Plan Assets $ 1,993 $ 2,325 Accumulated Benefit Obligation $ 2,039 $ 2,389 Funded Status 97.8 % 97.3 %

SHARE-BASED AND OTHER COMPENS_2

SHARE-BASED AND OTHER COMPENSATION PROGRAMS (Tables)	12 Months Ended
	Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of compensation costs	Compensation costs for 2018 , 2017 and 2016 for share-based payment arrangements as further described herein are as follows: Years Ended December 31, 2018 2017 2016 (in millions) Performance Shares (1) $ 12 $ 18 $ 17 Stock Options 2 1 1 AXA Shareplan — 9 14 Restricted Stock Unit Awards (2) 16 2 — Other Compensation Plans (3) — — 1 Total Compensation Expenses $ 30 $ 30 $ 33 ____________ (1) Reflects change to performance share retirement rules. Specifically, individuals who retire at any time after the grant date will continue to vest in their 2017 performance shares while individuals who retire prior to March 1, 2019 will forfeit all 2018 performance shares. (2) Reflects a $10 million adjustment for awards in 2018 with graded vesting, service-only conditions from the graded to the straight-line attribution method. (3) Includes stock appreciation rights and employee stock purchase plans.
Summary of stock option activity	A summary of activity in the AXA and Holdings option plans during 2018 follows: Options Outstanding EQH Shares AXA Ordinary Shares AXA ADRs (2) Number Outstanding (In 000’s) Weighted Average Exercise Price Number Outstanding (In 000’s) Weighted Average Exercise Price Number Outstanding (In 000’s) Weighted Average Exercise Price Options Outstanding at January 1, 2018 — $ — 3,653 € 17.36 20 $ 20.98 Options granted 869 $ 21.34 — € — — $ — Options exercised — $ — (337 ) € 11.80 — $ — Options forfeited, net (35 ) $ 21.34 — € — — $ — Options expired — $ — (707 ) € 17.45 (5 ) $ 35.25 Options Outstanding at December 31, 2018 834 $ 21.34 2,609 € 18.20 15 $ 15.37 Aggregate Intrinsic Value (1) $ — € 2,383 $ 151 Weighted Average Remaining Contractual Term (in years) 9.16 4.50 0.58 Options Exercisable at December 31, 2018 — $ — 1,369 € 15.27 15 $ 15.37 Aggregate Intrinsic Value (1) $ — € 7,698 $ 151 Weighted Average Remaining Contractual Term (in years) — 2.45 0.58 ____________ (1) Aggregate intrinsic value, presented in thousands, is calculated as the excess of the closing market price on December 31, 2018 of the respective underlying shares over the strike prices of the option awards. For awards with strike prices higher then market prices, intrinsic value is shown as zero. (2) AXA ordinary shares will be delivered to participants in lieu of AXA ADRs at exercise or maturity.
Schedule of share-based payment award, valuation assumptions	Shown below are the relevant input assumptions used to derive the fair values of options awarded in 2018 , 2017 and 2016 , respectively. EQH Shares AXA Ordinary Shares (1) 2018 2018 2017 2016 Dividend yield 2.44 % NA 6.53 % 6.49 % Expected volatility 25.40 % NA 25.05 % 26.6 % Risk-free interest rates 2.83 % NA 0.59 % 0.33 % Expected life in years 9.7 NA 8.8 8.1 Weighted average fair value per option at grant date $ 4.61 NA $ 2.01 $ 2.06 ____________ (1) There were no options to buy AXA Ordinary Shares awarded durin g 2018 . As such, the input assumptions for 2018 are not applicable.
Schedule of share-based compensation, restricted stock units award activity	The following table summarizes restricted Holdings share and AXA ordinary share activity for 2018 . Shares of Holdings Restricted Stock (in thousands) Weighted Average Grant Date Fair Value Shares of AXA Restricted Stock (in thousands) Weighted Average Grant Date Fair Value Unvested as of January 1, 2018 — $ — 84 $ 21.07 Granted 1,696 $ 20.83 — $ — Cancelled 56 $ 21.21 — $ 26.64 Vested 381 $ 21.09 $ — 36 $ 21.99 Unvested as of December 31, 2018 1,259 $ 21.00 $ — 48 $ 20.38

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2018
Income Tax Disclosure [Abstract]
Summary of income tax expense (benefit)	A summary of the income tax (expense) benefit in the consolidated statements of income (loss) follows: Years Ended December 31, 2018 2017 2016 (in millions) Income tax (expense) benefit: Current (expense) benefit $ 234 $ (6 ) $ (274 ) Deferred (expense) benefit 212 1,216 438 Total $ 446 $ 1,210 $ 164
Schedule of effective income tax rate reconciliation	Years Ended December 31, 2018 2017 2016 (in millions) Expected income tax (expense) benefit $ 311 $ (542 ) $ 14 Noncontrolling interest (1 ) — — Non-taxable investment income (loss) 104 241 173 Tax audit interest (11 ) (6 ) (14 ) State income taxes (1 ) (3 ) (6 ) Tax settlements/uncertain tax position release — 221 — Change in tax law 46 1,308 — Other (2 ) (9 ) (3 ) Income tax (expense) benefit $ 446 $ 1,210 $ 164
Schedule of net deferred income taxes	The components of the net deferred income taxes are as follows: As of December 31, 2018 2017 Assets Liabilities Assets Liabilities (in millions) Compensation and related benefits $ 47 $ — $ 47 $ — Net operating loss 239 — — — Reserves and reinsurance — 32 — 83 DAC — 864 — 821 Unrealized investment gains (losses) 123 — — 298 Investments 670 — — 997 Tax credits 314 — 387 — Other 14 — 67 — Total $ 1,407 $ 896 $ 501 $ 2,199
Unrecognized tax benefits reconciliation	A reconciliation of unrecognized tax benefits (excluding interest and penalties) follows: Years Ended December 31, 2018 2017 2016 (in millions) Balance at January 1, $ 205 $ 444 $ 406 Additions for tax positions of prior years 98 28 38 Reductions for tax positions of prior years (30 ) (234 ) — Settlements with tax authorities — (33 ) — Balance at December 31, $ 273 $ 205 $ 444 Unrecognized tax benefits that, if recognized, would impact the effective rate $ 202 $ 172 $ 329

ACCUMULATED OTHER COMPREHENSI_2

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)	12 Months Ended
	Dec. 31, 2018
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	AOCI represents cumulative gains (losses) on items that are not reflected in income (loss). The balances for the past three years follow: December 31, 2018 2017 2016 (in millions) Unrealized gains (losses) on investments (1) $ (484 ) $ 581 $ (44 ) Defined benefit pension plans (2) (7 ) (51 ) (46 ) Total accumulated other comprehensive income (loss) from continuing operations (491 ) 530 (90 ) Less: Accumulated other comprehensive (income) loss attributable to non-controlling interest — 68 86 Accumulated other comprehensive income (loss) attributable to AXA Equitable $ (491 ) $ 598 $ (4 ) ____________ (1) 2018 includes a $86 million decrease to Accumulated other comprehensive loss from the impact of adoption of ASU 2018-02. (2) 2018 includes a $3 million increas e to Accumulated other comprehensive loss from the impact of adoption of ASU 2018-02.
Comprehensive Income (Loss)	The components of OCI for the years ended December 31, 2018, 2017 and 2016, net of tax, follow: Years Ended December 31, 2018 2017 2016 (in millions) Change in net unrealized gains (losses) on investments: Net unrealized gains (losses) arising during the year $ (1,663 ) $ 782 $ (178 ) (Gains) losses reclassified into net income (loss) during the year (1) (4 ) 8 2 Net unrealized gains (losses) on investments (1,667 ) 790 (176 ) Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other 437 (165 ) (57 ) Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $(310), $244, and $(97)) (1,230 ) 625 (233 ) Change in defined benefit plans: Less: Reclassification adjustments to Net income (loss) for: (2) Amortization of net (gains) losses included in net periodic cost (4 ) (5 ) (3 ) Change in defined benefit plans (net of deferred income tax expense (benefit) of $0, $(2) and $(2)) (4 ) (5 ) (3 ) Total other comprehensive income (loss), net of income taxes from continuing operations (1,234 ) 620 (236 ) Other comprehensive income (loss) from discontinued operations, net of income taxes — (18 ) 17 Other comprehensive income (loss) attributable to AXA Equitable $ (1,234 ) $ 602 $ (219 ) ____________ (1) See “Reclassification adjustments” in Note 3 . Reclassification amounts presented net of income tax expense (benefit) of $(1) million , $(5) million and $(1) million for the years ended December 31, 2018 , 2017 and 2016 , respectively. (2) These AOCI components are included in the computation of net periodic costs (see “Employee Benefit Plans” in Note 13 ). Reclassification amounts presented net of income tax expense (benefit) of $ 0 million, $2 million and $2 million for the years ended December 31, 2018 , 2017 and 2016 , respectively.

COMMITMENTS AND CONTINGENT LI_2

COMMITMENTS AND CONTINGENT LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]
Activity of Funding Agreements with FHLBNY	Outstanding balance at end of period Maturity of outstanding balance Issued during the period Repaid during the period (in millions) December 31, 2018: Short-term FHLBNY funding agreements $ 1,490 Less than one month $ 7,980 $ 6,990 Long-term FHLBNY funding agreements 1,621 Less than four years — — 98 Less than five years — — 781 Greater than five years — — Total long-term funding agreements 2,500 — — Total FHLBNY funding agreements at December 31, 2018 (1) $ 3,990 $ 7,980 $ 6,990 December 31, 2017: Short-term FHLBNY funding agreements $ 500 Less than one month $ 6,000 $ 6,000 Long-term FHLBNY funding agreements 1,244 Less than four years 324 377 Less than five years 303 879 Greater than five years 135 Total long-term funding agreements 2,500 762 $ — Total FHLBNY funding agreements at December 31, 2017 (1) $ 3,000 $ 6,762 $ 6,000 ____________ (1) The $11 million and $14 million difference between the funding agreements carrying value shown in fair value table for 2018 and 2017 , respectively, reflects the remaining amortization of a hedge implemented and closed, which locked in the funding agreements borrowing rates.

DISCONTINUED OPERATIONS (Tables

DISCONTINUED OPERATIONS (Tables)	12 Months Ended
	Dec. 31, 2018
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations	The following table presents the amounts related to the financial position of AB as of December 31, 2017. As the Company deconsolidated AB effective December 31, 2018, amounts related to AB’s financial position as of December 31, 2018 are not included in the Company’s consolidated balance sheet as of that date. The amounts as of December 31, 2017 have been reflected in either the Assets of disposed subsidiary or Liabilities of disposed subsidiary, as applicable, in the Company’s consolidated balance sheet: Assets and Liabilities of Disposed Subsidiary As of December 31, 2017 (in millions) ASSETS Investments: Other equity investments $ 87 Trading securities, at fair value 351 Other invested assets 1,291 Total investments 1,729 Cash and cash equivalents 1,009 Cash and securities segregated, at fair value 816 Broker-dealer related receivables 2,158 Intangible assets, net 3,709 Other assets 414 Total Assets of Disposed Subsidiary $ 9,835 As of December 31, 2017 (in millions) LIABILITIES Broker-dealer related payables $ 334 Customer related payables 2,229 Long-term debt 566 Current and deferred income taxes 404 Other liabilities 1,421 Total Liabilities of Disposed Subsidiary $ 4,954 Redeemable noncontrolling interest of disposed subsidiary 602 The table below presents AB’s revenues recognized in 2018 , 2017 and 2016 , disaggregated by category: Years Ended December 31, 2018 2017 2016 (in millions) Investment management, advisory and service fees: Base fees $ 2,156 $ 2,025 $ 1,809 Performance-based fees 118 95 33 Research services 439 450 480 Distribution services 419 412 384 Other revenues: Shareholder services 76 75 78 Other 35 42 21 Total investment management and service fees $ 3,243 $ 3,099 $ 2,804 The following table presents the amounts related to the Net income (loss) of AB that has been reflected in Discontinued operations: Years Ended December 31, 2018 2017 2016 (in millions) REVENUES Net derivative gains (losses) $ 12 $ (24 ) $ (16 ) Net investment income (loss) 24 142 150 Investment gains (losses), net: Other investment gains (losses), net — — (2 ) Total investment gains (losses), net — — (2 ) Investment management and service fees 3,243 3,099 2,804 Total revenues $ 3,279 $ 3,217 $ 2,936 BENEFITS AND OTHER DEDUCTIONS Compensation and benefits $ 1,370 $ 1,307 $ 1,231 Commissions and distribution related payments 427 415 372 Interest expense 8 6 3 Other operating costs and expenses 727 789 699 Total benefits and other deductions 2,532 2,517 2,305 Income (loss) from discontinued operations, before income taxes 747 700 631 Income tax (expense) benefit (69 ) (82 ) (69 ) Net income (loss) from discontinued operations, net of taxes 678 618 562 Less: Net (income) loss attributable to the noncontrolling interest (564 ) (533 ) (496 ) Net income (loss) from discontinued operations, net of taxes and noncontrolling interest $ 114 $ 85 $ 66

QUARTERLY FINANCIAL INFORMATI_2

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) (Tables)	12 Months Ended
	Dec. 31, 2018
Quarterly Financial Data [Abstract]
Schedule of quarterly interim financial information	The unaudited quarterly financial information for the years ended December 31, 2018 and 2017 are summarized in the table below: Three Months Ended March 31 June 30 September 30 December 31 (in millions) 2018 Total revenues $ 1,139 $ 1,621 $ 27 $ 4,164 Total benefits and other deductions 1,512 4,278 763 1,879 Net income (loss) $ (264 ) $ (2,084 ) $ (509 ) $ 1,936 2017 Total revenues $ 1,554 $ 3,763 $ 1,621 $ 1,518 Total benefits and other deductions 1,921 1,858 1,708 1,420 Net income (loss) $ (201 ) $ 1,508 $ 23 $ 1,515
Revision Tables	As of December 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs $ 4,547 $ — $ 4,547 $ (55 ) $ 4,492 Total Assets $ 225,985 $ — $ 225,985 $ (55 ) $ 225,930 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities 29,034 — 29,034 36 29,070 Current and deferred taxes 1,973 (404 ) 1,569 (19 ) 1,550 Total Liabilities 205,795 — 205,795 17 205,812 Equity: Retained Earnings 9,010 — 9,010 (72 ) 8,938 AXA Equitable Equity 16,469 — 16,469 (72 ) 16,397 Total Equity 19,564 — 19,564 (72 ) 19,492 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 225,985 $ — $ 225,985 $ (55 ) $ 225,930 Year Ended December 31, 2017 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 3,334 $ — $ — $ 3,334 $ (40 ) $ 3,294 Net derivative gains (losses) 890 — 24 914 (20 ) 894 Total revenues 11,733 — (3,217 ) 8,516 (60 ) 8,456 Benefits and other deductions: Policyholders’ benefits 3,462 — — 3,462 11 3,473 Interest credited to policyholder’s account balances 1,040 — — 1,040 (119 ) 921 Compensation and benefits 1,762 (128 ) (1,307 ) 327 — 327 Commissions and distribution related payments 1,486 (443 ) (415 ) 628 — 628 Amortization of deferred policy acquisition costs 268 578 — 846 54 900 Other operating costs and expenses 1,431 (7 ) (789 ) 635 — 635 Total benefits and other deductions 9,478 — (2,517 ) 6,961 (54 ) 6,907 Income (loss) from continuing operations, before income taxes 2,255 — (700 ) 1,555 (6 ) 1,549 Income tax (expense) benefit from continuing operations 1,139 — (111 ) 1,028 182 1,210 Net income (loss) from continuing operations 3,394 — (811 ) 2,583 176 2,759 Net income (loss) 3,394 — (533 ) 2,861 (17 ) 2,844 Net income (loss) attributable to AXA Equitable $ 2,860 $ — $ — $ 2,860 $ (17 ) $ 2,843 Year Ended December 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ 3,394 $ (533 ) $ 2,861 $ (17 ) $ 2,844 Change in unrealized gains (losses), net of reclassification adjustment 563 — 563 21 584 Other comprehensive income 599 (18 ) 581 21 602 Comprehensive income (loss) 3,993 (551 ) 3,442 4 3,446 Comprehensive income (loss) attributable to AXA Equitable $ 3,441 $ — $ 3,441 $ 4 $ 3,445 Year Ended December 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 6,150 $ — $ 6,150 $ (55 ) $ 6,095 Net income (loss) attributable to AXA Equitable 2,860 — 2,860 (17 ) 2,843 Retained earnings, end of period 9,010 — 9,010 (72 ) 8,938 Accumulated other comprehensive income, beginning of year 17 — 17 (21 ) (4 ) Other comprehensive income (loss) 581 — 581 21 602 Accumulated other comprehensive income, end of year 598 — 598 — 598 Total AXA Equitable’s equity, end of year 16,469 — 16,469 (72 ) 16,397 Total Equity, End of Year $ 19,564 $ — $ 19,564 $ (72 ) $ 19,492 Year Ended December 31, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ 3,394 $ — $ (17 ) $ 3,377 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances 1,040 — (119 ) 921 Policy charges and fee income (3,334 ) — 40 (3,294 ) Net derivative (gains) losses (890 ) — 20 (870 ) Amortization and depreciation (136 ) 907 54 825 Amortization of deferred sales commission 32 (32 ) — — Amortization of other intangibles 31 (31 ) — — Equity (income) loss from limited partnerships — (157 ) — (157 ) Distributions from joint ventures and limited partnerships 140 (140 ) — — Year Ended December 31, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Changes in: Reinsurance recoverable (416 ) — (602 ) (1,018 ) Deferred policy acquisition costs 268 (268 ) — — Capitalization of deferred policy acquisition costs — (578 ) — (578 ) Future policy benefits 1,511 — (322 ) 1,189 Current and deferred income taxes (664 ) — (510 ) (1,174 ) Other, net 189 297 — 486 Net cash provided by (used in) operating activities $ 1,077 $ (2 ) $ (1,456 ) $ (381 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Short-term investments $ — $ 2,204 $ — $ 2,204 Payment for the purchase/origination of: Short-term investments — (2,456 ) — (2,456 ) Change in short-term investments (264 ) 254 10 — Other, net 238 — 84 322 Net cash provided by (used in) investing activities $ (9,010 ) $ 2 $ 94 $ (8,914 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 9,882 $ — $ (548 ) $ 9,334 Withdrawals (5,926 ) — 2,000 (3,926 ) Transfer (to) from Separate Accounts 1,656 — (90 ) 1,566 Net cash provided by (used in) financing activities $ 8,370 $ — $ 1,362 $ 9,732 _______________ (1) Net income (loss) includes $533 million in 2017 of the discontinued operations that are not included in net income (loss) in the Consolidated Statements of Income (Loss). The following table presents line items for the consolidated financial statements for the year ended December 31, 2016 that have been affected by the aforementioned adjustments and revisions. This information has been corrected from the information previously presented and restated in the 2017 Form 10-K. For these items, the table details the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, adjustments for the discontinued operation, and revisions and the amounts as currently revised. Year Ended December 31, 2016 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 3,344 $ — $ — $ 3,344 $ (33 ) $ 3,311 Net derivative gains (losses) (1,211 ) — 16 (1,195 ) (126 ) (1,321 ) Total revenues 9,138 — (2,936 ) 6,202 (159 ) 6,043 Year Ended December 31, 2016 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Benefits and other deductions: Interest credited to Policyholder’s account balances 1,029 — — 1,029 (124 ) 905 Compensation and benefits 1,723 (128 ) (1,231 ) 364 — 364 Commissions and distribution related payments 1,467 (460 ) (372 ) 635 — 635 Amortization of deferred policy acquisition costs 52 594 — 646 (4 ) 642 Other operating costs and expenses 1,458 (6 ) (699 ) 753 — 753 Total benefits and other deductions 8,516 — (2,305 ) 6,211 (128 ) 6,083 Income (loss) from continuing operations, before income taxes 622 — (631 ) (9 ) (31 ) (40 ) Income tax (expense) benefit from continuing operations 84 — 69 153 11 164 Net income (loss) from continuing operations 706 — (562 ) 144 (20 ) 124 Net income (loss) 706 — (496 ) 210 (20 ) 190 Net income (loss) attributable to AXA Equitable $ 210 $ — $ — $ 210 $ (20 ) $ 190 Year Ended December 31, 2016 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ 706 $ (496 ) $ 210 $ (20 ) $ 190 Change in unrealized gains (losses), net of reclassification adjustment (194 ) — (194 ) (21 ) (215 ) Other comprehensive income (215 ) 17 (198 ) (21 ) (219 ) Comprehensive income (loss) 491 (479 ) 12 (41 ) (29 ) Comprehensive income (loss) attributable to AXA Equitable $ 12 $ — $ 12 $ (41 ) $ (29 ) Year Ended December 31, 2016 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 6,990 $ — $ 6,990 $ (35 ) $ 6,955 Net income (loss) attributable to AXA Equitable 210 — 210 (20 ) 190 Retained earnings, end of period 6,150 — 6,150 (55 ) 6,095 Other comprehensive income (loss) (198 ) — (198 ) (21 ) (219 ) Accumulated other comprehensive income, end of period 17 — 17 (21 ) (4 ) Total AXA Equitable’s equity, end of period $ 11,508 $ — $ 11,508 $ (76 ) $ 11,432 Year Ended December 31, 2016 As Reported Presentation Reclassifications Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ 706 $ — $ (20 ) $ 686 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances 1,029 — (124 ) 905 Policy charges and fee income (3,344 ) — 33 (3,311 ) Net derivative (gains) losses 1,211 — 126 1,337 Amortization and depreciation — 618 (4 ) 614 Amortization of deferred sales commission 41 (41 ) — — Other depreciation and amortization (98 ) 98 — — Amortization of other intangibles 29 (29 ) — — Equity (income) loss from limited partnerships — (91 ) — (91 ) Return of real estate joint venture and limited partnerships 126 (126 ) — — Changes in: Deferred policy acquisition costs 52 (52 ) — — Capitalization of deferred policy acquisition costs — (594 ) — (594 ) Current and deferred income taxes (742 ) — (11 ) (753 ) Other, net (161 ) 217 — 56 Net cash provided by (used in) operating activities $ (461 ) $ — $ — $ (461 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Short-term investments — 2,984 — 2,984 Payment for the purchase/origination of: Short-term investments — (3,187 ) — (3,187 ) Change in short-term investments (205 ) 205 — — Other, net 409 (2 ) — 407 Net cash provided by (used in) investing activities $ (5,358 ) $ — $ — $ (5,358 ) _______________ (1) Net income (loss) includes $496 million in 2016 of the discontinued operations that are not included in Net income (loss) in the Consolidated Statements of Income (Loss). Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As of March 31, 2018 As Pre-viously Reported Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs 4,826 — 4,826 (119 ) 4,707 Total Assets $ 222,424 $ — $ 222,424 $ (119 ) $ 222,305 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities $ 28,374 $ — $ 28,374 $ (10 ) $ 28,364 Current and deferred taxes 1,728 (432 ) 1,296 (38 ) 1,258 Other liabilities 3,041 (1,941 ) 1,100 70 1,170 Total Liabilities $ 202,767 $ — $ 202,767 $ 22 $ 202,789 Equity: Retained Earnings $ 8,824 $ — $ 8,824 $ (141 ) $ 8,683 AXA Equitable Equity 15,545 — 15,545 (141 ) 15,404 Total Equity 18,633 — 18,633 (141 ) 18,492 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 222,424 $ — $ 222,424 $ (119 ) $ 222,305 Three Months Ended March 31, 2018 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 869 $ — $ — $ 869 $ (8 ) $ 861 Net derivative gains (losses) (777 ) — (2 ) (779 ) (38 ) (817 ) Total Revenues 2,031 — (846 ) 1,185 (46 ) 1,139 Benefits and other deductions: Policyholders’ benefits 489 — — 489 (9 ) 480 Interest credited to policyholders’ account balances 338 — — 338 (83 ) 255 Compensation and benefits 456 (33 ) (344 ) 79 70 149 Commissions and distribution related payments 371 (101 ) (110 ) 160 — 160 Amortization of deferred policy acquisition costs 10 135 — 145 64 209 Other operating costs and expenses 440 (1 ) (189 ) 250 — 250 Total benefits and other deductions 2,115 — (645 ) 1,470 42 1,512 Income (loss) from continuing operations, before income taxes (84 ) — (201 ) (285 ) (88 ) (373 ) Income tax (expense) benefit from continuing operations 44 — 17 61 19 80 Net income (loss) from continuing operations (40 ) — (184 ) (224 ) (69 ) (293 ) Net income (loss) (40 ) — (155 ) (195 ) (69 ) (264 ) Net income (loss) attributable to AXA Equitable $ (194 ) $ — $ — $ (194 ) $ (69 ) $ (263 ) Three Months Ended March 31, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Statements of Comprehensive Income (Loss): Net income (loss) $ (40 ) $ (155 ) $ (195 ) $ (69 ) $ (264 ) Comprehensive income (loss) $ (789 ) $ (162 ) $ (951 ) $ (69 ) $ (1,020 ) Comprehensive income (loss) attributable to AXA Equitable $ (950 ) $ — $ (950 ) $ (69 ) $ (1,019 ) Three Months Ended March 31, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 9,010 $ — $ 9,010 $ (72 ) $ 8,938 Net income (loss) (194 ) — (194 ) (69 ) (263 ) Retained earnings, end of period 8,824 — 8,824 (141 ) 8,683 Total AXA Equitable’s equity, end of period 15,545 15,545 (141 ) 15,404 Total Equity, End of Period $ 18,633 $ — $ 18,633 $ (141 ) $ 18,492 Three Months Ended March 31, 2018 As Reported Presentation Reclassifi- cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ (40 ) $ — $ (69 ) $ (109 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances $ 338 $ — $ (83 ) $ 255 Policy charges and fee income (869 ) — 8 (861 ) Net derivative (gains) losses 777 — 38 815 Amortization and depreciation — 137 64 201 Amortization of deferred sales commission 7 (7 ) — — Other depreciation and amortization (23 ) 23 — — Amortization of other Intangibles 8 (8 ) — — Equity (income) loss from limited partnerships — (39 ) — (39 ) Distributions from joint ventures and limited partnerships 25 (25 ) — — Changes in: Reinsurance recoverable 2 — (149 ) (147 ) Deferred policy acquisition costs 10 (10 ) — — Capitalization of deferred policy acquisition costs — (135 ) — (135 ) Future policy benefits (191 ) — (7 ) (198 ) Current and deferred income taxes (52 ) — 132 80 Other, net (122 ) 64 70 12 Net cash provided by (used in) operating activities $ (21 ) $ — $ 4 $ (17 ) Three Months Ended March 31, 2018 As Reported Presentation Reclassifi- cations Revisions As Revised (in millions) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Trading account securities $ 1,606 $ — $ 77 $ 1,683 Real estate held for the production of income — 140 — 140 Short-term investments — 688 — 688 Other 54 (140 ) — (86 ) Payment for the purchase/origination of: Short-term investments — (377 ) — (377 ) Cash settlements related to derivative instruments (14 ) — (489 ) (503 ) Change in short-term investments 396 (311 ) (85 ) — Other, net (560 ) — 153 (407 ) Net cash provided by (used in) investing activities $ (639 ) $ — $ (344 ) $ (983 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 2,366 $ — $ (468 ) $ 1,898 Withdrawals (1,322 ) — 241 (1,081 ) Transfer (to) from Separate Accounts (115 ) — 567 452 Net cash provided by (used in) financing activities $ 1,040 $ — $ 340 $ 1,380 ________________ (1) Net income (loss) includes $154 million in the three months ended March 31, 2018 of the discontinued operations that are not included in net income (loss) in the Consolidated Statements of Income (Loss). This information has been corrected from the information previously presented in the Company’s June 30, 2018 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, the adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As of June 30, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs $ 4,786 $ — $ 4,786 $ (76 ) $ 4,710 Amounts due from reinsurers 3,088 — 3,088 (9 ) 3,079 Current and deferred taxes 159 422 581 3 584 Total Assets $ 219,306 $ — $ 219,306 $ (82 ) $ 219,224 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities $ 28,122 $ — $ 28,122 $ (64 ) $ 28,058 Total Liabilities $ 202,196 $ — $ 202,196 $ (64 ) $ 202,132 Equity: Retained Earnings $ 6,617 $ — $ 6,617 $ (18 ) $ 6,599 AXA Equitable Equity 13,925 — 13,925 (18 ) 13,907 Total Equity 16,964 — 16,964 (18 ) 16,946 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 219,306 $ — $ 219,306 $ (82 ) $ 219,224 Three Months Ended June 30, 2018 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 904 $ — $ — $ 904 $ (21 ) $ 883 Net derivative gains (losses) (312 ) — — (312 ) 27 (285 ) Total revenues 2,439 — (824 ) 1,615 6 1,621 Benefits and other deductions: Policyholders’ benefits 1,339 — — 1,339 (38 ) 1,301 Compensation and benefits 466 (32 ) (360 ) 74 — 74 Commissions and distribution related payments 377 (112 ) (106 ) 159 — 159 Amortization of deferred policy acquisition costs 31 145 1 177 5 182 Other operating costs and expenses 2,486 (1 ) (172 ) 2,313 — 2,313 Total benefits and other deductions 4,950 — (639 ) 4,311 (33 ) 4,278 Income (loss) from continuing operations, before income taxes (2,511 ) — (185 ) (2,696 ) 39 (2,657 ) Income tax (expense) benefit from continuing operations 553 — 8 561 (9 ) 552 Net income (loss) from continuing operations (1,958 ) — (177 ) (2,135 ) 30 (2,105 ) Net income (loss) (1,958 ) — (156 ) (2,114 ) 30 (2,084 ) Net income (loss) attributable to AXA Equitable $ (2,114 ) $ — $ — $ (2,114 ) $ 30 $ (2,084 ) Three Months Ended June 30, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ (1,958 ) $ (156 ) $ (2,114 ) $ 30 $ (2,084 ) Comprehensive income (loss) (2,278 ) (142 ) (2,420 ) 30 (2,390 ) Comprehensive income (loss) attributable to AXA Equitable $ (2,420 ) $ — $ (2,420 ) $ 30 $ (2,390 ) Six Months Ended June 30, 2018 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 1,773 $ — $ — $ 1,773 $ (29 ) $ 1,744 Net derivative gains (losses) (1,172 ) — (2 ) (1,174 ) 72 (1,102 ) Total revenues 4,387 — (1,670 ) 2,717 43 2,760 Benefits and other deductions: Policyholders’ benefits 1,828 — — 1,828 (47 ) 1,781 Compensation and benefits 992 (65 ) (704 ) 223 — 223 Commissions and distribution related payments 748 (213 ) (216 ) 319 — 319 Amortization of deferred policy acquisition costs 89 280 1 370 21 391 Other operating costs and expenses 2,926 (2 ) (361 ) 2,563 — 2,563 Total benefits and other deductions 7,100 — (1,284 ) 5,816 (26 ) 5,790 Income (loss) from continuing operations, before income taxes (2,713 ) — (386 ) (3,099 ) 69 (3,030 ) Income tax (expense) benefit from continuing operations 622 — 25 647 (15 ) 632 Net income (loss) from continuing operations (2,091 ) — (361 ) (2,452 ) 54 (2,398 ) Net income (loss) (2,091 ) — (311 ) (2,402 ) 54 (2,348 ) Net income (loss) attributable to AXA Equitable $ (2,401 ) $ — $ — $ (2,401 ) $ 54 $ (2,347 ) Six Months Ended June 30, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ (2,091 ) $ (311 ) $ (2,402 ) $ 54 $ (2,348 ) Comprehensive income (loss) (3,160 ) (305 ) (3,465 ) 54 (3,411 ) Comprehensive income (loss) attributable to AXA Equitable $ (3,463 ) $ — $ (3,463 ) $ 54 $ (3,409 ) Six Months Ended June 30, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 9,010 $ — $ 9,010 $ (72 ) $ 8,938 Net income (loss) attributable to AXA Equitable (2,401 ) — (2,401 ) 54 (2,347 ) Retained earnings, end of period 6,617 — 6,617 (18 ) 6,599 Total AXA Equitable’s equity, end of period 13,925 — 13,925 (18 ) 13,907 Total Equity, End of Period $ 16,964 $ — $ 16,964 $ (18 ) $ 16,946 Six Months Ended June 30, 2018 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ (2,091 ) $ — $ 54 $ (2,037 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Policy charges and fee income (1,773 ) — 29 (1,744 ) Net derivative (gains) losses 1,172 — (72 ) 1,100 Amortization and depreciation — 335 21 356 Amortization of deferred sales commission 13 (13 ) — — Other depreciation and amortization (45 ) 45 — — Equity (income) loss from limited partnerships — (60 ) — (60 ) Distributions from joint ventures and limited partnerships 44 (44 ) — — Cash received on the recapture of captive reinsurance 1,099 — 174 1,273 Changes in: Reinsurance recoverable 15 — 166 181 Deferred policy acquisition costs 89 (89 ) — — Capitalization of deferred policy acquisition costs — (280 ) — (280 ) Future policy benefits 396 — (554 ) (158 ) Current and deferred income taxes (645 ) — 167 (478 ) Other, net 416 104 (304 ) 216 Net cash provided by (used in) operating activities $ 1,190 $ (2 ) $ (319 ) $ 869 Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Trading account securities 4,843 — 24 4,867 Real estate joint ventures $ — $ 140 $ — $ 140 Short-term investments — 1,331 (24 ) 1,307 Other 260 (140 ) — 120 Payment for the purchase/origination of: Short-term investments — (1,081 ) 205 (876 ) Cash settlements related to derivative instruments (267 ) — (489 ) (756 ) Change in short-term investments 248 (248 ) — — Other, net 379 — 11 390 Net cash provided by (used in) investing activities $ (1,605 ) $ 2 $ (273 ) $ (1,876 ) Six Months Ended June 30, 2018 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 5,227 $ — $ (1,107 ) $ 4,120 Withdrawals (2,611 ) — 480 (2,131 ) Transfer (to) from Separate Accounts (305 ) — 1,219 914 ________________ (1) Net income (loss) includes $310 million in the six months ended June 30, 2018 of the discontinued operations that are not included in net income (loss) in the Consolidated Statements of Income (Loss). The following tables present line items of the consolidated statement of cash flows for the nine months ended September 30, 2018 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s September 30, 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, the adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. Tables for the other consolidated financial statements as of or for the three and nine months ended September 30, 2018 are not presented as these revisions were already reflected in the Company’s September 30, 2018 Form 10-Q. Nine Months Ended September 30, 2018 As Reported Presentation Reclassifi- cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Amortization and depreciation $ — $ 258 $ — $ 258 Amortization of deferred sales commission 17 (17 ) — — Other depreciation and amortization (60 ) 60 — — Equity (income) loss from limited partnerships — (83 ) — (83 ) Distribution from joint ventures and limited partnerships 63 (63 ) — — Cash received on the recapture of captive reinsurance 1,099 — 174 1,273 Changes in: Reinsurance recoverable 20 — 86 106 Deferred policy acquisition costs (129 ) 129 — — Capitalization of deferred policy acquisition costs — (432 ) — (432 ) Future policy benefits (58 ) — (541 ) (599 ) Current and deferred income taxes (264 ) — (400 ) (664 ) Other, net 123 146 179 448 Net cash provided by (used in) operating activities $ 1,614 $ (2 ) $ (502 ) $ 1,110 Nine Months Ended September 30, 2018 As Reported Presentation Reclassifi- cations Revisions As Revised (in millions) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Trading account securities $ 6,913 $ — $ 77 $ 6,990 Real estate joint ventures — 140 — 140 Short-term investments — 1,806 — 1,806 Other 344 (140 ) — 204 Short-term investments — (1,530 ) 204 (1,326 ) Cash settlements related to derivative instruments (584 ) — (492 ) (1,076 ) Change in short-term investments 350 (274 ) (77 ) (1 ) Other, net 305 — (19 ) 286 Net cash provided by (used in) investing activities $ (2,990 ) $ 2 $ (307 ) $ (3,295 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 7,852 $ — $ (1,668 ) $ 6,184 Withdrawals (4,014 ) — 760 (3,254 ) Transfer (to) from Separate Accounts (338 ) — 1,717 1,379 Net cash provided by (used in) financing activities $ 1,293 $ — $ 809 $ 2,102 The following tables present line items of the consolidated financial statements as of and for the three months ended March 31, 20 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s March 31, 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, the adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As of March 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs 4,961 — 4,961 (64 ) 4,897 Total Assets $ 210,013 $ — $ 210,013 $ (64 ) $ 209,949 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities 28,691 — 28,691 66 28,757 Current and deferred taxes 2,726 (562 ) 2,164 (46 ) 2,118 Total Liabilities $ 195,091 $ — $ 195,091 $ 20 $ 195,111 Equity: Retained Earnings $ 5,978 $ — $ 5,978 $ (84 ) $ 5,894 AXA Equitable Equity 11,459 — 11,459 (84 ) 11,375 Noncontrolling interest 3,046 — 3,046 — 3,046 Total Equity 14,505 — 14,505 (84 ) 14,421 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 210,013 $ — $ 210,013 $ (64 ) $ 209,949 Three Months Ended March 31, 2017 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 852 $ — $ — $ 852 $ (22 ) $ 830 Net derivative gains (losses) (362 ) — 10 (352 ) 7 (345 ) Total revenues 2,314 — (745 ) 1,569 (15 ) 1,554 Benefits and other deductions: Policyholders’ benefits 975 — — 975 (3 ) 972 Interest credited to policyholders’ account balances 279 — — 279 (30 ) 249 Compensation and benefits 438 (33 ) (322 ) 83 — 83 Commissions and distribution related payments 382 (114 ) (96 ) 172 — 172 Amortization of deferred policy acquisition costs 29 148 — 177 63 240 Other operating costs and expenses 381 (1 ) (179 ) 201 — 201 Total benefits and other deductions 2,489 — (598 ) 1,891 30 1,921 Income (loss) from continuing operations, before income taxes (175 ) — (147 ) (322 ) (45 ) (367 ) Income tax (expense) benefit from continuing operations 121 — 11 132 16 148 Net income (loss) from continuing operations (54 ) — (136 ) (190 ) (29 ) (219 ) Net income (loss) (54 ) — (118 ) (172 ) (29 ) (201 ) Net income (loss) attributable to AXA Equitable $ (172 ) $ — $ — $ (172 ) $ (29 ) $ (201 ) Three Months Ended March 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ (54 ) $ (118 ) $ (172 ) $ (29 ) $ (201 ) Change in unrealized gains (losses), net of reclassification adjustment 92 — 92 21 113 Total other comprehensive income (loss), net of income taxes 127 (7 ) 120 21 141 Comprehensive income (loss) 73 (125 ) (52 ) (8 ) (60 ) Comprehensive income (loss) attributable to AXA Equitable $ (52 ) $ — $ (52 ) $ (8 ) $ (60 ) Three Months Ended March 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 6,150 $ — $ 6,150 $ (55 ) $ 6,095 Net income (loss) attributable to AXA Equitable (172 ) — (172 ) (29 ) (201 ) Retained earnings, end of period 5,978 — 5,978 (84 ) 5,894 Accumulated other comprehensive income, beginning of year 17 — 17 (21 ) (4 ) Other comprehensive income (loss) 120 — 120 21 141 Accumulated other comprehensive income, end of period 137 — 137 — 137 Total AXA Equitable’s equity, end of period 11,459 — 11,459 (84 ) 11,375 Total Equity, End of Period $ 14,505 $ — $ 14,505 $ (84 ) $ 14,421 Three Months Ended March 31, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ (54 ) $ — $ (29 ) $ (83 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances 279 — (30 ) 249 Policy charges and fee income (852 ) — 22 (830 ) Net derivative (gains) losses 362 — (7 ) 355 Amortization and depreciation — 229 63 292 Amortization of deferred sales commission 9 (9 ) — — Other depreciation and amortization 36 (36 ) — — Amortization of other intangibles 8 (8 ) — — Equity (income) loss from limited partnerships — (39 ) — (39 ) Distributions from joint ventures and limited partnerships 26 (26 ) — — Changes in: — Reinsurance recoverable (23 ) — (173 ) (196 ) Deferred policy acquisition costs 29 (29 ) — — Capitalization of deferred policy acquisition costs — (148 ) — (148 ) Future policy benefits 241 — 17 258 Current and deferred income taxes (188 ) — (6 ) (194 ) Other, net 151 65 — 216 Net cash provided by (used in) operating activities $ 18 $ (1 ) $ (143 ) $ (126 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Short-term investments — 631 — 631 Payment for the purchase/origination of: Short-term investments — (376 ) (289 ) (665 ) Change in short-term investments 254 (254 ) — — Other, net 43 — 100 143 Net cash provided by (used in) investing activities $ (2,447 ) $ 1 $ (189 ) $ (2,635 ) Three Months Ended March 31, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 2,240 $ — $ 269 $ 2,509 Withdrawals (785 ) — (157 ) (942 ) Transfer (to) from Separate Accounts 176 — 220 396 Net cash provided by (used in) financing activities $ 2,306 $ — $ 332 $ 2,638 ________________ (1) Net income (loss) includes $118 million in the three months ended March 31, 2017 of the discontinued operations that are not included in Net income (loss) in the Consolidated Statements of Income (Loss). The following tables present line items of the consolidated financial statements as of and for the three and six months ended June 30, 2017 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s June 30, 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, the adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to curre

REVISION OF PRIOR PERIOD FINA_2

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS (Tables)	12 Months Ended
	Dec. 31, 2018
Accounting Changes and Error Corrections [Abstract]
Revision Tables	As of December 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs $ 4,547 $ — $ 4,547 $ (55 ) $ 4,492 Total Assets $ 225,985 $ — $ 225,985 $ (55 ) $ 225,930 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities 29,034 — 29,034 36 29,070 Current and deferred taxes 1,973 (404 ) 1,569 (19 ) 1,550 Total Liabilities 205,795 — 205,795 17 205,812 Equity: Retained Earnings 9,010 — 9,010 (72 ) 8,938 AXA Equitable Equity 16,469 — 16,469 (72 ) 16,397 Total Equity 19,564 — 19,564 (72 ) 19,492 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 225,985 $ — $ 225,985 $ (55 ) $ 225,930 Year Ended December 31, 2017 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 3,334 $ — $ — $ 3,334 $ (40 ) $ 3,294 Net derivative gains (losses) 890 — 24 914 (20 ) 894 Total revenues 11,733 — (3,217 ) 8,516 (60 ) 8,456 Benefits and other deductions: Policyholders’ benefits 3,462 — — 3,462 11 3,473 Interest credited to policyholder’s account balances 1,040 — — 1,040 (119 ) 921 Compensation and benefits 1,762 (128 ) (1,307 ) 327 — 327 Commissions and distribution related payments 1,486 (443 ) (415 ) 628 — 628 Amortization of deferred policy acquisition costs 268 578 — 846 54 900 Other operating costs and expenses 1,431 (7 ) (789 ) 635 — 635 Total benefits and other deductions 9,478 — (2,517 ) 6,961 (54 ) 6,907 Income (loss) from continuing operations, before income taxes 2,255 — (700 ) 1,555 (6 ) 1,549 Income tax (expense) benefit from continuing operations 1,139 — (111 ) 1,028 182 1,210 Net income (loss) from continuing operations 3,394 — (811 ) 2,583 176 2,759 Net income (loss) 3,394 — (533 ) 2,861 (17 ) 2,844 Net income (loss) attributable to AXA Equitable $ 2,860 $ — $ — $ 2,860 $ (17 ) $ 2,843 Year Ended December 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ 3,394 $ (533 ) $ 2,861 $ (17 ) $ 2,844 Change in unrealized gains (losses), net of reclassification adjustment 563 — 563 21 584 Other comprehensive income 599 (18 ) 581 21 602 Comprehensive income (loss) 3,993 (551 ) 3,442 4 3,446 Comprehensive income (loss) attributable to AXA Equitable $ 3,441 $ — $ 3,441 $ 4 $ 3,445 Year Ended December 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 6,150 $ — $ 6,150 $ (55 ) $ 6,095 Net income (loss) attributable to AXA Equitable 2,860 — 2,860 (17 ) 2,843 Retained earnings, end of period 9,010 — 9,010 (72 ) 8,938 Accumulated other comprehensive income, beginning of year 17 — 17 (21 ) (4 ) Other comprehensive income (loss) 581 — 581 21 602 Accumulated other comprehensive income, end of year 598 — 598 — 598 Total AXA Equitable’s equity, end of year 16,469 — 16,469 (72 ) 16,397 Total Equity, End of Year $ 19,564 $ — $ 19,564 $ (72 ) $ 19,492 Year Ended December 31, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ 3,394 $ — $ (17 ) $ 3,377 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances 1,040 — (119 ) 921 Policy charges and fee income (3,334 ) — 40 (3,294 ) Net derivative (gains) losses (890 ) — 20 (870 ) Amortization and depreciation (136 ) 907 54 825 Amortization of deferred sales commission 32 (32 ) — — Amortization of other intangibles 31 (31 ) — — Equity (income) loss from limited partnerships — (157 ) — (157 ) Distributions from joint ventures and limited partnerships 140 (140 ) — — Year Ended December 31, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Changes in: Reinsurance recoverable (416 ) — (602 ) (1,018 ) Deferred policy acquisition costs 268 (268 ) — — Capitalization of deferred policy acquisition costs — (578 ) — (578 ) Future policy benefits 1,511 — (322 ) 1,189 Current and deferred income taxes (664 ) — (510 ) (1,174 ) Other, net 189 297 — 486 Net cash provided by (used in) operating activities $ 1,077 $ (2 ) $ (1,456 ) $ (381 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Short-term investments $ — $ 2,204 $ — $ 2,204 Payment for the purchase/origination of: Short-term investments — (2,456 ) — (2,456 ) Change in short-term investments (264 ) 254 10 — Other, net 238 — 84 322 Net cash provided by (used in) investing activities $ (9,010 ) $ 2 $ 94 $ (8,914 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 9,882 $ — $ (548 ) $ 9,334 Withdrawals (5,926 ) — 2,000 (3,926 ) Transfer (to) from Separate Accounts 1,656 — (90 ) 1,566 Net cash provided by (used in) financing activities $ 8,370 $ — $ 1,362 $ 9,732 _______________ (1) Net income (loss) includes $533 million in 2017 of the discontinued operations that are not included in net income (loss) in the Consolidated Statements of Income (Loss). The following table presents line items for the consolidated financial statements for the year ended December 31, 2016 that have been affected by the aforementioned adjustments and revisions. This information has been corrected from the information previously presented and restated in the 2017 Form 10-K. For these items, the table details the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, adjustments for the discontinued operation, and revisions and the amounts as currently revised. Year Ended December 31, 2016 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 3,344 $ — $ — $ 3,344 $ (33 ) $ 3,311 Net derivative gains (losses) (1,211 ) — 16 (1,195 ) (126 ) (1,321 ) Total revenues 9,138 — (2,936 ) 6,202 (159 ) 6,043 Year Ended December 31, 2016 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Benefits and other deductions: Interest credited to Policyholder’s account balances 1,029 — — 1,029 (124 ) 905 Compensation and benefits 1,723 (128 ) (1,231 ) 364 — 364 Commissions and distribution related payments 1,467 (460 ) (372 ) 635 — 635 Amortization of deferred policy acquisition costs 52 594 — 646 (4 ) 642 Other operating costs and expenses 1,458 (6 ) (699 ) 753 — 753 Total benefits and other deductions 8,516 — (2,305 ) 6,211 (128 ) 6,083 Income (loss) from continuing operations, before income taxes 622 — (631 ) (9 ) (31 ) (40 ) Income tax (expense) benefit from continuing operations 84 — 69 153 11 164 Net income (loss) from continuing operations 706 — (562 ) 144 (20 ) 124 Net income (loss) 706 — (496 ) 210 (20 ) 190 Net income (loss) attributable to AXA Equitable $ 210 $ — $ — $ 210 $ (20 ) $ 190 Year Ended December 31, 2016 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ 706 $ (496 ) $ 210 $ (20 ) $ 190 Change in unrealized gains (losses), net of reclassification adjustment (194 ) — (194 ) (21 ) (215 ) Other comprehensive income (215 ) 17 (198 ) (21 ) (219 ) Comprehensive income (loss) 491 (479 ) 12 (41 ) (29 ) Comprehensive income (loss) attributable to AXA Equitable $ 12 $ — $ 12 $ (41 ) $ (29 ) Year Ended December 31, 2016 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 6,990 $ — $ 6,990 $ (35 ) $ 6,955 Net income (loss) attributable to AXA Equitable 210 — 210 (20 ) 190 Retained earnings, end of period 6,150 — 6,150 (55 ) 6,095 Other comprehensive income (loss) (198 ) — (198 ) (21 ) (219 ) Accumulated other comprehensive income, end of period 17 — 17 (21 ) (4 ) Total AXA Equitable’s equity, end of period $ 11,508 $ — $ 11,508 $ (76 ) $ 11,432 Year Ended December 31, 2016 As Reported Presentation Reclassifications Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ 706 $ — $ (20 ) $ 686 Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances 1,029 — (124 ) 905 Policy charges and fee income (3,344 ) — 33 (3,311 ) Net derivative (gains) losses 1,211 — 126 1,337 Amortization and depreciation — 618 (4 ) 614 Amortization of deferred sales commission 41 (41 ) — — Other depreciation and amortization (98 ) 98 — — Amortization of other intangibles 29 (29 ) — — Equity (income) loss from limited partnerships — (91 ) — (91 ) Return of real estate joint venture and limited partnerships 126 (126 ) — — Changes in: Deferred policy acquisition costs 52 (52 ) — — Capitalization of deferred policy acquisition costs — (594 ) — (594 ) Current and deferred income taxes (742 ) — (11 ) (753 ) Other, net (161 ) 217 — 56 Net cash provided by (used in) operating activities $ (461 ) $ — $ — $ (461 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Short-term investments — 2,984 — 2,984 Payment for the purchase/origination of: Short-term investments — (3,187 ) — (3,187 ) Change in short-term investments (205 ) 205 — — Other, net 409 (2 ) — 407 Net cash provided by (used in) investing activities $ (5,358 ) $ — $ — $ (5,358 ) _______________ (1) Net income (loss) includes $496 million in 2016 of the discontinued operations that are not included in Net income (loss) in the Consolidated Statements of Income (Loss). Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As of March 31, 2018 As Pre-viously Reported Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs 4,826 — 4,826 (119 ) 4,707 Total Assets $ 222,424 $ — $ 222,424 $ (119 ) $ 222,305 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities $ 28,374 $ — $ 28,374 $ (10 ) $ 28,364 Current and deferred taxes 1,728 (432 ) 1,296 (38 ) 1,258 Other liabilities 3,041 (1,941 ) 1,100 70 1,170 Total Liabilities $ 202,767 $ — $ 202,767 $ 22 $ 202,789 Equity: Retained Earnings $ 8,824 $ — $ 8,824 $ (141 ) $ 8,683 AXA Equitable Equity 15,545 — 15,545 (141 ) 15,404 Total Equity 18,633 — 18,633 (141 ) 18,492 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 222,424 $ — $ 222,424 $ (119 ) $ 222,305 Three Months Ended March 31, 2018 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 869 $ — $ — $ 869 $ (8 ) $ 861 Net derivative gains (losses) (777 ) — (2 ) (779 ) (38 ) (817 ) Total Revenues 2,031 — (846 ) 1,185 (46 ) 1,139 Benefits and other deductions: Policyholders’ benefits 489 — — 489 (9 ) 480 Interest credited to policyholders’ account balances 338 — — 338 (83 ) 255 Compensation and benefits 456 (33 ) (344 ) 79 70 149 Commissions and distribution related payments 371 (101 ) (110 ) 160 — 160 Amortization of deferred policy acquisition costs 10 135 — 145 64 209 Other operating costs and expenses 440 (1 ) (189 ) 250 — 250 Total benefits and other deductions 2,115 — (645 ) 1,470 42 1,512 Income (loss) from continuing operations, before income taxes (84 ) — (201 ) (285 ) (88 ) (373 ) Income tax (expense) benefit from continuing operations 44 — 17 61 19 80 Net income (loss) from continuing operations (40 ) — (184 ) (224 ) (69 ) (293 ) Net income (loss) (40 ) — (155 ) (195 ) (69 ) (264 ) Net income (loss) attributable to AXA Equitable $ (194 ) $ — $ — $ (194 ) $ (69 ) $ (263 ) Three Months Ended March 31, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Statements of Comprehensive Income (Loss): Net income (loss) $ (40 ) $ (155 ) $ (195 ) $ (69 ) $ (264 ) Comprehensive income (loss) $ (789 ) $ (162 ) $ (951 ) $ (69 ) $ (1,020 ) Comprehensive income (loss) attributable to AXA Equitable $ (950 ) $ — $ (950 ) $ (69 ) $ (1,019 ) Three Months Ended March 31, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 9,010 $ — $ 9,010 $ (72 ) $ 8,938 Net income (loss) (194 ) — (194 ) (69 ) (263 ) Retained earnings, end of period 8,824 — 8,824 (141 ) 8,683 Total AXA Equitable’s equity, end of period 15,545 15,545 (141 ) 15,404 Total Equity, End of Period $ 18,633 $ — $ 18,633 $ (141 ) $ 18,492 Three Months Ended March 31, 2018 As Reported Presentation Reclassifi- cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ (40 ) $ — $ (69 ) $ (109 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances $ 338 $ — $ (83 ) $ 255 Policy charges and fee income (869 ) — 8 (861 ) Net derivative (gains) losses 777 — 38 815 Amortization and depreciation — 137 64 201 Amortization of deferred sales commission 7 (7 ) — — Other depreciation and amortization (23 ) 23 — — Amortization of other Intangibles 8 (8 ) — — Equity (income) loss from limited partnerships — (39 ) — (39 ) Distributions from joint ventures and limited partnerships 25 (25 ) — — Changes in: Reinsurance recoverable 2 — (149 ) (147 ) Deferred policy acquisition costs 10 (10 ) — — Capitalization of deferred policy acquisition costs — (135 ) — (135 ) Future policy benefits (191 ) — (7 ) (198 ) Current and deferred income taxes (52 ) — 132 80 Other, net (122 ) 64 70 12 Net cash provided by (used in) operating activities $ (21 ) $ — $ 4 $ (17 ) Three Months Ended March 31, 2018 As Reported Presentation Reclassifi- cations Revisions As Revised (in millions) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Trading account securities $ 1,606 $ — $ 77 $ 1,683 Real estate held for the production of income — 140 — 140 Short-term investments — 688 — 688 Other 54 (140 ) — (86 ) Payment for the purchase/origination of: Short-term investments — (377 ) — (377 ) Cash settlements related to derivative instruments (14 ) — (489 ) (503 ) Change in short-term investments 396 (311 ) (85 ) — Other, net (560 ) — 153 (407 ) Net cash provided by (used in) investing activities $ (639 ) $ — $ (344 ) $ (983 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 2,366 $ — $ (468 ) $ 1,898 Withdrawals (1,322 ) — 241 (1,081 ) Transfer (to) from Separate Accounts (115 ) — 567 452 Net cash provided by (used in) financing activities $ 1,040 $ — $ 340 $ 1,380 ________________ (1) Net income (loss) includes $154 million in the three months ended March 31, 2018 of the discontinued operations that are not included in net income (loss) in the Consolidated Statements of Income (Loss). This information has been corrected from the information previously presented in the Company’s June 30, 2018 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, the adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As of June 30, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs $ 4,786 $ — $ 4,786 $ (76 ) $ 4,710 Amounts due from reinsurers 3,088 — 3,088 (9 ) 3,079 Current and deferred taxes 159 422 581 3 584 Total Assets $ 219,306 $ — $ 219,306 $ (82 ) $ 219,224 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities $ 28,122 $ — $ 28,122 $ (64 ) $ 28,058 Total Liabilities $ 202,196 $ — $ 202,196 $ (64 ) $ 202,132 Equity: Retained Earnings $ 6,617 $ — $ 6,617 $ (18 ) $ 6,599 AXA Equitable Equity 13,925 — 13,925 (18 ) 13,907 Total Equity 16,964 — 16,964 (18 ) 16,946 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 219,306 $ — $ 219,306 $ (82 ) $ 219,224 Three Months Ended June 30, 2018 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 904 $ — $ — $ 904 $ (21 ) $ 883 Net derivative gains (losses) (312 ) — — (312 ) 27 (285 ) Total revenues 2,439 — (824 ) 1,615 6 1,621 Benefits and other deductions: Policyholders’ benefits 1,339 — — 1,339 (38 ) 1,301 Compensation and benefits 466 (32 ) (360 ) 74 — 74 Commissions and distribution related payments 377 (112 ) (106 ) 159 — 159 Amortization of deferred policy acquisition costs 31 145 1 177 5 182 Other operating costs and expenses 2,486 (1 ) (172 ) 2,313 — 2,313 Total benefits and other deductions 4,950 — (639 ) 4,311 (33 ) 4,278 Income (loss) from continuing operations, before income taxes (2,511 ) — (185 ) (2,696 ) 39 (2,657 ) Income tax (expense) benefit from continuing operations 553 — 8 561 (9 ) 552 Net income (loss) from continuing operations (1,958 ) — (177 ) (2,135 ) 30 (2,105 ) Net income (loss) (1,958 ) — (156 ) (2,114 ) 30 (2,084 ) Net income (loss) attributable to AXA Equitable $ (2,114 ) $ — $ — $ (2,114 ) $ 30 $ (2,084 ) Three Months Ended June 30, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ (1,958 ) $ (156 ) $ (2,114 ) $ 30 $ (2,084 ) Comprehensive income (loss) (2,278 ) (142 ) (2,420 ) 30 (2,390 ) Comprehensive income (loss) attributable to AXA Equitable $ (2,420 ) $ — $ (2,420 ) $ 30 $ (2,390 ) Six Months Ended June 30, 2018 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 1,773 $ — $ — $ 1,773 $ (29 ) $ 1,744 Net derivative gains (losses) (1,172 ) — (2 ) (1,174 ) 72 (1,102 ) Total revenues 4,387 — (1,670 ) 2,717 43 2,760 Benefits and other deductions: Policyholders’ benefits 1,828 — — 1,828 (47 ) 1,781 Compensation and benefits 992 (65 ) (704 ) 223 — 223 Commissions and distribution related payments 748 (213 ) (216 ) 319 — 319 Amortization of deferred policy acquisition costs 89 280 1 370 21 391 Other operating costs and expenses 2,926 (2 ) (361 ) 2,563 — 2,563 Total benefits and other deductions 7,100 — (1,284 ) 5,816 (26 ) 5,790 Income (loss) from continuing operations, before income taxes (2,713 ) — (386 ) (3,099 ) 69 (3,030 ) Income tax (expense) benefit from continuing operations 622 — 25 647 (15 ) 632 Net income (loss) from continuing operations (2,091 ) — (361 ) (2,452 ) 54 (2,398 ) Net income (loss) (2,091 ) — (311 ) (2,402 ) 54 (2,348 ) Net income (loss) attributable to AXA Equitable $ (2,401 ) $ — $ — $ (2,401 ) $ 54 $ (2,347 ) Six Months Ended June 30, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ (2,091 ) $ (311 ) $ (2,402 ) $ 54 $ (2,348 ) Comprehensive income (loss) (3,160 ) (305 ) (3,465 ) 54 (3,411 ) Comprehensive income (loss) attributable to AXA Equitable $ (3,463 ) $ — $ (3,463 ) $ 54 $ (3,409 ) Six Months Ended June 30, 2018 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 9,010 $ — $ 9,010 $ (72 ) $ 8,938 Net income (loss) attributable to AXA Equitable (2,401 ) — (2,401 ) 54 (2,347 ) Retained earnings, end of period 6,617 — 6,617 (18 ) 6,599 Total AXA Equitable’s equity, end of period 13,925 — 13,925 (18 ) 13,907 Total Equity, End of Period $ 16,964 $ — $ 16,964 $ (18 ) $ 16,946 Six Months Ended June 30, 2018 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ (2,091 ) $ — $ 54 $ (2,037 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Policy charges and fee income (1,773 ) — 29 (1,744 ) Net derivative (gains) losses 1,172 — (72 ) 1,100 Amortization and depreciation — 335 21 356 Amortization of deferred sales commission 13 (13 ) — — Other depreciation and amortization (45 ) 45 — — Equity (income) loss from limited partnerships — (60 ) — (60 ) Distributions from joint ventures and limited partnerships 44 (44 ) — — Cash received on the recapture of captive reinsurance 1,099 — 174 1,273 Changes in: Reinsurance recoverable 15 — 166 181 Deferred policy acquisition costs 89 (89 ) — — Capitalization of deferred policy acquisition costs — (280 ) — (280 ) Future policy benefits 396 — (554 ) (158 ) Current and deferred income taxes (645 ) — 167 (478 ) Other, net 416 104 (304 ) 216 Net cash provided by (used in) operating activities $ 1,190 $ (2 ) $ (319 ) $ 869 Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Trading account securities 4,843 — 24 4,867 Real estate joint ventures $ — $ 140 $ — $ 140 Short-term investments — 1,331 (24 ) 1,307 Other 260 (140 ) — 120 Payment for the purchase/origination of: Short-term investments — (1,081 ) 205 (876 ) Cash settlements related to derivative instruments (267 ) — (489 ) (756 ) Change in short-term investments 248 (248 ) — — Other, net 379 — 11 390 Net cash provided by (used in) investing activities $ (1,605 ) $ 2 $ (273 ) $ (1,876 ) Six Months Ended June 30, 2018 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 5,227 $ — $ (1,107 ) $ 4,120 Withdrawals (2,611 ) — 480 (2,131 ) Transfer (to) from Separate Accounts (305 ) — 1,219 914 ________________ (1) Net income (loss) includes $310 million in the six months ended June 30, 2018 of the discontinued operations that are not included in net income (loss) in the Consolidated Statements of Income (Loss). The following tables present line items of the consolidated statement of cash flows for the nine months ended September 30, 2018 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s September 30, 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, the adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. Tables for the other consolidated financial statements as of or for the three and nine months ended September 30, 2018 are not presented as these revisions were already reflected in the Company’s September 30, 2018 Form 10-Q. Nine Months Ended September 30, 2018 As Reported Presentation Reclassifi- cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Amortization and depreciation $ — $ 258 $ — $ 258 Amortization of deferred sales commission 17 (17 ) — — Other depreciation and amortization (60 ) 60 — — Equity (income) loss from limited partnerships — (83 ) — (83 ) Distribution from joint ventures and limited partnerships 63 (63 ) — — Cash received on the recapture of captive reinsurance 1,099 — 174 1,273 Changes in: Reinsurance recoverable 20 — 86 106 Deferred policy acquisition costs (129 ) 129 — — Capitalization of deferred policy acquisition costs — (432 ) — (432 ) Future policy benefits (58 ) — (541 ) (599 ) Current and deferred income taxes (264 ) — (400 ) (664 ) Other, net 123 146 179 448 Net cash provided by (used in) operating activities $ 1,614 $ (2 ) $ (502 ) $ 1,110 Nine Months Ended September 30, 2018 As Reported Presentation Reclassifi- cations Revisions As Revised (in millions) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Trading account securities $ 6,913 $ — $ 77 $ 6,990 Real estate joint ventures — 140 — 140 Short-term investments — 1,806 — 1,806 Other 344 (140 ) — 204 Short-term investments — (1,530 ) 204 (1,326 ) Cash settlements related to derivative instruments (584 ) — (492 ) (1,076 ) Change in short-term investments 350 (274 ) (77 ) (1 ) Other, net 305 — (19 ) 286 Net cash provided by (used in) investing activities $ (2,990 ) $ 2 $ (307 ) $ (3,295 ) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 7,852 $ — $ (1,668 ) $ 6,184 Withdrawals (4,014 ) — 760 (3,254 ) Transfer (to) from Separate Accounts (338 ) — 1,717 1,379 Net cash provided by (used in) financing activities $ 1,293 $ — $ 809 $ 2,102 The following tables present line items of the consolidated financial statements as of and for the three months ended March 31, 20 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s March 31, 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, the adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to current period presentation, where applicable, and are summarized in the accompanying tables. As of March 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Balance Sheet: Assets: Deferred policy acquisition costs 4,961 — 4,961 (64 ) 4,897 Total Assets $ 210,013 $ — $ 210,013 $ (64 ) $ 209,949 Liabilities: Future policyholders’ benefits and other policyholders’ liabilities 28,691 — 28,691 66 28,757 Current and deferred taxes 2,726 (562 ) 2,164 (46 ) 2,118 Total Liabilities $ 195,091 $ — $ 195,091 $ 20 $ 195,111 Equity: Retained Earnings $ 5,978 $ — $ 5,978 $ (84 ) $ 5,894 AXA Equitable Equity 11,459 — 11,459 (84 ) 11,375 Noncontrolling interest 3,046 — 3,046 — 3,046 Total Equity 14,505 — 14,505 (84 ) 14,421 Total Liabilities, Redeemable Noncontrolling Interest and Equity $ 210,013 $ — $ 210,013 $ (64 ) $ 209,949 Three Months Ended March 31, 2017 As Pre-viously Gross DAC Adjustment Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Income (Loss): Revenues: Policy charges and fee income $ 852 $ — $ — $ 852 $ (22 ) $ 830 Net derivative gains (losses) (362 ) — 10 (352 ) 7 (345 ) Total revenues 2,314 — (745 ) 1,569 (15 ) 1,554 Benefits and other deductions: Policyholders’ benefits 975 — — 975 (3 ) 972 Interest credited to policyholders’ account balances 279 — — 279 (30 ) 249 Compensation and benefits 438 (33 ) (322 ) 83 — 83 Commissions and distribution related payments 382 (114 ) (96 ) 172 — 172 Amortization of deferred policy acquisition costs 29 148 — 177 63 240 Other operating costs and expenses 381 (1 ) (179 ) 201 — 201 Total benefits and other deductions 2,489 — (598 ) 1,891 30 1,921 Income (loss) from continuing operations, before income taxes (175 ) — (147 ) (322 ) (45 ) (367 ) Income tax (expense) benefit from continuing operations 121 — 11 132 16 148 Net income (loss) from continuing operations (54 ) — (136 ) (190 ) (29 ) (219 ) Net income (loss) (54 ) — (118 ) (172 ) (29 ) (201 ) Net income (loss) attributable to AXA Equitable $ (172 ) $ — $ — $ (172 ) $ (29 ) $ (201 ) Three Months Ended March 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Comprehensive Income (Loss): Net income (loss) $ (54 ) $ (118 ) $ (172 ) $ (29 ) $ (201 ) Change in unrealized gains (losses), net of reclassification adjustment 92 — 92 21 113 Total other comprehensive income (loss), net of income taxes 127 (7 ) 120 21 141 Comprehensive income (loss) 73 (125 ) (52 ) (8 ) (60 ) Comprehensive income (loss) attributable to AXA Equitable $ (52 ) $ — $ (52 ) $ (8 ) $ (60 ) Three Months Ended March 31, 2017 As Pre-viously Dis-continued Operations Adjustment As Adjusted Impact of Revisions As Revised (in millions) Consolidated Statement of Equity: Retained earnings, beginning of year $ 6,150 $ — $ 6,150 $ (55 ) $ 6,095 Net income (loss) attributable to AXA Equitable (172 ) — (172 ) (29 ) (201 ) Retained earnings, end of period 5,978 — 5,978 (84 ) 5,894 Accumulated other comprehensive income, beginning of year 17 — 17 (21 ) (4 ) Other comprehensive income (loss) 120 — 120 21 141 Accumulated other comprehensive income, end of period 137 — 137 — 137 Total AXA Equitable’s equity, end of period 11,459 — 11,459 (84 ) 11,375 Total Equity, End of Period $ 14,505 $ — $ 14,505 $ (84 ) $ 14,421 Three Months Ended March 31, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Consolidated Statement of Cash Flows: Net income (loss) (1) $ (54 ) $ — $ (29 ) $ (83 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Interest credited to policyholders’ account balances 279 — (30 ) 249 Policy charges and fee income (852 ) — 22 (830 ) Net derivative (gains) losses 362 — (7 ) 355 Amortization and depreciation — 229 63 292 Amortization of deferred sales commission 9 (9 ) — — Other depreciation and amortization 36 (36 ) — — Amortization of other intangibles 8 (8 ) — — Equity (income) loss from limited partnerships — (39 ) — (39 ) Distributions from joint ventures and limited partnerships 26 (26 ) — — Changes in: — Reinsurance recoverable (23 ) — (173 ) (196 ) Deferred policy acquisition costs 29 (29 ) — — Capitalization of deferred policy acquisition costs — (148 ) — (148 ) Future policy benefits 241 — 17 258 Current and deferred income taxes (188 ) — (6 ) (194 ) Other, net 151 65 — 216 Net cash provided by (used in) operating activities $ 18 $ (1 ) $ (143 ) $ (126 ) Cash flows from investing activities: Proceeds from the sale/maturity/prepayment of: Short-term investments — 631 — 631 Payment for the purchase/origination of: Short-term investments — (376 ) (289 ) (665 ) Change in short-term investments 254 (254 ) — — Other, net 43 — 100 143 Net cash provided by (used in) investing activities $ (2,447 ) $ 1 $ (189 ) $ (2,635 ) Three Months Ended March 31, 2017 As Reported Presentation Reclassifi-cations Revisions As Revised (in millions) Cash flows from financing activities: Policyholders’ account balances: Deposits $ 2,240 $ — $ 269 $ 2,509 Withdrawals (785 ) — (157 ) (942 ) Transfer (to) from Separate Accounts 176 — 220 396 Net cash provided by (used in) financing activities $ 2,306 $ — $ 332 $ 2,638 ________________ (1) Net income (loss) includes $118 million in the three months ended March 31, 2017 of the discontinued operations that are not included in Net income (loss) in the Consolidated Statements of Income (Loss). The following tables present line items of the consolidated financial statements as of and for the three and six months ended June 30, 2017 that have been affected by the revisions. This information has been corrected from the information previously presented in the Company’s June 30, 2018 Form 10-Q. For these items, the tables detail the amounts as previously reported and the impact upon those line items due to the reclassifications to conform to the current presentation, the adjustment for the discontinued operation, revisions and the amounts as currently revised. Prior period amounts have been reclassified to conform to curre

ORGANIZATION - Narrative (Detai

ORGANIZATION - Narrative (Details)	1 Months Ended	12 Months Ended
	Mar. 31, 2018	Dec. 31, 2018
AXA Equity Holdings
Organization Basis Of Presentation [Line Items]
Ownership percentage		59.00%
AXA Financial
Organization Basis Of Presentation [Line Items]
Noncontrolling interest, ownership percentage	0.50%
Economic interest in subsidiary	100.00%

SIGNIFICANT ACCOUNTING POLICI_4

SIGNIFICANT ACCOUNTING POLICIES - New Accounting Pronouncements (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Jan. 01, 2019	Mar. 31, 2018
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Retained earnings	$ 5,098	$ 8,938			$ 8,683
Noncontrolling interest	12	3,095
Difference Between Revenue Guidance In Effect Before And After Topic 606 | Accounting Standards Update 2014-09
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Retained earnings	13
Minimum | Accounting Standards Update 2016-02 | Pro Forma
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Right of use assets				$ 300
Operating lease liability				400
Maximum | Accounting Standards Update 2016-02 | Pro Forma
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Right of use assets				400
Operating lease liability				$ 500
Accumulated other comprehensive income (loss) attributable to AXA Equitable
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Cumulative effect of adoption of ASU 2018-02, Reclassification of Certain Tax Effects	$ 83	$ 0	$ 0

SIGNIFICANT ACCOUNTING POLICI_5

SIGNIFICANT ACCOUNTING POLICIES - Investments and Commercial and Agricultural Mortgage Loans on Real Estate (Details) $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)Rate	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Mortgage Loans on Real Estate, Write-down or Reserve, Management Judgment Factor [Line Items]
Carrying value of COLI	$ 873	$ 911	$ 892
Loan-to-Value Ratio for Allowance to be Recommended | Rate	100.00%
Debt Service Coverage Ratio Threshold	1
Minimum
Mortgage Loans on Real Estate, Write-down or Reserve, Management Judgment Factor [Line Items]
Lease Expiration Period	12 months
Mortgage Loan Maturity Period for Monitoring	12 months
Maximum
Mortgage Loans on Real Estate, Write-down or Reserve, Management Judgment Factor [Line Items]
Lease Expiration Period	36 months
Mortgage Loan Maturity Period for Monitoring	24 months
Commercial Real Estate Portfolio Segment
Mortgage Loans on Real Estate, Write-down or Reserve, Management Judgment Factor [Line Items]
Recorded Investment, Nonaccrual Status	$ 19	$ 19
Real estate held for the production of income | Minimum
Mortgage Loans on Real Estate, Write-down or Reserve, Management Judgment Factor [Line Items]
Real estate held for the production of income, useful lives	40 years
Real estate held for the production of income | Maximum
Mortgage Loans on Real Estate, Write-down or Reserve, Management Judgment Factor [Line Items]
Real estate held for the production of income, useful lives	50 years

SIGNIFICANT ACCOUNTING POLICI_6

SIGNIFICANT ACCOUNTING POLICIES - Deferred Acquisition Costs (Details)	Dec. 31, 2018
Accounting Policies [Abstract]
Average annual rate of return, gross	7.00%
Average annual rate of return, net	4.70%
Future annual rate of return, gross, maximum	15.00%
Future annual rate of return, gross, minimum	0.00%
Future annual rate of return, net, maximum	12.70%
Future annual rate of return, net, minimum	(2.30%)
Assumed average investment yield excluding policy loans, high end	4.70%
Assumed average investment yield excluding policy loans, low end	4.30%

SIGNIFICANT ACCOUNTING POLICI_7

SIGNIFICANT ACCOUNTING POLICIES - Policyholders' Account Balances and Future Policy Benefits (Details) - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Liability For Future Policy Benefits Assumptions [Line Items]
Percentage of life insurance liabilities calculate within traditional life interest rate range	99.20%
Separate Accounts Disclosure [Abstract]
Gain (loss) recognized on assets transferred to separate account	$ (7.2)	$ 16.7	$ 8.2
Minimum | Life Insurance Liabilities
Liability For Future Policy Benefits Assumptions [Line Items]
Liability for future policy benefits, interest rate	4.50%
Minimum | Annuity Liabilities
Liability For Future Policy Benefits Assumptions [Line Items]
Liability for policyholder contract deposits, interest rate	1.60%
Maximum | Life Insurance Liabilities
Liability For Future Policy Benefits Assumptions [Line Items]
Liability for future policy benefits, interest rate	6.30%
Maximum | Annuity Liabilities
Liability For Future Policy Benefits Assumptions [Line Items]
Liability for policyholder contract deposits, interest rate	5.50%
Weighted Average | Life Insurance Liabilities
Liability For Future Policy Benefits Assumptions [Line Items]
Liability for future policy benefits, interest rate	5.00%
Weighted Average | Annuity Liabilities
Liability For Future Policy Benefits Assumptions [Line Items]
Liability for policyholder contract deposits, interest rate	4.80%
Computer Software, Intangible Asset | Minimum
Liability For Future Policy Benefits Assumptions [Line Items]
Intangible asset useful life	3 years
Computer Software, Intangible Asset | Maximum
Liability For Future Policy Benefits Assumptions [Line Items]
Intangible asset useful life	5 years

SIGNIFICANT ACCOUNTING POLICI_8

SIGNIFICANT ACCOUNTING POLICIES - Assumption Updates and Model Changes (Details) - USD ($) $ in Millions	3 Months Ended				12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Dec. 31, 2017	Sep. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Change in Accounting Estimate [Line Items]
Policy charges and fee income					$ 3,523	$ 3,294	$ 3,311
Policyholders’ benefits increase (decrease)					3,005	3,473	2,771
Net derivative gains (losses)					(1,010)	870	(1,337)
Amortization of deferred policy acquisition costs, net increase (decrease)					431	900	642
Income (loss) from operations, before income taxes					(1,481)	1,549	(40)
Net income (loss)	$ 1,936	$ (509)	$ 1,515	$ 23	(921)	2,844	190
Increase (decrease) in the fair value of the reinsurance contract asset					$ 8,497	174	268
Long-term Lapses, Partial Withdrawal Rates and Election Assumptions Updates
Change in Accounting Estimate [Line Items]
Policy charges and fee income		12				88	35
Policyholders’ benefits increase (decrease)		(684)				23	(135)
Net derivative gains (losses)		1,100
Amortization of deferred policy acquisition costs, net increase (decrease)		(165)				(247)	193
Income (loss) from operations, before income taxes		(228)				1,700	(23)
Net income (loss)		$ 187				1,100	$ (15)
Long-term Lapses, Partial Withdrawal Rates and Election Assumptions Updates | GMIB
Change in Accounting Estimate [Line Items]
Increase (decrease) in the fair value of the reinsurance contract asset						1,500
Increase (decrease) in fair value of policy liability						$ 447

SIGNIFICANT ACCOUNTING POLICI_9

SIGNIFICANT ACCOUNTING POLICIES - Reclassification of DAC Capitalization (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Increase to expense line item:	$ 431	$ 900	$ 642
Reclassification of DAC Capitalization
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Reductions to expense line items:		578	594
Increase to expense line item:		578	594
Reclassification of DAC Capitalization | Compensation and benefits
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Reductions to expense line items:		128	128
Reclassification of DAC Capitalization | Commissions and distribution plan payments
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Reductions to expense line items:		443	460
Reclassification of DAC Capitalization | Other operating costs and expenses
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Reductions to expense line items:		$ 7	$ 6

INVESTMENTS - Available-for-sal

INVESTMENTS - Available-for-sale Securities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 42,492	$ 34,988
Gross Unrealized Gains	618	1,774
Gross Unrealized Losses	1,195	247
Fair Value	41,915	36,515
OTTI in AOCI	2	2
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Subtotal, Fair Value	41,915	36,358
Available For Sale Fixed Maturities Proceeds Gross Gains And Gross Losses From Sales And Other Than Temporary Impairments [Abstract]
Proceeds from sales	7,136	7,232	$ 4,324
Gross gains on sales	145	98	111
Gross losses on sales	(103)	(211)	(58)
Total other-than-temporary impairment losses	(37)	(13)	(65)
Non-credit losses recognized in OCI	0	0	0
Net impairment losses recognized	(37)	(13)	(65)
Fixed Maturities - Credit Loss Impairments
Beginning balance	19,492	14,528
Ending balance	12,428	19,492	14,528
Corporate
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	26,690	20,596
Gross Unrealized Gains	385	942
Gross Unrealized Losses	699	56
Fair Value	26,376	21,482
OTTI in AOCI	0	0
U.S. Treasury, government and agency
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	13,646	12,644
Gross Unrealized Gains	143	676
Gross Unrealized Losses	454	185
Fair Value	13,335	13,135
OTTI in AOCI	0	0
States and political subdivisions
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	408	414
Gross Unrealized Gains	47	67
Gross Unrealized Losses	1	0
Fair Value	454	481
OTTI in AOCI	0	0
Foreign governments
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	515	387
Gross Unrealized Gains	17	27
Gross Unrealized Losses	13	5
Fair Value	519	409
OTTI in AOCI	0	0
Residential mortgage-backed
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	193	236
Gross Unrealized Gains	9	15
Gross Unrealized Losses	0	0
Fair Value	202	251
OTTI in AOCI	0	0
Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]
Amortized Cost Basis, without Single Maturity Date	193
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Fair Value, without Single Maturity Date	202
Asset-backed
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	600	93
Gross Unrealized Gains	1	3
Gross Unrealized Losses	11	0
Fair Value	590	96
OTTI in AOCI	2	2
Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]
Amortized Cost Basis, without Single Maturity Date	600
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Fair Value, without Single Maturity Date	590
Redeemable preferred stock
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	440	461
Gross Unrealized Gains	16	44
Gross Unrealized Losses	17	1
Fair Value	439	504
OTTI in AOCI	0	0
Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]
Amortized Cost Basis, without Single Maturity Date	440
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Fair Value, without Single Maturity Date	439
Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	42,492	34,831
Gross Unrealized Gains		1,774
Gross Unrealized Losses		247
Fair Value		36,358
OTTI in AOCI		2
Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]
Due in one year or less, Amortized Cost	2,085
Due in years two through five, Amortized Cost	8,087
Due in years six through ten, Amortized Cost	14,337
Due after ten years, Amortized Cost	16,750
Subtotal, Amortized Cost Basis	41,259
Amortized Cost Basis, without Single Maturity Date	42,492
Debt Securities, Available-for-sale, Fair Value, Fiscal Year Maturity [Abstract]
Due in one year or less, Fair Value	2,090
Due in years two through five, Fair Value	8,141
Due in years six through ten, Fair Value	14,214
Due after ten years, Fair Value	16,239
Subtotal, Fair Value	40,684
Fair Value, without Single Maturity Date	41,915
Equity securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		157
Gross Unrealized Gains		0
Gross Unrealized Losses		0
Fair Value		157
OTTI in AOCI		0
Accumulated Other-than-Temporary Impairment Attributable to Parent
Fixed Maturities - Credit Loss Impairments
Recognized impairments on securities impaired to fair value this period	0	0
Increases due to passage of time on previously recorded credit losses	0	0
Accretion of previously recognized impairments due to increases in expected cash flows	0	0
Accumulated Other-than-Temporary Impairment Attributable to Parent | Fixed maturities
Fixed Maturities - Credit Loss Impairments
Beginning balance	(10)	(190)
Previously recognized impairments on securities that matured, paid, prepaid or sold	1	193
Impairments recognized this period on securities not previously impaired	(37)	(13)
Additional impairments this period on securities previously impaired	0	0
Ending balance	$ (46)	$ (10)	$ (190)

INVESTMENTS - Net Unrealized In

INVESTMENTS - Net Unrealized Investments (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	$ 5
DAC	353	$ (211)	$ (6)
Balance, end of the period	(30)	5
Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	1,527
Balance, end of the period	(577)	1,527
Unrealized Investment Gains Losses With Otti Losses | Net Unrealized Gains (Losses) on Investments | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	1	19
Net unrealized gains (losses) arising during the year	(1)	(18)
Included in Net income (loss)	0	0
Excluded from Net earnings (loss)	0	0
DAC	0	0
Deferred income taxes	0	0
Policyholders’ liabilities	0	0
Balance, end of the period	0	1	19
Unrealized Investment Gains Losses With Otti Losses | DAC | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	1	(1)
Net unrealized gains (losses) arising during the year	0	0
Included in Net income (loss)	0	0
Excluded from Net earnings (loss)	0	0
DAC	(1)	2
Deferred income taxes	0	0
Policyholders’ liabilities	0	0
Balance, end of the period	0	1	(1)
Unrealized Investment Gains Losses With Otti Losses | Policyholders’ Liabilities | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	(1)	(10)
Net unrealized gains (losses) arising during the year	0	0
Included in Net income (loss)	0	0
Excluded from Net earnings (loss)	0	0
DAC	0	0
Deferred income taxes	0	0
Policyholders’ liabilities	1	9
Balance, end of the period	0	(1)	(10)
Unrealized Investment Gains Losses With Otti Losses | Deferred Income Tax Asset (Liability) | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	(5)	(3)
Net unrealized gains (losses) arising during the year	0	0
Included in Net income (loss)	0	0
Excluded from Net earnings (loss)	0	0
DAC	0	0
Deferred income taxes	5	(2)
Policyholders’ liabilities	0	0
Balance, end of the period	0	(5)	(3)
Unrealized Investment Gains Losses With Otti Losses | AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	(4)	5
Net unrealized gains (losses) arising during the year	(1)	(18)
Included in Net income (loss)	0	0
Excluded from Net earnings (loss)	0	0
DAC	(1)	2
Deferred income taxes	5	(2)
Policyholders’ liabilities	1	9
Balance, end of the period	0	(4)	5
Unrealized Investment Gains Losses All Other | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	1,526
Balance, end of the period	(577)	1,526
Unrealized Investment Gains Losses All Other | Net Unrealized Gains (Losses) on Investments | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	1,526	428
Net unrealized gains (losses) arising during the year	(2,098)	1,085
Included in Net income (loss)	(5)	13
Excluded from Net earnings (loss)	0	0
DAC	0	0
Deferred income taxes	0	0
Policyholders’ liabilities	0	0
Balance, end of the period	(577)	1,526	428
Unrealized Investment Gains Losses All Other | DAC | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	(315)	(104)
Net unrealized gains (losses) arising during the year	0	0
Included in Net income (loss)	0	0
Excluded from Net earnings (loss)	0	0
DAC	354	(211)
Deferred income taxes	0	0
Policyholders’ liabilities	0	0
Balance, end of the period	39	(315)	(104)
Unrealized Investment Gains Losses All Other | Policyholders’ Liabilities | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	(232)	(188)
Net unrealized gains (losses) arising during the year	0	0
Included in Net income (loss)	0	0
Excluded from Net earnings (loss)	0	0
DAC	0	0
Deferred income taxes	0	0
Policyholders’ liabilities	177	(44)
Balance, end of the period	(55)	(232)	(188)
Unrealized Investment Gains Losses All Other | Deferred Income Tax Asset (Liability) | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	(300)	(47)
Net unrealized gains (losses) arising during the year	0	0
Included in Net income (loss)	0	0
Excluded from Net earnings (loss)	0	0
DAC	0	0
Deferred income taxes	425	(253)
Policyholders’ liabilities	0	0
Balance, end of the period	125	(300)	(47)
Unrealized Investment Gains Losses All Other | AOCI Gain (Loss) Related to Net Unrealized Investment Gains (Losses) | Fixed maturities
Debt Securities, Available-for-sale [Line Items]
Balance, beginning of the period	679	89
Net unrealized gains (losses) arising during the year	(2,098)	1,085
Included in Net income (loss)	(5)	13
Excluded from Net earnings (loss)	0	0
DAC	354	(211)
Deferred income taxes	425	(253)
Policyholders’ liabilities	177	(44)
Balance, end of the period	(468)	$ 679	$ 89
Accounting Standards Updated 2018-02
Debt Securities, Available-for-sale [Line Items]
Cumulative effect of adoption of ASU 2018-02, Reclassification of Certain Tax Effects	$ 86

INVESTMENTS - Available-for-s_2

INVESTMENTS - Available-for-sale Securities Fixed Maturities (Details) $ in Millions	Dec. 31, 2018USD ($)security	Dec. 31, 2017USD ($)security
Investments, Debt and Equity Securities [Abstract]
Number of positions in unrealized loss position | security	1,471	620
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	$ 11,832	$ 4,315
Less than 12 Months, Gross unrealized Losses	400	23
12 Months or Longer, Fair Value	9,460	4,255
12 Months or Longer, Gross unrealized Losses	795	224
Total Fair Value	21,292	8,570
Total Gross unrealized losses	$ 1,195	247
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Debt securities exposure in single issuer greater than stated percentage of total investments	0.80%
Amortized Cost	$ 42,492	34,988
Unrealized loss on available for sale securities	(30)	5
Trading securities, at fair value	15,166	12,277
Separate account equity investment carrying value	48	49
Corporate
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	8,369	2,102
Less than 12 Months, Gross unrealized Losses	306	17
12 Months or Longer, Fair Value	6,161	1,163
12 Months or Longer, Gross unrealized Losses	393	39
Total Fair Value	14,530	3,265
Total Gross unrealized losses	699	56
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Exposure in single issuer of total investments	210	182
Amortized Cost	26,690	20,596
U.S. Treasury, government and agency
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	2,636	2,150
Less than 12 Months, Gross unrealized Losses	68	6
12 Months or Longer, Fair Value	3,154	3,005
12 Months or Longer, Gross unrealized Losses	386	179
Total Fair Value	5,790	5,155
Total Gross unrealized losses	454	185
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	13,646	12,644
States and political subdivisions
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	0	20
Less than 12 Months, Gross unrealized Losses	0	0
12 Months or Longer, Fair Value	19	0
12 Months or Longer, Gross unrealized Losses	1	0
Total Fair Value	19	20
Total Gross unrealized losses	1	0
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	408	414
Foreign governments
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	109	11
Less than 12 Months, Gross unrealized Losses	3	0
12 Months or Longer, Fair Value	76	73
12 Months or Longer, Gross unrealized Losses	10	5
Total Fair Value	185	84
Total Gross unrealized losses	13	5
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	515	387
Residential mortgage-backed
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	0	18
Less than 12 Months, Gross unrealized Losses	0	0
12 Months or Longer, Fair Value	13	0
12 Months or Longer, Gross unrealized Losses	0	0
Total Fair Value	13	18
Total Gross unrealized losses	0	0
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	193	236
Asset-backed
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	558	7
Less than 12 Months, Gross unrealized Losses	11	0
12 Months or Longer, Fair Value	6	2
12 Months or Longer, Gross unrealized Losses	0	0
Total Fair Value	564	9
Total Gross unrealized losses	11	0
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	600	93
Redeemable preferred stock
Available For Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than Twelve Months, Fair Value	160	7
Less than 12 Months, Gross unrealized Losses	12	0
12 Months or Longer, Fair Value	31	12
12 Months or Longer, Gross unrealized Losses	5	1
Total Fair Value	191	19
Total Gross unrealized losses	17	1
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	440	461
Fixed maturities
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Amortized Cost	42,492	34,831
Unrealized loss on available for sale securities	(577)	1,527
Carrying value of fixed maturities non-income producing	1
Fixed maturities | Other Than Investment Grade | External Credit Rating, Non Investment Grade
Investments In Fixed Maturity Securities Other Disclosure [Abstract]
Available-for-sale securities, amortized cost basis other than investment grade	$ 1,228	$ 1,309
Percentage of available for sale securities	2.90%	3.80%

INVESTMENTS - Mortgage Loans (D

INVESTMENTS - Mortgage Loans (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Individually Evaluated for Impairment	$ 7	$ 8
Commercial Real Estate Portfolio Segment
Financing Receivable, Allowance for Credit Losses [Line Items]
Recorded Investment, Nonaccrual Status	19	19
Financing Receivable, Allowance for Credit Losses [Roll Forward]
Beginning balance	8	8	$ 6
Charge-offs	0	0	0
Recoveries	(1)	0	(2)
Provisions	0	0	4
Ending balance	7	8	8
Financing Receivable, Allowance for Credit Loss, Additional Information [Abstract]
Individually Evaluated for Impairment	$ 7	$ 8	$ 8

INVESTMENTS - Loans (Details)

INVESTMENTS - Loans (Details) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Agricultural Mortgages
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Financing Receivable, Allowance for Credit Losses	$ 0	$ 0	$ 0
Commercial Real Estate Portfolio Segment
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Financing Receivable, Allowance for Credit Losses	7,000,000	8,000,000	$ 8,000,000	$ 6,000,000
Face amount of mortgage loans	9,130,000,000	8,369,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	27,000,000	27,000,000
Current	9,103,000,000	8,342,000,000
Total Financing Receivables	9,130,000,000	8,369,000,000
Financing Receivable, Recorded Investment, 90 Days Past Due and Still Accruing	0	0
Commercial Real Estate Portfolio Segment | With no related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	0	0
Unpaid Principal Balance	0	0
Related Allowance	0	0
Average Recorded Investment	0	0
Interest Income Recognized	0	0
Commercial Real Estate Portfolio Segment | With related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	27,000,000	27,000,000
Unpaid Principal Balance	31,000,000	31,000,000
Related Allowance	(7,000,000)	(8,000,000)
Average Recorded Investment	27,000,000	27,000,000
Interest Income Recognized	0	2,000,000
Commercial Real Estate Portfolio Segment | 30-59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	0	27,000,000
Commercial Real Estate Portfolio Segment | 60-89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	0	0
Commercial Real Estate Portfolio Segment | 90 Days Or Greater
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	27,000,000	0
Commercial Real Estate Portfolio Segment | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	5,948,000,000	4,999,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	5,948,000,000	4,999,000,000
Commercial Real Estate Portfolio Segment | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	677,000,000	792,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	677,000,000	792,000,000
Commercial Real Estate Portfolio Segment | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,510,000,000	1,609,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,510,000,000	1,609,000,000
Commercial Real Estate Portfolio Segment | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	746,000,000	774,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	746,000,000	774,000,000
Commercial Real Estate Portfolio Segment | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	249,000,000	195,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	249,000,000	195,000,000
Commercial Real Estate Portfolio Segment | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Commercial Real Estate Portfolio Segment | 0% - 50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,072,000,000	1,136,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,072,000,000	1,136,000,000
Commercial Real Estate Portfolio Segment | 0% - 50% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	780,000,000	742,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	780,000,000	742,000,000
Commercial Real Estate Portfolio Segment | 0% - 50% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	21,000,000	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	21,000,000	0
Commercial Real Estate Portfolio Segment | 0% - 50% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	247,000,000	320,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	247,000,000	320,000,000
Commercial Real Estate Portfolio Segment | 0% - 50% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	24,000,000	74,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	24,000,000	74,000,000
Commercial Real Estate Portfolio Segment | 0% - 50% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Commercial Real Estate Portfolio Segment | 0% - 50% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Commercial Real Estate Portfolio Segment | 50% - 70%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	7,186,000,000	6,409,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	7,186,000,000	6,409,000,000
Commercial Real Estate Portfolio Segment | 50% - 70% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	4,908,000,000	4,088,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	4,908,000,000	4,088,000,000
Commercial Real Estate Portfolio Segment | 50% - 70% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	656,000,000	682,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	656,000,000	682,000,000
Commercial Real Estate Portfolio Segment | 50% - 70% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,146,000,000	1,066,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,146,000,000	1,066,000,000
Commercial Real Estate Portfolio Segment | 50% - 70% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	325,000,000	428,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	325,000,000	428,000,000
Commercial Real Estate Portfolio Segment | 50% - 70% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	151,000,000	145,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	151,000,000	145,000,000
Commercial Real Estate Portfolio Segment | 50% - 70% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Commercial Real Estate Portfolio Segment | 70% - 90%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	845,000,000	797,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	845,000,000	797,000,000
Commercial Real Estate Portfolio Segment | 70% - 90% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	260,000,000	169,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	260,000,000	169,000,000
Commercial Real Estate Portfolio Segment | 70% - 90% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	110,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	110,000,000
Commercial Real Estate Portfolio Segment | 70% - 90% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	117,000,000	196,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	117,000,000	196,000,000
Commercial Real Estate Portfolio Segment | 70% - 90% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	370,000,000	272,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	370,000,000	272,000,000
Commercial Real Estate Portfolio Segment | 70% - 90% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	98,000,000	50,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	98,000,000	50,000,000
Commercial Real Estate Portfolio Segment | 70% - 90% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Commercial Real Estate Portfolio Segment | 90% plus
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	27,000,000	27,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	27,000,000	27,000,000
Commercial Real Estate Portfolio Segment | 90% plus | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Commercial Real Estate Portfolio Segment | 90% plus | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Commercial Real Estate Portfolio Segment | 90% plus | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	27,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	27,000,000
Commercial Real Estate Portfolio Segment | 90% plus | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	27,000,000	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	27,000,000	0
Commercial Real Estate Portfolio Segment | 90% plus | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Commercial Real Estate Portfolio Segment | 90% plus | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Agricultural Real Estate Portfolio Segment
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	2,695,000,000	2,574,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	68,000,000	74,000,000
Current	2,627,000,000	2,500,000,000
Total Financing Receivables	2,695,000,000	2,574,000,000
Financing Receivable, Recorded Investment, 90 Days Past Due and Still Accruing	40,000,000	22,000,000
Agricultural Real Estate Portfolio Segment | With no related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	2,000,000	0
Unpaid Principal Balance	2,000,000	0
Related Allowance	0	0
Average Recorded Investment	0	0
Interest Income Recognized	0	0
Agricultural Real Estate Portfolio Segment | With related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	0	0
Unpaid Principal Balance	0	0
Related Allowance	0	0
Average Recorded Investment	0	0
Interest Income Recognized	0	0
Agricultural Real Estate Portfolio Segment | 30-59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	18,000,000	49,000,000
Agricultural Real Estate Portfolio Segment | 60-89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	8,000,000	3,000,000
Agricultural Real Estate Portfolio Segment | 90 Days Or Greater
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	42,000,000	22,000,000
Agricultural Real Estate Portfolio Segment | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	394,000,000	383,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	394,000,000	383,000,000
Agricultural Real Estate Portfolio Segment | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	193,000,000	195,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	193,000,000	195,000,000
Agricultural Real Estate Portfolio Segment | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	513,000,000	502,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	513,000,000	502,000,000
Agricultural Real Estate Portfolio Segment | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	941,000,000	878,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	941,000,000	878,000,000
Agricultural Real Estate Portfolio Segment | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	572,000,000	537,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	572,000,000	537,000,000
Agricultural Real Estate Portfolio Segment | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	82,000,000	79,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	82,000,000	79,000,000
Agricultural Real Estate Portfolio Segment | 0% - 50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,611,000,000	1,557,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,611,000,000	1,557,000,000
Agricultural Real Estate Portfolio Segment | 0% - 50% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	282,000,000	272,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	282,000,000	272,000,000
Agricultural Real Estate Portfolio Segment | 0% - 50% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	147,000,000	149,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	147,000,000	149,000,000
Agricultural Real Estate Portfolio Segment | 0% - 50% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	267,000,000	275,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	267,000,000	275,000,000
Agricultural Real Estate Portfolio Segment | 0% - 50% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	543,000,000	515,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	543,000,000	515,000,000
Agricultural Real Estate Portfolio Segment | 0% - 50% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	321,000,000	316,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	321,000,000	316,000,000
Agricultural Real Estate Portfolio Segment | 0% - 50% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	51,000,000	30,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	51,000,000	30,000,000
Agricultural Real Estate Portfolio Segment | 50% - 70%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,038,000,000	1,013,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,038,000,000	1,013,000,000
Agricultural Real Estate Portfolio Segment | 50% - 70% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	112,000,000	111,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	112,000,000	111,000,000
Agricultural Real Estate Portfolio Segment | 50% - 70% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	46,000,000	46,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	46,000,000	46,000,000
Agricultural Real Estate Portfolio Segment | 50% - 70% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	246,000,000	227,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	246,000,000	227,000,000
Agricultural Real Estate Portfolio Segment | 50% - 70% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	379,000,000	359,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	379,000,000	359,000,000
Agricultural Real Estate Portfolio Segment | 50% - 70% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	224,000,000	221,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	224,000,000	221,000,000
Agricultural Real Estate Portfolio Segment | 50% - 70% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	31,000,000	49,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	31,000,000	49,000,000
Agricultural Real Estate Portfolio Segment | 70% - 90%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	46,000,000	4,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	46,000,000	4,000,000
Agricultural Real Estate Portfolio Segment | 70% - 90% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Agricultural Real Estate Portfolio Segment | 70% - 90% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Agricultural Real Estate Portfolio Segment | 70% - 90% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Agricultural Real Estate Portfolio Segment | 70% - 90% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	19,000,000	4,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	19,000,000	4,000,000
Agricultural Real Estate Portfolio Segment | 70% - 90% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	27,000,000	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	27,000,000	0
Agricultural Real Estate Portfolio Segment | 70% - 90% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Agricultural Real Estate Portfolio Segment | 90% plus | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Mortgages Loan
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	11,825,000,000	10,943,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	95,000,000	101,000,000
Current	11,730,000,000	10,842,000,000
Total Financing Receivables	11,825,000,000	10,943,000,000
Financing Receivable, Recorded Investment, 90 Days Past Due and Still Accruing	40,000,000	22,000,000
Total Mortgages Loan | With no related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	2,000,000	0
Unpaid Principal Balance	2,000,000	0
Related Allowance	0	0
Average Recorded Investment	0	0
Interest Income Recognized	0	0
Total Mortgages Loan | With related allowance recorded
Impaired Mortgage Loans [Abstract]
Recorded Investment	27,000,000	27,000,000
Unpaid Principal Balance	31,000,000	31,000,000
Related Allowance	(7,000,000)	(8,000,000)
Average Recorded Investment	27,000,000	27,000,000
Interest Income Recognized	0	2,000,000
Total Mortgages Loan | 30-59 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	18,000,000	76,000,000
Total Mortgages Loan | 60-89 Days
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	8,000,000	3,000,000
Total Mortgages Loan | 90 Days Or Greater
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Past Due	69,000,000	22,000,000
Total Mortgages Loan | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	6,342,000,000	5,382,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	6,342,000,000	5,382,000,000
Total Mortgages Loan | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	870,000,000	987,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	870,000,000	987,000,000
Total Mortgages Loan | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	2,023,000,000	2,111,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	2,023,000,000	2,111,000,000
Total Mortgages Loan | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,687,000,000	1,652,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,687,000,000	1,652,000,000
Total Mortgages Loan | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	821,000,000	732,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	821,000,000	732,000,000
Total Mortgages Loan | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	82,000,000	79,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	82,000,000	79,000,000
Total Mortgages Loan | 0% - 50%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	2,683,000,000	2,693,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	2,683,000,000	2,693,000,000
Total Mortgages Loan | 0% - 50% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,062,000,000	1,014,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,062,000,000	1,014,000,000
Total Mortgages Loan | 0% - 50% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	168,000,000	149,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	168,000,000	149,000,000
Total Mortgages Loan | 0% - 50% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	514,000,000	595,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	514,000,000	595,000,000
Total Mortgages Loan | 0% - 50% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	567,000,000	589,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	567,000,000	589,000,000
Total Mortgages Loan | 0% - 50% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	321,000,000	316,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	321,000,000	316,000,000
Total Mortgages Loan | 0% - 50% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	51,000,000	30,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	51,000,000	30,000,000
Total Mortgages Loan | 50% - 70%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	8,224,000,000	7,422,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	8,224,000,000	7,422,000,000
Total Mortgages Loan | 50% - 70% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	5,020,000,000	4,199,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	5,020,000,000	4,199,000,000
Total Mortgages Loan | 50% - 70% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	702,000,000	728,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	702,000,000	728,000,000
Total Mortgages Loan | 50% - 70% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	1,392,000,000	1,293,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	1,392,000,000	1,293,000,000
Total Mortgages Loan | 50% - 70% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	704,000,000	787,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	704,000,000	787,000,000
Total Mortgages Loan | 50% - 70% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	375,000,000	366,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	375,000,000	366,000,000
Total Mortgages Loan | 50% - 70% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	31,000,000	49,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	31,000,000	49,000,000
Total Mortgages Loan | 70% - 90%
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	891,000,000	801,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	891,000,000	801,000,000
Total Mortgages Loan | 70% - 90% | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	260,000,000	169,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	260,000,000	169,000,000
Total Mortgages Loan | 70% - 90% | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	110,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	110,000,000
Total Mortgages Loan | 70% - 90% | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	117,000,000	196,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	117,000,000	196,000,000
Total Mortgages Loan | 70% - 90% | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	389,000,000	276,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	389,000,000	276,000,000
Total Mortgages Loan | 70% - 90% | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	125,000,000	50,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	125,000,000	50,000,000
Total Mortgages Loan | 70% - 90% | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Mortgages Loan | 90% plus
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	27,000,000	27,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	27,000,000	27,000,000
Total Mortgages Loan | 90% plus | Greater than 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Mortgages Loan | 90% plus | 1.8x to 2.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Mortgages Loan | 90% plus | 1.5x to 1.8x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	27,000,000
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	27,000,000
Total Mortgages Loan | 90% plus | 1.2x to 1.5x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	27,000,000	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	27,000,000	0
Total Mortgages Loan | 90% plus | 1.0x to 1.2x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	0	0
Total Mortgages Loan | 90% plus | Less than 1.0x
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]
Face amount of mortgage loans	0	0
Financing Receivable, Recorded Investment, Aging [Abstract]
Total Financing Receivables	$ 0	$ 0

INVESTMENTS - Derivatives (Deta

INVESTMENTS - Derivatives (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Derivatives, Fair Value [Line Items]
Notional Amount	$ 81,636	$ 61,541
Net investment income (loss) from derivatives	4	(125)	$ 18
Asset Derivatives	4,936	14,210
Liability Derivatives	9,226	9,554
Gains (Losses) Reported In Income (Loss)	(1,010)	894
Futures
Derivatives, Fair Value [Line Items]
Notional Amount	10,411	2,950
Asset Derivatives	0	0
Liability Derivatives	0	0
Gains (Losses) Reported In Income (Loss)	550	(655)
Swaps
Derivatives, Fair Value [Line Items]
Notional Amount	7,697	4,587
Asset Derivatives	140	3
Liability Derivatives	168	125
Gains (Losses) Reported In Income (Loss)	675	(842)
Options
Derivatives, Fair Value [Line Items]
Notional Amount	21,698	20,630
Asset Derivatives	2,119	3,334
Liability Derivatives	1,163	1,426
Gains (Losses) Reported In Income (Loss)	(899)	1,203
Swaps
Derivatives, Fair Value [Line Items]
Notional Amount	27,003	18,988
Asset Derivatives	632	319
Liability Derivatives	194	190
Gains (Losses) Reported In Income (Loss)	(456)	655
Futures
Derivatives, Fair Value [Line Items]
Notional Amount	11,448	11,032
Asset Derivatives	0	0
Liability Derivatives	0	0
Gains (Losses) Reported In Income (Loss)	118	125
Credit default swaps
Derivatives, Fair Value [Line Items]
Notional Amount	1,282	2,057
Asset Derivatives	17	34
Liability Derivatives	0	2
Gains (Losses) Reported In Income (Loss)	(3)	21
Foreign currency contracts
Derivatives, Fair Value [Line Items]
Notional Amount	2,097	1,297
Asset Derivatives	27	11
Liability Derivatives	14	2
Gains (Losses) Reported In Income (Loss)	6	(38)
Margin
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Asset Derivatives	7	18
Liability Derivatives	5	0
Gains (Losses) Reported In Income (Loss)	0	0
Collateral
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Asset Derivatives	3	3
Liability Derivatives	1,564	1,855
Gains (Losses) Reported In Income (Loss)	0	0
GMIB reinsurance contracts
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Asset Derivatives	1,991	10,488
Liability Derivatives	0	0
Gains (Losses) Reported In Income (Loss)	(1,068)	69
GMxB derivative features’ liability
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Asset Derivatives	0	0
Liability Derivatives	5,431	4,256
Gains (Losses) Reported In Income (Loss)	(786)	1,592
SCS, SIO, MSO and IUL indexed features’ liability
Derivatives, Fair Value [Line Items]
Notional Amount	0	0
Asset Derivatives	0	0
Liability Derivatives	687	1,698
Gains (Losses) Reported In Income (Loss)	$ 853	$ (1,236)

INVESTMENTS - Derivatives 1 (De

INVESTMENTS - Derivatives 1 (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Exchange Traded Future Contract [Line Items]
Collateralized derivative transactions	$ 3	$ 3
S&P 500, Russell 1000, NASDAQ 100 and Emerging Market Indices
Exchange Traded Future Contract [Line Items]
Initial margin requirement	245
Us Treasury Notes Ultra Long Bonds And Euro Dollar
Exchange Traded Future Contract [Line Items]
Initial margin requirement	70
Euro Stoxx, FTSE100, EAFE And Topix Indices
Exchange Traded Future Contract [Line Items]
Initial margin requirement	$ 25

INVESTMENTS - Offsetting (Detai

INVESTMENTS - Offsetting (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Offsetting Assets [Line Items]
Interest Expense, Securities Sold under Agreements to Repurchase	$ 2	$ 5
Securities sold under agreements to repurchase	573	1,887
LIABILITIES
Gross Amount Recognized	3,109	3,614
Gross Amount Offset in the Balance Sheets	2,912	3,614
Net Amount Presented in the Balance Sheets	197	0
Expense in securities sold under agreement to repurchase	3	3	$ 4
Derivatives Subject to an ISDA Master Agreements
ASSETS
Gross Amount Recognized	2,946	3,740
Gross Amount Offset in the Balance Sheets	2,912	3,614
Net Amount Presented in the Balance Sheets	34	126
Other financial instruments
ASSETS
Gross Amount Recognized	1,520	1,704
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	1,520	1,704
Other invested assets
ASSETS
Gross Amount Recognized	4,466	5,444
Gross Amount Offset in the Balance Sheets	2,912	3,614
Net Amount Presented in the Balance Sheets	1,554	1,830
Other financial liabilities
LIABILITIES
Gross Amount Recognized	1,263	1,242
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	1,263	1,242
Other liabilities
LIABILITIES
Gross Amount Recognized	4,372	4,856
Gross Amount Offset in the Balance Sheets	2,912	3,614
Net Amount Presented in the Balance Sheets	1,460	1,242
Securities sold under agreement to repurchase
Offsetting Assets [Line Items]
Securities sold under agreements to repurchase	571	1,882
LIABILITIES
Gross Amount Recognized	571	1,882
Gross Amount Offset in the Balance Sheets	0	0
Net Amount Presented in the Balance Sheets	$ 571	$ 1,882

INVESTMENTS - Offsetting 1 (Det

INVESTMENTS - Offsetting 1 (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Offsetting Assets [Line Items]
Interest Expense, Securities Sold under Agreements to Repurchase	$ 2	$ 5
Securities sold under agreements to repurchase	573	1,887
Gross Amount Recognized	3,109	3,614
Gross Amount Offset in the Balance Sheets	2,912	3,614
Net Amounts Of Liabilities Presented In Statement Of Financial Position	197	0
Expense in securities sold under agreement to repurchase	3	3	$ 4
Derivative investments
Offsetting Assets [Line Items]
Net Amount Presented in the Balance Sheets	1,397	1,954
Collateral (Received)/Held, Financial Instruments	0	0
Collateral (Received)/Held, Cash	(1,363)	(1,828)
Net Amount	34	126
Other financial instruments
Offsetting Assets [Line Items]
Net Amount Presented in the Balance Sheets	1,520	1,704
Collateral (Received)/Held, Financial Instruments	0	0
Collateral (Received)/Held, Cash	0	0
Net Amount	1,520	1,704
Other investment income
Offsetting Assets [Line Items]
Net Amount Presented in the Balance Sheets	2,917	3,658
Collateral (Received)/Held, Financial Instruments	0	0
Collateral (Received)/Held, Cash	(1,363)	(1,828)
Net Amount	1,554	1,830
Other financial liabilities
Offsetting Assets [Line Items]
Securities Purchased under Agreements to Resell	1,263	1,242
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Securities	0	0
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Cash	0	0
Securities Purchased under Agreements to Resell, Amount Offset Against Collateral	1,263	1,242
Gross Amount Recognized	1,263	1,242
Gross Amount Offset in the Balance Sheets	0	0
Net Amounts Of Liabilities Presented In Statement Of Financial Position	1,263	1,242
Derivative investments
Offsetting Assets [Line Items]
Securities Purchased under Agreements to Resell	197
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Securities	0
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Cash	0
Securities Purchased under Agreements to Resell, Amount Offset Against Collateral	197
Securities sold under agreement to repurchase
Offsetting Assets [Line Items]
Securities sold under agreements to repurchase	571	1,882
Securities Sold under Agreements to Repurchase, Collateral, Right to Reclaim Securities	(588)	(1,988)
Securities Sold under Agreements to Repurchase, Collateral, Right to Reclaim Cash	0	(21)
Gross Amount Recognized	571	1,882
Gross Amount Offset in the Balance Sheets	0	0
Net Amounts Of Liabilities Presented In Statement Of Financial Position	571	1,882
Net amounts	(17)	(127)
Other liabilities
Offsetting Assets [Line Items]
Gross Amount Recognized	4,372	4,856
Gross Amount Offset in the Balance Sheets	2,912	3,614
Net Amounts Of Liabilities Presented In Statement Of Financial Position	1,460	1,242
Securities sold under agreement to repurchase
Offsetting Assets [Line Items]
Securities Purchased under Agreements to Resell	1,460	1,242
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Securities	0	0
Securities Purchased under Agreements to Resell, Collateral, Obligation to Return Cash	0	0
Securities Purchased under Agreements to Resell, Amount Offset Against Collateral	$ 1,460	$ 1,242

INVESTMENTS - Repurchase to Mat

INVESTMENTS - Repurchase to Maturity Transactions (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Derivative [Line Items]
Securities sold under agreement to repurchase	$ 571	$ 1,882
U.S. Treasury, government and agency
Derivative [Line Items]
Securities sold under agreement to repurchase	571	1,882
Maturity Overnight and Continuous
Derivative [Line Items]
Securities sold under agreement to repurchase	0	0
Maturity Overnight and Continuous | U.S. Treasury, government and agency
Derivative [Line Items]
Securities sold under agreement to repurchase	0	0
Maturity Up To 30 Days
Derivative [Line Items]
Securities sold under agreement to repurchase	571	1,882
Maturity Up To 30 Days | U.S. Treasury, government and agency
Derivative [Line Items]
Securities sold under agreement to repurchase	571	1,882
Maturity 30 to 90 Days
Derivative [Line Items]
Securities sold under agreement to repurchase	0	0
Maturity 30 to 90 Days | U.S. Treasury, government and agency
Derivative [Line Items]
Securities sold under agreement to repurchase	0	0
Maturity Greater than 90 Days
Derivative [Line Items]
Securities sold under agreement to repurchase	0	0
Maturity Greater than 90 Days | U.S. Treasury, government and agency
Derivative [Line Items]
Securities sold under agreement to repurchase	$ 0	$ 0

INVESTMENTS - Net Investment In

INVESTMENTS - Net Investment Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Net Investment Income [Line Items]
Investment income	$ 2,549	$ 2,506	$ 2,225
Investment expenses	(71)	(65)	(57)
Net investment income (loss)	2,478	2,441	2,168
Net investment income (loss) from derivatives	4	(125)	18
Schedule Of Gain Loss On Investments Including Marketable Securities And Investments Held At Cost Income Statement Reported Amounts Summary [Abstract]
Expense in securities sold under agreement to repurchase	3	3	4
Fixed maturities
Net Investment Income [Line Items]
Investment income	1,540	1,365	1,418
Net investment income (loss) from derivatives	6	(130)	(3)
Mortgage loans on real estate
Net Investment Income [Line Items]
Investment income	494	453	461
Net investment income (loss) from derivatives	0	2	(2)
Real estate held for the production of income
Net Investment Income [Line Items]
Investment income	(6)	2	0
Repurchase agreement
Net Investment Income [Line Items]
Investment income	0	0	1
Other equity investments
Net Investment Income [Line Items]
Investment income	123	169	55
Net investment income (loss) from derivatives	0	3	0
Policy loans
Net Investment Income [Line Items]
Investment income	201	205	210
Trading securities
Net Investment Income [Line Items]
Investment income	128	258	64
Other investment income
Net Investment Income [Line Items]
Investment income	69	54	16
Net investment income (loss) from derivatives	$ (2)	$ 0	$ 23

INVESTMENTS - Trading Securitie

INVESTMENTS - Trading Securities (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Investments, Debt and Equity Securities [Abstract]
Net investment gains (losses) recognized during the period on securities held at the end of the period	$ (174)	$ 63	$ (45)
Net investment gains (losses) recognized on securities sold during the period	(24)	(19)	(11)
Unrealized and realized gains (losses) on trading securities	(198)	44	(56)
Interest and dividend income from trading securities	326	214	120
Net investment income (loss) from trading securities	$ 128	$ 258	$ 64

INVESTMENTS - Narrative (Detail

INVESTMENTS - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Investment [Line Items]
Proceeds from sale	$ 3,905
Liability Derivatives	9,226	$ 9,554
Collateralized derivative transactions	3	3
Securities sold under agreements to repurchase	573	1,887
Expense in securities sold under agreement to repurchase	3	3	$ 4
US Treasury Securities
Investment [Line Items]
Investment securities	3,690
Total Return Swap
Investment [Line Items]
Investment securities	24
Collateral
Investment [Line Items]
Liability Derivatives	1,564	$ 1,855
S&P 500, Russell 1000, NASDAQ 100 and Emerging Market Indices
Investment [Line Items]
Initial margin requirement	245
Us Treasury Notes Ultra Long Bonds And Euro Dollar
Investment [Line Items]
Initial margin requirement	70
Euro Stoxx, FTSE100, EAFE And Topix Indices
Investment [Line Items]
Initial margin requirement	$ 25

INTANGIBLE ASSETS (Details)

INTANGIBLE ASSETS (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Capitalized software, net	$ 115	$ 96
Amortization of capitalized software	35	$ 37	$ 42
2019	43
2020	47
2021	47
2022	47
2023	$ 47

CLOSED BLOCK (Details)

CLOSED BLOCK (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2018	Dec. 31, 2017
Closed Block Liabilities:
Future policy benefits, policyholders’ account balances and other				$ 6,709	$ 6,958
Policyholder’ dividend obligation	$ 19	$ 52	$ 52	0	19
Other liabilities				47	271
Total Closed Block liabilities				6,756	7,248
Assets Designated To The Closed Block:
Fixed maturities, available for sale, at fair value (amortized cost of $ 3,680 and $3,923)				3,672	4,070
Mortgage loans on real estate, net of valuation allowance of $- and $-				1,824	1,720
Policy loans				736	781
Cash and other invested assets				76	351
Other assets				179	182
Total assets designated to the Closed Block				6,487	7,104
Excess of Closed Block liabilities over assets designated to the Closed Block				269	144
Amounts included in Accumulated other comprehensive income (loss):
Net unrealized investment gains (losses), net of policyholders’ dividend obligation of $- and $19				8	138
Maximum future income to be recognized from closed block assets and liabilities				277	282
Closed block investments fixed maturity available for sale amortized cost				$ 3,680	$ 3,923
Revenues:
Premiums and other income	194	224	212
Net investment income (loss)	291	314	349
Investment gains (losses), net	(3)	(20)	(1)
Total revenues	482	518	560
Benefits and Other Deductions:
Policyholders’ benefits and dividends	471	537	522
Other operating costs and expenses	3	2	4
Total benefits and other deductions	474	539	526
Net income, before income taxes	8	(21)	34
Income tax (expense) benefit	(3)	(36)	(12)
Net income (losses)	5	(57)	22
Movement in Closed Block Dividend Obligation [Roll Forward]
Balances, beginning of year	19	52
Unrealized investment gains (losses)	(19)	(33)
Balances, End of year	$ 0	$ 19	$ 52

DAC AND POLICYHOLDER BONUS IN_3

DAC AND POLICYHOLDER BONUS INTEREST CREDITS - Rollforward of DAC Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Balance, beginning of year	$ 4,492	$ 5,025	$ 5,079
Capitalization of commissions, sales and issue expenses	597	578	594
Amortization:
Impact of assumptions updates and model changes	165	(247)	(193)
All other	(596)	(653)	(449)
Amortization	(431)	(900)	(642)
Change in unrealized investment gains (losses)	353	(211)	(6)
Balance, End of Year	$ 5,011	$ 4,492	$ 5,025

DAC AND POLICYHOLDER BONUS IN_4

DAC AND POLICYHOLDER BONUS INTEREST CREDITS - Rollforward of DAC Credits (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Changes in the deferred asset for contractholder bonus interest credits
Balance, beginning of year	$ 473	$ 504	$ 534
Policyholder bonus interest credits deferred	4	6	13
Amortization charged to income	(51)	(37)	(43)
Balance, End of Year	$ 426	$ 473	$ 504

FAIR VALUE DISCLOSURES - SCHEDU

FAIR VALUE DISCLOSURES - SCHEDULES OF ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	$ 41,915	$ 36,515
Trading securities, at fair value	15,166	12,277
Fair Value, Measurements, Recurring
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	41,915	36,358
Other equity investments	12	13
Trading securities, at fair value	15,166	12,277
Other invested assets	1,827	2,743
Cash equivalents	2,160	1,908
Segregated securities		9
GMIB reinsurance contracts asset	1,991	10,488
Separate Accounts assets	108,266	122,315
Total Assets	171,337	186,111
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	6,118	5,954
Fair Value, Measurements, Recurring | Corporate (1)
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	26,376	21,482
Fair Value, Measurements, Recurring | U.S. Treasury, government and agency
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	13,335	13,135
Fair Value, Measurements, Recurring | States and political subdivisions
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	454	481
Fair Value, Measurements, Recurring | Foreign governments
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	519	409
Fair Value, Measurements, Recurring | Residential Mortgage- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	202	251
Fair Value, Measurements, Recurring | Asset- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	590	96
Fair Value, Measurements, Recurring | Redeemable preferred stock
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	439	504
Fair Value, Measurements, Recurring | Short-term investments
Investment Fair Value Disclosure [Abstract]
Other invested assets	412	763
Fair Value, Measurements, Recurring | Assets of consolidated VIEs/VOEs
Investment Fair Value Disclosure [Abstract]
Other invested assets	19	25
Fair Value, Measurements, Recurring | Swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	423	15
Fair Value, Measurements, Recurring | Credit default swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	17	33
Fair Value, Measurements, Recurring | Options
Investment Fair Value Disclosure [Abstract]
Other invested assets	956	1,907
Fair Value, Measurements, Recurring | GMxB derivative features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	5,431	4,256
Fair Value, Measurements, Recurring | SCS, SIO, MSO and IUL indexed features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	687	1,698
Fair Value, Measurements, Recurring | Level 1
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	163	180
Other equity investments	12	13
Trading securities, at fair value	218	180
Other invested assets	0	0
Cash equivalents	2,160	1,908
Segregated securities		0
GMIB reinsurance contracts asset	0	0
Separate Accounts assets	105,159	118,983
Total Assets	107,712	121,264
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	0	0
Fair Value, Measurements, Recurring | Level 1 | Corporate (1)
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0	0
Fair Value, Measurements, Recurring | Level 1 | U.S. Treasury, government and agency
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0	0
Fair Value, Measurements, Recurring | Level 1 | States and political subdivisions
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0	0
Fair Value, Measurements, Recurring | Level 1 | Foreign governments
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0	0
Fair Value, Measurements, Recurring | Level 1 | Residential Mortgage- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0	0
Fair Value, Measurements, Recurring | Level 1 | Asset- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0	0
Fair Value, Measurements, Recurring | Level 1 | Redeemable preferred stock
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	163	180
Fair Value, Measurements, Recurring | Level 1 | Short-term investments
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 1 | Assets of consolidated VIEs/VOEs
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 1 | Swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 1 | Credit default swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 1 | Options
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 1 | GMxB derivative features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	0	0
Fair Value, Measurements, Recurring | Level 1 | SCS, SIO, MSO and IUL indexed features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	0	0
Fair Value, Measurements, Recurring | Level 2
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	40,021	34,991
Other equity investments	0	0
Trading securities, at fair value	14,919	12,097
Other invested assets	1,808	2,718
Cash equivalents	0	0
Segregated securities		9
GMIB reinsurance contracts asset	0	0
Separate Accounts assets	2,733	2,983
Total Assets	59,481	52,798
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	687	1,698
Fair Value, Measurements, Recurring | Level 2 | Corporate (1)
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	25,202	20,343
Fair Value, Measurements, Recurring | Level 2 | U.S. Treasury, government and agency
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	13,335	13,135
Fair Value, Measurements, Recurring | Level 2 | States and political subdivisions
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	416	441
Fair Value, Measurements, Recurring | Level 2 | Foreign governments
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	519	409
Fair Value, Measurements, Recurring | Level 2 | Residential Mortgage- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	202	251
Fair Value, Measurements, Recurring | Level 2 | Asset- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	71	88
Fair Value, Measurements, Recurring | Level 2 | Redeemable preferred stock
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	276	324
Fair Value, Measurements, Recurring | Level 2 | Short-term investments
Investment Fair Value Disclosure [Abstract]
Other invested assets	412	763
Fair Value, Measurements, Recurring | Level 2 | Assets of consolidated VIEs/VOEs
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 2 | Swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	423	15
Fair Value, Measurements, Recurring | Level 2 | Credit default swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	17	33
Fair Value, Measurements, Recurring | Level 2 | Options
Investment Fair Value Disclosure [Abstract]
Other invested assets	956	1,907
Fair Value, Measurements, Recurring | Level 2 | GMxB derivative features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	0	0
Fair Value, Measurements, Recurring | Level 2 | SCS, SIO, MSO and IUL indexed features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	687	1,698
Fair Value, Measurements, Recurring | Level 3
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	1,731	1,187
Other equity investments	0	0
Trading securities, at fair value	29	0
Other invested assets	19	25
Cash equivalents	0	0
Segregated securities		0
GMIB reinsurance contracts asset	1,991	10,488
Separate Accounts assets	374	349
Total Assets	4,144	12,049
Liabilities, Fair Value Disclosure [Abstract]
Total Liabilities	5,431	4,256
Fair Value, Measurements, Recurring | Level 3 | Corporate (1)
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	1,174	1,139
Fair Value, Measurements, Recurring | Level 3 | U.S. Treasury, government and agency
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0	0
Fair Value, Measurements, Recurring | Level 3 | States and political subdivisions
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	38	40
Fair Value, Measurements, Recurring | Level 3 | Foreign governments
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0	0
Fair Value, Measurements, Recurring | Level 3 | Residential Mortgage- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0	0
Fair Value, Measurements, Recurring | Level 3 | Asset- backed
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	519	8
Fair Value, Measurements, Recurring | Level 3 | Redeemable preferred stock
Investment Fair Value Disclosure [Abstract]
Fixed maturities, available-for-sale	0	0
Fair Value, Measurements, Recurring | Level 3 | Short-term investments
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 3 | Assets of consolidated VIEs/VOEs
Investment Fair Value Disclosure [Abstract]
Other invested assets	19	25
Fair Value, Measurements, Recurring | Level 3 | Swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 3 | Credit default swaps
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 3 | Options
Investment Fair Value Disclosure [Abstract]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 3 | GMxB derivative features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	5,431	4,256
Fair Value, Measurements, Recurring | Level 3 | SCS, SIO, MSO and IUL indexed features’ liability
Liabilities, Fair Value Disclosure [Abstract]
Liabilities	$ 0	$ 0

FAIR VALUE DISCLOSURES - ASSETS

FAIR VALUE DISCLOSURES - ASSETS AND LIABILITIES MEASURED ON RECURRING BASIS (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Fixed maturities, available-for-sale	$ 41,915	$ 36,515
Fair value adjustments on GMIB asset	184	69
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net [Abstract]
AFS fixed maturities transferred from Level 3 to Level 2	28	6
AFS fixed maturities transferred from Level 3 to Level 2	$ 83	$ 7
AFS fixed maturities transferred between Level 2 and 3 (percentage)	0.90%	0.10%
Fair Value, Measurements, Recurring
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Fixed maturities, available-for-sale	$ 41,915	$ 36,358
Other invested assets	1,827	2,743
Fair Value, Measurements, Recurring | Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Fixed maturities, available-for-sale	163	180
Other invested assets	0	0
Fair Value, Measurements, Recurring | Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Fixed maturities, available-for-sale	40,021	34,991
Other invested assets	1,808	2,718
Fair Value, Measurements, Recurring | Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Fixed maturities, available-for-sale	1,731	1,187
Other invested assets	19	25
Fair Value, Measurements, Recurring | Assets of consolidated VIEs/VOEs
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Other invested assets	19	25
Fair Value, Measurements, Recurring | Assets of consolidated VIEs/VOEs | Level 1
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Assets of consolidated VIEs/VOEs | Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Other invested assets	0	0
Fair Value, Measurements, Recurring | Assets of consolidated VIEs/VOEs | Level 3
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Quantitative Disclosure [Line Items]
Other invested assets	$ 19	$ 25

FAIR VALUE DISCLOSURES - FAIR V

FAIR VALUE DISCLOSURES - FAIR VALUE MEASUREMENT RECONCILIATION FOR ALL LEVELS (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment gains (losses), net	$ 3	$ (125)	$ 16
Transfers into level 3	83	7
Transfers out of Level 3	(28)	(6)
Level 3 | States and political subdivisions
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	40	42	45
Net investment income (loss)	0	0
Investment gains (losses), net	0	0	0
Subtotal	0	0	0
Other comprehensive income (loss)	(1)	(1)	(2)
Purchases	0	0	0
Sales	(1)	(1)	(1)
Transfers into level 3	0	0	0
Transfers out of Level 3	0	0	0
Closing Balance	38	40	42
Level 3 | Asset- backed
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	8	24	40
Net investment income (loss)	(2)	0
Investment gains (losses), net	0	15	0
Subtotal	(2)	15	0
Other comprehensive income (loss)	(7)	(9)	1
Purchases	550	0	0
Sales	(30)	(21)	(8)
Transfers into level 3	0	0	0
Transfers out of Level 3	0	(1)	(9)
Closing Balance	519	8	24
Level 3 | Corporate
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	1,139	845	420
Net investment income (loss)	7	5
Investment gains (losses), net	(8)	2	1
Subtotal	(1)	7	1
Other comprehensive income (loss)	(20)	4	7
Purchases	322	612	572
Sales	(321)	(331)	(142)
Transfers into level 3	83	7	25
Transfers out of Level 3	(28)	(5)	(38)
Closing Balance	1,174	1,139	845
Level 3 | Redeemable preferred stock
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	0	1	0
Investment gains (losses), net	0	0	0
Net derivative gains (losses), excluding non-performance risk	0	0	0
Nonperformance risk	0	0	0
Subtotal	0	0	0
Other comprehensive income (loss)		(1)	0
Purchases	0	0	1
Sales	0	0	0
Settlements	0	0	0
Activity related to consolidated VIEs/VOEs	0	0	0
Transfers into level 3	0	0	0
Transfers out of Level 3	0	0	0
Closing Balance	0	0	1
Level 3 | Other equity investments
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	25	40	1
Investment gains (losses), net	0	0	0
Net derivative gains (losses), excluding non-performance risk	0	0	0
Nonperformance risk	0	0	0
Subtotal	0	0	0
Other comprehensive income (loss)		0	(1)
Purchases	29	0	0
Sales	0	0	0
Settlements	0	0	0
Activity related to consolidated VIEs/VOEs	(6)	(15)	40
Transfers into level 3	5	0	0
Transfers out of Level 3	(5)	0
Closing Balance	48	25	40
Level 3 | GMIB reinsurance contracts
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	10,488	10,313	10,582
Investment gains (losses), net	0	0	0
Net derivative gains (losses), excluding non-performance risk	(972)	(6)	(242)
Nonperformance risk	(96)	75	(20)
Subtotal	(1,068)	69	(262)
Other comprehensive income (loss)		0	0
Purchases	96	221	223
Sales	(62)	(115)	(230)
Settlements	(7,463)	0	0
Activity related to consolidated VIEs/VOEs	0	0	0
Transfers into level 3	0	0	0
Transfers out of Level 3	0	0	0
Closing Balance	1,991	10,488	10,313
Level 3 | Separate Accounts’ assets
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	349	313	313
Investment gains (losses), net	26	29	19
Net derivative gains (losses), excluding non-performance risk	0	0	0
Nonperformance risk	0	0	0
Subtotal	26	29	19
Other comprehensive income (loss)		0	0
Purchases	5	13	10
Sales	(1)	(2)	0
Settlements	(5)	(4)	(7)
Activity related to consolidated VIEs/VOEs	0	0	0
Transfers into level 3	0	0	1
Transfers out of Level 3	0	0	(23)
Closing Balance	374	349	313
Level 3 | GMxB derivative features liability
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	(4,256)	(5,473)	(5,266)
Investment gains (losses), net	0	0	0
Net derivative gains (losses), excluding non-performance risk	(296)	1,443	(126)
Nonperformance risk	(490)	149	263
Subtotal	(786)	1,592	137
Other comprehensive income (loss)		0	0
Purchases	(403)	(381)	(348)
Sales	14	6	4
Settlements	0	0	0
Activity related to consolidated VIEs/VOEs	0	0	0
Transfers into level 3	0	0	0
Transfers out of Level 3	0	0	0
Closing Balance	(5,431)	(4,256)	(5,473)
Level 3 | Foreign governments
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	0	0	1
Net investment income (loss)	0	0
Investment gains (losses), net	0	0	0
Subtotal	0	0	0
Other comprehensive income (loss)	0	0	0
Purchases	0	0	0
Sales	0	0	0
Transfers into level 3	0	0	0
Transfers out of Level 3	0	0	(1)
Closing Balance	0	0	0
Level 3 | Commercial mortgage-backed
Total Gains Losses Realized Unrealized Included In [Abstract]
Beginning Balance	0	349	503
Net investment income (loss)	0	(2)
Investment gains (losses), net	0	(63)	(67)
Subtotal	0	(65)	(67)
Other comprehensive income (loss)	0	45	14
Purchases	0	0	0
Sales	0	(329)	(87)
Transfers into level 3	0	0	0
Transfers out of Level 3	0	0	(14)
Closing Balance	0	0	349
Level 3 Assets And Liabilities Held
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment gains (losses), net	26	29	20
Net derivative gains (losses) for assets and liabilities held	(1,854)	1,661	(125)
Other comprehensive income (loss)	(26)	40	20
Level 3 Assets And Liabilities Held | States and political subdivisions
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment gains (losses), net	0		0
Net derivative gains (losses) for assets and liabilities held	0		0
Other comprehensive income (loss)	(1)		(1)
Level 3 Assets And Liabilities Held | Asset- backed
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment gains (losses), net	0	0	0
Net derivative gains (losses) for assets and liabilities held	0	0	0
Other comprehensive income (loss)	(7)	(9)	1
Level 3 Assets And Liabilities Held | Corporate
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment gains (losses), net	0	0	0
Net derivative gains (losses) for assets and liabilities held	0	0	0
Other comprehensive income (loss)	(18)	4	11
Level 3 Assets And Liabilities Held | Total debt maturities available for sale
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment gains (losses), net	0	0	0
Net derivative gains (losses) for assets and liabilities held	0	0	0
Other comprehensive income (loss)	(26)	40	20
Level 3 Assets And Liabilities Held | GMIB reinsurance contracts
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment gains (losses), net	0	0	0
Net derivative gains (losses) for assets and liabilities held	(1,068)	69	(262)
Other comprehensive income (loss)	0	0	0
Level 3 Assets And Liabilities Held | Separate Accounts’ assets
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment gains (losses), net	26	29	20
Net derivative gains (losses) for assets and liabilities held	0	0	0
Other comprehensive income (loss)	0	0	0
Level 3 Assets And Liabilities Held | GMxB derivative features liability
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment gains (losses), net	0	0	0
Net derivative gains (losses) for assets and liabilities held	(786)	1,592	137
Other comprehensive income (loss)	$ 0	0	0
Level 3 Assets And Liabilities Held | Commercial mortgage-backed
Total Gains Losses Realized Unrealized Included In [Abstract]
Investment gains (losses), net		0	0
Net derivative gains (losses) for assets and liabilities held		0	0
Other comprehensive income (loss)		$ 45	$ 9

FAIR VALUE DISCLOSURES - QUANTI

FAIR VALUE DISCLOSURES - QUANTITATIVE INFORMATION ABOUT LEVEL 3 (Details)	12 Months Ended
	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Asset Derivatives	$ 4,936,000,000	$ 14,210,000,000
Corporate | Matrix Pricing Model Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value unobservable inputs, assets	93,000,000	53,000,000
Corporate | Market Comparable Companies Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value unobservable inputs, assets	881,000,000	789,000,000
Separate Accounts assets | Third Party Appraisal Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value unobservable inputs, assets	352,000,000	326,000,000
Separate Accounts assets | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value unobservable inputs, assets	1,000,000	1,000,000
GMIB reinsurance contracts | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value unobservable inputs, assets		10,488,000,000
Asset Derivatives	1,991,000,000
GMIBNLG | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Embedded and freestanding derivative liability	5,341	4,149,000,000
GWBL/GMWB | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Embedded and freestanding derivative liability	130	130,000,000
GIB | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Embedded and freestanding derivative liability	(48)	(27,000,000)
GMAB | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Embedded and freestanding derivative liability	7	5,000,000
Level 3 | States and political subdivisions
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value unobservable inputs, assets	38,000,000	40,000,000	$ 42,000,000	$ 45,000,000
Level 3 | Asset- backed
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value unobservable inputs, assets	519,000,000	8,000,000	24,000,000	40,000,000
Level 3 | Corporate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value unobservable inputs, assets	1,174,000,000	1,139,000,000	845,000,000	420,000,000
Level 3 | Separate Accounts assets
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value unobservable inputs, assets	$ 374,000,000	349,000,000	313,000,000	313,000,000
Level 3 | Separate Accounts assets | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Inputs Spread Over Industry Yield Curve Bps	0.0248
Level 3 | Separate Accounts assets | Discount Rate | Third Party Appraisal Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.065
Level 3 | Separate Accounts assets | Discount Rate | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.051
Level 3 | Separate Accounts assets | Cap Rate | Third Party Appraisal Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.044
Level 3 | Separate Accounts assets | Exit Cap Rate | Third Party Appraisal Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.056
Level 3 | GMIB reinsurance contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value unobservable inputs, assets	$ 1,991,000,000	10,488,000,000	10,313,000,000	10,582,000,000
Level 3 | Foreign governments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value unobservable inputs, assets	0	0	0	1,000,000
Level 3 | Commercial mortgage-backed
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value unobservable inputs, assets	$ 0	$ 0	$ 349,000,000	$ 503,000,000
Guaranteed Insurance Benefits [Member] | Level 3 | Lapse Rate | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.005	0.009
Guaranteed Insurance Benefits [Member] | Level 3 | Lapse Rate | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.057	0.057
Guaranteed Insurance Benefits [Member] | Level 3 | Withdrawal Rate | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
Guaranteed Insurance Benefits [Member] | Level 3 | Withdrawal Rate | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.080	0.070
Guaranteed Insurance Benefits [Member] | Level 3 | Utilization Rate | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
Guaranteed Insurance Benefits [Member] | Level 3 | Utilization Rate | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.160	0.160
Guaranteed Insurance Benefits [Member] | Level 3 | Measurement Input, Equity Volatility [Member] | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.100	0.099
Guaranteed Insurance Benefits [Member] | Level 3 | Measurement Input, Equity Volatility [Member] | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.340	0.309
GWBL/GMWB | Level 3 | Lapse Rate | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.005	0.009
GWBL/GMWB | Level 3 | Lapse Rate | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.057	0.057
GWBL/GMWB | Level 3 | Withdrawal Rate | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
GWBL/GMWB | Level 3 | Withdrawal Rate | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.070	0.070
GWBL/GMWB | Level 3 | Utilization Rate | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	1	1
GWBL/GMWB | Level 3 | Measurement Input, Equity Volatility [Member] | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.100	0.099
GWBL/GMWB | Level 3 | Measurement Input, Equity Volatility [Member] | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.340	0.309
Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing Liability, Non Performance Liability	0.0189	0.010
Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Withdrawal Rate | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Withdrawal Rate | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.121	0.124
Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Utilization Rate | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0	0
Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Utilization Rate | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	1	0.160
Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Forfeiture Rate | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input		0.006
Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Forfeiture Rate | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input		0.021
Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Measurement Input, Equity Volatility [Member] | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input		0.200
Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Measurement Input, Equity Volatility [Member] | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.008	0.008
Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Measurement Input, Equity Volatility [Member] | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.262	0.262
GMIB reinsurance contracts | Level 3 | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing Asset, Non Performance Risk	0.0074	0.0005
Servicing asset, measurement input	0.010
GMIB reinsurance contracts | Level 3 | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing Asset, Non Performance Risk	0.00159	0.0010
Servicing asset, measurement input	0.0627
GMIB reinsurance contracts | Level 3 | Lapse Rate | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input		0.010
GMIB reinsurance contracts | Level 3 | Lapse Rate | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input		0.063
GMIB reinsurance contracts | Level 3 | Withdrawal Rate | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0	0
GMIB reinsurance contracts | Level 3 | Withdrawal Rate | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.08	0.080
GMIB reinsurance contracts | Level 3 | Utilization Rate | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0	0
GMIB reinsurance contracts | Level 3 | Utilization Rate | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.16	0.160
GMIB reinsurance contracts | Level 3 | Measurement Input, Equity Volatility [Member] | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.100	0.099
GMIB reinsurance contracts | Level 3 | Measurement Input, Equity Volatility [Member] | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.340	0.309
Corporate | Level 3 | Matrix Pricing Model Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Inputs Spread Over Industry Yield Curve Bps	0.0015	0
Corporate | Level 3 | Matrix Pricing Model Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Inputs Spread Over Industry Yield Curve Bps	0.0580	0.0565
Corporate | Level 3 | Matrix Pricing Model Valuation Technique | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Inputs Spread Over Industry Yield Curve Bps	0.0104	0.0125
Corporate | Level 3 | Measurement Input, EBITDA Multiple [Member] | Market Comparable Companies Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity Securities, FV-NI, Measurement Input	4.1	5.3
Corporate | Level 3 | Measurement Input, EBITDA Multiple [Member] | Market Comparable Companies Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity Securities, FV-NI, Measurement Input	37.8	27.9
Corporate | Level 3 | Measurement Input, EBITDA Multiple [Member] | Market Comparable Companies Valuation Technique | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity Securities, FV-NI, Measurement Input	12.1	12.9
Corporate | Level 3 | Discount Rate | Market Comparable Companies Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity Securities, FV-NI, Measurement Input	0.064	0.072
Corporate | Level 3 | Discount Rate | Market Comparable Companies Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity Securities, FV-NI, Measurement Input	0.165	0.170
Corporate | Level 3 | Discount Rate | Market Comparable Companies Valuation Technique | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity Securities, FV-NI, Measurement Input	0.107	0.111
Corporate | Level 3 | Cash Flow Multiples | Market Comparable Companies Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity Securities, FV-NI, Measurement Input	1.8	9
Corporate | Level 3 | Cash Flow Multiples | Market Comparable Companies Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity Securities, FV-NI, Measurement Input	18	17.7
Corporate | Level 3 | Cash Flow Multiples | Market Comparable Companies Valuation Technique | Weighted Average
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity Securities, FV-NI, Measurement Input	11.4	13.1
Separate Accounts assets | Level 3 | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Inputs Spread Over Industry Yield Curve Bps		0.0243
Separate Accounts assets | Level 3 | Discount Rate | Third Party Appraisal Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input		0.066
Separate Accounts assets | Level 3 | Discount Rate | Discounted Cash Flow Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input		0.044
Separate Accounts assets | Level 3 | Cap Rate | Third Party Appraisal Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input		0.046
Separate Accounts assets | Level 3 | Exit Cap Rate | Third Party Appraisal Valuation Technique
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input		0.056
GMAB | Level 3 | Lapse Rate | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.010	0.005
GMAB | Level 3 | Lapse Rate | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.057	0.110
GMAB | Level 3 | Measurement Input, Equity Volatility [Member] | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.100	0.099
GMAB | Level 3 | Measurement Input, Equity Volatility [Member] | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.340	0.309
Range One [Member] | Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Measurement Input, Mortality Rate [Member] | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0001	0.0001
Range One [Member] | Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Measurement Input, Mortality Rate [Member] | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0019	0.0019
Range One [Member] | GMIB reinsurance contracts | Level 3 | Measurement Input, Mortality Rate [Member] | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0001	0.0001
Range One [Member] | GMIB reinsurance contracts | Level 3 | Measurement Input, Mortality Rate [Member] | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0018	0.0018
Range Two [Member] | Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Measurement Input, Mortality Rate [Member] | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0006	0.0006
Range Two [Member] | Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Measurement Input, Mortality Rate [Member] | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0053	0.0053
Range Two [Member] | GMIB reinsurance contracts | Level 3 | Measurement Input, Mortality Rate [Member] | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0007	0.0007
Range Two [Member] | GMIB reinsurance contracts | Level 3 | Measurement Input, Mortality Rate [Member] | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0054	0.0054
Range Three [Member] | Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Measurement Input, Mortality Rate [Member] | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.0041	0.0041
Range Three [Member] | Guaranteed Minimum Insurance Benefits no Lapse Guarantee [Member] | Level 3 | Measurement Input, Mortality Rate [Member] | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing liability, measurement input	0.412	0.412
Range Three [Member] | GMIB reinsurance contracts | Level 3 | Measurement Input, Mortality Rate [Member] | Discounted Cash Flow Valuation Technique | Minimum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.0042	0.0042
Range Three [Member] | GMIB reinsurance contracts | Level 3 | Measurement Input, Mortality Rate [Member] | Discounted Cash Flow Valuation Technique | Maximum
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Servicing asset, measurement input	0.420	0.420

FAIR VALUE DISCLOSURES - NARRAT

FAIR VALUE DISCLOSURES - NARRATIVE (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Fair Value Inputs Assets Quantitative Information 1 [Line Items]
Fair value adjustments on GMIB asset	$ 184	$ 69
AFS fixed maturities transferred from Level 3 to Level 2	28	6
Fair value measurements not included in quantitative information about level 3 fair value measurements	826	392
AFS fixed maturities transferred from Level 3 to Level 2	$ 83	$ 7
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Percentage	0.90%	0.10%

FAIR VALUE DISCLOSURES - CARRYI

FAIR VALUE DISCLOSURES - CARRYING VALUES AND FAIR VALUES OF FINANCIAL INSTRUMENTS (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Consolidated Amounts [Abstract]
Mortgage loans on real estate	$ 11,818	$ 10,935
Loans to affiliates	600	703
Policyholders’ liabilities: Investment contracts	46,403	43,805
Policy loans	3,267	3,315
Loans from affiliates	572	0
Separate Accounts liabilities	108,487	122,537
Carrying Value
Consolidated Amounts [Abstract]
Mortgage loans on real estate	11,818	10,935
Loans to affiliates	600	703
Policyholders’ liabilities: Investment contracts	1,974	2,068
FHLBNY funding agreements	4,002	3,014
Policy loans	3,267	3,315
Short-term and long-term debt	0	203
Loans from affiliates	572
Separate Accounts liabilities	7,406	7,537
Measured at Fair Value
Consolidated Amounts [Abstract]
Mortgage loans on real estate	11,478	10,895
Loans to affiliates	603	700
Policyholders’ liabilities: Investment contracts	2,015	2,170
FHLBNY funding agreements	3,956	3,020
Policy loans	3,944	4,210
Short-term and long-term debt	0	202
Loans from affiliates	572
Separate Accounts liabilities	7,406	7,537
Measured at Fair Value | Level 1
Consolidated Amounts [Abstract]
Mortgage loans on real estate	0	0
Loans to affiliates	0	0
Policyholders’ liabilities: Investment contracts	0	0
FHLBNY funding agreements	0	0
Policy loans	0	0
Short-term and long-term debt	0	0
Loans from affiliates	0
Separate Accounts liabilities	0	0
Measured at Fair Value | Level 2
Consolidated Amounts [Abstract]
Mortgage loans on real estate	0	0
Loans to affiliates	603	700
Policyholders’ liabilities: Investment contracts	0	0
FHLBNY funding agreements	3,956	3,020
Policy loans	0	0
Short-term and long-term debt	0	202
Loans from affiliates	572
Separate Accounts liabilities	0	0
Measured at Fair Value | Level 3
Consolidated Amounts [Abstract]
Mortgage loans on real estate	11,478	10,895
Loans to affiliates	0	0
Policyholders’ liabilities: Investment contracts	2,015	2,170
FHLBNY funding agreements	0	0
Policy loans	3,944	4,210
Short-term and long-term debt	0	0
Loans from affiliates	0
Separate Accounts liabilities	$ 7,406	$ 7,537

INSURANCE LIABILITIES - Separat

INSURANCE LIABILITIES - Separate Account Investments, Hedging Programs and Variable and Interest-Sensitive Live Insurance Policies (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
GMDB
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fair Value of Assets	$ 83,154	$ 94,672
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Opening Balance	4,054	3,159	$ 2,991
Paid guarantee benefits	(394)	(354)	(357)
Other changes in reserves	994	1,249	525
Closing Balance	4,654	4,054	3,159
GMIB
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fair Value of Assets	52,835	61,498
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Opening Balance	4,754	3,808	3,886
Paid guarantee benefits	(153)	(151)	(281)
Other changes in reserves	(860)	1,097	203
Closing Balance	3,741	4,754	3,808
Equity | GMDB
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fair Value of Assets	35,541	41,658
Equity | GMIB
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fair Value of Assets	15,759	19,676
Fixed income | GMDB
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fair Value of Assets	5,173	5,469
Fixed income | GMIB
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fair Value of Assets	2,812	3,110
Balanced | GMDB
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fair Value of Assets	41,588	46,577
Balanced | GMIB
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fair Value of Assets	33,974	38,398
Other | GMDB
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fair Value of Assets	852	968
Other | GMIB
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Fair Value of Assets	290	314
Direct Liabilities For Guarantees
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Opening Balance	692	1,182	1,144
Paid guarantee benefits	(23)	(24)
Other changes in reserves	118	(466)	38
Closing Balance	787	692	1,182
Net Liabilities For Guarantees
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Opening Balance	28	576	634
Paid guarantee benefits	(23)	(24)
Other changes in reserves	49	(524)	(58)
Closing Balance	$ 54	$ 28	$ 576

INSURANCE LIABILITIES - Variabl

INSURANCE LIABILITIES - Variable Annuity Contracts with GMDB and GMIB Features and Buybacks (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 14,382
Separate Accounts	83,154	$ 94,672
Total Account Values	97,536
Net Amount at Risk, gross	24,087
Net Amount at Risk, net of amounts reinsured	$ 23,392
Average attained age of contractholders (in years)	55 years 3 months 19 days
Percentage of policyholders over age 70	18.80%
Range of contractually specified interest rates (as a percent), minimum	3.00%
Range of contractually specified interest rates (as a percent), maximum	6.50%
GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 270
Separate Accounts	52,835	$ 61,498
Total Account Values	53,105
Net Amount at Risk, gross	10,150
Net Amount at Risk, net of amounts reinsured	$ 8,577
Average attained age of contractholders (in years)	68 years 9 months 18 days
Weighted average years remaining until annuitization (in years)	7 months 6 days
Range of contractually specified interest rates (as a percent), minimum	3.00%
Range of contractually specified interest rates (as a percent), maximum	6.50%
Return of Premium | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 14,035
Separate Accounts	41,463
Total Account Values	55,498
Net Amount at Risk, gross	418
Net Amount at Risk, net of amounts reinsured	$ 418
Average attained age of contractholders (in years)	51 years 4 months 24 days
Percentage of policyholders over age 70	10.00%
Return of Premium | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 0
Separate Accounts	0
Total Account Values	0
Net Amount at Risk, gross	0
Net Amount at Risk, net of amounts reinsured	0
Ratchet | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	102
Separate Accounts	8,382
Total Account Values	8,484
Net Amount at Risk, gross	791
Net Amount at Risk, net of amounts reinsured	$ 772
Average attained age of contractholders (in years)	67 years
Percentage of policyholders over age 70	43.00%
Ratchet | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 0
Separate Accounts	0
Total Account Values	0
Net Amount at Risk, gross	0
Net Amount at Risk, net of amounts reinsured	0
Roll-Up | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	61
Separate Accounts	2,903
Total Account Values	2,964
Net Amount at Risk, gross	2,291
Net Amount at Risk, net of amounts reinsured	$ 1,615
Average attained age of contractholders (in years)	73 years 7 months 6 days
Percentage of policyholders over age 70	65.50%
Range of contractually specified interest rates (as a percent), minimum	3.00%
Range of contractually specified interest rates (as a percent), maximum	6.00%
Roll-Up | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 19
Separate Accounts	19,407
Total Account Values	19,426
Net Amount at Risk, gross	994
Net Amount at Risk, net of amounts reinsured	$ 309
Average attained age of contractholders (in years)	68 years 10 months 25 days
Weighted average years remaining until annuitization (in years)	1 year 8 months 12 days
Range of contractually specified interest rates (as a percent), minimum	3.00%
Range of contractually specified interest rates (as a percent), maximum	6.00%
Combo | GMDB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 184
Separate Accounts	30,406
Total Account Values	30,590
Net Amount at Risk, gross	20,587
Net Amount at Risk, net of amounts reinsured	$ 20,587
Average attained age of contractholders (in years)	69 years
Percentage of policyholders over age 70	49.90%
Range of contractually specified interest rates (as a percent), minimum	3.00%
Range of contractually specified interest rates (as a percent), maximum	6.50%
Combo | GMIB
Net Amount at Risk by Product and Guarantee [Line Items]
General Account	$ 251
Separate Accounts	33,428
Total Account Values	33,679
Net Amount at Risk, gross	9,156
Net Amount at Risk, net of amounts reinsured	$ 8,268
Average attained age of contractholders (in years)	68 years 9 months 18 days
Weighted average years remaining until annuitization (in years)	6 months
Range of contractually specified interest rates (as a percent), minimum	3.00%
Range of contractually specified interest rates (as a percent), maximum	6.50%

INSURANCE LIABILITIES - Change

INSURANCE LIABILITIES - Change in Liability for Variable Annuity Contracts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
GMDB
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward]
Opening Balance	$ 4,054	$ 3,159	$ 2,991
Opening Balance	(2,030)	(1,558)	(1,430)
Paid guarantee benefits	(394)	(354)	(357)
Paid guarantee benefits	70	171	174
Other changes in reserves	994	1,249	525
Other changes in reserve	1,853	(643)	(302)
Closing Balance	4,654	4,054	3,159
Closing Balance	(107)	(2,030)	(1,558)
GMIB
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward]
Opening Balance	4,754	3,808	3,886
Opening Balance	(10,488)	(10,314)	(10,575)
Paid guarantee benefits	(153)	(151)	(281)
Paid guarantee benefits	61	115	230
Other changes in reserves	(860)	1,097	203
Other changes in reserve	8,435	(289)	31
Closing Balance	3,741	4,754	3,808
Closing Balance	(1,992)	(10,488)	(10,314)
Ceded Liabilities For Guarantees
Movement in Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross [Roll Forward]
Opening Balance	(664)	(606)	(510)
Paid guarantee benefits	0	0
Other changes in reserve	(69)	(58)	(96)
Closing Balance	$ (733)	$ (664)	$ (606)

REVENUE RECOGNITION - Disaggreg

REVENUE RECOGNITION - Disaggregation of Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Total investment management and service fees
Disaggregation Of Revenue Table [Line Items]
Revenues disaggregated by category	$ 1,029	$ 1,007	$ 951
Base fees
Disaggregation Of Revenue Table [Line Items]
Revenues disaggregated by category	728	720	674
Distribution services
Disaggregation Of Revenue Table [Line Items]
Revenues disaggregated by category	301	287	277
Other income
Disaggregation Of Revenue Table [Line Items]
Revenues disaggregated by category	$ 33	$ 35	$ 23

REINSURANCE AGREEMENTS - Effect

REINSURANCE AGREEMENTS - Effect of reinsurance (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Premiums:
Direct premiums	$ 836	$ 880	$ 850
Reinsurance assumed	186	195	206
Reinsurance ceded	(160)	(171)	(176)
Premiums	862	904	880
Policy charges and fee income ceded	467	718	640
Policyholders’ Benefits Ceded	$ 592	$ 694	$ 942

REINSURANCE AGREEMENTS (Details

REINSURANCE AGREEMENTS (Details) - USD ($) $ in Millions	Feb. 01, 2018	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance retention policy, percentage of excess reinsured		100.00%
GMIB reinsurance contract asset, at fair value		$ 1,991	$ 10,488
Increase (decrease) in the fair value of the reinsurance contract asset		8,497	174	$ 268
Amounts due to reinsurers		113	134
AXA Equitable Life Insurance Co [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance retention policy, amount retained	$ 635
Deposit contracts, assets	$ 635
Exposure reinsured percentage	90.00%
Amount retained, excluding cash	$ 604
Amount retained, cash	$ 31
Non Affiliated Entity
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance recoverables related to insurance contracts		2,243	2,420
Amounts due to reinsurers		113	134
Non Affiliated Entity | Credit Concentration Risk
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance recoverables related to insurance contracts		1,689	1,882
Variable Universal Term Life Insurance Single Life
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance retention policy, amount retained		25
Variable Universal Term Life Insurance Joint Life
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Reinsurance retention policy, amount retained		30
Group Life And Health Insurance | Non Affiliated Entity
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Insurance liabilities ceded		62	71
Reinsurance assumed reserves		$ 712	$ 716
GMDB | Non Affiliated Entity
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Exposure reinsured percentage		2.90%	3.50%
GMIB | Non Affiliated Entity
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Exposure reinsured percentage		15.50%	16.80%

LONG-TERM DEBT - Narrative (Det

LONG-TERM DEBT - Narrative (Details) $ in Millions	1 Months Ended
	Mar. 31, 2018USD ($)
Line of Credit Facility [Line Items]
Extinguishment of debt	$ 202
AXA France
Line of Credit Facility [Line Items]
Consideration	143
Loss on disposal	$ 0.2

RELATED PARTY TRANSACTIONS - Na

RELATED PARTY TRANSACTIONS - Narrative (Details) - USD ($) $ in Millions

Dec. 28, 2018

Dec. 21, 2018

Apr. 12, 2018

Mar. 31, 2018

Jan. 31, 2018

Jun. 30, 2018

Dec. 31, 2018

Dec. 31, 2017

Dec. 31, 2016

Apr. 20, 2018

Jun. 30, 2016

Sep. 30, 2007

Related Party Transaction [Line Items]

Loans to affiliates

$ 600

$ 703

Additional loans from affiliates

$ 50

572

0

$ 0

Extraordinary cash dividend

572

Guaranteed minimum income benefit reinsurance asset, at fair value

1,991

10,488

Ceded premiums

4

4

4

Deferred Tax Asset, Intra-entity Transfer, Asset Other than Inventory

$ 1,200

Transfer to Investments

7,615

Notes Reduction

300

Assumed Premiums Earned Affiliated

20

20

20

Reinsurance Effect On Claims And Benefits Incurred Amount Assumed Affiliates

8

5

6

Extinguishment of debt

$ 202

Affiliated Entity

Related Party Transaction [Line Items]

Expenses paid or accrued for:

724

799

$ 777

AXA | Senior Unsecured Notes

Related Party Transaction [Line Items]

Loans to affiliates

$ 700

Related party transaction, original rate (as a percent)

5.70%

AXA Equitable

Related Party Transaction [Line Items]

Equity method investment, ownership percentage

70.00%

Investment in real estate joint venture

$ 25

AXA Arizona

Related Party Transaction [Line Items]

Reinsurance, Loss on Uncollectible Accounts in Period, Amount

$ 2,600

Guaranteed minimum income benefit reinsurance asset, at fair value

8,594

Reinsurance, Loss On Uncollectible Accounts In Period, Amount, Net Of Tax

2,100

Reinsurance, Write Off Of Deferred Costs

1,800

Reinsurance, Difference In Cost Basis

$ 400

AXA Arizona | Universal Life And No Lapse Guarantee Riders

Related Party Transaction [Line Items]

Ceded premiums

454

$ 447

Ceded claims paid

$ 213

$ 65

EQ AZ Life Re

Related Party Transaction [Line Items]

Guaranteed minimum income benefit reinsurance asset, at fair value

259

EQ AZ Life Re | Universal Life And No Lapse Guarantee Riders

Related Party Transaction [Line Items]

Ceded premiums

100

Ceded claims paid

78

Saum Sing

Related Party Transaction [Line Items]

Equity method investment, ownership percentage

30.00%

XL Catlin

Related Party Transaction [Line Items]

Liabilities for Guarantees on Long-Duration Contracts, Guaranteed Benefit Liability, Gross

93

Cost Sharing And General Service Agreements

Related Party Transaction [Line Items]

Expenses paid or accrued for:

138

Assets Removed

Related Party Transaction [Line Items]

Donation made to AXA Foundation

11,889

Senior Surplus Notes

Related Party Transaction [Line Items]

Extraordinary cash dividend

572

Related party transaction, rate (as a percent)

3.75%

Payable To Related Party | Assets Removed

Related Party Transaction [Line Items]

Donation made to AXA Foundation

$ 270

AXA Holdings | Notes Payable, Other Payables [Member]

Related Party Transaction [Line Items]

Debt Instrument, Face Amount

$ 800

Debt Instrument, Interest Rate, Stated Percentage

3.69%

Repayments of Notes Payable

$ 200

Notes Payable

600

EQ AZ | AXA Equitable

Related Party Transaction [Line Items]

Guaranteed minimum income benefit reinsurance asset, at fair value

1,600

Undrawn letters of credit related to reinsurance

$ 2,500

AXA France

Related Party Transaction [Line Items]

Consideration

143

Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal

$ (0.2)

RELATED PARTY TRANSACTIONS - As

RELATED PARTY TRANSACTIONS - Assets Received (Removed) (Details) $ in Millions	Apr. 12, 2018USD ($)
Assets Received [Member]
Related Party Transaction [Line Items]
Donation made to AXA Foundation	$ 8,888
Assets Removed
Related Party Transaction [Line Items]
Donation made to AXA Foundation	11,889
Fixed Income Securities [Member] | Assets Received [Member]
Related Party Transaction [Line Items]
Donation made to AXA Foundation	7,083
Short-term investments | Assets Received [Member]
Related Party Transaction [Line Items]
Donation made to AXA Foundation	205
Money Market Funds [Member] | Assets Received [Member]
Related Party Transaction [Line Items]
Donation made to AXA Foundation	2
Accrued Interest [Member] | Assets Received [Member]
Related Party Transaction [Line Items]
Donation made to AXA Foundation	43
Derivative investments | Assets Received [Member]
Related Party Transaction [Line Items]
Donation made to AXA Foundation	282
Cash [Member] | Assets Received [Member]
Related Party Transaction [Line Items]
Donation made to AXA Foundation	1,273
Deferred Cost Of Reinsurance Asset [Member] | Assets Removed
Related Party Transaction [Line Items]
Donation made to AXA Foundation	1,839
GMDB Ceded Reserves [Member] | Assets Removed
Related Party Transaction [Line Items]
Donation made to AXA Foundation	2,317
GMIB Reinsurance Contract Asset [Member] | Assets Removed
Related Party Transaction [Line Items]
Donation made to AXA Foundation	7,463
Payable To Related Party | Assets Removed
Related Party Transaction [Line Items]
Donation made to AXA Foundation	$ 270

RELATED PARTY TRANSACTIONS - Sc

RELATED PARTY TRANSACTIONS - Schedule of Expenses Reimbursed from Related Party Transactions (Details) - Affiliated Entity - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Related Party Transaction [Line Items]
Expenses paid or accrued for:	$ 724	$ 799	$ 777
Revenue received or accrued for:	1,234	1,204	1,214
Paid or accrued commission and fee expenses for sale of insurance products by AXA Distribution
Related Party Transaction [Line Items]
Expenses paid or accrued for:	613	608	587
General services provided by AXA Affiliates
Related Party Transaction [Line Items]
Expenses paid or accrued for:	109	186	188
Investment management services provided by AXA IM, AXA REIM and AXA Rosenberg
Related Party Transaction [Line Items]
Expenses paid or accrued for:	2	5	2
Investment management and administrative services provided to EQAT, VIP Trust, 1290 Funds and Other AXA Trusts
Related Party Transaction [Line Items]
Revenue received or accrued for:	727	720	674
General services provided to AXA Affiliates
Related Party Transaction [Line Items]
Revenue received or accrued for:	463	439	497
Amounts received or accrued for commissions and fees earned for sale of MONY America’s insurance products
Related Party Transaction [Line Items]
Revenue received or accrued for:	$ 44	$ 45	$ 43

EMPLOYEE BENEFIT PLANS - Narrat

EMPLOYEE BENEFIT PLANS - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
AXA Equitable 401(k) Plan
Defined Benefit Plan Disclosure [Line Items]
Expenses associated with plans	$ 19	$ 15	$ 16
Qualified Plan
Defined Benefit Plan Disclosure [Line Items]
Expenses associated with plans	60	27	31
Nonqualified Plan
Defined Benefit Plan Disclosure [Line Items]
Expenses associated with plans	$ 70	$ 37	$ 44

EMPLOYEE BENEFIT PLANS - Summar

EMPLOYEE BENEFIT PLANS - Summary of Plan (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Retirement Benefits [Abstract]
Total Plan Assets	$ 1,993	$ 2,325
Accumulated Benefit Obligation	$ 2,039	$ 2,389
Funded Status	97.80%	97.30%

SHARE-BASED AND OTHER COMPENS_3

SHARE-BASED AND OTHER COMPENSATION PROGRAMS - Summary of Compensation Expenses (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Expenses	$ 30	$ 30	$ 33
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Expenses	12	18	17
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Expenses	2	1	1
AXA Shareplan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Expenses	0	9	14
Restricted Stock Unit Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Expenses	16	2	0
Other Compensation plans
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total Compensation Expenses	0	$ 0	$ 1
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Plan modification	$ 10

SHARE-BASED AND OTHER COMPENS_4

SHARE-BASED AND OTHER COMPENSATION PROGRAMS - Stock Option Activity (Details) - 12 months ended Dec. 31, 2018 € / shares in Units, $ / shares in Units, € in Thousands, shares in Thousands, $ in Thousands	USD ($)$ / sharesshares	USD ($)$ / shares€ / sharesshares	EUR (€)€ / sharesshares
EQH Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options, Number Outstanding, Beginning Balance (in shares)	0	0
Options granted (in shares)	869	869
Options exercised (in shares)	0	0
Options forfeited, net (in shares)	(35)	(35)
Options expired/reinstated (in shares)	0	0
Options, Number Outstanding, Ending Balance (in shares)	834	834
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options, Weighted Average Exercise Price, Beginning Balance (in dollars per share) | $ / shares	$ 0
Options granted, Weighted Average Exercise Price (in dollars per share) | $ / shares	21.34
Options exercised, Weighted Average Exercise Price (in dollars per share) | $ / shares	0
Options forfeited, net, Weighted Average Exercise Price (in dollars per share) | $ / shares	21.34
Options expired/reinstated, Weighted Average Exercise Price (in dollars per share) | $ / shares	0
Options, Weighted Average Exercise Price, Ending Balance (in dollars per share) | $ / shares	$ 21.34
Options Outstanding, Aggregate Intrinsic Value | $	$ 0	$ 0
Weighted Average Remaining Contractual Term (in years)	9 years 1 month 28 days	9 years 1 month 28 days
Options Exercisable (in shares)	0	0	0
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares	$ 0	$ 0
Options Exercisable, Aggregate Intrinsic Value | $	$ 0	$ 0
AXA Ordinary Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options, Number Outstanding, Beginning Balance (in shares)	3,653	3,653
Options granted (in shares)	0	0
Options exercised (in shares)	(337)	(337)
Options forfeited, net (in shares)	0	0
Options expired/reinstated (in shares)	(707)	(707)
Options, Number Outstanding, Ending Balance (in shares)	2,609	2,609
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options, Weighted Average Exercise Price, Beginning Balance (in dollars per share) | € / shares		$ 17.36
Options granted, Weighted Average Exercise Price (in dollars per share) | € / shares		0
Options exercised, Weighted Average Exercise Price (in dollars per share) | € / shares		11.80
Options forfeited, net, Weighted Average Exercise Price (in dollars per share) | € / shares		0
Options expired/reinstated, Weighted Average Exercise Price (in dollars per share) | € / shares		17.45
Options, Weighted Average Exercise Price, Ending Balance (in dollars per share) | € / shares		$ 18.20
Options Outstanding, Aggregate Intrinsic Value | €			€ 2,383
Weighted Average Remaining Contractual Term (in years)	4 years 6 months	4 years 6 months
Options Exercisable (in shares)	1,369	1,369	1,369
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | € / shares			€ 15.27
Options Exercisable, Aggregate Intrinsic Value | €			€ 7,698
Weighted Average Remaining Contractual Term (in years)	2 years 5 months 12 days	2 years 5 months 12 days
AXA ADRs
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options, Number Outstanding, Beginning Balance (in shares)	20	20
Options granted (in shares)	0	0
Options exercised (in shares)	0	0
Options forfeited, net (in shares)	0	0
Options expired/reinstated (in shares)	(5)	(5)
Options, Number Outstanding, Ending Balance (in shares)	15	15
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options, Weighted Average Exercise Price, Beginning Balance (in dollars per share) | $ / shares	$ 20.98
Options granted, Weighted Average Exercise Price (in dollars per share) | $ / shares	0
Options exercised, Weighted Average Exercise Price (in dollars per share) | $ / shares	0
Options forfeited, net, Weighted Average Exercise Price (in dollars per share) | $ / shares	0
Options expired/reinstated, Weighted Average Exercise Price (in dollars per share) | $ / shares	35.25
Options, Weighted Average Exercise Price, Ending Balance (in dollars per share) | $ / shares	$ 15.37
Options Outstanding, Aggregate Intrinsic Value | $	$ 0	$ 0
Weighted Average Remaining Contractual Term (in years)	6 months 29 days	6 months 29 days
Options Exercisable (in shares)	15	15	15
Options Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares	$ 15.37	$ 15.37
Options Exercisable, Aggregate Intrinsic Value | $	$ 151	$ 151
Weighted Average Remaining Contractual Term (in years)	6 months 29 days	6 months 29 days

SHARE-BASED AND OTHER COMPENS_5

SHARE-BASED AND OTHER COMPENSATION PROGRAMS - Fair Value Stock Option Assumptions (Details) - Parent - AXA Ordinary Shares - $ / shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	2.44%	6.53%	6.49%
Expected volatility	25.40%	25.05%	26.60%
Risk-free interest rates	2.83%	0.59%	0.33%
Expected life in years	9 years 8 months 12 days	8 years 9 months 29 days	8 years 1 month 6 days
Weighted average fair value per option at grant date (in dollars per share)	$ 4.61	$ 2.01	$ 2.06

SHARE-BASED AND OTHER COMPENS_6

SHARE-BASED AND OTHER COMPENSATION PROGRAMS - Restricted Awards Activity (Details)	12 Months Ended
	Dec. 31, 2018$ / shares€ / sharesshares	Dec. 31, 2018€ / sharesshares	Dec. 31, 2017€ / shares
AXA Ordinary Shares
Restricted Awards Plan [Line Items]
Options exercised, Weighted Average Exercise Price (in dollars per share) | € / shares		€ 11.80
Options expired/reinstated, Weighted Average Exercise Price (in dollars per share) | € / shares		17.45
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | € / shares	€ 18.20	€ 18.20	€ 17.36
Holdings Restricted Stock | Restricted Stock Unit Awards
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested, Beginning Balance (in shares) | shares	0	0
Granted (in shares) | shares	1,695,906	1,695,906
Canceled (in shares) | shares	56,306	56,306
Vested (in shares) | shares	380,541	380,541
Unvested, Ending Balance (in shares) | shares	1,259,000	1,259,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	€ 0
Granted, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	20.83
Canceled, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	21.21
Vested, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	21.09
Unvested, Ending Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	€ 21
AXA Restricted Stock | Restricted Stock Unit Awards
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Unvested, Beginning Balance (in shares) | shares	84,000	84,000
Granted (in shares) | shares	0	0
Canceled (in shares) | shares	208	208
Vested (in shares) | shares	36,000	36,000
Unvested, Ending Balance (in shares) | shares	48,000	48,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Unvested, Beginning Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	€ 21.07
Granted, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	0
Canceled, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	26.64
Vested, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	21.99
Unvested, Ending Balance, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares	€ 20.38

SHARE-BASED AND OTHER COMPENS_7

SHARE-BASED AND OTHER COMPENSATION PROGRAMS - Narrative (Details) $ / shares in Units, $ in Millions	Jun. 11, 2018$ / sharesshares	May 17, 2018$ / sharesshares	May 09, 2018$ / sharesshares	Jun. 21, 2017shares	Mar. 24, 2017USD ($)shares	Jun. 06, 2016shares	Dec. 31, 2018USD ($)shares	Dec. 31, 2017USD ($)shares	Dec. 31, 2017€ / shares	Dec. 31, 2016USD ($)shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense							$ 30	$ 30		$ 33
Restricted Stock Unit Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense							16	2		0
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost not yet recognized							$ 1
Compensation cost, recognition period							2 years 2 months 19 days
Performance Unit Plan 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense							$ 9	4
Options granted (in shares) | shares				1,700,000
Performance Unit Plan 2017 | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage				0.00%
Performance Unit Plan 2017 | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage				130.00%
Performance Unit Plan 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense							4	4		10
Options granted (in shares) | shares						1,900,000
Performance Unit Plan 2016 | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage						0.00%
Performance Unit Plan 2016 | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage						130.00%
Performance Unit Plan 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity settlement of vested units with ordinary shares, value					$ 21
Equity settlement of vested units with ordinary shares number (in shares) | shares					2,300,000
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense							2	1		1
AXA Shareplan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense							$ 0	9		14
Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized (in shares) | shares							5,500,000
Holdings Plan | Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost not yet recognized							$ 3
Compensation cost, recognition period							9 months 22 days
AXA Holdings
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period							3 years
Grant of holding units (in shares) | shares	900,000
AXA Holdings | Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation costs not yet recognized							$ 4
Share based compensation expense							$ 1.7
Weighted average grant date fair value (in dollars and euros per share) | $ / shares	$ 21.34
Exercise price (in usd per share) | $ / shares	$ 4.61
Expected volatility							25.40%
Weighted average expected term							5 years 8 months 12 days
Dividend yield							2.44%
Fair value assumptions, risk free interest rate							2.83%
AXA Holdings | Employee Stock Option | Vesting tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							33.33%
AXA Holdings | Employee Stock Option | Vesting tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							33.33%
AXA Holdings | Employee Stock Option | Vesting tranche three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							33.33%
AXA Holdings | Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares) | shares		400,000
Compensation costs not yet recognized							$ 4
Share based compensation expense							$ 2
AXA Holdings | Performance Shares | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Potential shares earned, percent							0.00%
AXA Holdings | Performance Shares | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Potential shares earned, percent							200.00%
AXA Holdings | Transaction Incentive Grant Awards | Vesting tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value, outstanding							$ 6
AXA Holdings | Transaction Incentive Grant Awards | RSU Service Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period							2 years
Vesting percentage							50.00%
AXA Holdings | Transaction Incentive Grant Awards | Restricted Stock Unit Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares) | shares			600,000
Service period							5 years
Compensation costs not yet recognized							$ 3
AXA Holdings | Transaction Incentive Grant Awards | Restricted Stock Unit Awards | Vesting tranche three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense							$ 6
AXA Holdings | Transaction Incentive Grant Awards | Restricted Stock Unit Awards | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Growth rate							130.00%
AXA Holdings | Transaction Incentive Grant Awards | Restricted Stock Unit Awards | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Growth rate							150.00%
AXA Holdings | Transaction Incentive Grant Awards | RSU Performance Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares) | shares			158,008.5
Vesting percentage							50.00%
Compensation costs not yet recognized							$ 3
AXA Holdings | Transaction Incentive Grant Awards | RSU Performance Units | Vesting tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares) | shares			316,017
AXA Holdings | Transaction Incentive Grant Awards | RSU Performance Units | Vesting tranche three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares			$ 16.47
AXA Holdings | Transaction Incentive Grant Awards | RSU Performance Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period							2 years
AXA Holdings | Transaction Incentive Grant Awards | RSU Performance Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period							5 years
AXA Holdings | All-Employee Award | Restricted Stock Unit Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares) | shares			200,000
Grants on individual basis (in shares) | shares			50
Share based compensation expense							$ 5
AXA Holdings | Annual Awards 2018 | Restricted Stock Unit Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares) | shares		800,000
Vesting period							3 years
Compensation costs not yet recognized							$ 18
AXA Holdings | Annual Awards 2018 | Restricted Stock Unit Awards | Vesting tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							33.33%
AXA Holdings | Annual Awards 2018 | Restricted Stock Unit Awards | Vesting tranche two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							33.33%
AXA Holdings | Annual Awards 2018 | Restricted Stock Unit Awards | Vesting tranche three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage							33.33%
AXA Holdings | TSR Performance Share Plan | Restricted Stock Unit Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price (in usd per share) | $ / shares		$ 23.17
IPO | AXA Holdings
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share price (in usd per share) | $ / shares			$ 20
Parent
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Post-vesting holding period							5 years
Parent | Restricted Stock Unit Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share based compensation expense							$ 16	$ 2		$ 0
Unvested restricted shares and holding units (in shares) | shares							2,300,000
Compensation cost not yet recognized							$ 19
Compensation cost, recognition period							1 year 2 months 16 days
AXA Shareplan Option A 2017 | Parent
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Discount from market price, purchase date								20.00%
Weighted average purchase price of shares purchased (Euro/share) | € / shares									€ 20.19
AXA Shareplan Option B 2015 | Parent
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Discount from market price, purchase date								8.98%
Weighted average purchase price of shares purchased (Euro/share) | € / shares									€ 22.96
Shares issued during period under employee stock ownership plan | shares								4,000,000		6,000,000

INCOME TAXES - Components of In

INCOME TAXES - Components of Income Tax Expense (Benefit) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Current (expense) benefit	$ 234	$ (6)	$ (274)
Deferred (expense) benefit	212	1,216	438
Total	$ 446	$ 1,210	$ 164

INCOME TAXES - Reconciliation o

INCOME TAXES - Reconciliation of Effective Tax Rate (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Effective Income Tax Rate Reconciliation
Expected income tax (expense) benefit	$ 311	$ (542)	$ 14
Noncontrolling interest	(1)	0	0
Non-taxable investment income (loss)	104	241	173
Tax audit interest	(11)	(6)	(14)
State income taxes	(1)	(3)	(6)
Tax settlements/uncertain tax position release	0	221	0
Change in tax law	46	1,308	0
Other	(2)	(9)	(3)
Total	$ 446	$ 1,210	$ 164

INCOME TAXES - Deferred Tax Ass

INCOME TAXES - Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Components of Deferred Tax Assets [Abstract]
Compensation and related benefits	$ 47	$ 47
Net operating loss	239	0
Reserves and reinsurance	0	0
Unrealized investment gains (losses)	123	0
Investments	670	0
Tax credits	314	387
Other	14	67
Total	1,407	501
Components of Deferred Tax Liabilities [Abstract]
Reserves and reinsurance	32	83
DAC	864	821
Unrealized investment gains (losses)	0	298
Investments	0	997
Other	0	0
Total	$ 896	$ 2,199

INCOME TAXES - Unrecognized Def

INCOME TAXES - Unrecognized Deferred Tax Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at January 1,	$ 205	$ 444	$ 406
Additions for tax positions of prior years	98	28	38
Reductions for tax positions of prior years	(30)	(234)	0
Settlements with tax authorities	0	(33)	0
Balance at December 31,	273	205	444
Unrecognized tax benefits that, if recognized, would impact the effective rate	$ 202	$ 172	$ 329

INCOME TAXES - Narrative (Detai

INCOME TAXES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2018	Jun. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Tax Reform Act, income tax benefit for reduction of deferred taxes			$ 4
Expense (benefit) from change in tax policy	$ (43)
Tax settlement, amount		$ (221)
Tax credits	314		314	$ 387
Interest and penalties included in unrecognized tax benefits	$ 41		41	23
Interest expense related to unrecognized tax benefits			18	$ (44)	$ 15
Tax Cuts and Jobs Act of 2017, Incomplete Accounting, Transition Tax for Accumulated Foreign Earnings, Provisional Income Tax Expense			13
Tax Cuts and Jobs Act of 2017, Deferred Tax Asset Revaluation Due To Sequestration Fee, Income Tax Expense			$ 20

ACCUMULATED OTHER COMPREHENSI_3

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - Components of AOCI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Mar. 31, 2018	Dec. 31, 2015	Dec. 31, 2014
Equity [Abstract]
Unrealized gains (losses) on investments	$ (484)	$ 581				$ (44)
Defined benefit pension plans	(7)	(51)				(46)
Less: Accumulated other comprehensive (income) loss attributable to non-controlling interest	0	68				86
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity	12,428	19,492	$ 14,528	$ 18,492
AOCI Including Portion Attributable to Noncontrolling Interest [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity	(491)	530				(90)
Defined benefit plans
Accumulated Other Comprehensive Income (Loss) [Line Items]
Cumulative effect of adoption of ASU 2018-02, Reclassification of Certain Tax Effects	(3)
Accumulated other comprehensive income (loss) attributable to AXA Equitable
Accumulated Other Comprehensive Income (Loss) [Line Items]
Equity	(491)	598	(4)		$ 215	$ (4)
Cumulative effect of adoption of ASU 2018-02, Reclassification of Certain Tax Effects	$ 83	$ 0	$ 0

- Changes in AOCI (Details)

- Changes in AOCI (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Other Comprehensive Income (Loss), Tax [Abstract]
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $(310), $244, and $(97))	$ (1,230)	$ 625	$ (233)
Change in defined benefit plans (net of deferred income tax expense (benefit) of $0, $(2) and $(2))	(4)	(5)	(3)
Total other comprehensive income (loss), net of income taxes	(1,234)	620	(236)
Other comprehensive income (loss) from discontinued operations	0	(18)	17
Unrealized gains (losses) on investments
Other Comprehensive Income (Loss), Tax [Abstract]
Net unrealized gains (losses) arising during the year	(1,663)	782	(178)
(Gains) losses reclassified into net income (loss) during the year	(4)	8	2
Net unrealized gains (losses) on investments	(1,667)	790	(176)
Adjustments for policyholders’ liabilities, DAC, insurance liability loss recognition and other	(437)	165	57
Change in unrealized gains (losses), net of adjustments (net of deferred income tax expense (benefit) of $(310), $244, and $(97))	(1,230)	625	(233)
Other Comprehensive Income (Loss), Tax, Parenthetical Disclosures [Abstract]
Other comprehensive income (loss), income tax expense (benefit)	(310)	(244)	(97)
Reclassifications from AOCI, income tax expense (benefit)	(1)	(5)	(1)
Defined benefit pension plans
Other Comprehensive Income (Loss), Tax [Abstract]
Amortization of net (gains) losses included in net periodic cost	(4)	(5)	(3)
Change in defined benefit plans (net of deferred income tax expense (benefit) of $0, $(2) and $(2))	(4)	(5)	(3)
Other Comprehensive Income (Loss), Tax, Parenthetical Disclosures [Abstract]
Other comprehensive income (loss), income tax expense (benefit)	6	(2)	(2)
Accumulated other comprehensive income (loss) attributable to AXA Equitable
Other Comprehensive Income (Loss), Tax [Abstract]
Other comprehensive income (loss) attributable to AXA Equitable	(1,234)	602	(219)
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest
Other Comprehensive Income (Loss), Tax, Parenthetical Disclosures [Abstract]
Reclassifications from AOCI, income tax expense (benefit)	$ 0	$ 2	$ 2

COMMITMENTS AND CONTINGENT LI_3

COMMITMENTS AND CONTINGENT LIABILITIES - Funding Agreements with FHBLNY (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Restructuring Cost and Reserve [Line Items]
Outstanding balance at end of period	$ 3,990	$ 3,000
Issued during the period	7,980	6,762
Repaid during the period	6,990	6,000
Difference related to remaining amortization	11	14
Federal Home Loan Bank of New York Short-Term Funding Agreements Maturing in Less than One Month
Restructuring Cost and Reserve [Line Items]
Outstanding balance at end of period	1,490	500
Issued during the period	7,980	6,000
Repaid during the period	6,990	6,000
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Less than Four Years
Restructuring Cost and Reserve [Line Items]
Outstanding balance at end of period	1,621	1,244
Issued during the period	0	324
Repaid during the period	0
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Less than Five Years
Restructuring Cost and Reserve [Line Items]
Outstanding balance at end of period	98	377
Issued during the period	0	303
Repaid during the period	0
Federal Home Loan Bank of New York Long-Term Funding Agreements Maturing in Greater than Five Years
Restructuring Cost and Reserve [Line Items]
Outstanding balance at end of period	781	879
Issued during the period	0	135
Repaid during the period	0
Federal Home Loan Bank of New York Long-Term Funding Agreements
Restructuring Cost and Reserve [Line Items]
Outstanding balance at end of period	2,500	2,500
Issued during the period	0	762
Repaid during the period	$ 0	$ 0

COMMITMENTS AND CONTINGENT LI_4

COMMITMENTS AND CONTINGENT LIABILITIES - Narrative (Details) $ / policy in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)	Dec. 31, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Feb. 29, 2016$ / policy
Loss Contingencies [Line Items]
Unaccrued amounts of reasonably possible range of losses	$ 95
Future minimum payments under non-cancelable operating leases - 2019	81
Future minimum payments under non-cancelable operating leases - 2020	74
Future minimum payments under non-cancelable operating leases - 2021	69
Future minimum payments under non-cancelable operating leases - 2022	67
Future minimum payments under non-cancelable operating leases - 2023	63
Future minimum payments under non-cancelable operating leases - thereafter	66
Minimum future sublease rental income under non-cancelable operating leases - 2019	12
Minimum future sublease rental income under non-cancelable operating leases - 2020	12
Minimum future sublease rental income under non-cancelable operating leases - 2021	12
Minimum future sublease rental income under non-cancelable operating leases - 2022	12
Minimum future sublease rental income under non-cancelable operating leases - 2023	12
Minimum future sublease rental income under non-cancelable operating leases - thereafter	0
Rent expense	82	$ 78	$ 72
Sublease income	12		$ 16	$ 13
Federal home loan bank stock	190
Carrying value of collateral pledged for federal home loan bank	6,100
Brach Family Foundation Litigation
Loss Contingencies [Line Items]
Current face amount per policy | $ / policy					1
Letter of Credit
Loss Contingencies [Line Items]
Undrawn balance	18
AXA
Loss Contingencies [Line Items]
Commitments by the Company to provide equity financing	927
Commitments under existing mortgage loan agreements	606
Affiliated Entity | AXA
Loss Contingencies [Line Items]
Commitments by the Company to provide equity financing	280
Assets of Consolidated VIEs/VOEs | AXA
Loss Contingencies [Line Items]
Commitments by the Company to provide equity financing	$ 12

INSURANCE GROUP STATUTORY FIN_2

INSURANCE GROUP STATUTORY FINANCIAL INFORMATION - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Insurance Group Statutory Financial Information [Abstract]
Statutory accounting practices, statutory Amount available for dividend payments without regulatory approval	$ 1,000
Insurance Groups statutory net income (loss)	3,120	$ 748	$ 679
Statutory surplus, capital stock and Asset Valuation Reserve	7,900	$ 8,700
Shareholder dividends	1,100		$ 1,100
Securities on deposit with such government or state agencies	55
Extraordinary dividend	1,700
Extraordinary cash dividend	572
Statutory amount available for dividend payments	$ 2,100

DISCONTINUED OPERATIONS - Trans

DISCONTINUED OPERATIONS - Transactions Prior to Distribution (Details) - Alliance Bernstein - Discontinued Operations - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	$ 3,243	$ 3,099	$ 2,804
Base fees
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	2,156	2,025	1,809
Performance-based fees
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	118	95	33
Research services
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	439	450	480
Distribution services
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	419	412	384
Shareholder services
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	76	75	78
Other revenues - other
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Total investment management and service fees	$ 35	$ 42	$ 21

DISCONTINUED OPERATIONS - Incom

DISCONTINUED OPERATIONS - Income Statement Disclosures (Details) - USD ($) $ in Millions	3 Months Ended						6 Months Ended		12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net derivative gains (losses)									$ (1,010)	$ 870	$ (1,337)
Net investment income (loss)									2,478	2,441	2,168
Total other-than-temporary impairment losses									(37)	(13)	(65)
Other investment gains (losses), net									41	(112)	83
Investment gains (losses), net									3	(125)	16
Investment management and service fees									1,029	1,007	951
Other income									65	41	36
Total revenues	$ 4,164	$ 27		$ 1,518	$ 1,621				6,951	8,456	6,043
Compensation and benefits									422	327	364
Commissions and distribution related payments									620	628	635
Interest expense									34	23	13
Other operating costs and expenses									2,918	635	753
Total benefits and other deductions	$ 1,879	$ 763		$ 1,420	$ 1,708				8,432	6,907	6,083
Net income (loss) from discontinued operations, net of taxes									114	85	66
Less: net (income) loss attributable to the noncontrolling interest									3	(1)	0
Net income (loss) attributable to AXA Equitable									(918)	2,843	190
Alliance Bernstein | Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net derivative gains (losses)									12	(24)	(16)
Net investment income (loss)									24	142	150
Other investment gains (losses), net									0	0	(2)
Investment gains (losses), net									0	0	(2)
Investment management and service fees									3,243	3,099	2,804
Total revenues									3,279	3,217	2,936
Compensation and benefits									1,370	1,307	1,231
Commissions and distribution related payments									427	415	372
Interest expense									8	6	3
Other operating costs and expenses									727	789	699
Total benefits and other deductions									2,532	2,517	2,305
Income (loss) from discontinued operations, before income taxes									747	700	631
Income tax expense (benefit)									(69)	82	(69)
Net income (loss) from discontinued operations, net of taxes									678	618	562
Less: net (income) loss attributable to the noncontrolling interest			$ (154)			$ (118)	$ (310)	$ (231)	(564)	(533)	(496)
Net income (loss) attributable to AXA Equitable									$ 114	$ 85	$ 66

DISCONTINUED OPERATIONS - Balan

DISCONTINUED OPERATIONS - Balance Sheet Disclosures (Details) - USD ($) $ in Millions	Dec. 31, 2018	Dec. 31, 2017
Investments:
Cash and cash equivalents	$ 0
Total Assets of Disposed Subsidiary	0	$ 9,835
LIABILITIES
Total Liabilities of Disposed Subsidiary	0	4,954
Redeemable noncontrolling interest of disposed subsidiary	$ 0	602
Alliance Bernstein | Discontinued Operations
Investments:
Other equity investments		87
Trading securities, at fair value		351
Other invested assets		1,291
Total investments		1,729
Cash and cash equivalents		1,009
Cash and securities segregated, at fair value		816
Broker-dealer related receivables		2,158
Intangible assets, net		3,709
Other assets		414
Total Assets of Disposed Subsidiary		9,835
LIABILITIES
Broker-dealer related payables		334
Customer related payables		2,229
Long-term debt		566
Current and deferred income taxes		404
Other liabilities		1,421
Total Liabilities of Disposed Subsidiary		4,954
Redeemable noncontrolling interest of disposed subsidiary		$ 602

DISCONTINUED OPERATIONS - Narra

DISCONTINUED OPERATIONS - Narrative (Details) $ in Millions	12 Months Ended
	Dec. 31, 2018USD ($)
Discontinued Operations and Disposal Groups [Abstract]
Extraordinary cash dividend	$ 572

QUARTERLY FINANCIAL INFORMATI_3

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) (Details) - USD ($) $ in Millions	3 Months Ended				12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Dec. 31, 2017	Sep. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Quarterly Financial Data [Abstract]
Total revenues	$ 4,164	$ 27	$ 1,518	$ 1,621	$ 6,951	$ 8,456	$ 6,043
Total benefits and other deductions	1,879	763	1,420	1,708	8,432	6,907	6,083
Net income (loss)	$ 1,936	$ (509)	$ 1,515	$ 23	$ (921)	$ 2,844	$ 190

QUARTERLY FINANCIAL INFORMATI_4

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) - Summary of Quarterly Information (Details) - USD ($) $ in Millions	3 Months Ended								6 Months Ended		12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Schedule of Error Correction, Change in Accounting Principal and Prior Period Adjustments Restatement [Line Items]
Total revenues	$ 4,164	$ 27			$ 1,518	$ 1,621					$ 6,951	$ 8,456	$ 6,043
Total benefits and other deductions	1,879	763			1,420	1,708					8,432	6,907	6,083
Net income (loss)	$ 1,936	$ (509)			$ 1,515	$ 23					$ (921)	2,844	190
As Previously Reported
Schedule of Error Correction, Change in Accounting Principal and Prior Period Adjustments Restatement [Line Items]
Total revenues			$ 2,439	$ 2,031			$ 4,548	$ 2,314	$ 4,387	$ 6,823		11,733	9,138
Total benefits and other deductions			4,950	2,115			2,516	2,489	7,100	4,966		9,478	8,516
Net income (loss)			$ (1,958)	$ (40)			$ 1,613	$ (54)	$ (2,091)	$ 1,559		$ 3,394	$ 706

REVISION OF PRIOR PERIOD FINA_3

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Balance Sheets (Details) - USD ($) $ in Millions	Dec. 31, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
ASSETS
Other equity investments	$ 1,144			$ 1,264
Trading securities, at fair value	15,166			12,277
Other invested assets	1,554			1,830
Total investments	74,916			66,369
Cash and cash equivalents	2,622			2,400			$ 1,944	$ 2,467
Cash and securities segregated, at fair value	0			9
Deferred policy acquisition costs	5,011			4,492			5,025	$ 5,079
Amounts due from reinsurers	3,124			5,079
Current and deferred income taxes	438			0
Loans to affiliates	600			703
Guaranteed minimum income benefit reinsurance asset, at fair value	1,991			10,488
Other assets	2,763			4,018
Assets of disposed subsidiary	0			9,835
Total Assets	199,952			225,930
LIABILITIES
Policyholders' account balances	46,403			43,805
Future policy benefits and other policyholders' liabilities	29,808			29,070
Broker-dealer related payables	69			430
Current and deferred income taxes	0			1,550
Other liabilities	1,460			1,242
Liabilities of disposed subsidiary	0			4,954
Total Liabilities	187,485			205,812
Redeemable noncontrolling interest:
Continuing operations	39			24
Disposed subsidiary	0			602
EQUITY
Retained earnings	5,098		$ 8,683	8,938
Accumulated other comprehensive income (loss)	(491)			598
AXA Equitable Equity	12,416		15,404	16,397
Noncontrolling interest	12			3,095
Equity	12,428		18,492	19,492			$ 14,528
Total Liabilities, Redeemable Noncontrolling Interest and Equity	$ 199,952		222,305	225,930
As Previously Reported
ASSETS
Deferred policy acquisition costs		$ 4,786	4,826	4,547	$ 4,913	$ 4,961
Amounts due from reinsurers		3,088
Current and deferred income taxes		159
Total Assets		219,306	222,424	225,985	215,713	210,013
LIABILITIES
Future policy benefits and other policyholders' liabilities		28,122	28,374	29,034	29,679	28,691
Current and deferred income taxes			1,728	1,973	3,267	2,726
Other liabilities			3,041
Total Liabilities		202,196	202,767	205,795	199,095	195,091
EQUITY
Retained earnings		6,617	8,824	9,010	7,479	5,978
AXA Equitable Equity		13,925	15,545	16,469	13,273	11,459
Noncontrolling interest						3,046
Equity		16,964	18,633	19,564	16,257	14,505
Total Liabilities, Redeemable Noncontrolling Interest and Equity		219,306	222,424	225,985	215,713	210,013
Discontinued Ops Adjustment
ASSETS
Deferred policy acquisition costs		0	0	0	0	0
Amounts due from reinsurers		0
Current and deferred income taxes		422
Total Assets		0	0	0	0	0
LIABILITIES
Future policy benefits and other policyholders' liabilities		0	0	0	0	0
Current and deferred income taxes			(432)	(404)	(542)	(562)
Other liabilities			(1,941)
Total Liabilities		0	0	0	0	0
EQUITY
Retained earnings		0	0	0	0	0
AXA Equitable Equity		0	0	0	0	0
Noncontrolling interest						0
Equity		0	0	0	0	0
Total Liabilities, Redeemable Noncontrolling Interest and Equity		0	0	0	0	0
As Adjusted
ASSETS
Deferred policy acquisition costs		4,786	4,826	4,547	4,913	4,961
Amounts due from reinsurers		3,088
Current and deferred income taxes		581
Total Assets		219,306	222,424	225,985	215,713	210,013
LIABILITIES
Future policy benefits and other policyholders' liabilities		28,122	28,374	29,034	29,679	28,691
Current and deferred income taxes			1,296	1,569	2,725	2,164
Other liabilities			1,100
Total Liabilities		202,196	202,767	205,795	199,095	195,091
EQUITY
Retained earnings		6,617	8,824	9,010	7,479	5,978
AXA Equitable Equity		13,925	15,545	16,469	13,273	11,459
Noncontrolling interest						3,046
Equity		16,964	18,633	19,564	16,257	14,505
Total Liabilities, Redeemable Noncontrolling Interest and Equity		219,306	222,424	225,985	215,713	210,013
Impact of Revisions
ASSETS
Deferred policy acquisition costs		(76)	(119)	(55)	(63)	(64)
Amounts due from reinsurers		(9)
Current and deferred income taxes		3
Total Assets		(82)	(119)	(55)	(63)	(64)
LIABILITIES
Future policy benefits and other policyholders' liabilities		(64)	(10)	36	53	66
Current and deferred income taxes			(38)	(19)	(39)	(46)
Other liabilities			70
Total Liabilities		(64)	22	17	14	20
EQUITY
Retained earnings		(18)	(141)	(72)	(77)	(84)
AXA Equitable Equity		(18)	(141)	(72)	(77)	(84)
Noncontrolling interest						0
Equity		(18)	(141)	(72)	(77)	(84)
Total Liabilities, Redeemable Noncontrolling Interest and Equity		(82)	(119)	(55)	(63)	(64)
As Adjusted and Revised
ASSETS
Deferred policy acquisition costs		4,710	4,707	4,492	4,850	4,897
Amounts due from reinsurers		3,079
Current and deferred income taxes		584
Total Assets		219,224	222,305	225,930	215,650	209,949
LIABILITIES
Future policy benefits and other policyholders' liabilities		28,058	28,364	29,070	29,732	28,757
Current and deferred income taxes			1,258	1,550	2,686	2,118
Other liabilities			1,170
Total Liabilities		202,132	202,789	205,812	199,109	195,111
EQUITY
Retained earnings		6,599		8,938	7,402	5,894
AXA Equitable Equity		13,907		16,397	13,196	11,375
Noncontrolling interest						3,046
Equity		16,946	$ 18,492	19,492	16,180	14,421
Total Liabilities, Redeemable Noncontrolling Interest and Equity		$ 219,224		$ 225,930	$ 215,650	$ 209,949

QUARTERLY FINANCIAL INFORMATI_5

QUARTERLY FINANCIAL INFORMATION (UNAUDITED) - Revised Statements of Cash Flow (Details) - USD ($)		3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
		Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Cash flow from operating activities:
Net income (loss)		$ 1,936,000,000	$ (509,000,000)			$ 1,515,000,000	$ 23,000,000							$ (921,000,000)	$ 2,844,000,000	$ 190,000,000
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances														1,002,000,000	921,000,000	905,000,000
Policy charges and fee income														(3,523,000,000)	(3,294,000,000)	(3,311,000,000)
Net derivative (gains) losses														1,010,000,000	(870,000,000)	1,337,000,000
Amortization of deferred cost of reinsurance asset														1,882,000,000	(84,000,000)	159,000,000
Other amortization and depreciation	[1]													340,000,000	825,000,000	614,000,000
Equity (income) loss from limited partnerships														(120,000,000)	(157,000,000)	(91,000,000)
Changes in:
Net broker-dealer and customer related receivables/payables														838,000,000	(278,000,000)	608,000,000
Capitalization of deferred policy acquisition costs	[1]													(597,000,000)	(578,000,000)	(594,000,000)
Future policy benefits														(284,000,000)	1,189,000,000	431,000,000
Current and deferred income taxes														(556,000,000)	(1,174,000,000)	(753,000,000)
Other, net	[1]													810,000,000	486,000,000	56,000,000
Net cash provided by (used in) operating activities														1,418,000,000	(381,000,000)	(461,000,000)
Cash flows from investing activities:
Trading account securities														9,298,000,000	9,125,000,000	6,271,000,000
Real estate joint ventures														139,000,000	0	0
Other														190,000,000	228,000,000	32,000,000
Short term investments	[1]													(1,852,000,000)	(2,456,000,000)	(3,187,000,000)
Change in short-term investments																0
Cash settlements related to derivative instruments														805,000,000	(1,259,000,000)	102,000,000
Other, net	[1]													(91,000,000)	322,000,000	407,000,000
Short-term investments	[1]													2,315,000,000	2,204,000,000	2,984,000,000
Net cash provided by (used in) investing activities														(4,806,000,000)	(8,914,000,000)	(5,358,000,000)
Cash flows from financing activities:
Deposits														9,365,000,000	9,334,000,000	9,746,000,000
Withdrawals														(4,496,000,000)	(3,926,000,000)	(2,874,000,000)
Transfer (to) from Separate Accounts														1,809,000,000	1,566,000,000	1,202,000,000
Net cash provided by (used in) financing activities														2,613,000,000	9,732,000,000	5,751,000,000
Effect of exchange rate changes on cash and cash equivalents														(12,000,000)	22,000,000	(10,000,000)
Change in cash and cash equivalents														(787,000,000)	459,000,000	(78,000,000)
Cash and cash equivalents		2,622,000,000				$ 2,400,000,000								2,622,000,000	2,400,000,000	1,944,000,000	$ 2,467,000,000
Other, net														11,000,000	(10,000,000)	8,000,000
Net cash provided by (used in) operating activities														1,137,000,000	715,000,000	1,041,000,000
Net cash provided by (used in) investing activities														(102,000,000)	(297,000,000)	323,000,000
Net cash provided by (used in) financing activities														(1,360,000,000)	(437,000,000)	(909,000,000)
Effect of exchange rate changes on cash and cash equivalents														(12,000,000)	22,000,000	(10,000,000)
Cash and cash equivalents		$ 0												$ 0
As Previously Reported
Cash flow from operating activities:
Net income (loss)				$ (1,958,000,000)	$ (40,000,000)			$ 1,613,000,000	$ (54,000,000)	$ (2,091,000,000)	$ 1,559,000,000				3,394,000,000	706,000,000
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances					338,000,000			208,000,000	279,000,000						1,040,000,000	1,029,000,000
Policy charges and fee income				(904,000,000)	(869,000,000)			(846,000,000)	(852,000,000)	(1,773,000,000)	(1,698,000,000)				(3,334,000,000)	(3,344,000,000)
Net derivative (gains) losses				$ 312,000,000	777,000,000			$ (1,763,000,000)	362,000,000	1,172,000,000	(1,362,000,000)				(890,000,000)	1,211,000,000
Amortization of deferred cost of reinsurance asset					7,000,000				9,000,000	13,000,000	17,000,000	$ 17,000,000			32,000,000	41,000,000
Other amortization and depreciation					(23,000,000)				36,000,000	(45,000,000)	(61,000,000)	(60,000,000)	$ (67,000,000)		(136,000,000)	(98,000,000)
Amortization of Intangible Assets					8,000,000				8,000,000						31,000,000	29,000,000
Distributions from joint ventures and limited partnerships					25,000,000				26,000,000	44,000,000	50,000,000	63,000,000	94,000,000		140,000,000
Equity (income) loss from limited partnerships					0				0	0	0	0	0		0	0
Changes in:
Reinsurance recoverable					2,000,000
Deferred policy acquisition costs					10,000,000				29,000,000	89,000,000	43,000,000	(129,000,000)	42,000,000		268,000,000	52,000,000
Capitalization of deferred policy acquisition costs					0				0	0	(63,000,000)	0	0		0	0
Future policy benefits					(191,000,000)				241,000,000	396,000,000	1,303,000,000	(58,000,000)	1,146,000,000		1,511,000,000
Current and deferred income taxes					(52,000,000)				(188,000,000)	(645,000,000)	204,000,000	(264,000,000)	640,000,000		(664,000,000)	(742,000,000)
Other, net					(122,000,000)				151,000,000	416,000,000	84,000,000	123,000,000	617,000,000		189,000,000	(161,000,000)
Net cash provided by (used in) operating activities					(21,000,000)				18,000,000	1,190,000,000	(75,000,000)	1,614,000,000	994,000,000		1,077,000,000	(461,000,000)
Cash flows from investing activities:
Trading account securities					1,606,000,000					4,843,000,000		6,913,000,000
Real estate joint ventures					0					0		0
Other					54,000,000					260,000,000		344,000,000
Short term investments					0				0	0	0		0		0	0
Change in short-term investments					396,000,000				254,000,000	248,000,000	(508,000,000)	350,000,000	(266,000,000)		(264,000,000)	(205,000,000)
Cash settlements related to derivative instruments					(14,000,000)					(267,000,000)		(584,000,000)
Other, net					(560,000,000)				43,000,000	379,000,000	243,000,000	305,000,000	(258,000,000)		238,000,000	409,000,000
Short-term investments					0				0	0	0	0	0
Net cash provided by (used in) investing activities					(639,000,000)				(2,447,000,000)	(1,605,000,000)	(3,588,000,000)	(2,990,000,000)	(5,231,000,000)		(9,010,000,000)	(5,358,000,000)
Cash flows from financing activities:
Deposits					2,366,000,000				2,240,000,000	5,227,000,000	4,109,000,000	7,852,000,000	5,871,000,000		9,882,000,000
Withdrawals					(1,322,000,000)				(785,000,000)	(2,611,000,000)	(1,557,000,000)	(4,014,000,000)	(2,574,000,000)		(5,926,000,000)
Transfer (to) from Separate Accounts					(115,000,000)				176,000,000	(305,000,000)	767,000,000	(338,000,000)	1,617,000,000		1,656,000,000
Net cash provided by (used in) financing activities					1,040,000,000				2,306,000,000		4,182,000,000	1,293,000,000	5,460,000,000		8,370,000,000
Effect of exchange rate changes on cash and cash equivalents																(10,000,000)
Change in cash and cash equivalents																(78,000,000)
Presentation Reclassifications
Cash flow from operating activities:
Net income (loss)					0				0	0	0				0	0
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances					0				0						0	0
Policy charges and fee income					0				0	0	0				0	0
Net derivative (gains) losses					0				0	0	0				0	0
Amortization of deferred cost of reinsurance asset					(7,000,000)				(9,000,000)	(13,000,000)	(17,000,000)	(17,000,000)			(32,000,000)	(41,000,000)
Other amortization and depreciation					23,000,000				(36,000,000)	45,000,000	61,000,000	60,000,000	67,000,000		907,000,000	98,000,000
Amortization of Intangible Assets					(8,000,000)				(8,000,000)						(31,000,000)	(29,000,000)
Distributions from joint ventures and limited partnerships					(25,000,000)				(26,000,000)	(44,000,000)	(50,000,000)	(63,000,000)	(94,000,000)		(140,000,000)
Equity (income) loss from limited partnerships					(39,000,000)				(39,000,000)	(60,000,000)	(65,000,000)	(83,000,000)	(103,000,000)		(157,000,000)	(91,000,000)
Changes in:
Reinsurance recoverable					0
Deferred policy acquisition costs					(10,000,000)				(29,000,000)	(89,000,000)	(43,000,000)	129,000,000	(42,000,000)		(268,000,000)	(52,000,000)
Capitalization of deferred policy acquisition costs					(135,000,000)				(148,000,000)	(280,000,000)	(235,000,000)	(432,000,000)	(433,000,000)		(578,000,000)	(594,000,000)
Future policy benefits					0				0	0	0	0	0		0
Current and deferred income taxes					0				0	0	0	0	0		0	0
Other, net					64,000,000				65,000,000	104,000,000	115,000,000	146,000,000	197,000,000		297,000,000	217,000,000
Net cash provided by (used in) operating activities					0				(1,000,000)	(2,000,000)	(1,000,000)	(2,000,000)	(1,000,000)		(2,000,000)	0
Cash flows from investing activities:
Trading account securities					0					0		0
Real estate joint ventures					140,000,000					140,000,000		140,000,000
Other					(140,000,000)					(140,000,000)		(140,000,000)
Short term investments					(377,000,000)				(376,000,000)	(1,081,000,000)	(1,599,000,000)		(2,174,000,000)		(2,456,000,000)	(3,187,000,000)
Change in short-term investments					(311,000,000)				(254,000,000)	(248,000,000)	522,000,000	(274,000,000)	266,000,000		254,000,000	205,000,000
Cash settlements related to derivative instruments					0					0		0
Other, net					0				0	0	0	0	0		0	(2,000,000)
Short-term investments					688,000,000				631,000,000	1,331,000,000	1,078,000,000	(1,530,000,000)	1,909,000,000
Net cash provided by (used in) investing activities					0				1,000,000	2,000,000	1,000,000	2,000,000	1,000,000		2,000,000	0
Cash flows from financing activities:
Deposits					0				0	0	0	0	0		0
Withdrawals					0				0	0	0	0	0		0
Transfer (to) from Separate Accounts					0				0	0	0	0	0		0
Net cash provided by (used in) financing activities					0				0		0	0	0		0
Effect of exchange rate changes on cash and cash equivalents																0
Change in cash and cash equivalents																0
Revisions
Cash flow from operating activities:
Net income (loss)					(69,000,000)				(29,000,000)	54,000,000	(21,000,000)				(17,000,000)	(20,000,000)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances					(83,000,000)				(30,000,000)						(119,000,000)	(124,000,000)
Policy charges and fee income					8,000,000				22,000,000	29,000,000	34,000,000				40,000,000	33,000,000
Net derivative (gains) losses					38,000,000				(7,000,000)	(72,000,000)	(54,000,000)				20,000,000	126,000,000
Amortization of deferred cost of reinsurance asset					0				0	0	0	0			0	0
Other amortization and depreciation					0				0	0	0	0	0		54,000,000	0
Amortization of Intangible Assets					0				0						0	0
Distributions from joint ventures and limited partnerships					0				0	0	0	0	0		0
Equity (income) loss from limited partnerships					0				0	0	0	0	0		0	0
Changes in:
Reinsurance recoverable					(149,000,000)
Deferred policy acquisition costs					0				0	0	0	0	0		0	0
Capitalization of deferred policy acquisition costs					0				0	0	0	0	0		0	0
Future policy benefits					(7,000,000)				17,000,000	(554,000,000)	45,000,000	(541,000,000)	168,000,000		(322,000,000)
Current and deferred income taxes					132,000,000				(6,000,000)	167,000,000	3,000,000	(400,000,000)	(389,000,000)		(510,000,000)	(11,000,000)
Other, net					70,000,000				0	(304,000,000)	0	179,000,000	0		0	0
Net cash provided by (used in) operating activities					4,000,000				(143,000,000)	(319,000,000)	(285,000,000)	(502,000,000)	(676,000,000)		(1,456,000,000)	0
Cash flows from investing activities:
Trading account securities					77,000,000					24,000,000		77,000,000
Real estate joint ventures					0					0		0
Other					0					0		0
Short term investments					0				(289,000,000)	205,000,000	0		0		0	0
Change in short-term investments					(85,000,000)				0	0	(14,000,000)	(77,000,000)	0		10,000,000	0
Cash settlements related to derivative instruments					(489,000,000)					(489,000,000)		(492,000,000)
Other, net					153,000,000				100,000,000	11,000,000	(197,000,000)	(19,000,000)	203,000,000		84,000,000	0
Short-term investments					0				0	(24,000,000)	0	204,000,000	0
Net cash provided by (used in) investing activities					(344,000,000)				(189,000,000)	(273,000,000)	(211,000,000)	(307,000,000)	203,000,000		94,000,000	0
Cash flows from financing activities:
Deposits					(468,000,000)				269,000,000	(1,107,000,000)	784,000,000	(1,668,000,000)	1,116,000,000		(548,000,000)
Withdrawals					241,000,000				(157,000,000)	480,000,000	(284,000,000)	760,000,000	(244,000,000)		2,000,000,000
Transfer (to) from Separate Accounts					567,000,000				220,000,000	1,219,000,000	(4,000,000)	1,717,000,000	(399,000,000)		(90,000,000)
Net cash provided by (used in) financing activities					340,000,000				332,000,000		496,000,000	809,000,000	473,000,000		1,362,000,000
Effect of exchange rate changes on cash and cash equivalents																0
Change in cash and cash equivalents																0
As Revised
Cash flow from operating activities:
Net income (loss)					(109,000,000)				(83,000,000)	(2,037,000,000)	1,538,000,000
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances					255,000,000				249,000,000
Policy charges and fee income					(861,000,000)				(830,000,000)	(1,744,000,000)	(1,664,000,000)
Net derivative (gains) losses					815,000,000				355,000,000	1,100,000,000	(1,416,000,000)
Amortization of deferred cost of reinsurance asset					0				0	0	0	0
Other amortization and depreciation					0				0	0	0	0	0
Amortization of Intangible Assets					0				0
Distributions from joint ventures and limited partnerships					0				0	0	0	0	0
Equity (income) loss from limited partnerships					(39,000,000)				(39,000,000)	(60,000,000)	(65,000,000)	(83,000,000)	(103,000,000)
Changes in:
Reinsurance recoverable					(147,000,000)
Deferred policy acquisition costs					0				0	0	0	0	0
Capitalization of deferred policy acquisition costs					(135,000,000)				(148,000,000)	(280,000,000)	(298,000,000)	(432,000,000)	(433,000,000)
Future policy benefits					(198,000,000)				258,000,000	(158,000,000)	1,348,000,000	(599,000,000)	1,314,000,000
Current and deferred income taxes					80,000,000				(194,000,000)	(478,000,000)	207,000,000	(664,000,000)	251,000,000
Other, net					12,000,000				216,000,000	216,000,000	199,000,000	448,000,000	814,000,000
Net cash provided by (used in) operating activities					(17,000,000)				(126,000,000)	869,000,000	(361,000,000)	1,110,000,000	317,000,000
Cash flows from investing activities:
Trading account securities					1,683,000,000					4,867,000,000		6,990,000,000
Real estate joint ventures					140,000,000					140,000,000		140,000,000
Other					(86,000,000)					120,000,000		204,000,000
Short term investments					(377,000,000)				(665,000,000)	(876,000,000)	(1,599,000,000)		(2,174,000,000)
Change in short-term investments					0				0	0	0	(1,000,000)	0
Cash settlements related to derivative instruments					(503,000,000)					(756,000,000)		(1,076,000,000)
Other, net					(407,000,000)				143,000,000	390,000,000	46,000,000	286,000,000	(55,000,000)
Short-term investments					688,000,000				631,000,000	1,307,000,000	1,078,000,000	(1,326,000,000)	1,909,000,000
Net cash provided by (used in) investing activities					(983,000,000)				(2,635,000,000)	(1,876,000,000)	(3,798,000,000)	(3,295,000,000)	(5,027,000,000)
Cash flows from financing activities:
Deposits					1,898,000,000				2,509,000,000	4,120,000,000	4,893,000,000	6,184,000,000	6,987,000,000
Withdrawals					(1,081,000,000)				(942,000,000)	(2,131,000,000)	(1,841,000,000)	(3,254,000,000)	(2,818,000,000)
Transfer (to) from Separate Accounts					452,000,000				396,000,000	$ 914,000,000	763,000,000	1,379,000,000	1,218,000,000
Net cash provided by (used in) financing activities					$ 1,380,000,000				$ 2,638,000,000		$ 4,678,000,000	$ 2,102,000,000	$ 5,933,000,000
As Revised And Adjusted Herein Member
Cash flow from operating activities:
Net income (loss)															3,377,000,000	686,000,000
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Interest credited to policyholders’ account balances															921,000,000	905,000,000
Policy charges and fee income															(3,294,000,000)	(3,311,000,000)
Net derivative (gains) losses															(870,000,000)	1,337,000,000
Amortization of deferred cost of reinsurance asset															0	0
Other amortization and depreciation															825,000,000	0
Amortization of Intangible Assets															0	0
Distributions from joint ventures and limited partnerships															0
Equity (income) loss from limited partnerships															(157,000,000)	(91,000,000)
Changes in:
Deferred policy acquisition costs															0	0
Capitalization of deferred policy acquisition costs															(578,000,000)	(594,000,000)
Future policy benefits															1,189,000,000
Current and deferred income taxes															(1,174,000,000)	(753,000,000)
Other, net															486,000,000	$ 56,000,000
Net cash provided by (used in) operating activities															(381,000,000)
Cash flows from investing activities:
Short term investments															(2,456,000,000)
Change in short-term investments															0
Other, net															322,000,000
Net cash provided by (used in) investing activities															(8,914,000,000)
Cash flows from financing activities:
Deposits															9,334,000,000
Withdrawals															(3,926,000,000)
Transfer (to) from Separate Accounts															1,566,000,000
Net cash provided by (used in) financing activities															$ 9,732,000,000
[1]	Prior period amounts have been reclassified to conform to current period presentation. See Note 20 for further information.

REVISION OF PRIOR PERIOD FINA_4

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Income Statement and Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended								6 Months Ended		12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Revenues:
Policy charges and fee income											$ 3,523	$ 3,294	$ 3,311
Net derivative gains (losses)											(1,010)	870	(1,337)
Net investment income (loss)											2,478	2,441	2,168
Other investment gains (losses), net											41	(112)	83
Total investment gains (losses), net											3	(125)	16
Investment management and service fees											1,029	1,007	951
Other income											65	41	36
Premiums											862	904	880
Total revenues	$ 4,164	$ 27			$ 1,518	$ 1,621					6,951	8,456	6,043
Benefits and other deductions:
Policyholders’ benefits											3,005	3,473	2,771
Interest credited to policyholder's account balances											1,002	921	905
Compensation and benefits											422	327	364
Commissions and distribution related payments											620	628	635
Interest expense											34	23	13
Amortization of deferred policy acquisition costs											431	900	642
Other operating costs and expenses											2,918	635	753
Total benefits and other deductions	1,879	763			1,420	1,708					8,432	6,907	6,083
Income (loss) from continuing operations, before income taxes											(1,481)	1,549	(40)
Income tax (expense) benefit											446	1,210	164
Net income (loss) from discontinued operations, net of taxes and noncontrolling interest											114	85	66
Net income (loss) from continuing operations											(1,035)	2,759	124
Net income (loss)	$ 1,936	$ (509)			$ 1,515	$ 23					(921)	2,844	190
Less: net (income) loss attributable to the noncontrolling interest											3	(1)	0
Net income (loss) attributable to AXA Equitable											(918)	2,843	190
Statement of Comprehensive Income [Abstract]
Change in unrealized gains (losses), net of reclassification adjustment											(1,230)	625	(233)
Other comprehensive income (loss) from discontinued operations											0	(18)	17
Other comprehensive income (loss)											(1,234)	602	(219)
Comprehensive income (loss) attributable to AXA Equitable											$ (2,155)	3,446	(29)
As Previously Reported
Revenues:
Policy charges and fee income			$ 904	$ 869			$ 846	$ 852	$ 1,773	$ 1,698		3,334	3,344
Net derivative gains (losses)			(312)	(777)			1,763	(362)	(1,172)	1,362		890	(1,211)
Total revenues			2,439	2,031			4,548	2,314	4,387	6,823		11,733	9,138
Benefits and other deductions:
Policyholders’ benefits			1,339	489			1,363	975	1,828	2,338		3,462
Interest credited to policyholder's account balances				338			208	279				1,040	1,029
Compensation and benefits			466	456			450	438	992	888		1,762	1,723
Commissions and distribution related payments			377	371			389	382	748	771		1,486	1,467
Amortization of deferred policy acquisition costs			31	10			(49)	29	89	(20)		268	52
Other operating costs and expenses			2,486	440			149	381	2,926	530		1,431	1,458
Total benefits and other deductions			4,950	2,115			2,516	2,489	7,100	4,966		9,478	8,516
Income (loss) from continuing operations, before income taxes			(2,511)	(84)			2,032	(175)	(2,713)	1,857		2,255	622
Income tax (expense) benefit			553	44			(419)	121	622	(298)		1,139	84
Net income (loss) from continuing operations			(1,958)	(40)			1,613	(54)	(2,091)	1,559		3,394	706
Net income (loss)			(1,958)	(40)			1,613	(54)	(2,091)	1,559		3,394	706
Net income (loss) attributable to AXA Equitable			(2,114)	(194)			1,500	(172)	(2,401)	1,328		2,860	210
Statement of Comprehensive Income [Abstract]
Change in unrealized gains (losses), net of reclassification adjustment								92		386		563	(194)
Other comprehensive income (loss)								127		401		599	(215)
Comprehensive income (loss)			(2,278)	(789)			1,887	73	(3,160)			3,993	491
Comprehensive income (loss) attributable to AXA Equitable			(2,420)	(950)			1,794	(52)	(3,463)	1,742		3,441	12
Gross DAC Adjustment
Revenues:
Policy charges and fee income			0	0			0	0	0	0		0	0
Net derivative gains (losses)			0	0			0	0	0	0		0	0
Total revenues			0	0			0	0	0	0		0	0
Benefits and other deductions:
Policyholders’ benefits			0	0			0	0	0	0		0
Interest credited to policyholder's account balances				0			0	0				0	0
Compensation and benefits			(32)	(33)			(32)	(33)	(65)	(65)		(128)	(128)
Commissions and distribution related payments			(112)	(101)			(116)	(114)	(213)	(230)		(443)	(460)
Amortization of deferred policy acquisition costs			145	135			150	148	280	298		578	594
Other operating costs and expenses			(1)	(1)			(2)	(1)	(2)	(3)		(7)	(6)
Total benefits and other deductions			0	0			0	0	0	0		0	0
Income (loss) from continuing operations, before income taxes			0	0			0	0	0	0		0	0
Income tax (expense) benefit			0	0			0	0	0	0		0	0
Net income (loss) from continuing operations			0	0			0	0	0	0		0	0
Net income (loss)			0	0			0	0	0	0		0	0
Net income (loss) attributable to AXA Equitable			0	0			0	0	0	0		0	0
Discontinued Ops Adjustment
Revenues:
Policy charges and fee income			0	0			0	0	0	0		0	0
Net derivative gains (losses)			0	(2)			5	10	(2)	15		24	16
Total revenues			(824)	(846)			(781)	(745)	(1,670)	(1,526)		(3,217)	(2,936)
Benefits and other deductions:
Policyholders’ benefits			0	0			0	0	0	0		0
Interest credited to policyholder's account balances				0			0	0				0	0
Compensation and benefits			(360)	(344)			(328)	(322)	(704)	(650)		(1,307)	(1,231)
Commissions and distribution related payments			(106)	(110)			(103)	(96)	(216)	(199)		(415)	(372)
Amortization of deferred policy acquisition costs			1	0			0	0	1	0		0	0
Other operating costs and expenses			(172)	(189)			(208)	(179)	(361)	(387)		(789)	(699)
Total benefits and other deductions			(639)	(645)			(641)	(598)	(1,284)	(1,239)		(2,517)	(2,305)
Income (loss) from continuing operations, before income taxes			(185)	(201)			(140)	(147)	(386)	(287)		(700)	(631)
Income tax (expense) benefit			8	17			11	11	25	22		(111)	69
Net income (loss) from continuing operations			(177)	(184)			(129)	(136)	(361)	(265)		(811)	(562)
Net income (loss)			(156)	(155)			(113)	(118)	(311)	(231)		(533)	(496)
Net income (loss) attributable to AXA Equitable			0	0			0	0	0	0		0	0
Statement of Comprehensive Income [Abstract]
Change in unrealized gains (losses), net of reclassification adjustment								0		0		0	0
Other comprehensive income (loss)								(7)		13		(18)	17
Comprehensive income (loss)			(142)	(162)			(93)	(125)	(305)			(551)	(479)
Comprehensive income (loss) attributable to AXA Equitable			0	0			0	0	0	0		0	0
As Adjusted
Revenues:
Policy charges and fee income			904	869			846	852	1,773	1,698		3,334	3,344
Net derivative gains (losses)			(312)	(779)			1,768	(352)	(1,174)	1,377		914	(1,195)
Total revenues			1,615	1,185			3,767	1,569	2,717	5,297		8,516	6,202
Benefits and other deductions:
Policyholders’ benefits			1,339	489			1,363	975	1,828	2,338		3,462
Interest credited to policyholder's account balances				338			208	279				1,040	1,029
Compensation and benefits			74	79			90	83	223	173		327	364
Commissions and distribution related payments			159	160			170	172	319	342		628	635
Amortization of deferred policy acquisition costs			177	145			101	177	370	278		846	646
Other operating costs and expenses			2,313	250			(61)	201	2,563	140		635	753
Total benefits and other deductions			4,311	1,470			1,875	1,891	5,816	3,727		6,961	6,211
Income (loss) from continuing operations, before income taxes			(2,696)	(285)			1,892	(322)	(3,099)	1,570		1,555	(9)
Income tax (expense) benefit			561	61			(408)	132	647	(276)		1,028	153
Net income (loss) from continuing operations			(2,135)	(224)			1,484	(190)	(2,452)	1,294		2,583	144
Net income (loss)			(2,114)	(195)			1,500	(172)	(2,402)	1,328		2,861	210
Net income (loss) attributable to AXA Equitable			(2,114)	(194)			1,500	(172)	(2,401)	1,328		2,860	210
Statement of Comprehensive Income [Abstract]
Change in unrealized gains (losses), net of reclassification adjustment								92		386		563	(194)
Other comprehensive income (loss)								120		414		581	(198)
Comprehensive income (loss)			(2,420)	(951)			1,794	(52)	(3,465)			3,442	12
Comprehensive income (loss) attributable to AXA Equitable			(2,420)	(950)			1,794	(52)	(3,463)	1,742		3,441	12
Impact of Revisions
Revenues:
Policy charges and fee income			(21)	(8)			(12)	(22)	(29)	(34)		(40)	(33)
Net derivative gains (losses)			27	(38)			8	7	72	54		(20)	(126)
Total revenues			6	(46)			(4)	(15)	43	20		(60)	(159)
Benefits and other deductions:
Policyholders’ benefits			(38)	(9)			(7)	(3)	(47)	(10)		11
Interest credited to policyholder's account balances				(83)			(9)	(30)				(119)	(124)
Compensation and benefits			0	70			0	0	0	0		0	0
Commissions and distribution related payments			0	0			0	0	0	0		0	0
Amortization of deferred policy acquisition costs			5	64			(1)	63	21	62		54	(4)
Other operating costs and expenses			0	0			0	0	0	0		0	0
Total benefits and other deductions			(33)	42			(17)	30	(26)	52		(54)	(128)
Income (loss) from continuing operations, before income taxes			39	(88)			13	(45)	69	(32)		(6)	(31)
Income tax (expense) benefit			(9)	19			(5)	16	(15)	11		182	11
Net income (loss) from continuing operations			30	(69)			8	(29)	54	(21)		176	(20)
Net income (loss)			30	(69)			8	(29)	54	(21)		(17)	(20)
Net income (loss) attributable to AXA Equitable			30	(69)			8	(29)	54	(21)		(17)	(20)
Statement of Comprehensive Income [Abstract]
Change in unrealized gains (losses), net of reclassification adjustment								21		21		21	(21)
Other comprehensive income (loss)								21		21		21	(21)
Comprehensive income (loss)			30	(69)			8	(8)	54			4	(41)
Comprehensive income (loss) attributable to AXA Equitable			30	(69)			8	(8)	54	0		4	(41)
As Adjusted and Revised
Revenues:
Policy charges and fee income			883	861			834	830	1,744	1,664		3,294	3,311
Net derivative gains (losses)			(285)	(817)			1,776	(345)	(1,102)	1,431		894	(1,321)
Total revenues			1,621	1,139			3,763	1,554	2,760	5,317		8,456	6,043
Benefits and other deductions:
Policyholders’ benefits			1,301	480			1,356	972	1,781	2,328		3,473
Interest credited to policyholder's account balances				255			199	249				921	905
Compensation and benefits			74	149			90	83	223	173		327	364
Commissions and distribution related payments			159	160			170	172	319	342		628	635
Amortization of deferred policy acquisition costs			182	209			100	240	391	340		900	642
Other operating costs and expenses			2,313	250			(61)	201	2,563	140		635	753
Total benefits and other deductions			4,278	1,512			1,858	1,921	5,790	3,779		6,907	6,083
Income (loss) from continuing operations, before income taxes			(2,657)	(373)			1,905	(367)	(3,030)	1,538		1,549	(40)
Income tax (expense) benefit			552	80			(413)	148	632	(265)		1,210	164
Net income (loss) from continuing operations			(2,105)	(293)			1,492	(219)	(2,398)	1,273		2,759	124
Net income (loss)			(2,084)	(264)			1,508	(201)	(2,348)	1,307		2,844	190
Net income (loss) attributable to AXA Equitable			(2,084)	(263)			1,508	(201)	(2,347)	1,307		2,843	190
Statement of Comprehensive Income [Abstract]
Change in unrealized gains (losses), net of reclassification adjustment								113		407		584	(215)
Other comprehensive income (loss)								141		435		602	(219)
Comprehensive income (loss)			(2,390)	(1,020)			1,802	(60)	(3,411)			3,446	(29)
Comprehensive income (loss) attributable to AXA Equitable			$ (2,390)	$ (1,019)			$ 1,802	$ (60)	$ (3,409)	$ 1,742		$ 3,445	$ (29)

REVISION OF PRIOR PERIOD FINA_5

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Statements of Equity (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2018	Mar. 31, 2018	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	$ 18,492	$ 19,492		$ 14,528	$ 19,492	$ 14,528	$ 19,492	$ 14,528
Net income (loss)							(918)	2,843	$ 190
Other comprehensive income (loss)							(1,234)	602	(219)
Ending balance		18,492					12,428	19,492	14,528
As Adjusted
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	18,633	19,564	$ 14,505		19,564		19,564
Net income (loss)	(2,114)	(194)	1,500	(172)	(2,401)	1,328		2,860	210
Other comprehensive income (loss)				120		414		581	(198)
Ending balance	16,964	18,633	16,257	14,505	16,964	16,257		19,564
As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	18,633	19,564	14,505		19,564		19,564
Net income (loss)	(2,114)	(194)	1,500	(172)	(2,401)	1,328		2,860	210
Other comprehensive income (loss)				127		401		599	(215)
Ending balance	16,964	18,633	16,257	14,505	16,964	16,257		19,564
Discontinued Ops Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	0	0	0		0		0
Net income (loss)	0	0	0	0	0	0		0	0
Other comprehensive income (loss)				(7)		13		(18)	17
Ending balance	0	0	0	0	0	0		0
Impact of Revisions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	(141)	(72)	(84)		(72)		(72)
Net income (loss)	30	(69)	8	(29)	54	(21)		(17)	(20)
Other comprehensive income (loss)				21		21		21	(21)
Ending balance	(18)	(141)	(77)	(84)	(18)	(77)		(72)
As Adjusted and Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	18,492	19,492	14,421		19,492		19,492
Net income (loss)	(2,084)	(263)	1,508	(201)	(2,347)	1,307		2,843	190
Other comprehensive income (loss)				141		435		602	(219)
Ending balance	16,946	18,492	16,180	14,421	16,946	16,180		19,492
Retained Earnings
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		8,938		6,095	8,938	6,095	8,938	6,095	6,955
Ending balance							5,098	8,938	6,095
Retained Earnings | As Adjusted
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	8,824	9,010	5,978	6,150	9,010	6,150	9,010	6,150	6,990
Net income (loss)		(194)		(172)	(2,401)	1,328		2,860	210
Ending balance	6,617	8,824	7,479	5,978	6,617	7,479		9,010	6,150
Retained Earnings | As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	8,824	9,010	5,978	6,150	9,010	6,150	9,010	6,150	6,990
Net income (loss)		(194)		(172)	(2,401)	1,328		2,860	210
Ending balance	6,617	8,824	7,479	5,978	6,617	7,479		9,010	6,150
Retained Earnings | Discontinued Ops Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	0	0	0	0	0	0	0	0	0
Net income (loss)		0		0	0	0		0	0
Ending balance	0	0	0	0	0	0		0	0
Retained Earnings | Impact of Revisions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	(141)	(72)	(84)	(55)	(72)	(55)	(72)	(55)	(35)
Net income (loss)		(69)		(29)	54	(21)		(17)	(20)
Ending balance	(18)	(141)	(77)	(84)	(18)	(77)		(72)	(55)
Retained Earnings | As Adjusted and Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	8,683	8,938	5,894	6,095	8,938	6,095	8,938	6,095	6,955
Net income (loss)		(263)		(201)	(2,347)	1,307		2,843	190
Ending balance	6,599	8,683	7,402	5,894	6,599	7,402		8,938	6,095
Accumulated other comprehensive income (loss) attributable to AXA Equitable
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		598		(4)	598	(4)	598	(4)	215
Other comprehensive income (loss)							(1,234)		(219)
Ending balance							(491)	598	(4)
Accumulated other comprehensive income (loss) attributable to AXA Equitable | As Adjusted
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		598	137	17	598	17	598	17
Other comprehensive income (loss)				120		414		581	(198)
Ending balance			431	137		431		598	17
Accumulated other comprehensive income (loss) attributable to AXA Equitable | As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		598	137	17	598	17	598	17
Other comprehensive income (loss)				120		414		581	(198)
Ending balance			431	137		431		598	17
Accumulated other comprehensive income (loss) attributable to AXA Equitable | Discontinued Ops Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		0	0	0	0	0	0	0
Other comprehensive income (loss)				0		0		0	0
Ending balance			0	0		0		0	0
Accumulated other comprehensive income (loss) attributable to AXA Equitable | Impact of Revisions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		0	0	(21)	0	(21)	0	(21)
Other comprehensive income (loss)				21		21		21	(21)
Ending balance			0	0		0		0	(21)
Accumulated other comprehensive income (loss) attributable to AXA Equitable | As Adjusted and Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		598	137	(4)	598	(4)	598	(4)
Other comprehensive income (loss)				141		435		602	(219)
Ending balance			431	137		431		598	(4)
Parent
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		16,397		11,432	16,397	11,432	16,397	11,432
Ending balance							12,416	16,397	11,432
Parent | As Adjusted
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	15,545	16,469	11,459	11,508	16,469	11,508	16,469	11,508
Ending balance	13,925	15,545	13,273	11,459	13,925	13,273		16,469	11,508
Parent | As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	15,545	16,469	11,459	11,508	16,469	11,508	16,469	11,508
Ending balance	13,925	15,545	13,273	11,459	13,925	13,273		16,469	11,508
Parent | Discontinued Ops Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		0	0	0	0	0	0	0
Ending balance	0		0	0	0	0		0	0
Parent | Impact of Revisions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	(141)	(72)	(84)	(76)	(72)	(76)	(72)	(76)
Ending balance	(18)	(141)	(77)	(84)	(18)	(77)		(72)	(76)
Parent | As Adjusted and Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance	15,404	16,397	11,375	11,432	16,397	11,432	16,397	11,432
Ending balance	$ 13,907	15,404	13,196	11,375	13,907	13,196		16,397	11,432
Noncontrolling Interest
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Beginning balance		$ 3,095		$ 3,096	$ 3,095	3,096	3,095	3,096
Ending balance							$ 12	$ 3,095	$ 3,096
Noncontrolling Interest | As Adjusted
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ending balance			2,984			2,984
Noncontrolling Interest | As Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ending balance			2,984			2,984
Noncontrolling Interest | Discontinued Ops Adjustment
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ending balance			0			0
Noncontrolling Interest | Impact of Revisions
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ending balance			0			0
Noncontrolling Interest | As Adjusted and Revised
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Ending balance			$ 2,984			$ 2,984

REVISION OF PRIOR PERIOD FINA_6

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Statement of Cash Flows (Details) - USD ($)		3 Months Ended								6 Months Ended		9 Months Ended		12 Months Ended
		Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Sep. 30, 2018	Sep. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Cash flow from operating activities:
Net income (loss)		$ 1,936,000,000	$ (509,000,000)			$ 1,515,000,000	$ 23,000,000							$ (921,000,000)	$ 2,844,000,000	$ 190,000,000
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Interest credited to policyholder's account balances														1,002,000,000	921,000,000	905,000,000
Policy charges and fee income														(3,523,000,000)	(3,294,000,000)	(3,311,000,000)
Net derivative (gains) losses														1,010,000,000	(870,000,000)	1,337,000,000
Non-cash long term incentive compensation expense	[1]													218,000,000	185,000,000	152,000,000
Other amortization and depreciation	[1]													340,000,000	825,000,000	614,000,000
Amortization of deferred cost of reinsurance asset														1,882,000,000	(84,000,000)	159,000,000
Cash received on the recapture of captive reinsurance														1,273,000,000	0	0
Equity (income) loss from limited partnerships														(120,000,000)	(157,000,000)	(91,000,000)
Changes in:
Reinsurance recoverable	[1]													(390,000,000)	(1,018,000,000)	(304,000,000)
Capitalization of deferred policy acquisition costs	[1]													(597,000,000)	(578,000,000)	(594,000,000)
Future policy benefits														(284,000,000)	1,189,000,000	431,000,000
Current and deferred income taxes														(556,000,000)	(1,174,000,000)	(753,000,000)
Other	[1]													810,000,000	486,000,000	56,000,000
Net cash provided by (used in) operating activities														1,418,000,000	(381,000,000)	(461,000,000)
Proceeds from the sale/maturity/prepayment of:
Short term investments																2,984,000,000
Trading account securities														9,298,000,000	9,125,000,000	6,271,000,000
Real estate joint ventures														139,000,000	0	0
Short-term investments	[1]													2,315,000,000	2,204,000,000	2,984,000,000
Other														190,000,000	228,000,000	32,000,000
Payment for the purchase/origination of:
Short term investments	[1]													(1,852,000,000)	(2,456,000,000)	(3,187,000,000)
Trading account securities														(11,404,000,000)	(12,667,000,000)	(8,691,000,000)
Cash settlements related to derivative instruments														805,000,000	(1,259,000,000)	102,000,000
Change in short-term investments																0
Other, net	[1]													(91,000,000)	322,000,000	407,000,000
Net cash provided by (used in) investing activities														(4,806,000,000)	(8,914,000,000)	(5,358,000,000)
Cash flows from financing activities:
Deposits														9,365,000,000	9,334,000,000	9,746,000,000
Withdrawals														(4,496,000,000)	(3,926,000,000)	(2,874,000,000)
Transfer (to) from Separate Accounts														1,809,000,000	1,566,000,000	1,202,000,000
Net cash provided by (used in) financing activities														2,613,000,000	9,732,000,000	5,751,000,000
Effect of exchange rate changes on cash and cash equivalents														(12,000,000)	22,000,000	(10,000,000)
Change in cash and cash equivalents														(787,000,000)	459,000,000	(78,000,000)
Consolidated cash and cash equivalents, end of year		2,622,000,000				$ 3,409,000,000								2,622,000,000	3,409,000,000	2,950,000,000	$ 3,028,000,000
Cash flows of disposed subsidiary:
Net cash provided by (used in) operating activities														1,137,000,000	715,000,000	1,041,000,000
Net cash provided by (used in) investing activities														(102,000,000)	(297,000,000)	323,000,000
Net cash provided by (used in) financing activities														(1,360,000,000)	(437,000,000)	(909,000,000)
Effect of exchange rate changes on cash and cash equivalents														(12,000,000)	22,000,000	(10,000,000)
Cash and cash equivalents of disposed subsidiary, end of year		$ 0												$ 0
As Previously Reported
Cash flow from operating activities:
Net income (loss)				$ (1,958,000,000)	$ (40,000,000)			$ 1,613,000,000	$ (54,000,000)	$ (2,091,000,000)	$ 1,559,000,000				3,394,000,000	706,000,000
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Interest credited to policyholder's account balances					338,000,000			208,000,000	279,000,000						1,040,000,000	1,029,000,000
Policy charges and fee income				(904,000,000)	(869,000,000)			(846,000,000)	(852,000,000)	(1,773,000,000)	(1,698,000,000)				(3,334,000,000)	(3,344,000,000)
Net derivative (gains) losses				312,000,000	777,000,000			(1,763,000,000)	362,000,000	1,172,000,000	(1,362,000,000)				(890,000,000)	1,211,000,000
Amortization and depreciation					0				0	0	0	$ 0	$ 0			0
Other amortization and depreciation					(23,000,000)				36,000,000	(45,000,000)	(61,000,000)	(60,000,000)	(67,000,000)		(136,000,000)	(98,000,000)
Amortization of deferred cost of reinsurance asset					7,000,000				9,000,000	13,000,000	17,000,000	17,000,000			32,000,000	41,000,000
Amortization of Intangible Assets					8,000,000				8,000,000						31,000,000	29,000,000
Distributions from joint ventures and limited partnerships					25,000,000				26,000,000	44,000,000	50,000,000	63,000,000	94,000,000		140,000,000
Cash received on the recapture of captive reinsurance										1,099,000,000		1,099,000,000
Equity (income) loss from limited partnerships					0				0	0	0	0	0		0	0
Return of real estate joint venture and limited partnerships																126,000,000
Changes in:
Reinsurance recoverable									(23,000,000)	15,000,000	(194,000,000)	20,000,000	(361,000,000)		(416,000,000)
Deferred policy acquisition costs					10,000,000				29,000,000	89,000,000	43,000,000	(129,000,000)	42,000,000		268,000,000	52,000,000
Capitalization of deferred policy acquisition costs					0				0	0	(63,000,000)	0	0		0	0
Future policy benefits					(191,000,000)				241,000,000	396,000,000	1,303,000,000	(58,000,000)	1,146,000,000		1,511,000,000
Current and deferred income taxes					(52,000,000)				(188,000,000)	(645,000,000)	204,000,000	(264,000,000)	640,000,000		(664,000,000)	(742,000,000)
Other					(122,000,000)				151,000,000	416,000,000	84,000,000	123,000,000	617,000,000		189,000,000	(161,000,000)
Net cash provided by (used in) operating activities					(21,000,000)				18,000,000	1,190,000,000	(75,000,000)	1,614,000,000	994,000,000		1,077,000,000	(461,000,000)
Proceeds from the sale/maturity/prepayment of:
Short term investments												0			0	0
Trading account securities					1,606,000,000					4,843,000,000		6,913,000,000
Real estate joint ventures					0					0		0
Short-term investments					0				0	0	0	0	0
Other					54,000,000					260,000,000		344,000,000
Payment for the purchase/origination of:
Short term investments					0				0	0	0		0		0	0
Trading account securities										(5,075,000,000)
Cash settlements related to derivative instruments					(14,000,000)					(267,000,000)		(584,000,000)
Change in short-term investments					396,000,000				254,000,000	248,000,000	(508,000,000)	350,000,000	(266,000,000)		(264,000,000)	(205,000,000)
Other, net					(560,000,000)				43,000,000	379,000,000	243,000,000	305,000,000	(258,000,000)		238,000,000	409,000,000
Net cash provided by (used in) investing activities					(639,000,000)				(2,447,000,000)	(1,605,000,000)	(3,588,000,000)	(2,990,000,000)	(5,231,000,000)		(9,010,000,000)	(5,358,000,000)
Cash flows from financing activities:
Deposits					2,366,000,000				2,240,000,000	5,227,000,000	4,109,000,000	7,852,000,000	5,871,000,000		9,882,000,000
Withdrawals					(1,322,000,000)				(785,000,000)	(2,611,000,000)	(1,557,000,000)	(4,014,000,000)	(2,574,000,000)		(5,926,000,000)
Transfer (to) from Separate Accounts					(115,000,000)				176,000,000	(305,000,000)	767,000,000	(338,000,000)	1,617,000,000		1,656,000,000
Net cash provided by (used in) financing activities					1,040,000,000				2,306,000,000		4,182,000,000	1,293,000,000	5,460,000,000		8,370,000,000
Effect of exchange rate changes on cash and cash equivalents																(10,000,000)
Change in cash and cash equivalents																(78,000,000)
Consolidated cash and cash equivalents, end of year																2,950,000,000
Restatement, Impact of Revisions
Cash flow from operating activities:
Net income (loss)				30,000,000	(69,000,000)			8,000,000	(29,000,000)	54,000,000	(21,000,000)				(17,000,000)	(20,000,000)
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Interest credited to policyholder's account balances					(83,000,000)			(9,000,000)	(30,000,000)						(119,000,000)	(124,000,000)
Policy charges and fee income				21,000,000	8,000,000			12,000,000	22,000,000	29,000,000	34,000,000				40,000,000	33,000,000
Net derivative (gains) losses				(27,000,000)	38,000,000			(8,000,000)	(7,000,000)	(72,000,000)	(54,000,000)				20,000,000	126,000,000
As Adjusted and Revised
Cash flow from operating activities:
Net income (loss)				(2,084,000,000)	(264,000,000)			1,508,000,000	(201,000,000)	(2,348,000,000)	1,307,000,000				2,844,000,000	190,000,000
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Interest credited to policyholder's account balances					255,000,000			199,000,000	249,000,000						921,000,000	905,000,000
Policy charges and fee income				(883,000,000)	(861,000,000)			(834,000,000)	(830,000,000)	(1,744,000,000)	(1,664,000,000)				(3,294,000,000)	(3,311,000,000)
Net derivative (gains) losses				285,000,000	817,000,000			(1,776,000,000)	345,000,000	1,102,000,000	(1,431,000,000)				(894,000,000)	1,321,000,000
Gross DAC Adjustment
Cash flow from operating activities:
Net income (loss)				0	0			0	0	0	0				0	0
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Interest credited to policyholder's account balances					0			0	0						0	0
Policy charges and fee income				0	0			0	0	0	0				0	0
Net derivative (gains) losses				0	0			0	0	0	0				0	0
Discontinued Ops Adjustment
Cash flow from operating activities:
Net income (loss)				(156,000,000)	(155,000,000)			(113,000,000)	(118,000,000)	(311,000,000)	(231,000,000)				(533,000,000)	(496,000,000)
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Interest credited to policyholder's account balances					0			0	0						0	0
Policy charges and fee income				0	0			0	0	0	0				0	0
Net derivative (gains) losses				$ 0	2,000,000			$ (5,000,000)	(10,000,000)	2,000,000	(15,000,000)				(24,000,000)	(16,000,000)
Presentation Reclassifications
Cash flow from operating activities:
Net income (loss)					0				0	0	0				0	0
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Interest credited to policyholder's account balances					0				0						0	0
Policy charges and fee income					0				0	0	0				0	0
Net derivative (gains) losses					0				0	0	0				0	0
Amortization and depreciation					137,000,000				229,000,000	335,000,000	233,000,000	258,000,000	432,000,000			618,000,000
Other amortization and depreciation					23,000,000				(36,000,000)	45,000,000	61,000,000	60,000,000	67,000,000		907,000,000	98,000,000
Amortization of deferred cost of reinsurance asset					(7,000,000)				(9,000,000)	(13,000,000)	(17,000,000)	(17,000,000)			(32,000,000)	(41,000,000)
Amortization of Intangible Assets					(8,000,000)				(8,000,000)						(31,000,000)	(29,000,000)
Distributions from joint ventures and limited partnerships					(25,000,000)				(26,000,000)	(44,000,000)	(50,000,000)	(63,000,000)	(94,000,000)		(140,000,000)
Cash received on the recapture of captive reinsurance										0		0
Equity (income) loss from limited partnerships					(39,000,000)				(39,000,000)	(60,000,000)	(65,000,000)	(83,000,000)	(103,000,000)		(157,000,000)	(91,000,000)
Return of real estate joint venture and limited partnerships																(126,000,000)
Changes in:
Reinsurance recoverable									0	0	0	0	0		0
Deferred policy acquisition costs					(10,000,000)				(29,000,000)	(89,000,000)	(43,000,000)	129,000,000	(42,000,000)		(268,000,000)	(52,000,000)
Capitalization of deferred policy acquisition costs					(135,000,000)				(148,000,000)	(280,000,000)	(235,000,000)	(432,000,000)	(433,000,000)		(578,000,000)	(594,000,000)
Future policy benefits					0				0	0	0	0	0		0
Current and deferred income taxes					0				0	0	0	0	0		0	0
Other					64,000,000				65,000,000	104,000,000	115,000,000	146,000,000	197,000,000		297,000,000	217,000,000
Net cash provided by (used in) operating activities					0				(1,000,000)	(2,000,000)	(1,000,000)	(2,000,000)	(1,000,000)		(2,000,000)	0
Proceeds from the sale/maturity/prepayment of:
Short term investments												1,806,000,000			2,204,000,000	2,984,000,000
Trading account securities					0					0		0
Real estate joint ventures					140,000,000					140,000,000		140,000,000
Short-term investments					688,000,000				631,000,000	1,331,000,000	1,078,000,000	(1,530,000,000)	1,909,000,000
Other					(140,000,000)					(140,000,000)		(140,000,000)
Payment for the purchase/origination of:
Short term investments					(377,000,000)				(376,000,000)	(1,081,000,000)	(1,599,000,000)		(2,174,000,000)		(2,456,000,000)	(3,187,000,000)
Trading account securities										0
Cash settlements related to derivative instruments					0					0		0
Change in short-term investments					(311,000,000)				(254,000,000)	(248,000,000)	522,000,000	(274,000,000)	266,000,000		254,000,000	205,000,000
Other, net					0				0	0	0	0	0		0	(2,000,000)
Net cash provided by (used in) investing activities					0				1,000,000	2,000,000	1,000,000	2,000,000	1,000,000		2,000,000	0
Cash flows from financing activities:
Deposits					0				0	0	0	0	0		0
Withdrawals					0				0	0	0	0	0		0
Transfer (to) from Separate Accounts					0				0	0	0	0	0		0
Net cash provided by (used in) financing activities					0				0		0	0	0		0
Effect of exchange rate changes on cash and cash equivalents																0
Change in cash and cash equivalents																0
Consolidated cash and cash equivalents, end of year																0
Revisions
Cash flow from operating activities:
Net income (loss)					(69,000,000)				(29,000,000)	54,000,000	(21,000,000)				(17,000,000)	(20,000,000)
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Interest credited to policyholder's account balances					(83,000,000)				(30,000,000)						(119,000,000)	(124,000,000)
Policy charges and fee income					8,000,000				22,000,000	29,000,000	34,000,000				40,000,000	33,000,000
Net derivative (gains) losses					38,000,000				(7,000,000)	(72,000,000)	(54,000,000)				20,000,000	126,000,000
Amortization and depreciation					64,000,000				63,000,000	21,000,000	62,000,000	0	0			(4,000,000)
Other amortization and depreciation					0				0	0	0	0	0		54,000,000	0
Amortization of deferred cost of reinsurance asset					0				0	0	0	0			0	0
Amortization of Intangible Assets					0				0						0	0
Distributions from joint ventures and limited partnerships					0				0	0	0	0	0		0
Cash received on the recapture of captive reinsurance										174,000,000		174,000,000
Equity (income) loss from limited partnerships					0				0	0	0	0	0		0	0
Return of real estate joint venture and limited partnerships																0
Changes in:
Reinsurance recoverable									(173,000,000)	166,000,000	(354,000,000)	86,000,000	(455,000,000)		(602,000,000)
Deferred policy acquisition costs					0				0	0	0	0	0		0	0
Capitalization of deferred policy acquisition costs					0				0	0	0	0	0		0	0
Future policy benefits					(7,000,000)				17,000,000	(554,000,000)	45,000,000	(541,000,000)	168,000,000		(322,000,000)
Current and deferred income taxes					132,000,000				(6,000,000)	167,000,000	3,000,000	(400,000,000)	(389,000,000)		(510,000,000)	(11,000,000)
Other					70,000,000				0	(304,000,000)	0	179,000,000	0		0	0
Net cash provided by (used in) operating activities					4,000,000				(143,000,000)	(319,000,000)	(285,000,000)	(502,000,000)	(676,000,000)		(1,456,000,000)	0
Proceeds from the sale/maturity/prepayment of:
Short term investments												0			0	0
Trading account securities					77,000,000					24,000,000		77,000,000
Real estate joint ventures					0					0		0
Short-term investments					0				0	(24,000,000)	0	204,000,000	0
Other					0					0		0
Payment for the purchase/origination of:
Short term investments					0				(289,000,000)	205,000,000	0		0		0	0
Trading account securities										0
Cash settlements related to derivative instruments					(489,000,000)					(489,000,000)		(492,000,000)
Change in short-term investments					(85,000,000)				0	0	(14,000,000)	(77,000,000)	0		10,000,000	0
Other, net					153,000,000				100,000,000	11,000,000	(197,000,000)	(19,000,000)	203,000,000		84,000,000	0
Net cash provided by (used in) investing activities					(344,000,000)				(189,000,000)	(273,000,000)	(211,000,000)	(307,000,000)	203,000,000		94,000,000	0
Cash flows from financing activities:
Deposits					(468,000,000)				269,000,000	(1,107,000,000)	784,000,000	(1,668,000,000)	1,116,000,000		(548,000,000)
Withdrawals					241,000,000				(157,000,000)	480,000,000	(284,000,000)	760,000,000	(244,000,000)		2,000,000,000
Transfer (to) from Separate Accounts					567,000,000				220,000,000	1,219,000,000	(4,000,000)	1,717,000,000	(399,000,000)		(90,000,000)
Net cash provided by (used in) financing activities					340,000,000				332,000,000		496,000,000	809,000,000	473,000,000		1,362,000,000
Effect of exchange rate changes on cash and cash equivalents																0
Change in cash and cash equivalents																0
Consolidated cash and cash equivalents, end of year																0
As Revised And Adjusted Herein Member
Cash flow from operating activities:
Net income (loss)															3,377,000,000	686,000,000
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Interest credited to policyholder's account balances															921,000,000	905,000,000
Policy charges and fee income															(3,294,000,000)	(3,311,000,000)
Net derivative (gains) losses															(870,000,000)	1,337,000,000
Amortization and depreciation																614,000,000
Other amortization and depreciation															825,000,000	0
Amortization of deferred cost of reinsurance asset															0	0
Amortization of Intangible Assets															0	0
Distributions from joint ventures and limited partnerships															0
Equity (income) loss from limited partnerships															(157,000,000)	(91,000,000)
Return of real estate joint venture and limited partnerships																0
Changes in:
Reinsurance recoverable															(1,018,000,000)
Deferred policy acquisition costs															0	0
Capitalization of deferred policy acquisition costs															(578,000,000)	(594,000,000)
Future policy benefits															1,189,000,000
Current and deferred income taxes															(1,174,000,000)	(753,000,000)
Other															486,000,000	$ 56,000,000
Net cash provided by (used in) operating activities															(381,000,000)
Proceeds from the sale/maturity/prepayment of:
Short term investments															2,204,000,000
Payment for the purchase/origination of:
Short term investments															(2,456,000,000)
Change in short-term investments															0
Other, net															322,000,000
Net cash provided by (used in) investing activities															(8,914,000,000)
Cash flows from financing activities:
Deposits															9,334,000,000
Withdrawals															(3,926,000,000)
Transfer (to) from Separate Accounts															1,566,000,000
Net cash provided by (used in) financing activities															$ 9,732,000,000
As Revised
Cash flow from operating activities:
Net income (loss)					(109,000,000)				(83,000,000)	(2,037,000,000)	1,538,000,000
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Interest credited to policyholder's account balances					255,000,000				249,000,000
Policy charges and fee income					(861,000,000)				(830,000,000)	(1,744,000,000)	(1,664,000,000)
Net derivative (gains) losses					815,000,000				355,000,000	1,100,000,000	(1,416,000,000)
Amortization and depreciation					201,000,000				292,000,000	356,000,000	295,000,000	258,000,000	432,000,000
Other amortization and depreciation					0				0	0	0	0	0
Amortization of deferred cost of reinsurance asset					0				0	0	0	0
Amortization of Intangible Assets					0				0
Distributions from joint ventures and limited partnerships					0				0	0	0	0	0
Cash received on the recapture of captive reinsurance										1,273,000,000		1,273,000,000
Equity (income) loss from limited partnerships					(39,000,000)				(39,000,000)	(60,000,000)	(65,000,000)	(83,000,000)	(103,000,000)
Changes in:
Reinsurance recoverable									(196,000,000)	181,000,000	(548,000,000)	106,000,000	(816,000,000)
Deferred policy acquisition costs					0				0	0	0	0	0
Capitalization of deferred policy acquisition costs					(135,000,000)				(148,000,000)	(280,000,000)	(298,000,000)	(432,000,000)	(433,000,000)
Future policy benefits					(198,000,000)				258,000,000	(158,000,000)	1,348,000,000	(599,000,000)	1,314,000,000
Current and deferred income taxes					80,000,000				(194,000,000)	(478,000,000)	207,000,000	(664,000,000)	251,000,000
Other					12,000,000				216,000,000	216,000,000	199,000,000	448,000,000	814,000,000
Net cash provided by (used in) operating activities					(17,000,000)				(126,000,000)	869,000,000	(361,000,000)	1,110,000,000	317,000,000
Proceeds from the sale/maturity/prepayment of:
Short term investments												1,806,000,000
Trading account securities					1,683,000,000					4,867,000,000		6,990,000,000
Real estate joint ventures					140,000,000					140,000,000		140,000,000
Short-term investments					688,000,000				631,000,000	1,307,000,000	1,078,000,000	(1,326,000,000)	1,909,000,000
Other					(86,000,000)					120,000,000		204,000,000
Payment for the purchase/origination of:
Short term investments					(377,000,000)				(665,000,000)	(876,000,000)	(1,599,000,000)		(2,174,000,000)
Trading account securities										(5,075,000,000)
Cash settlements related to derivative instruments					(503,000,000)					(756,000,000)		(1,076,000,000)
Change in short-term investments					0				0	0	0	(1,000,000)	0
Other, net					(407,000,000)				143,000,000	390,000,000	46,000,000	286,000,000	(55,000,000)
Net cash provided by (used in) investing activities					(983,000,000)				(2,635,000,000)	(1,876,000,000)	(3,798,000,000)	(3,295,000,000)	(5,027,000,000)
Cash flows from financing activities:
Deposits					1,898,000,000				2,509,000,000	4,120,000,000	4,893,000,000	6,184,000,000	6,987,000,000
Withdrawals					(1,081,000,000)				(942,000,000)	(2,131,000,000)	(1,841,000,000)	(3,254,000,000)	(2,818,000,000)
Transfer (to) from Separate Accounts					452,000,000				396,000,000	$ 914,000,000	763,000,000	1,379,000,000	1,218,000,000
Net cash provided by (used in) financing activities					$ 1,380,000,000				$ 2,638,000,000		$ 4,678,000,000	$ 2,102,000,000	$ 5,933,000,000
[1]	Prior period amounts have been reclassified to conform to current period presentation. See Note 20 for further information.

REVISION OF PRIOR PERIOD FINA_7

REVISION OF PRIOR PERIOD FINANCIAL STATEMENTS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2018	Mar. 31, 2017	Jun. 30, 2018	Jun. 30, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net (income) loss attributable to the noncontrolling interest					$ (3)	$ 1	$ 0
Alliance Bernstein | Discontinued Operations
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net (income) loss attributable to the noncontrolling interest	$ 154	$ 118	$ 310	$ 231	$ 564	$ 533	$ 496

SUBSEQUENT EVENTS - Narrative (

SUBSEQUENT EVENTS - Narrative (Details) - USD ($) shares in Millions, $ in Millions	Mar. 25, 2019	Feb. 25, 2019	Dec. 28, 2018	Dec. 31, 2018	Jan. 01, 2019
Subsequent Event [Line Items]
Extraordinary cash dividend				$ 572
Senior Surplus Notes
Subsequent Event [Line Items]
Extraordinary cash dividend				$ 572
Related party transaction, rate (as a percent)			3.75%
AXA | Secondary Offering | Subsequent event
Subsequent Event [Line Items]
Shares in transaction (in shares)	46
EQH | Subsequent event
Subsequent Event [Line Items]
Ownership percentage	48.30%
EQH | Secondary Offering | Subsequent event
Subsequent Event [Line Items]
Shares in transaction (in shares)	30
Omnibus Incentive Plan 2019 | Subsequent event
Subsequent Event [Line Items]
Shares authorized (in shares)					5.2
Incremental shares authorized (in shares)		2

SCHEDULE I - SUMMARY OF INVES_2

SCHEDULE I - SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES (Details) $ in Millions	Dec. 31, 2018USD ($)
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	$ 75,654
Fair Value	75,253
Amount at Which Shown on Balance Sheet	74,916
U.S. Treasury, government and agency
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	13,646
Fair Value	13,335
Amount at Which Shown on Balance Sheet	13,335
States and political subdivisions
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	408
Fair Value	454
Amount at Which Shown on Balance Sheet	454
Foreign governments
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	515
Fair Value	519
Amount at Which Shown on Balance Sheet	519
Public utilities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	4,614
Fair Value	4,569
Amount at Which Shown on Balance Sheet	4,569
All other corporate bonds
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	22,076
Fair Value	21,807
Amount at Which Shown on Balance Sheet	21,807
Residential mortgage-backed
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	193
Fair Value	202
Amount at Which Shown on Balance Sheet	202
Asset-backed
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	600
Fair Value	590
Amount at Which Shown on Balance Sheet	590
Redeemable preferred stock
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	440
Fair Value	439
Amount at Which Shown on Balance Sheet	439
Fixed maturities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	42,492
Fair Value	41,915
Amount at Which Shown on Balance Sheet	41,915
Mortgage loans on real estate
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	11,825
Fair Value	11,478
Amount at Which Shown on Balance Sheet	11,818
Real estate held for the production of income
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	52
Fair Value	52
Amount at Which Shown on Balance Sheet	52
Policy loans
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	3,267
Fair Value	3,944
Amount at Which Shown on Balance Sheet	3,267
Other equity investments
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	1,103
Fair Value	1,144
Amount at Which Shown on Balance Sheet	1,144
Trading securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	15,361
Fair Value	15,166
Amount at Which Shown on Balance Sheet	15,166
Other invested assets
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Cost	1,554
Fair Value	1,554
Amount at Which Shown on Balance Sheet	$ 1,554

SCHEDULE IV - REINSURANCE (Deta

SCHEDULE IV - REINSURANCE (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Life insurance in-force
Gross Amount	$ 390,374	$ 392,926	$ 399,230
Ceded to Other Companies	69,768	73,843	78,760
Assumed from Other Companies	30,322	30,300	31,722
Net Amount	350,928	349,383	352,192
Premiums:
Gross Amount	836	880	850
Ceded to Other Companies	160	171	176
Assumed from Other Companies	186	195	206
Premiums	$ 862	$ 904	$ 880
Life Insurance In-Force, Percentage of Amount Assumed to Net	8.60%	8.70%	9.00%
Premiums, Percentage of Amount Assumed to Net	21.60%	21.60%	23.40%
Life insurance and annuities
Premiums:
Gross Amount	$ 787	$ 826	$ 790
Ceded to Other Companies	128	135	135
Assumed from Other Companies	177	186	197
Premiums	$ 836	$ 877	$ 852
Premiums, Percentage of Amount Assumed to Net	21.20%	21.20%	23.10%
Accident and health
Premiums:
Gross Amount	$ 49	$ 54	$ 60
Ceded to Other Companies	32	36	41
Assumed from Other Companies	9	9	9
Premiums	$ 26	$ 27	$ 28
Premiums, Percentage of Amount Assumed to Net	34.60%	33.30%	32.10%